var title_f37_0_37888="Relationship of medication errors and adverse drug events";
var content_f37_0_37888=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F68954&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F68954&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 540px\">",
"   <div class=\"ttl\">",
"    Relationship among medication errors, adverse drug events, preventable adverse drug events, close-call adverse drug events, and adverse drug reactions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 520px; height: 314px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Gandhi TK, Seger DL, Bates DW. Identifying drug safety issues: from research to practice. Int J Qual Health Care 2000; 12:69, by permission of Oxford University Press. Copyright &copy; 2000.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_0_37888=[""].join("\n");
var outline_f37_0_37888=null;
var title_f37_0_37889="Majocchis granuloma";
var content_f37_0_37889=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F71373&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F71373&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Majocchi's granuloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This 14-year-old boy with tinea pedis developed an itchy eruption on his leg that progressed after topical corticosteroid use. Localized erythematous papules and small pustules are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Bernard Cohen, MD, Dermatlas; file://www.dermatlas.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_0_37889=[""].join("\n");
var outline_f37_0_37889=null;
var title_f37_0_37890="Doppler MV MAC";
var content_f37_0_37890=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F86969&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F86969&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Spectral Doppler recording across the mitral valve in a patient with severe mitral annular calcification",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 301px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The transmitral diastolic mean gradient is 6 mmHg, consistent with moderate left ventricular inflow obstruction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Rosario V Freeman, MD, MS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_0_37890=[""].join("\n");
var outline_f37_0_37890=null;
var title_f37_0_37891="Glucagon: Pediatric drug information";
var content_f37_0_37891=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Glucagon: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?24/32/25093?source=see_link\">",
"    see \"Glucagon: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?15/48/16131?source=see_link\">",
"    see \"Glucagon: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F176479\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      GlucaGen&reg;;",
"     </li>",
"     <li>",
"      GlucaGen&reg; Diagnostic Kit;",
"     </li>",
"     <li>",
"      GlucaGen&reg; HypoKit&reg;;",
"     </li>",
"     <li>",
"      Glucagon Emergency Kit",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F14733086\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      GlucaGen&reg;;",
"     </li>",
"     <li>",
"      GlucaGen&reg; HypoKit&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1058929\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antihypoglycemic Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11442577\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hypoglycemia, persistent:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M., I.V., SubQ: 0.02-0.2 mg/kg/dose (maximum dose: 1 mg), may repeat dose in 20 minutes if needed (Hawdon, 1993; Mehta, 1987);",
"     <b>",
"      Note:",
"     </b>",
"     Wide variance in doses exists between manufacturer&rsquo;s labeling and published case reports.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Continuous I.V. infusion: 1 mg infused over 24 hours; doses &gt;0.02 mg/kg/",
"     <b>",
"      hour",
"     </b>",
"     did not produce additional benefit; dosing based on a retrospective observation of 55 newborns (GA: 24-41 weeks) with hypoglycemia due to multiple causes (Miralles, 2002)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Congenital hyperinsulinism; hyperinsulinemic hypoglycemia:  Continuous I.V. infusion: 0.005-0.02 mg/kg/",
"     <b>",
"      hour",
"     </b>",
"     ; some centers use a lower dose (0.001 mg/kg/",
"     <b>",
"      hour",
"     </b>",
"     ) in combination with octreotide (Aynsley-Green, 2000; Hussain, 2004, Kapoor, 2009)",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1058923\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?24/32/25093?source=see_link\">",
"      see \"Glucagon: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Hypoglycemia, persistent:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.M., I.V., SubQ (may repeat in 20 minutes as needed):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants and Children &le;20 kg: Manufacturer's recommendation: 0.02-0.03 mg/kg or 0.5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &gt;20 kg and Adults: 1 mg",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F176459\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Glucagon Emergency Kit: 1 mg [contains glycerin (in diluent), lactose 49 mg; equivalent to 1 unit]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution, as hydrochloride:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     GlucaGen&reg;: 1 mg [contains lactose 107 mg; equivalent to 1 unit]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     GlucaGen&reg; Diagnostic Kit: 1 mg [contains lactose 107 mg; equivalent to 1 unit]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     GlucaGen&reg; HypoKit&reg;: 1 mg [contains lactose 107 mg; equivalent to 1 unit]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F176444\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1058933\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral: Dilute with manufacturer provided diluent resulting in 1 mg/mL; administer by direct I.V. injection, I.M., or SubQ",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1058926\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Glucagon (rDNA origin) for injection (Lilly) should be stored at controlled room temperature; glucagon (rDNA origin) for injection (GlucaGen&reg;) should be refrigerated; both injections should be used immediately after reconstitution",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1058932\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of hypoglycemia; diagnostic aid in the radiologic examination of GI tract when a hypotonic state is needed; used with some success as a cardiac stimulant in management of severe cases of beta-adrenergic blocking agent overdosage",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F176517\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Hypertension, hypotension (up to 2 hours after GI procedures), tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Nausea, vomiting (high incidence with rapid administration of high doses)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylaxis, hypersensitivity reactions",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1058937\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to glucagon or any component",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1058922\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with a history of insulinoma and/or pheochromocytoma; because glucagon depletes glycogen stores, the patient should be given supplemental carbohydrates as soon as physically possible",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299406\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F176453\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Glucagon may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F176455\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13882222\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have not been observed in animal reproduction studies.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1058928\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blood glucose, blood pressure, ECG, heart rate, mentation, platelet count, serum sodium",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1058921\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Glucagon (rDNA origin) is genetically engineered and identical to human glucagon. It stimulates adenylate cyclase to produce increased cyclic AMP. It promotes hepatic glycogenolysis and gluconeogenesis, causing an increase in blood glucose levels; produces both positive inotropic and chronotropic effects.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1058935\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Blood glucose effect (after 1 mg dosage):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Onset of action: I.M.: 8-10 minutes; I.V.: 1 minute",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Duration: I.M.: 12-27 minutes; I.V.: 9-17 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     GI tract effect:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Onset of action: Within 1-10 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Duration: 12-30 minutes",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1058936\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 0.25 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensively degraded in liver and kidneys",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life, plasma: 8-18 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Clearance: 13.5 mL/minute/kg",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1058938\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     1 unit = 1 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Aynsley-Green A, Hussain K, Hall J, et al, \"Practical Management of Hyperinsulinism in Infancy,\"",
"      <i>",
"       Arch Dis Child Fetal Neonatal Ed",
"      </i>",
"      , 2000, 82(2):98-107.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/0/37891/abstract-text/10685981/pubmed\" id=\"10685981\" target=\"_blank\">",
"        10685981",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hawdon JM, Aynsley-Green A, and Ward Platt MP, \"Neonatal Blood Glucose Concentrations: Metabolic Effects of Intravenous Glucagon and Intragastric Medium Chain Triglyceride,\"",
"      <i>",
"       Arch Dis Child",
"      </i>",
"      , 1993, 68(3 Spec No):255-61.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/0/37891/abstract-text/8466259/pubmed\" id=\"8466259\" target=\"_blank\">",
"        8466259",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hussain K and Aynsley-Green A, \"Hyperinsulinaemic Hypoglycaemia in Preterm Neonates,\"",
"      <i>",
"       Arch Dis Child Fetal Neonatal Ed",
"      </i>",
"      , 2004, 89(1):65-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/0/37891/abstract-text/14711860/pubmed\" id=\"14711860\" target=\"_blank\">",
"        14711860",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kapoor RR, Flanagan SE, James C, et al, \"Hyperinsulinaemic Hypoglycaemia,\"",
"      <i>",
"       Arch Dis Child",
"      </i>",
"      , 2009, 94(6):450-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/0/37891/abstract-text/19193661/pubmed\" id=\"19193661\" target=\"_blank\">",
"        19193661",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mehta A, Wootton R, Cheng KN, et al, \"Effect of Diazoxide or Glucagon on Hepatic Glucose Production Rate During Extreme Neonatal Hypoglycaemia,\"",
"      <i>",
"       Arch Dis Child",
"      </i>",
"      , 1987, 62(9):924-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/0/37891/abstract-text/3314727/pubmed\" id=\"3314727\" target=\"_blank\">",
"        3314727",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Miralles RE, Lodha A, Perlman M, et al, \"Experience With Intravenous Glucagon Infusions as a Treatment for Resistant Neonatal Hypoglycemia,\"",
"      <i>",
"       Arch Pediatr Adolesc Med",
"      </i>",
"      , 2002, 156(10):999-1004.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/0/37891/abstract-text/12361445/pubmed\" id=\"12361445\" target=\"_blank\">",
"        12361445",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13335 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-221.179.173.170-7B5B02C4AA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_0_37891=[""].join("\n");
var outline_f37_0_37891=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F176479\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14733086\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058929\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11442577\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058923\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F176459\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F176444\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058933\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058926\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058932\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F176517\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058937\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058922\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299406\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F176453\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F176455\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13882222\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058928\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058921\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058935\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058936\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058938\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13335\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13335|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?24/32/25093?source=related_link\">",
"      Glucagon: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?15/48/16131?source=related_link\">",
"      Glucagon: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_0_37892="Asthma symptoms and diagnosis in children";
var content_f37_0_37892=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Asthma symptoms and diagnosis in children (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?37/0/37892/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/0/37892/contributors\" id=\"au7312\">",
"       Gregory Sawicki, MD, MPH",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/0/37892/contributors\" id=\"au7511\">",
"       Kenan Haver, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?37/0/37892/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/0/37892/contributors\" id=\"se5673\">",
"       Robert A Wood, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?37/0/37892/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/0/37892/contributors\" id=\"de2295\">",
"       Elizabeth TePas, MD, MS",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?37/0/37892?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      ASTHMA OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Asthma is a chronic condition with symptoms of cough, wheezing, chest tightness,",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     difficulty breathing. These symptoms occur periodically, usually related to specific triggering events. People with asthma have narrowed airways during these episodes; the narrowing is partially or completely reversible with asthma treatments. In addition, the airways of children with asthma react to a variety of stimuli, which may include viral illnesses (eg, the common cold), exercise, pollen, foods to which the child is allergic, or environmental conditions.",
"    </p>",
"    <p>",
"     Asthma is the most common chronic disease in children in developed countries, affecting about 12 percent of children who are less than 18 years. It is more common in males than females under the age of 15 years.",
"    </p>",
"    <p>",
"     This topic review discusses the risk factors, symptoms, and diagnosis of asthma in children. Other topics about asthma in children are available separately. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/60/18374?source=see_link\">",
"      \"Patient information: Asthma treatment in children (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/6/31841?source=see_link\">",
"      \"Patient information: How to use a peak flow meter (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?43/3/44083?source=see_link\">",
"      \"Patient information: Asthma inhaler techniques in children (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?30/25/31124?source=see_link\">",
"      \"Patient information: Trigger avoidance in asthma (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Discussions of asthma and asthma treatments in adults are also available. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?38/63/39925?source=see_link\">",
"      \"Patient information: Asthma treatment in adolescents and adults (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/6/31841?source=see_link\">",
"      \"Patient information: How to use a peak flow meter (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?28/25/29075?source=see_link\">",
"      \"Patient information: Asthma inhaler techniques in adults (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?30/25/31124?source=see_link\">",
"      \"Patient information: Trigger avoidance in asthma (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?14/20/14660?source=see_link\">",
"      \"Patient information: Asthma and pregnancy (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      ASTHMA RISK FACTORS",
"     </span>",
"    </p>",
"    <p>",
"     Asthma occurs when the small airways (bronchi) in the lungs become inflamed and narrowed, which limits the flow of air out of the lungs (",
"     <a class=\"graphic graphic_figure graphicRef56535 \" href=\"mobipreview.htm?28/23/29044\">",
"      figure 1",
"     </a>",
"     and",
"     <a class=\"graphic graphic_figure graphicRef65956 \" href=\"mobipreview.htm?0/52/837\">",
"      figure 2",
"     </a>",
"     ). This narrowing is almost always reversible in children with treatment. Many different genetic and environmental factors can increase the risk of developing asthma (see",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/12/20682?source=see_link\">",
"      \"Risk factors for asthma\"",
"     </a>",
"     ), a few of which include:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Pollution &mdash; Increased exposure to indoor and outdoor pollution may increase the risk of developing asthma.",
"      </li>",
"      <li>",
"       Exposure to tobacco smoke &mdash; Exposure to tobacco smoke during pregnancy and throughout childhood increase the risk of developing asthma.",
"      </li>",
"      <li>",
"       Family history &mdash; Children with a personal or family history of certain medical problems, such as asthma, allergies, or eczema, are at increased risk of developing asthma.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     However, not all children with asthma have known risk factors. In other words, even children who live in rural areas and whose parents do not smoke or have asthma can develop asthma. It is not clear if there are ways to reduce a child's risk of developing asthma.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      ASTHMA SYMPTOMS",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Coughing and wheezing",
"     </span>",
"     &nbsp;&mdash;&nbsp;Symptoms of asthma in children include coughing and wheezing. The cough is usually dry and hacking and is most noticeable while the child sleeps and during early morning hours. It may also be triggered by exercise. Wheezing is a high-pitched musical noise that is usually heard when the child breathes out. It can generally only be heard with a stethoscope.",
"    </p>",
"    <p>",
"     Coughing and wheezing tends to come and go during the day or night, depending upon the degree of airway narrowing in the lungs. Breathlessness, chest tightness or pressure, and chest pain may also occur. In addition to coughing or wheezing, a child may report that their chest or stomach hurts.",
"    </p>",
"    <p>",
"     Asthma symptoms often develop in children before five years of age, although it is sometimes difficult to diagnose asthma in infants and toddlers.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Asthma triggers",
"     </span>",
"     &nbsp;&mdash;&nbsp;Wheezing and coughing may occur at any time, but certain triggers are known to worsen asthma in many children.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h3\">",
"      Environmental conditions",
"     </span>",
"     &nbsp;&mdash;&nbsp;In children with seasonal allergies, asthma symptoms may worsen during certain pollen seasons; trees pollinate in early spring, grasses in the late spring and summer, and weeds in the summer and fall. Symptoms can also flare as a result of mold growth (eg, during rainy seasons or in damp areas). Cold air, changes in barometric pressure, rain, or wind may cause increased asthma symptoms in certain people.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h3\">",
"      Upper respiratory infections",
"     </span>",
"     &nbsp;&mdash;&nbsp;Viral upper respiratory infections (head and chest colds) are a common trigger of asthma in infants and young children. The most common viral infections include rhinovirus (the virus that causes most colds), respiratory syncytial virus, and influenza virus. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?39/44/40643?source=see_link\">",
"      \"Patient information: The common cold in children (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/19/27958?source=see_link\">",
"      \"Patient information: Bronchiolitis (and RSV) in infants and children (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Children with asthma should use their asthma treatments for cough and chest congestion rather than over-the-counter cold remedies.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h3\">",
"      Exercise",
"     </span>",
"     &nbsp;&mdash;&nbsp;Narrowing of the airways can be triggered by exercise. This is called exercise-induced asthma (also called exercise-induced bronchoconstriction or EIB). Breathlessness, wheeze,",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     cough usually occur within 5 to 10 minutes of the cool-down period after vigorous exercise. These symptoms tend to disappear after 20 to 45 minutes. Certain types of exercise (eg, swimming) are less likely to cause exercise-induced asthma than others (eg, running, skating), probably because they produce less airway cooling and drying. Short bursts of activity tend to be better tolerated than prolonged exercise. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/26/1442?source=see_link\">",
"      \"Patient information: Exercise-induced asthma (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h3\">",
"      Allergens and irritants",
"     </span>",
"     &nbsp;&mdash;&nbsp;Indoor and outdoor allergens are an important trigger of childhood asthma, particularly for children older than three years of age. Indoor pollutants can act as irritants and also trigger asthma symptoms. Irritants and allergens include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       House dust (ie, dust mites, cockroaches, mice droppings), particularly during vacuuming",
"      </li>",
"      <li>",
"       Animal exposures; cats and dogs are especially provocative but other furry animals (gerbils, rabbits, hamsters, etc) may be suspect, particularly if symptoms only occur in settings where these animals reside",
"      </li>",
"      <li>",
"       Pollens",
"      </li>",
"      <li>",
"       Molds",
"      </li>",
"      <li>",
"       Indoor pollutants (eg, paint, perfume, cleaning products, space heaters, gas stoves, room deodorizers)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     If allergies are a possible cause of symptoms, skin or blood testing may be recommended. This can help to both identify triggers and determine the necessity of avoiding these triggers at home.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Symptom patterns",
"     </span>",
"     &nbsp;&mdash;&nbsp;Children with chronic asthma may have one of several distinct patterns of symptoms:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Intermittent asthma attacks with no symptoms between attacks",
"      </li>",
"      <li>",
"       Chronic symptoms with intermittent worsening",
"      </li>",
"      <li>",
"       Attacks that become more severe or frequent over time",
"      </li>",
"      <li>",
"       Morning \"dipping\", when symptoms worsen in the morning and improve as the day progresses",
"      </li>",
"      <li>",
"       Symptoms that begin during upper respiratory tract infections (eg, colds) and linger for several weeks after, with resolution during warmer weather.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Most asthma attacks develop slowly over a period of several days. Uncommonly, a severe attack can occur suddenly and with minimal warning.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h1\">",
"      ASTHMA DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     The diagnosis of asthma in children requires a careful review of a child's current and past medical history, family history, and a physical examination. Specialized testing is sometimes needed to diagnose asthma and to rule out other possible causes of symptoms. Many children with asthma appear and sound completely normal.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Spirometry testing",
"     </span>",
"     &nbsp;&mdash;&nbsp;The most accurate test for diagnosing asthma is spirometry or pulmonary function testing. Spirometry measures the flow and volume of air generated after a child takes a very deep breath and then forcefully tries to blow the air out of",
"     <span class=\"nowrap\">",
"      his/her",
"     </span>",
"     lungs. If airflow obstruction is present, the test is repeated after the child uses an asthma inhaler (bronchodilator) to confirm that the obstruction is reversible (a feature of asthma).",
"    </p>",
"    <p>",
"     Children younger than six years sometimes have a hard time following the instructions to perform spirometry. Testing of younger children and infants is described below (see",
"     <a class=\"local\" href=\"#H16\">",
"      'Testing for young children'",
"     </a>",
"     below).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Peak flow rate measurement",
"     </span>",
"     &nbsp;&mdash;&nbsp;Peak expiratory flow rate (PEFR) measurements require repeatable, maximal efforts to be accurate. The test requires that the child take a very deep breath and then quickly blow out as hard as possible into a device called a peak flow meter. This is generally done three times, with the highest value recorded as the result. PEFR measurements are occasionally used in the daily home monitoring of people with asthma. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/6/31841?source=see_link\">",
"      \"Patient information: How to use a peak flow meter (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Challenge testing",
"     </span>",
"     &nbsp;&mdash;&nbsp;If a child is thought to have asthma based upon the spirometry or PEFR result, a bronchial challenge may be recommended. This testing is designed to cause the airways to narrow in children with asthma. Testing is done in a specialized asthma testing center that is capable of providing emergency asthma care if needed. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/4/1098?source=see_link\">",
"      \"Bronchoprovocation testing\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Additional testing",
"     </span>",
"     &nbsp;&mdash;&nbsp;Other tests may be recommended to ensure that another condition is not the cause of a child's coughing or wheezing. This may include a chest radiograph, sweat chloride test or blood test (for cystic fibrosis), barium swallow (for gastroesophageal reflux), modified barium swallow (for aspiration), or skin or blood testing (for allergies). (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/41/1689?source=see_link\">",
"      \"Wheezing illnesses other than asthma in children\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/49/28442?source=see_link\">",
"      \"Cystic fibrosis: Clinical manifestations and diagnosis\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/41/41625?source=see_link\">",
"      \"Clinical manifestations and diagnosis of gastroesophageal reflux disease in children and adolescents\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/46/30441?source=see_link\">",
"      \"Gastroesophageal reflux in infants\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/46/38632?source=see_link\">",
"      \"Aspiration due to swallowing dysfunction in infants and children\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/55/32633?source=see_link\">",
"      \"Overview of skin testing for allergic disease\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/22/44391?source=see_link\">",
"      \"Overview of in vitro allergy tests\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Testing for young children",
"     </span>",
"     &nbsp;&mdash;&nbsp;Infants and children younger than six years are usually not able to perform spirometry or peak expiratory flow rate testing. In most cases, a healthcare provider will recommend a trial of medication to confirm the diagnosis.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H17\">",
"     <span class=\"h1\">",
"      ASTHMA IN ADULTHOOD",
"     </span>",
"    </p>",
"    <p>",
"     Many parents wonder if their child will \"outgrow\" their asthma over time. Children do experience complete remission more frequently than adults, although children with more severe asthma are more likely to continue to have asthma as adults.",
"    </p>",
"    <p>",
"     Having asthma does not typically affect the length of a person's life. However, a small percentage of people with asthma develop permanent changes in lung function that worsen over time. It is not known why this happens in some people and not in others. Factors that are believed to increase this risk include exposure to tobacco smoke, severe allergies, and severe and persistent asthma symptoms.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H18\">",
"     <span class=\"h1\">",
"      ASTHMA TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     The treatment of asthma in children is discussed in a separate topic review. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/60/18374?source=see_link\">",
"      \"Patient information: Asthma treatment in children (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H19\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your child's healthcare provider is the best source of information for questions and concerns related to your child's medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H191\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23787662\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?16/58/17315?source=see_link\">",
"      Patient information: Asthma in children (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/7/13427?source=see_link\">",
"      Patient information: Cough in children (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?0/37/595?source=see_link\">",
"      Patient information: Secondhand smoke: Risks to children (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/57/40850?source=see_link\">",
"      Patient information: Bronchiectasis in children (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23787679\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/60/18374?source=see_link\">",
"      Patient information: Asthma treatment in children (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/6/31841?source=see_link\">",
"      Patient information: How to use a peak flow meter (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?43/3/44083?source=see_link\">",
"      Patient information: Asthma inhaler techniques in children (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?30/25/31124?source=see_link\">",
"      Patient information: Trigger avoidance in asthma (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?38/63/39925?source=see_link\">",
"      Patient information: Asthma treatment in adolescents and adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?28/25/29075?source=see_link\">",
"      Patient information: Asthma inhaler techniques in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?14/20/14660?source=see_link\">",
"      Patient information: Asthma and pregnancy (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?39/44/40643?source=see_link\">",
"      Patient information: The common cold in children (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/19/27958?source=see_link\">",
"      Patient information: Bronchiolitis (and RSV) in infants and children (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/26/1442?source=see_link\">",
"      Patient information: Exercise-induced asthma (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/23/11642?source=see_link\">",
"      Acute asthma exacerbations in children: Inpatient management",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/16/33034?source=see_link\">",
"      Acute asthma exacerbations in children: Outpatient management",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/44/22218?source=see_link\">",
"      Acute severe asthma exacerbations in children: Intensive care unit management",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/37/8794?source=see_link\">",
"      An overview of asthma management",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/24/20870?source=see_link\">",
"      Anticholinergic agents in the management of acute exacerbations of asthma",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/45/30424?source=see_link\">",
"      Approach to wheezing in children",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/30/37354?source=see_link\">",
"      Chronic asthma in children younger than 12 years: Controller medications",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/61/15319?source=see_link\">",
"      Chronic asthma in children younger than 12 years: Definition, epidemiology, and pathophysiology",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/25/26010?source=see_link\">",
"      Chronic asthma in children younger than 12 years: Evaluation and diagnosis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/47/39670?source=see_link\">",
"      Chronic asthma in children younger than 12 years: Quick-relief agents",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/30/1513?source=see_link\">",
"      Exercise-induced bronchoconstriction",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/13/7383?source=see_link\">",
"      Natural history of asthma",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/12/20682?source=see_link\">",
"      Risk factors for asthma",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/57/17304?source=see_link\">",
"      The impact of breastfeeding on the development of allergic disease",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/41/1689?source=see_link\">",
"      Wheezing illnesses other than asthma in children",
"     </a>",
"     <br/>",
"    </p>",
"    <p>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"        www.nlm.nih.gov/medlineplus/healthtopics.html",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       National Heart, Lung, and Blood Institute",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.nhlbi.nih.gov/\">",
"        www.nhlbi.nih.gov/",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       American Lung Association",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.lungusa.org/\">",
"        www.lungusa.org",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       American Academy of Allergy, Asthma, and Immunology",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.aaaai.org/patients.stm\">",
"        www.aaaai.org/patients.stm",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       American College of Allergy, Asthma, and Immunology",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.acaai.org/allergist\">",
"        www.acaai.org/allergist",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       Allergy and Asthma",
"       <span class=\"nowrap\">",
"        Network/Mothers",
"       </span>",
"       of Asthmatics, Inc.",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.aanma.org/\">",
"        www.aanma.org/",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?37/0/37892/abstract/1-5\">",
"      1-5",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 12, 2011.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?37/0/37892?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37892/abstract/1\">",
"      Bisgaard H, Szefler S. Prevalence of asthma-like symptoms in young children. Pediatr Pulmonol 2007; 42:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37892/abstract/2\">",
"      Gruchalla RS, Pongracic J, Plaut M, et al. Inner City Asthma Study: relationships among sensitivity, allergen exposure, and asthma morbidity. J Allergy Clin Immunol 2005; 115:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37892/abstract/3\">",
"      Porsbjerg C, von Linstow ML, Ulrik CS, et al. Risk factors for onset of asthma: a 12-year prospective follow-up study. Chest 2006; 129:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37892/abstract/4\">",
"      Sears MR, Greene JM, Willan AR, et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003; 349:1414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37892/abstract/5\">",
"      McFadden ER Jr. Natural history of chronic asthma and its long-term effects on pulmonary function. J Allergy Clin Immunol 2000; 105:S535.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f37_0_37892=[""].join("\n");
var outline_f37_0_37892=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           ASTHMA OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           ASTHMA RISK FACTORS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           ASTHMA SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11\">",
"           ASTHMA DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H17\">",
"           ASTHMA IN ADULTHOOD",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H18\">",
"           ASTHMA TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H19\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/23/29044\" title=\"figure 1\">",
"           Pediatric airway anatomy PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?0/52/837\" title=\"figure 2\">",
"           Asthma PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f37_0_37893="Intraoperative management of adults with obstructive sleep apnea";
var content_f37_0_37893=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Intraoperative management of adults with obstructive sleep apnea",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/0/37893/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/0/37893/contributors\">",
"     Eric Olson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/0/37893/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/0/37893/contributors\">",
"     Robert C Basner, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/0/37893/contributors\">",
"     Stephanie B Jones, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/0/37893/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/0/37893/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/0/37893/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 23, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H257773\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obstructive sleep apnea (OSA) is a disorder characterized by repetitive episodes of apnea or reduced inspiratory airflow due to upper airway obstruction during sleep. The incidence of perioperative complications (ie, preoperative, intraoperative, and postoperative complications collectively) is increased among patients with OSA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The Joint Commission has suggested that a National Patient Safety Goal be the reduction of perioperative complications among patients with OSA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/3\">",
"     3",
"    </a>",
"    ], while the American Society of Anesthesiology (ASA) and American Academy of Sleep Medicine (AASM) have developed clinical practice guidelines for the perioperative management of patients with OSA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. Common among the guidelines is an emphasis on maintaining a high index of suspicion for OSA, careful use of medications, vigilant monitoring for evidence of upper airway obstruction, an integrated team approach to perioperative management, and recognition that many recommendations are based upon clinical rationale and indirect evidence because direct evidence is scarce. Such interest in the perioperative management of patients with OSA probably reflects the recognition that the number of patients with OSA encountered in operating rooms is likely to increase as recognition of the disease and the prevalence of obesity increase [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/4,7\">",
"     4,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The intraoperative management of patients with OSA is reviewed here. This includes determining whether the surgery should be performed on an inpatient or outpatient basis, premedication, airway management, and anesthesia. Factors that contribute to the increased surgical risk of patients with OSA, preoperative evaluation, preoperative management, and postoperative management are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35288?source=see_link\">",
"     \"Surgical risk and the preoperative evaluation and management of adults with obstructive sleep apnea\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/9/34965?source=see_link\">",
"     \"Postoperative management of adults with obstructive sleep apnea\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H257780\">",
"    <span class=\"h1\">",
"     INPATIENT OR OUTPATIENT SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The decision about whether to perform surgery on an inpatient or outpatient basis must be individualized. Important considerations include the patient&rsquo;s age and comorbidities, type of surgery and anesthesia, severity of the OSA, and capabilities of the surgical center (ie, emergency airway and respiratory equipment, radiology, clinical laboratory, access to an inpatient facility):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      All surgeries that are performed on an inpatient basis in individuals without OSA should also be performed on an inpatient basis in patients with OSA.",
"     </li>",
"     <li>",
"      Upper airway surgery and laparoscopic upper abdominal surgery should be performed on an inpatient basis in patients with OSA, even though they are often performed on an outpatient basis in individuals without OSA, according to guidelines from the American Society of Anesthesiologists (ASA) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Lithotripsy, superficial surgeries, and minor orthopedic surgeries (eg, arthroscopy) requiring only local or regional anesthesia can be performed safely on an outpatient basis in patients with OSA [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/6\">",
"       6",
"      </a>",
"      ]. Colonoscopy, bronchoscopy, cataract surgery, and esophagogastroduodenoscopy (EGD) can generally be performed on an outpatient basis if general anesthesia, intravenous sedation, or intravenous analgesia is only required during the procedure and narcotics are not required after completion of the procedure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/8\">",
"       8",
"      </a>",
"      ]. Such plans may need to be modified on a case-by-case basis (eg, if the procedure is prolonged and large amounts of procedural sedation or analgesia are used).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A scoring system developed by the ASA to assess the risk of perioperative complications in patients with OSA may also be helpful in identifying patients who are poor candidates for surgery at freestanding outpatient facilities, although its use for this purpose has not been validated (",
"    <a class=\"graphic graphic_table graphicRef70982 \" href=\"mobipreview.htm?21/41/22173\">",
"     table 1",
"    </a>",
"    ). The scoring system has three components: the severity of the OSA (based upon a sleep study or clinical indicators), the invasiveness of the surgery and type of anesthesia planned, and the anticipated need for postoperative opioid analgesia. These components are used to calculate a score between zero and six. Patients with a score of five or six are poor candidates for surgery at freestanding outpatient facilities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An observational study confirmed that some surgeries can be safely performed as outpatient procedures in patients with OSA. The study compared 234 adults with polysomnographically proven OSA (mean respiratory disturbance index of 40 events per hour of sleep) who underwent non-otorhinolaryngological outpatient procedures (from 1997 through 2000) to 234 control patients who were matched according to the surgical procedure, type of anesthesia, surgical date, age, sex, and body mass index [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/9\">",
"     9",
"    </a>",
"    ]. There were no significant differences among those who underwent outpatient procedures compared to control in unplanned hospital admissions (24 versus 19 percent) or other adverse events (2.1 versus 1.3 percent). The only difference in operative management was that patients with OSA were less likely to be managed with a laryngeal mask airway. The study could not exclude the possibility that preferential scheduling of OSA patients for inpatients procedures (ie, selection bias) affected the findings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H257787\">",
"    <span class=\"h1\">",
"     PREMEDICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Premedication with sedatives or analgesics is discouraged among patients with OSA. Such patients are predisposed to upper airway obstruction and, therefore, the depression of upper airway muscle activity by sedatives may precipitate upper airway obstruction. If a sedative agent is administered, patients with OSA must be closely supervised at all times, including continuous monitoring of the oxyhemoglobin saturation. Intravenous access should be established in case an antagonist agent is required [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H257794\">",
"    <span class=\"h1\">",
"     AIRWAY MONITORING AND MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H257803\">",
"    <span class=\"h2\">",
"     No intubation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with OSA who are not intubated for surgery should have their oxygenation and ventilation monitored throughout surgery via pulse oximetry and capnography, respectively. Patients who use positive airway pressure (usually continuous positive airway pressure [CPAP]) should receive positive airway pressure during the surgery. Patients who use an oral appliance may also use their device during surgery, as long as it can be quickly removed if the anesthesiologist needs emergent access to the patient&rsquo;s airway.",
"   </p>",
"   <p>",
"    Snoring, apnea,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    oxyhemoglobin desaturation during surgery may indicate upper airway collapse, which can occur even if the patient is using positive airway pressure. Placing the patient&rsquo;s head in the sniffing position (ie, lower cervical flexion, upper cervical extension), thrusting the mandible forward,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    using an oral or nasopharyngeal airway may be sufficient to restore or maintain upper airway patency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/1,5\">",
"     1,5",
"    </a>",
"    ]. If these interventions are insufficient, intubation may be necessary. In the absence of snoring, apnea, oxyhemoglobin desaturation,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hypercapnia may indicate central apnea or hypoventilation. Such patients generally benefit from ventilatory support, either noninvasively (adding bilevel positive airway pressure ventilation [BPAP] or, if the patient is already receiving CPAP, changing the CPAP to BPAP) or invasively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H257810\">",
"    <span class=\"h2\">",
"     Intubation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with OSA require intubation for surgery. Clinical experience indicates that patients with OSA are more likely to have challenging intubations and patients with challenging intubations are more likely to have OSA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. However, these observations have not been confirmed experimentally, as one observational study found similar rates of difficult intubations among patients with OSA and controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/9\">",
"     9",
"    </a>",
"    ]. Nevertheless, it is safest to assume that a patient with OSA may be a difficult intubation and to plan accordingly.",
"   </p>",
"   <p>",
"    We believe that patients with OSA should be managed in accordance with clinical practice guidelines for the management of difficult airways from the ASA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/13\">",
"     13",
"    </a>",
"    ]. This consists of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Informing the patient about the risks and procedure of tracheal intubation.",
"     </li>",
"     <li>",
"      Preparation for difficult airway management by having the requisite equipment immediately accessible. This includes tracheal tube guides, flexible fiberoptic intubation equipment, transtracheal jet ventilation, and emergency cricothyroidotomy equipment.",
"     </li>",
"     <li>",
"      Establishing a primary and alternative intubation strategy in advance. Considerations include whether to intubate patients while they are awake or after the induction of anesthesia, whether to intubate patients while they are breathing spontaneously or apneic, and whether to use a noninvasive (ie, laryngoscopic) or invasive (ie, surgical or percutaneous tracheostomy) technique for intubation.",
"     </li>",
"     <li>",
"      Arranging for an additional individual to be available to assist with the intubation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All patients with OSA should receive pre-oxygenation by facemask for at least three minutes. The rationale is that many exhibit rapid oxyhemoglobin desaturation following the induction of anesthesia due to low oxygen reserves (a consequence of decreased functional residual capacity related to obesity) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/4\">",
"     4",
"    </a>",
"    ]. Two-person ventilation is often required following the induction of anesthesia, one person for jaw positioning and maintenance of the mask seal and the other person to ventilate the patient. An oropharyngeal airway, nasopharyngeal airway, or laryngeal mask airway may help maintain airway patency until the patient is successfully intubated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H257817\">",
"    <span class=\"h1\">",
"     ANESTHETIC TECHNIQUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;General anesthetics, neuromuscular blocking agents, sedatives, and analgesics are commonly used intraoperative medications, which are usually chosen according to the invasiveness of the surgery. These medications all inhibit the respiratory muscles, although the general anesthetics and neuromuscular blocking agents disproportionately affect the upper airway muscles relative to the diaphragm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/14\">",
"     14",
"    </a>",
"    ]. The desire to minimize inhibition of the upper airway muscles in patients with OSA underlies the strategies presented in this section.",
"   </p>",
"   <p>",
"    Patients with OSA who are undergoing superficial procedures (ie, procedures requiring small incisions with little blood loss, such as cataract extraction and dermatological procedures) should preferentially receive local anesthesia or a peripheral nerve block [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/6\">",
"     6",
"    </a>",
"    ]. This may or may not be accompanied by moderate sedation (ie, conscious sedation), which is defined as a drug-induced depression of consciousness during which patients respond purposefully to verbal commands, do not require assistance maintaining a patent upper airway, exhibit adequate spontaneous ventilation, and maintain normal cardiovascular function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/15\">",
"     15",
"    </a>",
"    ]. The moderate sedation should be administered by an anesthesiologist or someone with advanced training in anesthetic techniques (ie, a nurse anesthetist) because it is easy for a patient to advance from moderate to deep sedation, which is generally not well tolerated by someone with severe OSA.",
"   </p>",
"   <p>",
"    Patients with OSA who are undergoing peripheral procedures (ie, procedures that do not involve the torso, central nervous system, or major joints, such as hand surgery, foot surgery, or peripheral vascular surgery) should be considered for major conduction anesthesia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/6\">",
"     6",
"    </a>",
"    ]. Examples of major conduction anesthesia include spinal anesthesia, epidural anesthesia, brachial or lumbar plexus blocks, caudal blocks, and regional intravenous blocks. This may or may not be accompanied by moderate sedation.",
"   </p>",
"   <p>",
"    When moderate sedation is part of the anesthetic regimen, the sedative dose should be as low as possible. There are theoretical reasons that some agents may be better than others (eg, shorter acting agents will have less carryover into the postoperative period), but this has not been carefully studied [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For patients with OSA who are undergoing surgeries that require more extensive anesthesia, general anesthesia with a secure airway (eg, endotracheal tube) is preferred over deep sedation. The latter is defined as drug-induced depression of consciousness during which patients cannot be easily aroused, but respond purposefully to repeated",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    painful stimuli [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37893/abstract/15\">",
"     15",
"    </a>",
"    ]. Such patients may require assistance in maintaining a patent upper airway and adequate ventilation, but cardiovascular function is usually maintained.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H257824\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Obstructive sleep apnea (OSA) is a disorder characterized by repetitive episodes of apnea or reduced inspiratory airflow due to upper airway obstruction during sleep. The incidence of perioperative complications (ie, preoperative, intraoperative, and postoperative complications collectively) is increased among patients with OSA. (See",
"      <a class=\"local\" href=\"#H257773\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Intraoperative aspects of managing patients with OSA are discussed in this review. Factors that contribute to the increased surgical risk of patients with OSA, preoperative evaluation, preoperative management, and postoperative management are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35288?source=see_link\">",
"       \"Surgical risk and the preoperative evaluation and management of adults with obstructive sleep apnea\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/9/34965?source=see_link\">",
"       \"Postoperative management of adults with obstructive sleep apnea\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The decision about whether to perform surgery on an inpatient or outpatient basis must be individualized. Important considerations include the patient&rsquo;s age and comorbidities, type of surgery and anesthesia, severity of the OSA, and capabilities of the surgical center (ie, emergency airway and respiratory equipment, radiology, clinical laboratory, access to an inpatient facility). (See",
"      <a class=\"local\" href=\"#H257780\">",
"       'Inpatient or outpatient surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Premedication is discouraged among patients with OSA. (See",
"      <a class=\"local\" href=\"#H257787\">",
"       'Premedication'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with OSA who are not intubated for the surgery should have their oxygenation and ventilation monitored throughout the surgery via pulse oximetry and capnography, respectively. Patients who use positive airway pressure (usually continuous positive airway pressure [CPAP]) should receive positive airway pressure during the surgery. (See",
"      <a class=\"local\" href=\"#H257803\">",
"       'No intubation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with OSA who need to be intubated for surgery seem more likely to have challenging intubations than patients without OSA. Thus, patients should be informed about the risks and clinicians should be prepared for difficult airway management by having the requisite equipment immediately accessible, a primary and alternative intubation strategy, and an additional individual to assist with the intubation. (See",
"      <a class=\"local\" href=\"#H257810\">",
"       'Intubation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The preferred method of anesthesia depends upon the type of surgery that is planned. The goal is to minimize inhibition of the upper airway muscles. (See",
"      <a class=\"local\" href=\"#H257817\">",
"       'Anesthetic technique'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with OSA who are undergoing superficial procedures, we suggest NOT using general anesthesia (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Local anesthesia and peripheral nerve blocks are acceptable alternatives in this situation.",
"     </li>",
"     <li>",
"      For patients with OSA who are undergoing peripheral procedures, we suggest major conduction anesthesia rather than general anesthesia (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Examples of major conduction anesthesia include spinal anesthesia, epidural anesthesia, brachial or lumbar plexus blocks, caudal blocks, and regional intravenous blocks.",
"     </li>",
"     <li>",
"      Local anesthesia, peripheral nerve blocks, or major conduction anesthesia may be accompanied by moderate sedation (ie, conscious sedation). Whenever moderate sedation is employed, personnel and equipment should be available to secure the airway if the patient inadvertently becomes oversedated.",
"     </li>",
"     <li>",
"      For patients with OSA who are undergoing surgeries that require more extensive anesthesia, we suggest general anesthesia with a secure airway (eg, endotracheal tube) rather than deep sedation (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37893/abstract/1\">",
"      Hillman DR, Loadsman JA, Platt PR, Eastwood PR. Obstructive sleep apnoea and anaesthesia. Sleep Med Rev 2004; 8:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37893/abstract/2\">",
"      Boushra NN. Anaesthetic management of patients with sleep apnoea syndrome. Can J Anaesth 1996; 43:599.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.hcpro.com/NRS-66500-975/Sleep-apnea-among-proposed-National-Patient-Safety-Goals.html (Accessed on June 10, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37893/abstract/4\">",
"      Benumof JL. Obstructive sleep apnea in the adult obese patient: implications for airway management. Anesthesiol Clin North America 2002; 20:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37893/abstract/5\">",
"      Meoli AL, Rosen CL, Kristo D, et al. Upper airway management of the adult patient with obstructive sleep apnea in the perioperative period--avoiding complications. Sleep 2003; 26:1060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37893/abstract/6\">",
"      Gross JB, Bachenberg KL, Benumof JL, et al. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology 2006; 104:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37893/abstract/7\">",
"      Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288:1723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37893/abstract/8\">",
"      Bolden N, Smith CE, Auckley D. Avoiding adverse outcomes in patients with obstructive sleep apnea (OSA): development and implementation of a perioperative OSA protocol. J Clin Anesth 2009; 21:286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37893/abstract/9\">",
"      Sabers C, Plevak DJ, Schroeder DR, Warner DO. The diagnosis of obstructive sleep apnea as a risk factor for unanticipated admissions in outpatient surgery. Anesth Analg 2003; 96:1328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37893/abstract/10\">",
"      Hiremath AS, Hillman DR, James AL, et al. Relationship between difficult tracheal intubation and obstructive sleep apnoea. Br J Anaesth 1998; 80:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37893/abstract/11\">",
"      Siyam MA, Benhamou D. Difficult endotracheal intubation in patients with sleep apnea syndrome. Anesth Analg 2002; 95:1098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37893/abstract/12\">",
"      Stierer TL, Wright C, George A, et al. Risk assessment of obstructive sleep apnea in a population of patients undergoing ambulatory surgery. J Clin Sleep Med 2010; 6:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37893/abstract/13\">",
"      American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Practice guidelines for management of the difficult airway: an updated report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology 2003; 98:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37893/abstract/14\">",
"      Hillman DR, Platt PR, Eastwood PR. The upper airway during anaesthesia. Br J Anaesth 2003; 91:31.",
"     </a>",
"    </li>",
"    <li>",
"     Continuum of Depth of Sedation: Definition of General Anesthesia and Levels of Sedation/Analgesia. American Society of Anesthesiologists Standards, Guidelines, adb Statements, October 27, 2004 (file://www.asahq.org/publicationsAndServices/sgstoc.htm).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37893/abstract/16\">",
"      Chung SA, Yuan H, Chung F. A systemic review of obstructive sleep apnea and its implications for anesthesiologists. Anesth Analg 2008; 107:1543.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13517 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-190.111.122.2-0C8C6D5D65-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_0_37893=[""].join("\n");
var outline_f37_0_37893=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H257824\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H257773\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H257780\">",
"      INPATIENT OR OUTPATIENT SURGERY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H257787\">",
"      PREMEDICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H257794\">",
"      AIRWAY MONITORING AND MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H257803\">",
"      No intubation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H257810\">",
"      Intubation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H257817\">",
"      ANESTHETIC TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H257824\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/13517\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/13517|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?21/41/22173\" title=\"table 1\">",
"      OSA scoring system",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/9/34965?source=related_link\">",
"      Postoperative management of adults with obstructive sleep apnea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35288?source=related_link\">",
"      Surgical risk and the preoperative evaluation and management of adults with obstructive sleep apnea",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_0_37894="Deferoxamine: Pediatric drug information";
var content_f37_0_37894=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Deferoxamine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?22/10/22695?source=see_link\">",
"    see \"Deferoxamine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?0/59/949?source=see_link\">",
"    see \"Deferoxamine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F157271\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Desferal&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F157272\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Desferal&reg;;",
"     </li>",
"     <li>",
"      PMS-Deferoxamine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1057708\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antidote, Aluminum Toxicity",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antidote, Iron Toxicity",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Chelating Agent, Parenteral",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F15898662\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     <b>",
"      Acute iron intoxication:",
"     </b>",
"     Very limited data available: I.V. infusion: 5 mg/kg/hour; dosing based on a case report of an oral ferrous sulfate overdose in a former premature neonate (GA: 27 weeks and age at time of treatment PCA: 34 weeks); further studies needed (Valentine, 2009).",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1057699\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?22/10/22695?source=see_link\">",
"      see \"Deferoxamine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children and Adolescents:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Acute iron intoxication:",
"     </b>",
"     Limited data available:",
"     <b>",
"      Note:",
"     </b>",
"     The I.V. route is used when severe toxicity is evidenced by cardiovascular collapse or systemic symptoms (coma, shock, metabolic acidosis, or gastrointestinal bleeding) or potentially severe intoxications (peak serum iron level &gt;500 mcg/dL) (Perrone, 2011). When severe symptoms are not present, the I.M. route may be used.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Continuous I.V. infusion: Initial: 15 mg/kg/hour and reduce rate as clinically indicated; maximum daily dose: 80 mg/kg/",
"     <b>",
"      day",
"     </b>",
"     and not to exceed 6 g/",
"     <b>",
"      day",
"     </b>",
"     [Desferal&reg; prescribing information (Canada; UK), 2011]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     I.V.: Initial: 20 mg/kg (maximum dose: 1000 mg) administered no faster than 15 mg/kg/hour followed by 10 mg/kg (maximum dose: 500 mg) over 4-hour intervals for 2 doses; subsequent doses of 10 mg/kg (maximum dose: 500 mg) over 4-12 hours may be repeated depending upon the clinical response; maximum dose: 6 g/",
"     <b>",
"      day",
"     </b>",
"     ; this dosing may also be used I.M. if symptoms not severe.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     I.M.: 90 mg/kg/dose for one dose, then 45 mg/kg/dose every 4-12 hours as needed; maximum single dose: Children: 1000 mg; Adults: 2000 mg; maximum daily dose:  6 g/day [Desferal&reg; prescribing information (Canada; UK), 2011]; others have used  50 mg/kg/dose every 6 hours with maximum daily dose: 6",
"     <b>",
"      g/day",
"     </b>",
"     (Chang, 2011); may also use intermittent I.V. dosing (see above)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Chronic iron overload:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      General dosing:",
"     </i>",
"     Manufacturer&rsquo;s labeling: Children &ge;3 years and Adolescents:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     I.V. :",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Children and Growing Adolescents: 20-40 mg/kg/day over 8-12 hours, 5-7 days per week, usual maximum daily dose: 40 mg/kg/",
"     <b>",
"      day",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     Adolescents once growth has ceased: 40-50 mg/kg/day over 8-12 hours, 5-7 days per week, usual maximum daily dose: 60 mg/kg/",
"     <b>",
"      day",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     SubQ infusion via a portable, controlled infusion device: 20-40 mg/kg/day over 8-12 hours 3-7 days per week; maximum daily dose: 2000 mg/",
"     <b>",
"      day",
"     </b>",
"     . Doses &gt;60 mg/kg/day have  not been shown to provide additional benefit (Vlachos, 2008).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Sickle cell disease, chronic iron overload:",
"     </i>",
"     Children and Adolescents: SubQ infusion: 25 mg/kg/day over 8 hours; dose and duration may be increased as needed  (NHLBI, 2005)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     <i>",
"      Thalassemia, chronic iron overload:",
"     </i>",
"     <b>",
"      Note:",
"     </b>",
"     A lower dose may be required if the ferritin levels are low. In general, the therapeutic index should be kept &lt;0.025 at all times. Therapeutic index = mean daily deferoxamine dose (mg/kg)/ferritin (mcg/L) (Cappellini, 2008):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Children and Growing Adolescents: SubQ infusion: 20-40 mg/kg/day over 8-12 hours, 6-7 nights per week, maximum daily dose: 40 mg/kg/",
"     <b>",
"      day",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Adolescents once growth has ceased:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     SubQ infusion (preferred): 40-60 mg/kg/day over 8-12 hours, 6-7 nights per week, maximum daily dose: 2000 mg/",
"     <b>",
"      day",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;\">",
"     SubQ bolus: 45 mg/kg/dose, 5 times per week.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Aluminum-induced bone disease in chronic renal failure:",
"     </b>",
"     <b>",
"      Note:",
"     </b>",
"     Intended for predialysis serum aluminum concentration of 60-200 mcg/L; do not start chelation therapy if serum aluminum concentration &gt;200 mcg/L; intensive dialysis (6 days per week with a high flux dialysis membrane) should be used until serum aluminum concentration decreases below 200 mcg/L (National Kidney Foundation, 2003):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Test (diagnostic) dose: I.V.: 5 mg/kg as a single dose infused over the last hour of dialysis; measure serum aluminum concentration 2 days later; depending upon the change in serum aluminum concentration, treatment with deferoxamine may be indicated (see Treatment below)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Treatment: I.V.:  Monitor serum aluminum levels closely. See National Kidney Foundation guidelines for additional details on treatment algorithms.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Aluminum rise &ge;300 mcg/L or adverse effects with test dose: 5 mg/kg once a week 5 hours before dialysis for 4 months",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;\">",
"     Aluminum rise &lt;300 mcg/L: 5 mg/kg once a week during the last hour of dialysis for 2 months",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Acute iron intoxication: Note:",
"     </b>",
"     The I.V. route is used when severe toxicity is evidenced by cardiovascular collapse or systemic symptoms (coma, shock, metabolic acidosis, or gastrointestinal bleeding) or potentially severe intoxications (peak serum iron level &gt;500 mcg/dL) (Perrone, 2011). When severe symptoms are not present, the I.M. route may be used.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     I.M., I.V.: 1000 mg stat, then 500 mg every 4 hours for 2 doses, additional doses of 500 mg every 4-12 hours may be needed depending upon the clinical response; maximum daily dose: 6",
"     <b>",
"      g/day",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Chronic iron overload:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     I.M.: 500-1000 mg/dose; maximum daily dose: 1000 mg/",
"     <b>",
"      day",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     I.V.: 40-50 mg/kg/day over 8-12 hours for 5-7 days per week; maximum daily dose: 6",
"     <b>",
"      g/day",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     SubQ via portable, controlled infusion device: 1000-2000 mg/day or 20-40 mg/kg/day over 8-24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosage adjustment in renal impairment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Manufacturer&rsquo;s labeling: Severe renal disease or anuria: Use is contraindicated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Alternate recommendations: The following adjustments have been recommended (Aronoff, 2007): Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &gt;50 mL/minute: No adjustment required",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-50 mL/minute or CRRT: Administer 25% to 50% of normal dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute, hemodialysis, or peritoneal dialysis: Avoid use",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosage adjustment in hepatic impairment:",
"     </b>",
"     There are no dosage adjustments provided in the manufacturer&rsquo;s labeling (not studied).",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F157252\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution, as mesylate: 500 mg, 2 g",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Desferal&reg;: 500 mg, 2 g",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F157237\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1057713\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Intramuscular: Reconstitute 500 mg vial with 2 mL SWI or 2000 mg vial with 8 mL SWI; resulting concentration: 213 mg/mL; no further dilution required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Intravenous: May reconstitute 500 mg vial with 5 mL SWI or 2000 mg vial with 20 mL SWI, resulting concentration: 95 mg/mL; further dilute in D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS, 0.45% NS, or LR; may administer as intermittent I.V. infusion or as continuous I.V. infusion; maximum rate: 15 mg/kg/hour; may consider reducing infusion rate to &lt;125 mg/hour after the first 1000 mg have been infused.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Subcutaneous: Reconstitute 500 mg vial with 5 mL SWI or 2000 mg vial with 20 mL SWI; resulting concentration: 95 mg/mL; no further dilution required; local reactions at the site of subcutaneous infusion may be minimized by diluting the deferoxamine in 5-10 mL SWI and adding 1 mg hydrocortisone to each mL of deferoxamine solution (Kirking, 1991)",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F157319\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, LR, NS, sterile water for injection.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1057703\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store intact vials at &le;25&deg;C (77&deg;F). Following reconstitution, solutions may be stored for 24 hours at room temperature, although the manufacturer recommends use begin within 3 hours of reconstitution. Do not refrigerate solutions as it may cause precipitation. When stored at 30&deg;C in polypropylene infusion pump syringes, deferoxamine 250 mg/mL in sterile water for injection retained 95% of initial concentration for 14 days (Stiles, 1996).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1057712\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adjunct treatment of acute iron intoxication and treatment of chronic iron overload secondary to multiple transfusions (FDA approved in ages &ge;3 years and adults); has also been used in the diagnosis and treatment of aluminum accumulation in chronic renal failure",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F157321\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Deferoxamine may be confused with cefuroxime, deferasirox, deferiprone",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Desferal&reg; may be confused with desflurane, Desyrel&reg;, Dexferrum&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Desferal [U.S., Canada, and multiple international markets] may be confused with Deseril brand name for methysergide [Australia, Belgium, Great Britain, Netherlands]; Disophrol brand name for dexbrompheniramine and pseudoephedrine [Czech Republic, Poland, Turkey]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F157318\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Flushing, hypotension, shock, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dizziness, encephalopathy (aluminum toxicity/dialysis-related), fever, headache, seizure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Angioedema, rash,  urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Growth retardation (children), hyperparathyroidism (aggravated), hypocalcemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal discomfort, abdominal pain, diarrhea, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Dysuria, urine discoloration (reddish  color)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Leukopenia, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic:  Hepatic dysfunction, transaminases increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Injection site: Burning, crust, edema, erythema, eschar, induration, infiltration, irritation, pain, pruritus, swelling, vesicles, wheal formation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, metaphyseal dysplasia (children &lt;3 years; dose related), muscle spasms, myalgia, neuropathy (peripheral, sensory, motor, or mixed), paresthesia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision, cataract, corneal opacities, dyschromatopsia, loss of vision, night blindness, optic neuritis, peripheral vision impaired, retinal pigment abnormalities, scotoma, visual acuity decreased, visual field defects",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Hearing loss, tinnitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Acute renal failure, renal tubular disorders, serum creatinine increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Acute respiratory distress syndrome (dyspnea, cyanosis, and/or interstitial infiltrates), asthma",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylaxis (with or without shock), hypersensitivity reaction, infections (",
"     <i>",
"      Yersinia",
"     </i>",
"     , mucormycosis)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1057716\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to deferoxamine or any component; patients with severe renal disease, anuria",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1057698\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Patients with iron overload are at increased susceptibility to",
"     <i>",
"      Yersinia enterocolitica",
"     </i>",
"     and",
"     <i>",
"      Yersinia pseudotuberculosis",
"     </i>",
"     infections; treatment with deferoxamine may enhance this risk; if infection develops, discontinue therapy until resolved.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Deferoxamine is",
"     <b>",
"      not",
"     </b>",
"     indicated for the treatment of primary hemochromatosis (treatment of choice is phlebotomy). Patients should be informed that urine may have a reddish color.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Local injection site reactions may be minimized by daily rotation of subcutaneous injection sites and by applying topical corticosteroids; painful lumps formed under the skin may indicate that the rate of SubQ administration exceeds the rate of absorption from the injection site or the needle is inserted too close to the dermis.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1057697\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ocular disturbances (blurred vision, cataracts, corneal opacities, decreased visual acuity, impaired peripheral and color vision, impaired night vision, optic neuritis, retinal pigmentary abnormalities, scotoma, visual loss/deficit) have been reported following prolonged administration, at high dosages, or in patients with low ferritin levels; generally reversible with early detection and immediate discontinuation; periodic eye exams are recommended with long-term therapy.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Auditory disturbances (tinnitus and high-frequency hearing loss) have been reported with prolonged administration, at high doses, or in patients with low ferritin levels; effects are generally reversible with early detection and immediate discontinuation; periodic auditory exams are recommended.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Deferoxamine has been associated with ARDS following treatment of acute iron intoxication or thalassemia with high doses of deferoxamine. Flushing of the skin, urticaria, hypotension, and shock have been reported after rapid I.V. administration; may administer I.M., by slow subcutaneous infusion or slow I.V. infusion only. Increases in serum creatinine, acute renal failure, and renal tubular disorders have been reported; when iron is chelated with deferoxamine, the chelate is excreted renally. Rare and serious cases of mucormycosis (including fatalities) have been reported in chronic renal failure patients receiving deferoxamine. Ferrioxamine (chelated form of iron with deferoxamine) enhances the growth and pathogenicity of certain species of",
"     <i>",
"      Mucor",
"     </i>",
"     .",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Growth retardation in pediatric patients especially in patients &le;3 years has been associated with high doses (&gt;60 mg/kg) and  concurrent low ferritin levels; a reduction in deferoxamine dosage may partially improve growth velocity; monitor growth in children receiving chronic therapy closely.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Treatment with deferoxamine in patients with aluminum toxicity may cause hypocalcemia and aggravate hyperparathyroidism; deferoxamine may cause neurological symptoms (including seizure) in patients with aluminum-related encephalopathy receiving dialysis; deferoxamine may precipitate the onset of dialysis dementia. Avoid deferoxamine use in patients with serum aluminum levels &gt;200 mcg/L.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Patients with severe chronic iron overload treated with deferoxamine and high dose vitamin C have been reported to develop impaired cardiac function which is reversed after discontinuation of vitamin C; vitamin C increases the availability of iron for chelation with deferoxamine. To decrease the risk of impaired cardiac function, the manufacturer recommends: Avoiding vitamin C in patients with pre-existing cardiac failure; start vitamin C supplementation only after the first month of deferoxamine therapy; use vitamin C only if the patient is regularly receiving deferoxamine; monitor cardiac function; do not exceed vitamin C doses of: children &lt;10 years: 50 mg/day, older children and adolescents: 100 mg/day, and adults: 200 mg/day.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299129\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F157246\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ascorbic Acid: May enhance the adverse/toxic effect of Deferoxamine. Left ventricular dysfunction is of particular concern. Management: Avoid ascorbic acid doses greater than 200 mg/day.  Lower doses may be given to patients without cardiac failure, after one month of regular treatment with deferoxamine alone, ideally soon after setting up the infusion pump.  Monitor cardiac function.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May enhance the adverse/toxic effect of Deferoxamine. Left ventricular dysfunction is of particular concern. Management: Avoid ascorbic acid doses greater than 200 mg/day.  Lower doses may be given to patients without cardiac failure, after one month of regular treatment with deferoxamine alone, ideally soon after setting up the infusion pump.  Monitor cardiac function.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prochlorperazine: Deferoxamine may enhance the adverse/toxic effect of Prochlorperazine. Specifically, prolonged loss of consciousness has been reported.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F157248\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F802788\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline\">",
"     Skeletal anomalies and delayed ossification were observed in some but not all animal reproduction studies. Toxic amounts of iron or deferoxamine have not been noted to cross the placenta. In case of acute iron toxicity, treatment during pregnancy should not be withheld.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1057707\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serum ferritin, iron, total iron binding capacity; CBC with differential, renal function tests, liver function tests,  growth velocity (including weight and height) every 3 months, ophthalmologic exam, and audiometry (with chronic use); blood pressure (with I.V. infusions)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dialysis patients: Serum aluminum (yearly; every 3 months in patients on aluminum-containing medications)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aluminum-induced bone disease: Serum aluminum 2 days following test dose; test is considered positive if serum aluminum increases &ge;50 mcg/L",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F1057711\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iron, serum: Normal: 50-160 mcg/dL; peak levels &gt;500 mcg/dL associated with toxicity. Consider treatment in symptomatic patients with levels &ge;350 mcg/dL; toxicity cannot be excluded with serum iron levels &lt;350 mcg/dL.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aluminum, serum: &lt;20 mcg/L (National Kidney Foundation, 2003)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1057696\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Iron chelator; complexes with trivalent ions (ferric ions) to form ferrioxamine, which is removed by the kidneys; slows accumulation of hepatic iron and retards or eliminates progression of hepatic fibrosis",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1057715\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: I.M., SubQ: Well absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Distributed throughout body fluids",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Plasma enzymes; binds with iron to form ferrioxamine (iron complex)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: 14 hours; plasma: 20-30 minutes (Brittenham, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Primarily urine (as unchanged drug and ferrioxamine); feces (via bile)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dialysis: Dialyzable",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1057705\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?0/59/949?source=see_link\">",
"      see \"Deferoxamine: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May cause dizziness or impairment of vision or hearing; report any hearing loss, night blindness, decreased visual acuity, impaired peripheral vision, or loss of color vision; may cause the urine to turn a reddish color",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Aronoff GR, Bennett WM, Berns JS, et al,",
"      <i>",
"       Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children",
"      </i>",
"      , 5th ed, Philadelphia, PA: American College of Physicians, 2007, 116.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Brittenham GM, &ldquo;Iron-Chelating Therapy for Transfusional Iron Overload,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2011, 364(2):146-56.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/0/37894/abstract-text/21226580/pubmed\" id=\"21226580\" target=\"_blank\">",
"        21226580",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cappellini MD, Cohen A, Eleftheriou A, et al, \"Guidelines for the Clinical Management of Thallassemia,\" 2nd ed, Nicosia, Cyprus: Thalassaemia International Federation, November 2008. Available at file://www.thalassaemia.org.cy/pdf/Guidelines_2nd_revised_edition_EN.pdf",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chang TPY and Rangan C, &ldquo;Iron Poisoning-A Literature-Based Review of Epidemiology, Diagnosis, and Management,&rdquo;",
"      <i>",
"       Pediatr Emerg Care",
"      </i>",
"      , 2011, 27(10):978-85.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/0/37894/abstract-text/21975503/pubmed\" id=\"21975503\" target=\"_blank\">",
"        21975503",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Division of Blood Diseases and Resources, NHLBI, \"The Management of Sickle Cell Disease,\" Bethesda, MD: National Heart, Lung, and Blood Insitute, 2002. Available at",
"      <a href=\"file://www.nhlbi.nih.gov/health/prof/blood/sickle/sc_mngt.pdf\" target=\"_blank\">",
"       file://www.nhlbi.nih.gov/health/prof/blood/sickle/sc_mngt.pdf",
"      </a>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kirking MH, &ldquo;Treatment of Chronic Iron Overload,&rdquo;",
"      <i>",
"       Clin Pharm",
"      </i>",
"      , 1991, 10(10):775-83.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/0/37894/abstract-text/1742962/pubmed\" id=\"1742962\" target=\"_blank\">",
"        1742962",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Manoguerra AS, Erdman AR, Booze LL, et al, \"Iron Ingestion: An Evidence-Based Consensus Guideline for Out-of-Hospital Management,\"",
"      <i>",
"       Clin Toxicol (Phila)",
"      </i>",
"      , 2005, 43(6):553-70.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/0/37894/abstract-text/16255338/pubmed\" id=\"16255338\" target=\"_blank\">",
"        16255338",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Kidney Foundation, \"K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Failure,\"",
"      <i>",
"       Am J Kidney Dis",
"      </i>",
"      , 2003, 42(4 Suppl 3):1-201.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Perrone J, &ldquo;Iron,&rdquo;",
"      <i>",
"       Goldfrank's Toxicologic Emergencies",
"      </i>",
"      , 9th ed, Nelson LS, Hoffman RS, Lewin NA, et al, eds, New York, NY: McGraw-Hill Companies, Inc, 2011.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stiles ML, Allen LV, and Prince SJ, &ldquo;Stability of Deferoxamine Mesylate, Floxuridine, Fluorouracil, Hydromorphone Hydrochloride, Lorazepam, and Midazolam Hydrochloride in Polypropylene Infusion-Pump Syringes,&rdquo;",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 1996, 53(13):1583-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/0/37894/abstract-text/8809281/pubmed\" id=\"8809281\" target=\"_blank\">",
"        8809281",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Valentine K, Mastropietro C, and Sarnaik AP, &ldquo;Infantile Iron Poisoning: Challenges in Diagnosis and Management,&rdquo;",
"      <i>",
"       Pediatr Crit Care Med",
"      </i>",
"      , 2009, 10(3):e31-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/0/37894/abstract-text/19433938/pubmed\" id=\"19433938\" target=\"_blank\">",
"        19433938",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vlachos A, Ball S, Dahl N, et al, \"Diagnosing and Treating Diamond Blackfan Anaemia: Results of an International Clinical Consensus Conference,\"",
"      <i>",
"       Br J Haematol",
"      </i>",
"      , 2008, 142(6):859-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/0/37894/abstract-text/18671700/pubmed\" id=\"18671700\" target=\"_blank\">",
"        18671700",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13208 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-61.234.146.186-6C4A3AC97D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_0_37894=[""].join("\n");
var outline_f37_0_37894=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157271\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157272\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057708\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15898662\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057699\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157252\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157237\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057713\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157319\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057703\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057712\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157321\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157318\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057716\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057698\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057697\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299129\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157246\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157248\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F802788\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057707\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057711\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057696\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057715\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057705\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13208\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13208|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?22/10/22695?source=related_link\">",
"      Deferoxamine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?0/59/949?source=related_link\">",
"      Deferoxamine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_0_37895="Enteral stents for the palliation of malignant gastroduodenal obstruction";
var content_f37_0_37895=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Enteral stents for the palliation of malignant gastroduodenal obstruction",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/0/37895/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/0/37895/contributors\">",
"     Todd H Baron, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/0/37895/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/0/37895/contributors\">",
"     John R Saltzman, MD, FACP, FACG, FASGE",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/0/37895/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/0/37895/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/0/37895/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 21, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Self-expandable metal stents are a nonsurgical alternative for the palliation of luminal gastrointestinal neoplasms, particularly in the esophagus and biliary tract. They also have a role in the palliation of obstruction in other segments of the gastrointestinal tract, such as the stomach, proximal small bowel, and colon (enteral stents).",
"   </p>",
"   <p>",
"    In the Western world, malignant gastric outlet obstruction occurs most commonly from obstruction of the duodenum by pancreatic cancer. Other causes at the level of the duodenum include cholangiocarcinoma and metastatic disease. Malignant gastric obstruction at the level of the stomach due to gastric cancer (primary or postsurgical recurrence) is seen more commonly in Asian countries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/47/44793?source=see_link\">",
"     \"Gastric outlet obstruction in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Gastroduodenal obstruction causes significant morbidity, including nausea, intractable vomiting, esophagitis, electrolyte imbalances, poor nutrition, and severe dehydration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/2\">",
"     2",
"    </a>",
"    ]. In many cases, stenting can provide durable symptom relief without the morbidity associated with palliative surgery, and it may provide a better quality of life compared with other alternatives.",
"   </p>",
"   <p>",
"    This topic will review the role of enteral stents for the palliation of malignant gastroduodenal obstruction. An overview of gastric outlet obstruction, as well as topics on stenting of the esophagus, biliary tract, and colon are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/47/44793?source=see_link\">",
"     \"Gastric outlet obstruction in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/41/6809?source=see_link\">",
"     \"Expandable stents in the treatment of esophageal obstruction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/63/8186?source=see_link\">",
"     \"Endoscopic stenting for malignant pancreaticobiliary obstruction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/34/5673?source=see_link\">",
"     \"Enteral stents for the management of malignant colorectal obstruction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastroduodenal stent placement is used to treat symptomatic patients with an unresectable malignancy or recurrence of malignancy at an anastomotic site. Patients being considered for stent placement should have a short life expectancy (less than two to six months) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. One method for estimating survival uses the World Health Organization (WHO) performance status:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      WHO 0: Fully active",
"     </li>",
"     <li>",
"      WHO 1: Cannot carry out heavy physical work",
"     </li>",
"     <li>",
"      WHO 2: Up and about more than 50 percent of the day",
"     </li>",
"     <li>",
"      WHO 3: Up and about less than 50 percent of the day",
"     </li>",
"     <li>",
"      WHO 4: Bed or chair bound all day",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a study of 105 patients with malignant gastroduodenal obstruction, patients with a performance status [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/3,4\">",
"     3,4",
"    </a>",
"    ] of 3 or 4 had a three-month survival rate of 26 percent, compared with 60 percent for those with a performance status of 0 to 2 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/5\">",
"     5",
"    </a>",
"    ]. Surgical palliation with a gastrojejunal anastomosis should be considered for patients with longer life expectancies (predicted by a WHO performance status of 0 to 2) because it offers better long-term relief compared with stent placement.",
"   </p>",
"   <p>",
"    The goals of stent placement are to provide relief from obstructive symptoms, to allow the patient to resume a normal diet, and to improve the patient&rsquo;s quality of life. As such, stent placement is not indicated for patients with a gastric outlet obstruction who are asymptomatic and are tolerating a normal diet. Other contraindications to stent placement are the presence of multiple sites of small bowel obstruction (since stenting the proximal stricture is unlikely to provide symptom relief) and the presence of free perforation.",
"   </p>",
"   <p>",
"    In addition, patients with peritoneal carcinomatosis may not respond as well to stent placement due to the risk of multiple sites of obstruction, though there are some data to suggest that stents can work in such patients. In a retrospective study of 215 patients undergoing stent placement for malignant gastric outlet obstruction, 116 patients (60 percent) had carcinomatosis and 76 (40 percent) did not [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/6\">",
"     6",
"    </a>",
"    ]. Outcomes were similar for those with and without carcinomatosis with regard to clinical success (81 versus 84 percent, respectively), need for reintervention (18 versus 27 percent, respectively), and major complications (4 percent for both groups).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PREPROCEDURAL CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obtaining a radiographic contrast study to assess the anatomy, length of the stricture, and degree of obstruction may be helpful, especially in cases where it is unclear if the obstruction is functional (ie, is causing symptoms) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/7\">",
"     7",
"    </a>",
"    ]. However, this is often not necessary as a majority of patients will have had recent imaging (such as a computed tomographic scan) that shows the extent of the lesion.",
"   </p>",
"   <p>",
"    Prior to undertaking gastroduodenal stent placement, one should always consider the status of the biliary tree. Coexistent biliary obstruction is commonly present since it typically develops earlier than gastric outlet obstruction (at least in patients with pancreatic cancer) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/8\">",
"     8",
"    </a>",
"    ]. If there is known or impending biliary obstruction, an expandable metal biliary stent should be placed prior to placing the duodenal stent because it is difficult to obtain biliary tree access once a duodenal stent has been placed across the papilla [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. A percutaneous transhepatic or endoscopic ultrasound-guided approach may be required to treat a biliary obstruction that develops after duodenal stent placement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/63/8186?source=see_link\">",
"     \"Endoscopic stenting for malignant pancreaticobiliary obstruction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DEVICES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Duodenal self-expandable metal stents (SEMS) are used for the palliation of malignant gastroduodenal obstruction. SEMS may be covered or uncovered. Covered stents offer the advantage of less tumor ingrowth, but are more prone to migration than uncovered stents and are less flexible. Because of this, uncovered stents are generally used for the treatment of malignant gastric outlet obstruction. Uncovered stents are less prone to migration and are more flexible. In addition, uncovered stents allow for bile flow through the mesh in patients with previously placed biliary stents. However, tumor ingrowth is more common with uncovered stents. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/41/6809?source=see_link&amp;anchor=H4130516#H4130516\">",
"     \"Expandable stents in the treatment of esophageal obstruction\", section on 'Self-expandable metal stents'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Dedicated duodenal stents available in the United States are all uncovered, have delivery systems of small diameter that can be passed through the working channel of a therapeutic endoscope, are long enough to be passed through a colonoscope [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/12,13\">",
"     12,13",
"    </a>",
"    ], and are reconstrainable up to a certain point during deployment. These include the Wallstent Colonic and Duodenal Endoprosthesis, the WallFlex Duodenal Stent (Boston Scientific, Natick, Massachusetts), and the Evolution Duodenal Stent (Cook Endoscopy, Winston-Salem, NC). The Wallstent Colonic and Duodenal Endoprosthesis is made from a composite material, Elgiloy, and is unflanged. It is available in diameters from 20 to 22 mm and in lengths of 6 and 9 cm. [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The WallFlex Duodenal Stent is composed of nitinol, which is more flexible than the metals used in the Wallstent. The WallFlex stent has a diameter of 22 mm through its body, with a 27 mm proximal flare. It is available in lengths of 6, 9, and 12 cm. More recently, the Evolution Duodenal Stent has become available in the United States. It is composed of nitinol and has lengths of 6, 9, and 12 cm. It is unique in that it has both proximal and distal flanges of 27 mm and has a midbody diameter of 22 mm. There are many other stents available outside the US, some of which are covered, and these are anticipated to be introduced into the US marketplace sometime in the future.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PLACEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H146133458\">",
"    <span class=\"h2\">",
"     Personnel",
"    </span>",
"    &nbsp;&mdash;&nbsp;Duodenal stents should be placed by therapeutic endoscopists who are experienced with the placement techniques in a room equipped with fluoroscopy. [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/14\">",
"     14",
"    </a>",
"    ]. It is imperative to have a gastrointestinal assistant who is familiar with complex therapeutic endoscopic procedures, such as endoscopic retrograde cholangiopancreatography (ERCP) with placement of self-expandable metal biliary stents.",
"   </p>",
"   <p>",
"    The duration of the procedure is highly variable and depends upon the degree of difficulty encountered traversing or accessing the stricture. At least one full hour of time should be allotted once sedation is administered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H146133473\">",
"    <span class=\"h2\">",
"     Sedation requirements and patient preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Standard moderate procedural sedation with an opiate (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/44/11976?source=see_link\">",
"     meperidine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    ) and benzodiazepine (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    ) is usually sufficient. The majority of patients can be discharged following the procedure without the need for hospitalization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/22/24936?source=see_link\">",
"     \"Overview of procedural sedation for gastrointestinal endoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The patient should be placed in the left lateral decubitus or prone position to minimize the risk of aspiration due to retained gastric contents. A prone position allows for a better anatomic view under fluoroscopy. The supine position should be avoided (unless the patient is endotracheally intubated or the gastric contents have been completely evacuated) because of the high risk of aspiration. Patients should take nothing by mouth for at least four hours prior to the procedure, and should not eat solid foods for at least six hours prior to the procedure. However, since these patients have gastric outlet obstructions, gastric clearance times are prolonged. We initiate a clear liquid diet one or two days before the procedure to allow emptying of retained solids. Some authors suggest insertion of a nasogastric tube 24 to 48 hours prior to the procedure to remove gastric contents in the presence of complete gastric outlet obstruction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H146133437\">",
"    <span class=\"h2\">",
"     Predeployment evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;As the endoscope is passed to the site of obstruction, a gentle attempt should be made to pass it through the obstruction. Excessive force or aggressive dilation of the stricture increases the risk of perforation and should be avoided in most cases, since stent placement can usually be performed without the endoscope traversing the obstruction. If the endoscope does pass, it should be used to measure the length of the obstruction, so that an appropriate stent can be chosen. If the endoscope is unable to pass through the lesion, the length of the obstruction can be determined fluoroscopically by contrast injection. However, if the goal is to reach the papilla for the treatment of concomitant biliary obstruction, the duodenal obstruction may need to be traversed. In such cases, dilation may be required [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The stent chosen should be at least three to four centimeters longer than the obstruction because stents will shorten after deployment. Choosing a stent that is three to four centimeters longer than the obstruction increases the likelihood of an adequate margin of stent at the proximal and distal ends of the obstruction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H146133430\">",
"    <span class=\"h2\">",
"     Stent deployment",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the endoscope passes easily through the lesion, a 0.035 inch guidewire with a floppy tip is placed through the endoscope channel and passed at least 20 cm distal to the obstruction. If the diameter of the endoscope channel is large enough to allow the stent delivery system to pass (typically 3.7 mm or greater), the stent is placed over the guidewire and then advanced through the endoscope. It is then placed across the obstruction under endoscopic and fluoroscopic guidance.",
"   </p>",
"   <p>",
"    If the stent delivery system is too large to pass through the endoscope channel (eg, nondedicated duodenal stents such as esophageal stents), a much stiffer 0.035 or 0.038 inch guidewire is placed and the endoscope is withdrawn, leaving the guidewire in place. The stent is then loaded onto the guidewire and advanced fluoroscopically to the obstruction. The endoscope can then be reinserted alongside the stent delivery system to allow endoscopic guidance during deployment.",
"   </p>",
"   <p>",
"    If the endoscope cannot be passed easily through the lesion, a hydrophilic biliary guidewire preloaded through standard biliary accessories can be used to traverse the stricture, as is done during ERCP. Once the wire has passed through the stricture as demonstrated fluoroscopically (which can be recognized by the anatomically correct position of the wire passing into an air-filled distal bowel loop",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    injection of contrast), the catheter is advanced over the guidewire through the obstructing lesion. Water-soluble radiographic contrast is injected to confirm both proper position and to assess stricture length. The predeployed stent is passed over the guidewire and the procedure is continued as described above.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H146133444\">",
"    <span class=\"h2\">",
"     Postdeployment evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the stent is fully deployed, the ends of the stent should be carefully inspected fluoroscopically. If either end of the stent is not flared or expanded to produce a \"waist\" within the obstructing lesion, the endoscopist should be suspicious that the chosen stent may be too short to traverse the entire length of the stricture. At this point, contrast can be injected into the stent to assess complete patency. If needed, a second (and rarely a third) overlapping stent can be placed to adequately treat the stricture. In general, if the endoscope does not need to be passed through the stent immediately after deployment (which may be required if the papilla needs to be accessed for management of the biliary tree), passage of the endoscope through the stent should be avoided. Passage of the endoscope through the stent before the stent has fully expanded may lead to stent displacement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34234103\">",
"    <span class=\"h1\">",
"     POSTPROCEDURAL CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complete stent expansion usually occurs in 24 to 48 hours, though with very tight strictures expansion may take longer or the stent may not fully expand. Patients are allowed to ingest liquids following the procedure and to then cautiously advance their diet to a low-residue diet (",
"    <a class=\"graphic graphic_table graphicRef51448 \" href=\"mobipreview.htm?17/2/17453\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/8\">",
"     8",
"    </a>",
"    ]. However, there are limited data for guiding the optimal dietary approach and some patients can tolerate a normal diet [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/8\">",
"     8",
"    </a>",
"    ]. Patients with complete, prolonged obstruction may have a delay in return of normal gastric motility. In addition, factors such as neural involvement by tumor, prior gastric resection, and placement of the proximal end of the stent within the antrum rather than entirely in the duodenum (which maintains a functional pylorus) may determine which diet can be tolerated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     EFFICACY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stents can be placed successfully in over 90 percent of patients, with clinical success rates typically 80 percent or higher [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/17-23\">",
"     17-23",
"    </a>",
"    ]. Technical failure is usually due to the inability to pass a guidewire through the stricture, anatomic difficulties such as severe looping within the dilated stomach, or complicated postsurgical anatomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Published experience with enteral stenting for gastroduodenal obstruction is derived mostly from observational studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/8,13,17,20,21,23-44\">",
"     8,13,17,20,21,23-44",
"    </a>",
"    ], though small randomized trials have compared stent placement with surgical bypass for palliation of malignant gastric outlet obstruction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/3,45\">",
"     3,45",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one randomized trial, 39 patients with malignant gastric outlet obstruction were assigned to either gastrojejunostomy (18 patients) or enteral stent placement (21 patients) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/3\">",
"       3",
"      </a>",
"      ]. Food intake improved more rapidly in the stent group compared with the surgery group (median five versus eight days), but long-term relief was worse in the stent group (median duration of relief 50 versus 72 days). Major complications were more common in the stent group (six complications in four patients compared with no major complications in the surgical group). There were no differences in the groups with regard to survival or health-related quality of life scores.",
"     </li>",
"     <li>",
"      In a second randomized trial, 18 patients were assigned to endoscopic stent placement or surgical bypass. Endoscopic stenting was superior to surgery with regard to median operative time (40 versus 93 min), mean time to restoration of oral intake (2.1 versus 6.3 days), and median length of hospital stay (3.1 versus 10 days). There were no significant differences between the groups with regard to morbidity, mortality, gastric emptying, or clinical outcomes at three-month follow-up.",
"     </li>",
"     <li>",
"      Observational studies suggest that enteral stenting has a success rate similar to surgical palliation (with approximately 90 percent of patients improving clinically) and is associated with less morbidity, procedure-related mortality, and cost [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/13,18,22,35,46,47\">",
"       13,18,22,35,46,47",
"      </a>",
"      ]. Furthermore, some studies suggest that stenting may achieve a better quality of life compared with other forms of palliation (such as non-oral feeding through a jejunostomy tube) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/25,48,49\">",
"       25,48,49",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following conclusions were reached in a systematic review of 44 studies that evaluated enteral stenting versus gastrojejunostomy (1046 patients received a stent and 297 underwent gastrojejunostomy) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/18\">",
"     18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There were no significant differences between stent placement and gastrojejunostomy for technical success (96 versus 100 percent), early complications (7 versus 6 percent), late major complications (18 versus 17 percent), or persisting symptoms (8 versus 9 percent)",
"     </li>",
"     <li>",
"      Initial clinical success was higher after stent placement (89 versus 72 percent)",
"     </li>",
"     <li>",
"      Recurrent obstructive symptoms were more common after stent placement (18 versus 1 percent)",
"     </li>",
"     <li>",
"      Mean survival was 105 days after stent placement and 164 days after gastrojejunostomy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite initial success, 15 to 40 percent of patients require reintervention for recurrent symptoms or biliary obstruction following stent placement, whereas reintervention rates are generally lower in patients who undergo gastrojejunostomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/3,18,47,50\">",
"     3,18,47,50",
"    </a>",
"    ]. Furthermore, some patients may not improve even after successful stent placement. This may occur because of unidentified distal sites of malignant obstruction, diffuse peritoneal carcinomatosis with bowel encasement, or functional gastric outlet obstruction from neural (celiac axis) tumor involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/7,8,11\">",
"     7,8,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several complications can occur during or after duodenal stent placement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/51\">",
"     51",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intraprocedural complications include those related to sedation, pulmonary aspiration, stent malposition, perforation, and bleeding",
"     </li>",
"     <li>",
"      Late complications include distal stent migration, stent occlusion, bleeding, perforation, and fistula formation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the systematic review described above, there was no procedure-related mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/19\">",
"     19",
"    </a>",
"    ]. Severe complications (bleeding and perforation) were observed in seven patients (1.2 percent). Stent migration was reported in 31 patients (5 percent) and stent obstruction occurred in 104 cases (18 percent), mainly due to tumor infiltration.",
"   </p>",
"   <p>",
"    Obstruction of the stents by tumor ingrowth or overgrowth either due to malignant or benign tissue is usually managed by placement of additional stents through the original stents. There are currently no data concerning the safety of gastroduodenal stenting in patients who have undergone or are receiving radiation therapy, a setting in which stenting may be riskier [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37895/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Malignant gastroduodenal obstruction can cause significant morbidity, including nausea, intractable vomiting, esophagitis, electrolyte imbalances, poor nutrition, and severe dehydration. Stenting can provide acceptable palliation without the morbidity associated with palliative surgery and may provide a better quality of life compared with other alternatives. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients being considered for stenting should have a short life expectancy (less than two to six months). Surgical palliation with a gastrojejunal anastomosis should be considered for patients with longer life expectancies because it offers better long-term relief compared with stent placement. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Published experience with enteral stent placement suggests that it has a success rate similar to surgical palliation (with approximately 90 percent of patients improving clinically), but is associated with less morbidity, procedure-related mortality, and cost. However, 15 to 40 percent of patients require reintervention for recurrent symptoms or biliary obstruction. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Efficacy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several complications can occur during or after placement of the stents. Intraprocedural complications include complications of conscious sedation, pulmonary aspiration, stent malposition, perforation, and bleeding. Late complications include distal stent migration, stent occlusion, bleeding, perforation, and fistula formation. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/1\">",
"      Shone DN, Nikoomanesh P, Smith-Meek MM, Bender JS. Malignancy is the most common cause of gastric outlet obstruction in the era of H2 blockers. Am J Gastroenterol 1995; 90:1769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/2\">",
"      Patton JT, Carter R. Endoscopic stenting for recurrent malignant gastric outlet obstruction. Br J Surg 1997; 84:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/3\">",
"      Jeurnink SM, Steyerberg EW, van Hooft JE, et al. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc 2010; 71:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/4\">",
"      van Heek NT, van Geenen RC, Busch OR, Gouma DJ. Palliative treatment in \"peri\"-pancreatic carcinoma: stenting or surgical therapy? Acta Gastroenterol Belg 2002; 65:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/5\">",
"      van Hooft JE, Dijkgraaf MG, Timmer R, et al. Independent predictors of survival in patients with incurable malignant gastric outlet obstruction: a multicenter prospective observational study. Scand J Gastroenterol 2010; 45:1217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/6\">",
"      Mendelsohn RB, Gerdes H, Markowitz AJ, et al. Carcinomatosis is not a contraindication to enteral stenting in selected patients with malignant gastric outlet obstruction. Gastrointest Endosc 2011; 73:1135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/7\">",
"      Baron TH, Sch&ouml;fl R, Puespoek A, Sakai Y. Expandable metal stent placement for gastric outlet obstruction. Endoscopy 2001; 33:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/8\">",
"      Adler DG, Baron TH. Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J Gastroenterol 2002; 97:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/9\">",
"      Mutignani M, Tringali A, Shah SG, et al. Combined endoscopic stent insertion in malignant biliary and duodenal obstruction. Endoscopy 2007; 39:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/10\">",
"      Baron TH. Management of simultaneous biliary and duodenal obstruction: the endoscopic perspective. Gut Liver 2010; 4 Suppl 1:S50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/11\">",
"      Baron TH. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med 2001; 344:1681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/12\">",
"      Jeurnink SM, Repici A, Luigiano C, et al. Use of a colonoscope for distal duodenal stent placement in patients with malignant obstruction. Surg Endosc 2009; 23:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/13\">",
"      Mauro MA, Koehler RE, Baron TH. Advances in gastrointestinal intervention: the treatment of gastroduodenal and colorectal obstructions with metallic stents. Radiology 2000; 215:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/14\">",
"      Baron TH. Optimizing endoscopic placement of expandable stents throughout the GI tract. Expert Rev Gastroenterol Hepatol 2008; 2:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/15\">",
"      Weaver DW, Wiencek RG, Bouwman DL, Walt AJ. Gastrojejunostomy: is it helpful for patients with pancreatic cancer? Surgery 1987; 102:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/16\">",
"      Bo&scaron;koski I, Tringali A, Familiari P, et al. Self-expandable metallic stents for malignant gastric outlet obstruction. Adv Ther 2010; 27:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/17\">",
"      van Hooft JE, Uitdehaag MJ, Bruno MJ, et al. Efficacy and safety of the new WallFlex enteral stent in palliative treatment of malignant gastric outlet obstruction (DUOFLEX study): a prospective multicenter study. Gastrointest Endosc 2009; 69:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/18\">",
"      Jeurnink SM, van Eijck CH, Steyerberg EW, et al. Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review. BMC Gastroenterol 2007; 7:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/19\">",
"      Dormann A, Meisner S, Verin N, Wenk Lang A. Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy 2004; 36:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/20\">",
"      Holt AP, Patel M, Ahmed MM. Palliation of patients with malignant gastroduodenal obstruction with self-expanding metallic stents: the treatment of choice? Gastrointest Endosc 2004; 60:1010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/21\">",
"      Kaw M, Singh S, Gagneja H, Azad P. Role of self-expandable metal stents in the palliation of malignant duodenal obstruction. Surg Endosc 2003; 17:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/22\">",
"      Masci E, Viale E, Mangiavillano B, et al. Enteral self-expandable metal stent for malignant luminal obstruction of the upper and lower gastrointestinal tract: a prospective multicentric study. J Clin Gastroenterol 2008; 42:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/23\">",
"      Piesman M, Kozarek RA, Brandabur JJ, et al. Improved oral intake after palliative duodenal stenting for malignant obstruction: a prospective multicenter clinical trial. Am J Gastroenterol 2009; 104:2404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/24\">",
"      Binkert CA, Jost R, Steiner A, Zollikofer CL. Benign and malignant stenoses of the stomach and duodenum: treatment with self-expanding metallic endoprostheses. Radiology 1996; 199:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/25\">",
"      Kim JH, Yoo BM, Lee KJ, et al. Self-expanding coil stent with a long delivery system for palliation of unresectable malignant gastric outlet obstruction: a prospective study. Endoscopy 2001; 33:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/26\">",
"      Maetani I, Inoue H, Sato M, et al. Peroral insertion techniques of self-expanding metal stents for malignant gastric outlet and duodenal stenoses. Gastrointest Endosc 1996; 44:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/27\">",
"      Song GA, Kang DH, Kim TO, et al. Endoscopic stenting in patients with recurrent malignant obstruction after gastric surgery: uncovered versus simultaneously deployed uncovered and covered (double) self-expandable metal stents. Gastrointest Endosc 2007; 65:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/28\">",
"      Kim TO, Kang DH, Kim GH, et al. Self-expandable metallic stents for palliation of patients with malignant gastric outlet obstruction caused by stomach cancer. World J Gastroenterol 2007; 13:916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/29\">",
"      Feretis C, Benakis P, Dimopoulos C, et al. Palliation of malignant gastric outlet obstruction with self-expanding metal stents. Endoscopy 1996; 28:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/30\">",
"      Keymling M, Wagner HJ, Vakil N, Knyrim K. Relief of malignant duodenal obstruction by percutaneous insertion of a metal stent. Gastrointest Endosc 1993; 39:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/31\">",
"      Soetikno RM, Lichtenstein DR, Vandervoort J, et al. Palliation of malignant gastric outlet obstruction using an endoscopically placed Wallstent. Gastrointest Endosc 1998; 47:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/32\">",
"      Espinel J, Sanz O, Vivas S, et al. Malignant gastrointestinal obstruction: endoscopic stenting versus surgical palliation. Surg Endosc 2006; 20:1083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/33\">",
"      Feretis C, Benakis P, Dimopoulos C, et al. Duodenal obstruction caused by pancreatic head carcinoma: palliation with self-expandable endoprostheses. Gastrointest Endosc 1997; 46:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/34\">",
"      Maire F, Hammel P, Ponsot P, et al. Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas. Am J Gastroenterol 2006; 101:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/35\">",
"      Yim HB, Jacobson BC, Saltzman JR, et al. Clinical outcome of the use of enteral stents for palliation of patients with malignant upper GI obstruction. Gastrointest Endosc 2001; 53:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/36\">",
"      Schiefke I, Zabel-Langhennig A, Wiedmann M, et al. Self-expandable metallic stents for malignant duodenal obstruction caused by biliary tract cancer. Gastrointest Endosc 2003; 58:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/37\">",
"      Lindsay JO, Andreyev HJ, Vlavianos P, Westaby D. Self-expanding metal stents for the palliation of malignant gastroduodenal obstruction in patients unsuitable for surgical bypass. Aliment Pharmacol Ther 2004; 19:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/38\">",
"      Mittal A, Windsor J, Woodfield J, et al. Matched study of three methods for palliation of malignant pyloroduodenal obstruction. Br J Surg 2004; 91:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/39\">",
"      Maetani I, Akatsuka S, Ikeda M, et al. Self-expandable metallic stent placement for palliation in gastric outlet obstructions caused by gastric cancer: a comparison with surgical gastrojejunostomy. J Gastroenterol 2005; 40:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/40\">",
"      Mehta S, Hindmarsh A, Cheong E, et al. Prospective randomized trial of laparoscopic gastrojejunostomy versus duodenal stenting for malignant gastric outflow obstruction. Surg Endosc 2006; 20:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/41\">",
"      Kim JH, Song HY, Shin JH, et al. Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients. Gastrointest Endosc 2007; 66:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/42\">",
"      Telford JJ, Carr-Locke DL, Baron TH, et al. Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: outcomes from a multicenter study. Gastrointest Endosc 2004; 60:916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/43\">",
"      Nassif T, Prat F, Meduri B, et al. Endoscopic palliation of malignant gastric outlet obstruction using self-expandable metallic stents: results of a multicenter study. Endoscopy 2003; 35:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/44\">",
"      Shaw JM, Bornman PC, Krige JE, et al. Self-expanding metal stents as an alternative to surgical bypass for malignant gastric outlet obstruction. Br J Surg 2010; 97:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/45\">",
"      Fiori E, Lamazza A, Volpino P, et al. Palliative management of malignant antro-pyloric strictures. Gastroenterostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Res 2004; 24:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/46\">",
"      Cho YK, Kim SW, Hur WH, et al. Clinical outcomes of self-expandable metal stent and prognostic factors for stent patency in gastric outlet obstruction caused by gastric cancer. Dig Dis Sci 2010; 55:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/47\">",
"      Jeurnink SM, Steyerberg EW, Hof Gv, et al. Gastrojejunostomy versus stent placement in patients with malignant gastric outlet obstruction: a comparison in 95 patients. J Surg Oncol 2007; 96:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/48\">",
"      Shike M, Latkany L, Gerdes H, Bloch AS. Direct percutaneous endoscopic jejunostomies for enteral feeding. Gastrointest Endosc 1996; 44:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/49\">",
"      Giuliano AW, Yoon HC, Lomis NN, Miller FJ. Fluoroscopically guided percutaneous placement of large-bore gastrostomy and gastrojejunostomy tubes: review of 109 cases. J Vasc Interv Radiol 2000; 11:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/50\">",
"      Lillemoe KD, Cameron JL, Hardacre JM, et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 1999; 230:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37895/abstract/51\">",
"      Baron TH. Minimizing endoscopic complications: endoluminal stents. Gastrointest Endosc Clin N Am 2007; 17:83.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2676 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-41.78.124.10-AD1D6AEAC5-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_0_37895=[""].join("\n");
var outline_f37_0_37895=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PREPROCEDURAL CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DEVICES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PLACEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H146133458\">",
"      Personnel",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H146133473\">",
"      Sedation requirements and patient preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H146133437\">",
"      Predeployment evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H146133430\">",
"      Stent deployment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H146133444\">",
"      Postdeployment evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34234103\">",
"      POSTPROCEDURAL CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      EFFICACY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2676\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2676|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/2/17453\" title=\"table 1\">",
"      Dietary fiber in foods",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/63/8186?source=related_link\">",
"      Endoscopic stenting for malignant pancreaticobiliary obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/34/5673?source=related_link\">",
"      Enteral stents for the management of malignant colorectal obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/41/6809?source=related_link\">",
"      Expandable stents in the treatment of esophageal obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/47/44793?source=related_link\">",
"      Gastric outlet obstruction in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/22/24936?source=related_link\">",
"      Overview of procedural sedation for gastrointestinal endoscopy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_0_37896="Hemoptysis in children";
var content_f37_0_37896=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hemoptysis in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/0/37896/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/0/37896/contributors\">",
"     Diana R Quintero, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/0/37896/contributors\">",
"     Leland L Fan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/0/37896/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/0/37896/contributors\">",
"     George B Mallory, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/0/37896/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/0/37896/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/0/37896/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemoptysis is defined as the expectoration of blood or the presence of blood in the sputum. Young children usually swallow their sputum; as a result, hemoptysis is rare in children unless the bleeding is substantial [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The age of presentation is bimodal, with a frequency peaks in children less than five years of age and in adolescents 11 years or older [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In adults, the severity of hemoptysis is classified based upon the estimated volume of blood expectorated. In pediatric patients with hemoptysis, no such classification correlating severity with blood loss exists. Thus, clinical judgment is the primary tool that clinicians have in assessing the severity of hemoptysis in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lung contains two separate blood supplies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The pulmonary arterial circulation is a high volume, low pressure system in which maximal pressures normally do not exceed 40 mmHg [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/5\">",
"       5",
"      </a>",
"      ]. Its branches accompany the bronchi down to the level of the terminal bronchioles. Ultimately, pulmonary vessels branch to supply the capillary bed in the walls of the alveoli and then return to the left atrium via the pulmonary veins.",
"     </li>",
"     <li>",
"      The bronchial circulation carries a much smaller volume of oxygenated blood, but does so at higher, systemic pressures. Usually, the patient has three recognizable bronchial arteries, two that supply the left lung and one that supplies the right, although 20 to 30 percent of individuals have two vessels on each side [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/6\">",
"       6",
"      </a>",
"      ]. These arteries typically originate from the aorta or the intercostal arteries and perfuse conductive airways approximately to the level of the terminal bronchioles.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Bleeding can arise from either system. Although bleeding usually is minimal when it arises from the pulmonary circulation (eg, in the presence of left sided cardiac disease), it can be substantial when it arises from the bronchial circulation because of the higher hydrostatic pressures promoting hemorrhage.",
"   </p>",
"   <p>",
"    Mechanical trauma secondary to forceful cough can produce hemoptysis characterized by blood-streaked sputum; it tends to occur with an acute respiratory infection and usually is benign and self limited. Foreign bodies can cause hemoptysis arising from bronchial circulation by direct injury to the bronchial wall.",
"   </p>",
"   <p>",
"    In patients with bronchiectasis, chronic bacterial colonization produces a change of the ciliated epithelial lining to a stratified squamous epithelium with areas of granulation tissue. Cough and recurrent infection damage the airway wall, while the supplying bronchial blood vessels become dilated and tortuous and develop extensive fragile bronchopulmonary anastomoses. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/10/12458?source=see_link\">",
"     \"Clinical manifestations and diagnosis of bronchiectasis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the term hemoptysis refers to expectoration of blood originating from the lower respiratory tract, blood from the upper respiratory tract, the nasopharynx, and the upper gastrointestinal tract can be expectorated and can mimic blood coming from the lower respiratory tract.",
"   </p>",
"   <p>",
"    The causes of hemoptysis in children are outlined in the table (",
"    <a class=\"graphic graphic_table graphicRef62214 \" href=\"mobipreview.htm?13/57/14238\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/7-11\">",
"     7-11",
"    </a>",
"    ]. In children, respiratory infection, aspirated foreign bodies, and bronchiectasis are the most common etiologies. In some cases, hemoptysis is related to a specific exposure, including medications (",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?9/41/9882?source=see_link\">",
"     amiodarone",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?14/50/15142?source=see_link\">",
"     propylthiouracil",
"    </a>",
"    , or",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?6/26/6566?source=see_link\">",
"     penicillamine",
"    </a>",
"    ), or inhalation (nitrogen dioxide, pesticides, or cocaine). Several case reports describe hemoptysis due to inhalation of nitrogen dioxide in ice arenas with malfunctioning ice resurfacing and ventilation equipment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/24/14727?source=see_link&amp;anchor=H5#H5\">",
"     \"Etiology and evaluation of hemoptysis in adults\", section on 'Pulmonary parenchymal diseases'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Airways diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;In previously healthy patients, infection and foreign body aspiration are the most common causes of hemoptysis, as the majority of cases occur in children younger than four years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/8,13,14\">",
"     8,13,14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Bronchiectasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchiectasis, including that which occurs as a sequel of cystic fibrosis (CF), is another important etiology. In a series of 228 patients admitted to a tertiary center with hemoptysis, 65 percent had CF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/15\">",
"     15",
"    </a>",
"    ]. Children and young adults with CF frequently experience small-volume hemoptysis with blood-streaked sputum, particularly during pulmonary exacerbations. Over time, up to 60 percent of patients older than 18 years of age with CF have blood-streaked sputum in intermittent episodes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/16\">",
"     16",
"    </a>",
"    ]. Rupture of a bronchial vessel may cause massive hemoptysis in approximately 5 to 7 percent of adults with CF. Coagulopathy secondary to vitamin K deficiency caused by fat malabsorption may exacerbate hemoptysis in this population. Patients with bronchiectasis attributable to causes other than CF have an incidence of hemoptysis of approximately 10 to 15 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/45/27351?source=see_link\">",
"     \"Cystic fibrosis: Clinical manifestations of pulmonary disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/39/44662?source=see_link\">",
"     \"Clinical manifestations and evaluation of bronchiectasis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/43/16057?source=see_link\">",
"     \"Causes of bronchiectasis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8221348\">",
"    <span class=\"h3\">",
"     Foreign body aspiration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Foreign body aspiration is common in children, especially in those under three years. In a substantial minority of cases the aspiration is not initially recognized, and the child may present days or weeks after the aspiration event with wheezing, chronic cough or hemoptysis. A history of choking is highly suggestive of foreign body aspiration, but the event may not be recalled at the time of presentation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/33/2585?source=see_link\">",
"     \"Airway foreign bodies in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8221307\">",
"    <span class=\"h3\">",
"     Trauma from suctioning",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children with endotracheal or tracheostomy tubes, deep suctioning can lead to mucosal injury of central airways, resulting in bloody sputum. Ten percent of these children may have significant bleeding, and bronchoscopy findings include mucosal abrasions or granulation tissue. Use of humidification and soft suction catheters may help these lesions to heal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/17\">",
"     17",
"    </a>",
"    ]. Massive hemoptysis can occur in the rare instance of an airway tube eroding into a large vessel in the mediastinum or tracheal wall.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Pulmonary parenchymal diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Causes of bleeding originating from the pulmonary parenchyma fall into several major categories:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infection, especially tuberculosis, pneumonia, aspergilloma, and lung abscess. Hemoptysis, which can be life-threatening, complicates the course of 50 to 85 percent of patients with an aspergilloma. Another important but rare cause of hemoptysis is acute histoplasmosis, which can produce massive hemoptysis in otherwise healthy children [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/18\">",
"       18",
"      </a>",
"      ]. Influenza virus, including H1N1 influenza A, has been reported to present with significant bleeding [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/19-22\">",
"       19-22",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/56/22408?source=see_link\">",
"       \"Clinical manifestations and diagnosis of chronic pulmonary aspergillosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Inflammatory or immune disorders, including anti-glomerular basement membrane disease (Goodpasture), idiopathic pulmonary hemosiderosis, lupus pneumonitis, and granulomatosis with polyangiitis (Wegener&rsquo;s granulomatosis). Pulmonary capillaritis is an under-recognized cause of diffuse alveolar hemorrhage in children [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/23,24\">",
"       23,24",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/31/27130?source=see_link&amp;anchor=H14577579#H14577579\">",
"       \"Differential diagnosis and evaluation of glomerular disease\", section on 'Acute glomerulonephritis and pulmonary hemorrhage'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/51/12089?source=see_link\">",
"       \"Idiopathic pulmonary hemosiderosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/34/42534?source=see_link\">",
"       \"Pulmonary manifestations of systemic lupus erythematosus in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/62/17386?source=see_link\">",
"       \"Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/61/23512?source=see_link\">",
"       \"The diffuse alveolar hemorrhage syndromes\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A coagulopathy, such as von Willebrand disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/25\">",
"       25",
"      </a>",
"      ] or thrombocytopenia, or the use of anticoagulants [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/26\">",
"       26",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/40/3722?source=see_link\">",
"       \"Approach to the child with bleeding symptoms\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Acute idiopathic pulmonary hemorrhage of infancy (AIPH) is defined as an onset of pulmonary hemorrhage in a previously healthy infant less than one year of age, where no other causes for bleeding can be found [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/27\">",
"       27",
"      </a>",
"      ]. The infants present with hemoptysis or blood in the nose or upper airway with no evidence of upper respiratory or gastrointestinal bleeding [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/28\">",
"       28",
"      </a>",
"      ]. A possible association has been suggested between AIPH and exposure to Stachybotrys chartarum (S. atra), a mold found in damp ceilings and basements. However, the strength of this association is disputed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/27,29\">",
"       27,29",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/51/12089?source=see_link\">",
"       \"Idiopathic pulmonary hemosiderosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Pulmonary vascular disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although this category overlaps with pulmonary parenchymal disease, the disorders mentioned below are those in which the primary pathology is intrinsic to the pulmonary vasculature or affects the pressure within these vessels.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pulmonary embolism, which is rare in children younger than 15 years of age (incidence of 0.2 cases per 100,000",
"      <span class=\"nowrap\">",
"       children/year)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/30\">",
"       30",
"      </a>",
"      ]. This may present with dyspnea, pleuritic pain, cough,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hemoptysis.",
"     </li>",
"     <li>",
"      Pulmonary arteriovenous malformations, either with or without underlying hereditary hemorrhagic telangiectasia (also known as Osler-Weber-Rendu syndrome). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/0/27656?source=see_link\">",
"       \"Pulmonary arteriovenous malformations: Epidemiology, etiology, pathology, and clinical features\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/31/31226?source=see_link\">",
"       \"Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Iatrogenic, primarily resulting from pulmonary artery perforation from a Swan-Ganz catheter. Although this is a rare complication, it can be associated with massive bleeding and death [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cardiac hemoptysis is a known complication in patients with congenital heart disease (CHD). This symptom may account for up to 4.5 percent of cases of CHD presenting to the emergency department [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/32\">",
"       32",
"      </a>",
"      ]. Underlying defects that lead to hemoptysis include tetralogy of Fallot, Eisenmenger&rsquo;s syndrome, pulmonary venous obstruction, and aortopulmonary malformations [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/32\">",
"       32",
"      </a>",
"      ]. In patients with CHD, poor pulmonary flow leads to pulmonary hypertension as well as the development of aortopulmonary collaterals. These collaterals may eventually bleed into the airway and cause massive hemoptysis. Elevated pulmonary capillary pressure may also be seen with mitral stenosis or significant left ventricular failure.",
"      <br/>",
"      <br/>",
"      Hemoptysis caused by congenital heart defects has become less common with the evolution of early corrective cardiac surgery. However, there are several case reports of children presenting with massive hemoptysis caused by collateral neovascularization that was a long-term complication of the Fontan procedure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/3,33-35\">",
"       3,33-35",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Cryptogenic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many patients with hemoptysis have no cause identified even after careful evaluation; these patients are classified as having either cryptogenic or idiopathic hemoptysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/36\">",
"     36",
"    </a>",
"    ]. Previously healthy infants have developed significant hemoptysis and respiratory failure requiring mechanical ventilation, without apparent cause; after resolution of the acute episode, they had no recurrence of hemoptysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Factitious hemoptysis, where children have inflicted injuries mimicking pulmonary bleeding, has been described [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/38\">",
"     38",
"    </a>",
"    ]. Munchausen syndrome (or Munchausen syndrome by proxy) should be considered in a patient who presents with hemoptysis, unusual symptoms, and a negative evaluation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/39\">",
"     39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/21/7512?source=see_link\">",
"     \"Factitious disorder and Munchausen syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/16/36104?source=see_link\">",
"     \"Munchausen syndrome by proxy (medical child abuse)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;An overview of the evaluation of a patient with hemoptysis is shown in the algorithm (",
"    <a class=\"graphic graphic_algorithm graphicRef81459 \" href=\"mobipreview.htm?0/63/1008\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Initial efforts should attempt to localize the bleeding source to either the gastrointestinal tract or the upper or lower respiratory tract:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In hemoptysis, blood usually is bright red or rust colored, and it can be frothy and mixed with sputum. The pH usually is alkaline. Symptoms include coughing or a gurgling noise perceived by the patient. Older children may report discomfort in one hemithorax that may help localize the bleeding site.",
"     </li>",
"     <li>",
"      In contrast, with hematemesis, blood usually is crimson or brown with a coffee-ground appearance and may contain food particles. The pH is acidic, and nausea or retching may precede the episode.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     History and associated findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the patient is stable, a thorough history should be sought, with attention to the following details:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Blood streaking of mucopurulent sputum often suggests tracheobronchitis.",
"     </li>",
"     <li>",
"      Fever or chills accompanying blood-streaked purulent sputum suggest pneumonia, whereas putrid-smelling sputum raises the possibility of lung abscess.",
"     </li>",
"     <li>",
"      A history of a choking episode suggests the possibility of a tracheal foreign body, even if it occurred several days or weeks prior to the hemoptysis. (See",
"      <a class=\"local\" href=\"#H8221348\">",
"       'Foreign body aspiration'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A history of recent exposure to fumes from malfunctioning ice resurfacing and ventilation equipment in an ice arena raises the possibility of nitrogen dioxide inhalation. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/24/14727?source=see_link&amp;anchor=H5#H5\">",
"       \"Etiology and evaluation of hemoptysis in adults\", section on 'Pulmonary parenchymal diseases'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A thorough history of illicit drug use (particularly cocaine smoking) as well as use of medications that can impair platelet function or produce thrombocytopenia should be sought. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/30/23018?source=see_link&amp;anchor=H17#H17\">",
"       \"Cocaine: Acute intoxication\", section on 'Crack lung'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/40/1673?source=see_link\">",
"       \"Drug-induced thrombocytopenia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hematuria suggests a pulmonary-renal vasculitis, such as anti-glomerular basement membrane antibody disease (Goodpasture) or granulomatosis with polyangiitis (Wegener&rsquo;s granulomatosis). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/31/27130?source=see_link&amp;anchor=H14577579#H14577579\">",
"       \"Differential diagnosis and evaluation of glomerular disease\", section on 'Acute glomerulonephritis and pulmonary hemorrhage'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      One should inquire about weight loss, choking episodes, trauma, chronic pulmonary or cardiac disease, and recent travel.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Helpful findings in physical examination include bruises around the chest or neck (indicating trauma), telangiectasia or hemangioma (suggesting arteriovenous malformations), or clubbing (suggesting chronic lung disease, pulmonary arteriovenous malformations, or congenital cardiac disease). Bleeding in the oral cavity or nasopharynx or missing teeth may be suggestive of foreign body aspiration. If pneumonia is present, evaluation of the respiratory system may reveal signs of consolidation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Radiographic studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the clinical impression of hemoptysis has been confirmed, the initial evaluation should include a chest radiograph. Typical radiographic findings include parenchymal and alveolar infiltrates that may be diffuse throughout both lungs. Other features suggesting an etiology of bleeding include calcifications (suggesting tuberculosis), radiopaque foreign bodies or volume loss suggestive of endobronchial obstruction, or bronchiectasis. However, up to one-third of children with hemoptysis will have normal radiographs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/1\">",
"     1",
"    </a>",
"    ]. In this situation, a computed tomography (CT) scan without and with contrast may help identify anatomic abnormalities of both airways and vessels, and it is the test of choice to optimally visualize lung parenchyma. Arteriography should be considered if a high suspicion for vascular malformations exists despite a negative CT scan. In massive hemoptysis, computed tomography angiography (CTA) may localize the area of bleeding and facilitate a bronchial embolization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial evaluation should include the following laboratory tests:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A complete blood count and coagulation studies, including studies to exclude von Willebrand disease (plasma Von Willebrand factor antigen [VWF:Ag], Von Willebrand factor activity, and factor VIII activity) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/25\">",
"       25",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/13/24794?source=see_link\">",
"       \"Clinical presentation and diagnosis of von Willebrand disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with significant hemoptysis should have blood typed and cross-matched in case bleeding necessitates transfusion. Although no data are available, the need for transfusion in these patients is uncommon.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If a cause still cannot be identified and the patient has had two or more episodes of bleeding, additional work-up should be considered, including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Measurement of serum creatinine and BUN, urinalysis, anti-nuclear antibodies (ANA), anti-neutrophil cytoplasmic antibodies (ANCA), anti-glomerular basement membrane antibodies (anti-GBM) and complement. These tests are used to evaluate for anti-GBM disease (Goodpasture), granulomatosis with polyangiitis (Wegener) and systemic lupus erythematosus. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/38/33383?source=see_link\">",
"       \"Approach to evaluating childhood vasculitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Sweat test or genetic screening for cystic fibrosis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/49/28442?source=see_link\">",
"       \"Cystic fibrosis: Clinical manifestations and diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/49/28442?source=see_link&amp;anchor=H59100333#H59100333\">",
"       \"Cystic fibrosis: Clinical manifestations and diagnosis\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Sputum cultures for bacteria, fungus, virus and acid-fast bacilli (AFB).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Diagnostic bronchoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once bleeding is controlled, consideration should be given to bronchoscopy. Flexible bronchoscopy is used to help identify the bleeding site and possible cause, since it provides a good evaluation of the upper and distal airways. Hemosiderin-laden macrophages in bronchoalveolar fluid confirm the occurrence of pulmonary bleeding. They typically appear three days after the episode and may be present for days or weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/2,41,42\">",
"     2,41,42",
"    </a>",
"    ]. Rigid bronchoscopy is the procedure of choice if a foreign body extraction is required or if profuse bleeding occurs. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Bronchoscopy'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/33/2585?source=see_link\">",
"     \"Airway foreign bodies in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Lung biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A lung biopsy should be considered in any child who presents with diffuse alveolar hemorrhage, even if serology for immune-mediated disorders (ANCA, ANA, Ant-glomerular basement membrane antibodies) are negative, as there are reported cases of immune-mediated lung disease with negative serology [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients present with mild hemoptysis that resolves spontaneously and may not recur (eg, if due to bronchitis). No further intervention is necessary for small volume hemoptysis from a presumably benign cause (",
"    <a class=\"graphic graphic_algorithm graphicRef81459 \" href=\"mobipreview.htm?0/63/1008\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Routine measures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with massive hemoptysis require initial focus on the ABCs of life support (airway, breathing, circulation) because of the risk of asphyxiation and the more remote danger of exsanguination [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. Patients with massive hemoptysis will likely require supplementary oxygen and endotracheal intubation, which will help suction secretions and blood. In addition, mechanical ventilation with positive end-expiratory pressure (PEEP) may improve oxygenation and may tamponade the site of hemorrhage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/45\">",
"     45",
"    </a>",
"    ]. Selective intubation to the unaffected lung may help decrease the risk of asphyxia. When the site of bleeding is unknown, double-lumen tubes should be used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/46\">",
"     46",
"    </a>",
"    ]. Any underlying clotting abnormality should be corrected with fresh frozen plasma, platelets,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?14/45/15062?source=see_link\">",
"     desmopressin",
"    </a>",
"    , or other measures as appropriate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cough should be minimized by opiates in order to prevent worsening of hemoptysis. If the hemithorax in which the bleeding originates can be identified (either by chest radiograph or physical findings), the patient should lie with the bleeding side down in order to prevent blood from filling the unaffected lung. Chest physiotherapy and medications that may affect clotting should be stopped.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Bronchoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;If bleeding does not stop with these measures, bronchoscopy may be used to control active bleeding. No clear consensus exists as to whether rigid or flexible bronchoscopy (also called fiberoptic bronchoscopy) is preferable, as both have advantages and disadvantages.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Rigid bronchoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rigid bronchoscopy is preferred by some clinicians in cases of ongoing profuse bleeding because it allows good airway control and more rapid suctioning of large volumes of clots and debris. The larger lumen also permits easier introduction of packing material. However, this technique must be performed using general anesthesia, and generally it is performed by a surgeon in an operating room, so the patient needs to be moved [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/48\">",
"     48",
"    </a>",
"    ]. The visual range of rigid bronchoscopy is limited to the major bronchi.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Flexible bronchoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Flexible bronchoscopy also can be used to control bleeding. This technique is the preferred option unless the bleeding is profuse, as it can be performed at the bedside by a pulmonary specialist. It provides an advantage for intubated patients because they require minimal preparation and do not need to be transported to the operating room. Because of the smaller diameter of the flexible bronchoscope, distal airways can be visualized.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Hemostasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the bleeding site is identified during bronchoscopy, a solution of cold saline or topical epinephrine or both can be used to achieve hemostasis. If it fails, a mixture of fibrinogen and thrombin is applied [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. Other procedures that have been used to stop bleeding include bronchoscopy with carbon dioxide or Nd-YAG laser and selective occlusion of a lobe or main bronchus using an endoscopically placed balloon-tipped catheter (Fogarty catheter) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/50,51\">",
"     50,51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Embolotherapy by bronchial angiography should be considered in cases of persistent bleeding, and is widely used in patients with CF and hemoptysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/37,48\">",
"     37,48",
"    </a>",
"    ]. Bronchial vessels are identified by contrast media; gelatin sponge, polyvinyl alcohol, bucrylate pellets, or more recently described, tris-acryl gelatin microspheres [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/52\">",
"     52",
"    </a>",
"    ] are injected once these vessels are cannulated. Outcome is favorable in approximately 80 percent of cases, but bleeding may recur in a significant percentage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/53\">",
"     53",
"    </a>",
"    ]. Up to 50 percent of these recurrences may require a re-embolization procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/54\">",
"     54",
"    </a>",
"    ]. Rare complications include transverse myelitis or bowel necrosis if spinal arteries or superior mesenteric artery are inadvertently embolized. In addition, fever, dysphagia, and back and chest pain can occur after the procedure. The main contraindication to embolization is the identification of spinal arteries arising directly from the bronchial vessels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/53,55,56\">",
"     53,55,56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/49/8982?source=see_link\">",
"     Tranexamic acid",
"    </a>",
"    (TXA), an antifibrinolytic medication used mainly to control bleeding among hemophiliacs, has been employed successfully in children with CF and hemoptysis that did not respond to embolization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/57-59\">",
"     57-59",
"    </a>",
"    ]. However, it does not yet have an established role in the routine management of pediatric hemoptysis. A systematic review concluded that the use of antifibrinolytic agents was associated with a significant reduction in bleeding time of 19.47 hours compared to placebo. However, TXA did not affect remission of hemoptysis evaluated at seven days after the start of treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The final resort for control of ongoing hemoptysis is lung resection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/61\">",
"     61",
"    </a>",
"    ]. It is indicated only in patients who have massive bleeding or intractable hemorrhage, after all other measures to control bleeding have failed. Patients ideally should have an adequate respiratory reserve (FEV1 &gt;40 percent predicted) in order to avoid extreme pulmonary disability postoperatively. Unfortunately, patients with CF who have significantly advanced disease and limited pulmonary reserve may tolerate this procedure poorly.",
"   </p>",
"   <p>",
"    One center reported using extracorporeal membrane oxygenation (ECMO) to support a patient while preparing for surgery for hemoptysis that was otherwise uncontrollable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/0/37896/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These and other techniques for controlling hemoptysis that are used in adults are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/47/30454?source=see_link\">",
"     \"Massive hemoptysis: Initial management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?21/43/22195?source=see_link\">",
"       \"Patient information: Coughing up blood (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8221237\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hemoptysis refers to expectoration of blood originating from the lower respiratory tract. However, blood from the upper respiratory tract, the nasopharynx, and the upper gastrointestinal tract can be expectorated and can mimic blood coming from the lower respiratory tract. A bright red color, alkaline pH, and sometimes thoracic pain can help to distinguish hemoptysis from blood originating in the gastrointestinal tract. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Etiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnostic approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common causes of hemoptysis in children are respiratory infection, aspirated foreign bodies, and bronchiectasis. A variety of other processes also can cause hemoptysis (",
"      <a class=\"graphic graphic_table graphicRef62214 \" href=\"mobipreview.htm?13/57/14238\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Foreign body aspiration is common in children, especially in those under three years of age. In a substantial minority of cases the aspiration is not initially recognized, and the child may present days or weeks after the aspiration event with wheezing, chronic cough or hemoptysis. (See",
"      <a class=\"local\" href=\"#H8221348\">",
"       'Foreign body aspiration'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/33/2585?source=see_link\">",
"       \"Airway foreign bodies in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A chest radiograph and in some cases computerized tomography may help to determine the location of the bleeding and often provides clues to the type of lung disease. Up to one-third of children with hemoptysis will have normal radiographs. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Radiographic studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory testing includes a complete blood count and coagulation studies, including studies to exclude von Willebrand disease. Additional testing that may be helpful in determining the cause of hemoptysis in some cases includes measurement of serum creatinine and BUN, urinalysis, ANA, ANCA, sweat test, anti-glomerular basement membrane antibodies, complement. Sputum cultures for bacteria, fungus, virus and AFB should be considered. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Laboratory tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Flexible bronchoscopy can be helpful in some patients with hemoptysis to identify the bleeding site. Rigid bronchoscopy is the procedure of choice if a foreign body extraction is required or if profuse bleeding occurs. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Diagnostic bronchoscopy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18\">",
"       'Bronchoscopy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/1\">",
"      Pianosi P, al-sadoon H. Hemoptysis in children. Pediatr Rev 1996; 17:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/2\">",
"      Godfrey S. Pulmonary hemorrhage/hemoptysis in children. Pediatr Pulmonol 2004; 37:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/3\">",
"      Sim J, Kim H, Lee H, et al. Etiology of hemoptysis in children: a single institutional series of 40 cases. Allergy Asthma Immunol Res 2009; 1:41.",
"     </a>",
"    </li>",
"    <li>",
"     Boat TF. Pulmonary hemorrhage and hemoptysis. In: Kendig's Disorders of the Respiratory Tract in Children, Chernick V, Boat TF (Eds), WB Saunders, Philadelphia 1998. p.623.",
"    </li>",
"    <li>",
"     Rich S (ed). Executive summary from the World Symposium on Primary Pulmonary Hypertension, Evian, France, September 6-10, 1998, co-sponsored by The World Health Organization.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/6\">",
"      Deffebach ME, Charan NB, Lakshminarayan S, Butler J. The bronchial circulation. Small, but a vital attribute of the lung. Am Rev Respir Dis 1987; 135:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/7\">",
"      Imanaka K, Shimizu S, Matsumoto J, et al. Unilateral absence of pulmonary artery and ventricular septal defect in an infant. Ann Thorac Surg 1998; 66:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/8\">",
"      Thompson JW, Nguyen CD, Lazar RH, et al. Evaluation and management of hemoptysis in infants and children. A report of nine cases. Ann Otol Rhinol Laryngol 1996; 105:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/9\">",
"      Chung Y, Ahrens WR, Singh J. Massive hemoptysis in a child due to pulmonary arteriovenous malformation. J Emerg Med 1997; 15:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/10\">",
"      Alexiou C, Obuszko Z, Beggs D, Morgan WE. Inflammatory pseudotumors of the lung. Ann Thorac Surg 1998; 66:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/11\">",
"      Kayser K, Plodziszewska M, Waitr E, et al. Diffuse pulmonary hemosiderosis after exposure to pesticides. A case report. Respiration 1998; 65:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/12\">",
"      Centers for Disease Control and Prevention (CDC). Exposure to nitrogen dioxide in an indoor ice arena - New Hampshire, 2011. MMWR Morb Mortal Wkly Rep 2012; 61:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/13\">",
"      Tom LW, Weisman RA, Handler SD. Hemoptysis in children. Ann Otol Rhinol Laryngol 1980; 89:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/14\">",
"      Fabian MC, Smitheringale A. Hemoptysis in children: the hospital for sick children experience. J Otolaryngol 1996; 25:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/15\">",
"      Coss-Bu JA, Sachdeva RC, Bricker JT, et al. Hemoptysis: a 10-year retrospective study. Pediatrics 1997; 100:E7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/16\">",
"      di Sant'agnese PA, Davis PB. Cystic fibrosis in adults. 75 cases and a review of 232 cases in the literature. Am J Med 1979; 66:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/17\">",
"      Batra PS, Holinger LD. Etiology and management of pediatric hemoptysis. Arch Otolaryngol Head Neck Surg 2001; 127:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/18\">",
"      Shaffer JP, Barson W, Luquette M, et al. Massive hemoptysis as the presenting manifestation in a child with histoplasmosis. Pediatr Pulmonol 1997; 24:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/19\">",
"      Bond D, Vyas H. Viral pneumonia and hemoptysis. Crit Care Med 2001; 29:2040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/20\">",
"      Haura L, Warachit B, Makkoch J, Poovorawan Y. Hemoptysis in children with pandemic influenza H1N1 2009 infection. Southeast Asian J Trop Med Public Health 2009; 40:1259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/21\">",
"      Del Bianco R, Santos MS, Ribeiro MC, et al. Clinical aspects of influenza A (H1N1) in HIV-infected individuals in S&atilde;o Paulo during the pandemic of 2009. Braz J Infect Dis 2011; 15:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/22\">",
"      Gilbert CR, Vipul K, Baram M. Novel H1N1 influenza A viral infection complicated by alveolar hemorrhage. Respir Care 2010; 55:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/23\">",
"      Fullmer JJ, Langston C, Dishop MK, Fan LL. Pulmonary capillaritis in children: a review of eight cases with comparison to other alveolar hemorrhage syndromes. J Pediatr 2005; 146:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/24\">",
"      Susarla SC, Fan LL. Diffuse alveolar hemorrhage syndromes in children. Curr Opin Pediatr 2007; 19:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/25\">",
"      Centers for Disease Control and Prevention (CDC). Investigation of acute idiopathic pulmonary hemorrhage among infants - Massachusetts, December 2002-June 2003. MMWR Morb Mortal Wkly Rep 2004; 53:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/26\">",
"      Finley TN, Aronow A, Cosentino AM, Golde DW. Occult pulmonary hemorrhage in anticoagulated patients. Am Rev Respir Dis 1975; 112:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/27\">",
"      Brown CM, Redd SC, Damon SA, Centers for Disease Control and Prevention (CDC). Acute idiopathic pulmonary hemorrhage among infants. Recommendations from the Working Group for Investigation and Surveillance. MMWR Recomm Rep 2004; 53:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/28\">",
"      Habiba A. Acute idiopathic pulmonary haemorrhage in infancy: case report and review of the literature. J Paediatr Child Health 2005; 41:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/29\">",
"      Hossain MA, Ahmed MS, Ghannoum MA. Attributes of Stachybotrys chartarum and its association with human disease. J Allergy Clin Immunol 2004; 113:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/30\">",
"      Kinane TB, Grabowski EF, Sharma A, et al. Case records of the Massachusetts General Hospital. Case 7-2008. A 17-year-old girl with chest pain and hemoptysis. N Engl J Med 2008; 358:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/31\">",
"      Hannan AT, Brown M, Bigman O. Pulmonary artery catheter-induced hemorrhage. Chest 1984; 85:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/32\">",
"      Lee YS, Baek JS, Kwon BS, et al. Pediatric emergency room presentation of congenital heart disease. Korean Circ J 2010; 40:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/33\">",
"      B&eacute;dard E, Lopez S, Perron J, et al. Life-threatening hemoptysis following the Fontan procedure. Can J Cardiol 2008; 24:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/34\">",
"      Deisenberg M, Stayer SA. Severe hemoptysis in a child after the Fontan procedure. Paediatr Anaesth 2005; 15:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/35\">",
"      Suda K, Matsumura M, Sano A, et al. Hemoptysis from collateral arteries 12 years after a fontan-type operation. Ann Thorac Surg 2005; 79:e7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/36\">",
"      Sheikh S, Sisson B, Senler SO, Eid N. Moderate hemoptysis of unknown etiology. Pediatr Pulmonol 1999; 27:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/37\">",
"      Siden HB, Sanders GM, Moler FW. A report of four cases of acute, severe pulmonary hemorrhage in infancy and support with extracorporeal membrane oxygenation. Pediatr Pulmonol 1994; 18:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/38\">",
"      Sood M, Clarke JR, Murphy MS. Covert biting of the buccal mucosa masquerading as haematemesis or haemoptysis in children. Acta Paediatr 1999; 88:1038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/39\">",
"      Bjornson CL, Kirk VG. Munchausen's syndrome presenting as hemoptysis in a 12-year-old girl. Can Respir J 2001; 8:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/40\">",
"      No&euml; GD, Jaff&eacute; SM, Molan MP. CT and CT angiography in massive haemoptysis with emphasis on pre-embolization assessment. Clin Radiol 2011; 66:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/41\">",
"      Sherman JM, Winnie G, Thomassen MJ, et al. Time course of hemosiderin production and clearance by human pulmonary macrophages. Chest 1984; 86:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/42\">",
"      Epstein CE, Elidemir O, Colasurdo GN, Fan LL. Time course of hemosiderin production by alveolar macrophages in a murine model. Chest 2001; 120:2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/43\">",
"      D&uuml;pree HJ, Lewejohann JC, Gleiss J, et al. Fiberoptic bronchoscopy of intubated patients with life-threatening hemoptysis. World J Surg 2001; 25:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/44\">",
"      Cahill BC, Ingbar DH. Massive hemoptysis. Assessment and management. Clin Chest Med 1994; 15:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/45\">",
"      Noseworthy TW, Anderson BJ. Massive hemoptysis. CMAJ 1986; 135:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/46\">",
"      Anantham D, Jagadesan R, Tiew PE. Clinical review: Independent lung ventilation in critical care. Crit Care 2005; 9:594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/47\">",
"      Pea L, Roda L, Boussaud V, Lonjon B. Desmopressin therapy for massive hemoptysis associated with severe leptospirosis. Am J Respir Crit Care Med 2003; 167:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/48\">",
"      Wong KS, Wang CR, Lin TY. Hemoptysis in children. Changgeng Yi Xue Za Zhi 1998; 21:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/49\">",
"      Tsukamoto T, Sasaki H, Nakamura H. Treatment of hemoptysis patients by thrombin and fibrinogen-thrombin infusion therapy using a fiberoptic bronchoscope. Chest 1989; 96:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/50\">",
"      Sidman JD, Wheeler WB, Cabalka AK, et al. Management of acute pulmonary hemorrhage in children. Laryngoscope 2001; 111:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/51\">",
"      Toker A, Tanju S, Bayrak Y, et al. Life-threatening hemoptysis in a child: the only symptom. Ann Thorac Surg 2004; 77:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/52\">",
"      Samara KD, Tsetis D, Antoniou KM, et al. Bronchial artery embolization for management of massive cryptogenic hemoptysis: a case series. J Med Case Rep 2011; 5:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/53\">",
"      Uflacker R, Kaemmerer A, Neves C, Picon PD. Management of massive hemoptysis by bronchial artery embolization. Radiology 1983; 146:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/54\">",
"      Swanson KL, Johnson CM, Prakash UB, et al. Bronchial artery embolization : experience with 54 patients. Chest 2002; 121:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/55\">",
"      Cipolli M, Perini S, Valletta EA, Mastella G. Bronchial artery embolization in the management of hemoptysis in cystic fibrosis. Pediatr Pulmonol 1995; 19:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/56\">",
"      Brinson GM, Noone PG, Mauro MA, et al. Bronchial artery embolization for the treatment of hemoptysis in patients with cystic fibrosis. Am J Respir Crit Care Med 1998; 157:1951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/57\">",
"      Wong LT, Lillquist YP, Culham G, et al. Treatment of recurrent hemoptysis in a child with cystic fibrosis by repeated bronchial artery embolizations and long-term tranexamic acid. Pediatr Pulmonol 1996; 22:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/58\">",
"      Chang AB, Ditchfield M, Robinson PJ, Robertson CF. Major hemoptysis in a child with cystic fibrosis from multiple aberrant bronchial arteries treated with tranexamic acid. Pediatr Pulmonol 1996; 22:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/59\">",
"      Graff GR. Treatment of recurrent severe hemoptysis in cystic fibrosis with tranexamic acid. Respiration 2001; 68:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/60\">",
"      Prutsky G, Domecq JP, Salazar CA, Accinelli R. Antifibrinolytic therapy to reduce haemoptysis from any cause. Cochrane Database Syst Rev 2012; 4:CD008711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/0/37896/abstract/61\">",
"      Garzon AA, Cerruti MM, Golding ME. Exsanguinating hemoptysis. J Thorac Cardiovasc Surg 1982; 84:829.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6370 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-197.136.42.3-293D88DB16-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_0_37896=[""].join("\n");
var outline_f37_0_37896=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8221237\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Airways diseases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Bronchiectasis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8221348\">",
"      - Foreign body aspiration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8221307\">",
"      - Trauma from suctioning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Pulmonary parenchymal diseases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Pulmonary vascular disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Cryptogenic",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSTIC APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      History and associated findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Radiographic studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Diagnostic bronchoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Lung biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Routine measures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Bronchoscopy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Rigid bronchoscopy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Flexible bronchoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Hemostasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8221237\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6370\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6370|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?0/63/1008\" title=\"algorithm 1\">",
"      Algorithm for hemoptysis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6370|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?13/57/14238\" title=\"table 1\">",
"      Causes of hemoptysis in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/33/2585?source=related_link\">",
"      Airway foreign bodies in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/38/33383?source=related_link\">",
"      Approach to evaluating childhood vasculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/40/3722?source=related_link\">",
"      Approach to the child with bleeding symptoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/43/16057?source=related_link\">",
"      Causes of bronchiectasis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/10/12458?source=related_link\">",
"      Clinical manifestations and diagnosis of bronchiectasis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/56/22408?source=related_link\">",
"      Clinical manifestations and diagnosis of chronic pulmonary aspergillosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/62/17386?source=related_link\">",
"      Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/39/44662?source=related_link\">",
"      Clinical manifestations and evaluation of bronchiectasis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/13/24794?source=related_link\">",
"      Clinical presentation and diagnosis of von Willebrand disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/30/23018?source=related_link\">",
"      Cocaine: Acute intoxication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/49/28442?source=related_link\">",
"      Cystic fibrosis: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/45/27351?source=related_link\">",
"      Cystic fibrosis: Clinical manifestations of pulmonary disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/31/27130?source=related_link\">",
"      Differential diagnosis and evaluation of glomerular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/40/1673?source=related_link\">",
"      Drug-induced thrombocytopenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/24/14727?source=related_link\">",
"      Etiology and evaluation of hemoptysis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/21/7512?source=related_link\">",
"      Factitious disorder and Munchausen syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/31/31226?source=related_link\">",
"      Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/51/12089?source=related_link\">",
"      Idiopathic pulmonary hemosiderosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/47/30454?source=related_link\">",
"      Massive hemoptysis: Initial management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/16/36104?source=related_link\">",
"      Munchausen syndrome by proxy (medical child abuse)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?21/43/22195?source=related_link\">",
"      Patient information: Coughing up blood (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/0/27656?source=related_link\">",
"      Pulmonary arteriovenous malformations: Epidemiology, etiology, pathology, and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/34/42534?source=related_link\">",
"      Pulmonary manifestations of systemic lupus erythematosus in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/61/23512?source=related_link\">",
"      The diffuse alveolar hemorrhage syndromes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_0_37897="BL immunohistochemistry";
var content_f37_0_37897=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F50088&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F50088&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 603px\">",
"   <div class=\"ttl\">",
"    BL immunohistochemistry",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 583px; height: 390px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGGAkcDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6H8a+KrfwpZ2M9xY3t895c/ZYobTy95by5JCSZHRQAsTd/Sudi+J4liaWLwj4idF6kSWJx/5M1Q/aAlaDSfC8keN41g4ye/2K6rk/h94fGu6d4i1fUvEuraXBp135RW0W2EaxLawysx8yFyTmRz16Y4rmnVn7X2cLbX1OiFOHsvaSvvY7Nfi3btu2+E/Ep2nBx9i4/wDJio7f4xWVxP5MXhjxD5ucBWeyXP0zc1yXwqsfD/xE06/vvD3irxfB9nm8maG8isFfkBg2FgYbTzjn+E8VU8N+GV1jwtoWrXE0sVxdWEFxM6qvzSPGpZgBgDJPQVlVqYmCukn95dOFCbtdr7j0ib4kyQorv4M8TFW6FGsX/lcmobn4oi2CGfwf4mUOMg5sj/K54rlPDv2vSNHvEv7kBQT5UjtkkDvis5LgO63MM6lyMnc+cn2WonjJJaJGkMJFt3Oz/wCFw2mx3/4RTxLhOv8Ax5/oPtHP4VBJ8a9NjjDt4Y8SbD3H2M/yuKwtONve3MUzqq7N2d45PqMVTvtDimuGNhEHQAHyycqRnOfasZY2uldJfj/mXHCUr2bf9fI9D0/4hzahapcWfg3xJJC4yreZYDI/G5qKX4kyRXAgk8GeJhKeg3WRB/H7Tiue8Pa9ZWtnJFaxldrMcBTjj0BrnfEP9pSztqDedLbnAVlGAo9q2njrU1Jaszhg7zak7I7FfjPYtcCAeFfE3mltgXbaZz/4EVcHxUQuqjwh4m3MdoGbLk/+BNeXahLcLGgmQpJ5YJm28nI9epaifUrzy7aFXKlUEjMTg7u1cizOf2kv6+Zu8BC2jZ67dfEG4tIPOuPBfiVIvUyWH/yTVF/ixCkPmt4T8SeX/e3WX/yTXBaf4ju9QRLa/uC0SbiyyDLHHTn0qvC8t/dpHcuTaKSWVDggD2raeZae4tSY5fr7z0PQovi5by48vwn4kbPQg2XP/kzUV58Y7KzKi58LeI493Qk2WPz+0YrzySyfzZXhvGt4YY/3by85JP3SKo6haLHAb67jF7cvzDtbcoGfT1zSeYVEr6f18yvqNO+7PUofjFZzBzH4W8SEIu9v+PMYHr/x8VLJ8WoI7U3D+EvEohGMtmy79P8Al5rkPDNxBfaaJry3xhMMoG0A+479KxNE1tri7khBeWCWURmMjIBzxj0pf2hUSTdvx/zJ+pQ13/r5HpP/AAtuDaG/4RPxLg+9ln8vtNLP8WoIEjeXwn4jVZDhctZc/wDkzXE6jbtFqbQQybFQhlwdwK+5+tZMl1cT30JTMlupMbIBgY5yal5lUTs0vx/zKjgKctU2esaf8RpdQ/48/BniWTjd9+xHH43NaC+L9SbGPA/iTn/ptp//AMlV514L8TxpqckUUuxYjiWMjCr7CvRdI8QW1/ceSVaJyDt3fxV6FDExqq5xV8NKnLRaEN145vbWIy3HgrxJGg7mbT//AJKrIk+LlvGxVvCfiXIGSAbI/wDtxVXx74n02UNpg3yyRkMzI2MHPauC1K6l0+9ltbZlwuHctySD0wa5sVjpUpWhY3w+C9pG89D0+L4nmYJ5fgzxS2/7uBZ8/wDkxVfUfi5b6bN5V74S8TROBkg/Yzx9RcYriLMa3JqaSmdnhABiTGFAz1J/pWzqKxahNNNqVnFcQQZY5b5sDtgHp6VKx05Rut/T/glPBwUrXZr/APC57D7PDOPDHiQxTNtjI+xksfp9ozVuL4rRTKGi8J+I3B6bXsSfy+01554ovNK1fQYr+yc2TWxEaxoCGQn2HetvwfpkQgg1W4ui0sS7Vj27WJ9W9aqGLrSny2VglhKcYc13c60/E4hJHPg/xKEj+826ywP/ACZqHT/ivDqO77H4T8Ry7QSQGsh/O5qh4g1GC3W28+3c2twpWQYxs9ag8H6NpNrMt5azTymUExmQ9FPYCtpVqqqckUrGMaMOTnlcuN8ZrFZWifwr4mV1ODuW0A/M3GKWD4y2M8qxxeF/EZZjtBzZgE/U3GK4/WTa6fqV0NRMzOJCPkXcBnoRVfw54TfUb+3nNyTYq284k4OOwXtXJHHV5T5OVf18zpeDpKPM20epS+PbuKAzP4K8SiIckiSwP8rmsq4+LtvbjM3hPxMo9f8AQz/7cVa1bUV0/TX8sGR3/drvBI+uO9cWu6WzW4uZYiqEooAwrv7CuvFYmVF2ijmoYeNRXZ1n/C2YBZG8PhLxKLYceYTZAf8ApTSwfFiGeEyxeE/EjRjvusv/AJJrhoWuNQAsruLgkyBByqe30rc0WFrDTrhVvIZ7rPEcQB2rnpWEcZVctlb+vM1nhIRWjdzuPDvjePWPEMejz6FrGl3UlpJexte/ZyjojxqwBilcg5lXggd6q6r8RYbHxBqWk2/h7W9QlsJEimmtjaiPc0SS4HmTIx+WRe3XNct4FvJLv4p2Bl3Fk0e/G5up/f2dZHjW+n028+KF7ZsI7m1lM0cmAdrrplsVODweR0NehRn7SCkclSmoTcTu/wDhY8u/Z/whviTd6B7H/wCSagufiitt/rvCPiRecfesTz+FzXHeLxbeGfEa6I+ueO9Qvv7PfU2+xx6UFSBCQxJkiTkbegzTLq3iGl+EPEOleItcv7DW7rymhv4LVcxm1nkHEcKsGDxLznGM9a10M9DuT8SWAQnwf4jwwyp8yw5H/gTUX/C0R54h/wCEQ8SeYTjG+x/n9pxWLFKkkypICpC42npU+lQwy6q0kjyGMAlFJ+UepodkVyo3U+IVw7bV8F+JSf8ArpYf/JNMuPiNLbMqzeDPEqlunzWJ/wDbmp1v7Iy4jmiLAAnbg1FriLLaeYihzgFSBwP8+lTr1FZFJvixCs6wnwl4k8xuQN1l/wDJNWZPiU8bhX8G+JgSM/esf/kmsG1sY7ubzLlHlKcdNoOK04omklGw4jDcqe30qOaV/ItxiaEXxBuJgDH4M8SkHp+8sB/7c0k3xDnhbbJ4M8SA+nmWB/8Abmq0we9FxaWk7wyEYLAfcHt+FVrwQhoII5fMkjURlnb7+PfvVp3It2LjfEwqcHwf4jBxn/WWP/yTQvxMLPsHg/xJuxnG+x/+SawLxmggjjwss2T8/Hy88CmyzRCVF3Os5TGTyN3sKuyGoXOlk+I8ka7n8HeJAOn+ssP/AJJpg+JbNnb4O8SnBwcNYnB/8Ca52yNw0zqzbkJJOex9Pr+lT6dut5nMYby3b5s989xSdloPkR0cHj65n/1PgzxG/OOJtP8A/kqpG8cXqqWbwT4lCjqTLYf/ACVXMaX5uk35uJWZYixzyMOPYd62Z7wXjjCuFIJAJxgdqTFyDpfiU8QUv4O8S/NwMPYn+VzTo/iPLIAU8G+JWz0w9j/8k1kvEZLhLYAmM8ls9D64qzDbTJdllGIwOCnTApA4pGg/xEmjIDeDPEvPpJYn/wBuajX4kuzbR4N8SE4z9+x/+SayLZJUvgcsN+dxPQir1zCtvHutyWPQhuwptpaMFC5ab4jyqwU+DPEu49Bvsef/ACZqMfE0k4HhDxGTu2432PX/AMCay3ViySZO/O1iP4R7UmZkaN7K1jeQsQ0hHH5VSWgcqNxPiHM77F8GeJN3/XSw/wDkmll+IU8S7n8G+IwM7f8AW2B5/wDAqs6zecqXkERkXsOmeg4qrdTXE1tjUI40ff8AMsbkggdDn19qkOVXNMfE3IyPB/iTHT79j/8AJND/ABOKEA+DvExJOBtNk38rms+8lsxa7VBZVGCAMYqCBlCxySZjBXA+najV9B8qZtf8LJfYW/4Q7xJtHOd9j/8AJNEPxKacExeD/EbAdcSWH/yTWUVjEhVskSDbweuajii+wK8ilXzwAOOKdujDkN0fEOfYX/4QvxMFHcvYj/25qE/Ewh0U+D/EYZ/ujzLHn/yZqjp8stzE6yqfk4wT196R1tpWy8bJ/DuJ+9/hTtbcmxqx/EOeRsJ4M8SE/wDXSw/+SahPxMIcIfB/iTcTtA32PX/wJrLvWlinXZ8kQUYwCST9avxQxOVk8wec3O3vTsrXCxZb4jSrnPg3xJx1w9icf+TNMHxKY5x4P8R8HB/eWP8A8k1QuEj3EF3VypXbnrVZoZFjEiHAIAK+gFJJdQ5T0LwprsPiTRI9St7a5tVaWaBobnZ5iPFK8Tg7GZfvI3IJ4xRWB8HSW8DKW+8dT1Mn/wAD7iipJM34020d5D4RglAKNrJzn2srs/0rkLDwprGsfD74geGfDd1a29zeaysLz3TsFWFrO0Z8bVJJKkrj0J5rt/i2qPN4NWVgif202Sf+vG7rz7xv4d0u/wBXGoy+H7K4Z9qvNLaRuWAUAEkgk4AA69q5ako06jqPt+p00oSqx9mn1Os8CfDLUPA/xCl1LStUW78P3emRWd1FdbEnEsICxMqxRqhUIAvPPJJzXDfDjxbLB4N0C1NqrQx2FvGW3c8RrziqGq+CdJ1Gwtzp2h6JHKmfN8uzjU/iMVd8PwDSrOe1t7OIkQsI5FUAIBxhR2+lc1bG7KC0fU6aWF5U3LVmn4mE2s6St3o43xpMUVW4L+oArnruI6JpkV15SvduxRt4+VfYe9ami3by3K2l4RFBkBV68464p1/doNSXTnQTBpsGNhneuPvD0rzqko1PfWh2wUoe5v1+RT0HUG1CCWGeSCzuUG4SDgc9q2dRee2gt9pS5dl/eSpwrE+9U9VsLIXQttPijTAKncTjJ9TWlpET2GlJbygyMGz8gwSCfT2pQUm+R7im0vfj9xm2eqxRXUCja04P8S8Ka0U1O8vteWBY38puoPAAxz8vtVXxlZWVsIbqVZhJJIFxEo7d6t6HewXWrQXNi8jrjZPE/UEd/wAa1owlzOF7ETkuXnSuTXjGzLm8hcMCdpxwfT61ylteC11gDUrLzwx2ski9cnrn0rrvHut2k1otnCGEwkxnHIOO1c5LNAbe0g1ZXnmiIbzVbB29vrTxMYRlaL1QYfmcby6lXVdPu7a4nkgTzLaZg8eMfKuenrXReFiNSlnsCIkeWNgZY1+4w4xnvzWQIpTqUpS6iOcFSW7Yq7aSX0eorc2qPmIZ/dgH8cfrXLCynfoazu426kvjDwpqVrBa3EUhuNoJkbO1Mn1/CuctY5LDTsxyCZ2k37c58vtXQ6rqOpa7pxs/tP2icHzTH90svpVTw7oGoWO+6vEiU4KrAcFtvuKqrGMpfu72JhJxh+8auX9EuY/saSXDLEysQFHIf6iq+pT6Vaaqr2khExOdo4UPj9aLy2F/NbCN4YHTA2SMVAOf1pda8M2cuq24l1KFJGG0+Z2yecehPrVWlyqyvYfu3vJ7kWuyPNdxorJGrKA75AyfbFXvD8KxaaEVY3mZiWckB8e1Z8eg3v8AbnkFAbRFJaR8AD0IP0qzZG5ttSnEM0Mnlo/kknvjt681MLxqc0kOVnDlizS8q10u0WUWO65kbnGCxHriqmrqLqzhFjI0csZLKiybW+v/ANaue0mW5m1y2MihlyHnkdyyuvce3PSupgsYmuXvGuF+xscop5K49u1awk6iagrESioNNnKWelWz3S/b73y5SwIEhIdh3Hpiuo8Q6XYeZ9suWnWVVBUR8q46DP6Vg+JtDuPt4bS7oSpcDOV5YD+lTyyrBp1rbX9xMZYADuz949NprKLjG8Zot3dnFlsXKaeVN1K4ikj/AHZQ5J47VB4bjNzfyYxHDJiLax+aTI6t9OwqprVncX00cmmxSLsjWNQ5BHHJI9DVqxsEt7fMV8i6pKi+Yqc7MckD1ODRFylK3QHFJeZNqNkmkRT2sUsD6jONykjOVHpnvVHwalzZ3EkpnkNs+Q5kGBkdhTdf01ru6trpZBLuQKxc4dCO9Xk1RrtIUC7IVh8oyIcsrDvj3ofuy7WD7AzxJeC7njif97IDlcDIHH3TXReFGMlyIp8r5KgR+gHpWb4S0EXV6BeM7QNIroHX5sj09q9Il0WzI8+OJIpR1ZRjIrswtGpKXtWctetCMfZo8/8AG+hQ3mpQTLdxxSFfmjcnLehGK0vAgsYLM6Zbbgyknc2Dk1l3+i3s2u3ksgdo5TxKTkBOwHpzV7SdI/sxm1BbgIqt8wJ3Z9iaKDcK/NGI52lRs5ak3jm9ntVjR7dZRktuPAAHeuI8RQalrVjaXFjEi29s20xqPX+L8auXer6lrOvzxzAvFCSAAuQnvVtJJ/7NeyiGXPzu6gru9AtRUrc1SUkyqdN04JEMuoXNlsto7eOWcoELFueR6+v0p+l2c+n6iHvAYAuWjIbPmA9iKv6SxsdGkuUtm+V8bwN75PUjuKdf+SmntcX90bVdwKhxlifpUJS0lfYu6WltCH4XXtxefFiI3DLhdIvgqKu0L/pFp+eePyrL+JkqbvitEwGf3jA55OdLtwP5Vu/D2K0T4u2stntczaHdu8qggP8Av7THHbv+da8OlWmo+LfHQvbWOeN9TjidZFDKynT7TKkHgggnivXwV40Ffz/M8zEte2b/AK2IviP8O9R8Q/EWz8QQ6X4d1iwh0l7A2eryugEpdmEgxDIOAfY9eRWdf+Hb3wl4G+HOiarqDaleWeqSK9xzzmzvWCjPO1QQoz2HbpVe/wDA3hm1vFjPhfRGiJJ3iwiwB7/LSWnhvw9pN99ssNH0y2uVB8t4LOON0yMHawAPQkfjXUYqJpmZbcrKVJUKDwcgetW1nt0s2nggZnk+UrnGM9qgkhSaNl2MpY/Lk/eNJBGI02bg/OCDz/k0SsyzQ0x7KzQCNIYnYE7ZGGSfc+tRa40hhgt4pVXcM7S3Oc/yqGS1hmO1k2MDnJWmywxyPKFKzkKAUPDKPUU473uRY1ILe4+yQCVAxUfOVPOfSnXkMkFnGNpC/ebB5qpp2oJZRQxTScu23fnOM9Aa0NZv7aO1liFwrXAx8o5yfT2qFF31G9ypJqklmiRQxh5ZASzvyAPSsy62rIHXcMjJUjjJ6VHbTyXVuzLgYJA46Y9TSu8m5BLgHA+YnI+marlsPYLUNHd7jHtfd8+Rxil1CS2i3XI+Y78hQeCfcVI5ik+RpW+deMZP51TVUgu4Yr6VMtxhe9KzbKLAvJjZtdvFtVONoHXNQWk094swlbA3bQF4A78Vth4maSzKEwgYx/I1nSEWm+GKJVjGTgGiMrLVCFlVTBCZozvDnBBHH+NWLacvDIsCyDackEE5x2qDSw4fyplPlMckN2+nvVyZxE5S3VQnJTI3fiTRJrYLE01kZo2MmEAw3B5B9KoXGuizkW2SKRgAV3gdD9KSy1GZRLDqE+XH8XaqtyYjdAR7y5xzjg/hQkovULXNqw8lkEgYM27n059qhBaLUJWlD+T5eGGeCKpaXcSRSSgksdw+YggH6V0LlJQysnBGG5zWUo3loytlYwZlkN4HhB8k/cG7ipXcqzo8oQSAFSp6CpLyzcyNkb1GNuBwapPaTSzjZt8uRcdeA3fiuhWbtclFoWrA72bCkjOznPvUU8zTwCIZ3swUPjlT6mqxEwvUSPdx0Yen1q3NLFBcruRmk4zg9/Whqz7isQNLCkSKzBt/VgOnuakuZIxaxoSR0B288Z65pb+yWIPMrko3I5PB9/zpYFjvI4wGRQON4H3vwobW4xGXknkRcDcRn8RTmmUxlWjwn94rnIp1/wDu8iBwCoxgnAPrmmGLYqtL/Hgnj5RU9bsOhEksMSmd96q5Koo6n8KUBHuI7hZG24+6wxyPapfs8UzKLlmAiPybeMiq9/IIJUjt41VFxgkZyffNaryIL7yOJ/Myhx/Cfc0ioPOLKR5YORnqpNQx5nYuwCgqTnGMfj3qRV2252tuYkHC1DS7gVnsibpyGeQsQX+bgj3FN8mVrmQs7Ak5cgcfUfhVqJfLU7QWDZzluT7UkETglpSVU4UJ945qk9bMDf8Ag+MeCcA5xqep8/8Ab/cUUfCDb/whXyfd/tTU8fT7fcUVmQYXx8DHTfCmyTymGtht/pizuj/SsC91F9R0t7awLfaQN5ycZ9K6P46x+ZY+FF4/5DJPJx0sro9a5NIrKz0uW6muCLuaMqAo+6o55rysbzKsrdj0cLZ09d7/AORiaBa3a60ixzO8jNyMZAbvk+lautWn9n6kWQm3w3CnkPW38NdPke5a/wAo9pNHhdvAJ/xrr49HFzJOdUijuFB/dll+77CsMNhPa05O5tXxap1LPU8otLW51HVljhKGR+rkAYBHr2rY15o9NSMzRx/aFwN2ORjvnvVKfXBp/iCdIrJdkLfvECnPXAIPc0+61zT9bkaOfzleNuZjGOT6EVz8qhzJvU2bbafSxnzMJCZ2XbM3zHLfkKp6frl1JdzIm/Hlng/eGOwNaGsWUsFrGUhmljf+JFxt9zjoKj02K1tJi1xGjtIwVWb72O+KwbkpGq5eUqW+ptNbXNvqDecFG7GTlW7c1teFbyKG1vHs7cw3rou5ixf5cnHHaqN/ohj1oNFsaCQcAD7/AHxVlG1S0uZILPTlg3vz5IO0L2ye5q4c6lzPoKfK42RRuIreXUEubyRnJbOyLGFY/WjVYY5L1pluGjtXChiwx82MbRVqwt7SSY/aHEjCQqvHG/0B9azRImp3stpcyuiIxCB14Rh0zSmtLvqNP8B9rp1rfIXsbhzcbC0W9QD8v3s49P5Vq6NBdxxEwyqt15ZXci9Rjtmqp8OT6Pcw3EZVVBOfIJZWyOT+NaEtxbxWomnlkilPycpjPoKqFPW76EOV+pgQJN/a0Mds7KWkHnYXDKO9djFbg6rJHa3ESh2Ujc+Tx1xnpXM2kzWVyJL5p8M+w7QeR6D/ABq7oVtcagPtkE0b2bSFNw+8P9n6/pRRdrq1x1VfW9ibVNKgt752nukNushCswJZeegH9ayNd017m5d5njWCYhklkkI4HfjmtXWIxI73QR1iVRvDcsSDgCs2487WVS3jhZ3tsnCclxUztdoKd+5v6RbzX1qY4pnliCBPM7hvf2rMv9A1CG7VmtvNeOQOkinIHoRUvgbTZ7VdTieR1kYBlVjwcHp+VSadrT2geK4ke4jYlvKXKsvPFa2jOKcibzjJqI7CXcT25RQ8z7JFCbdp+vXrV59Hni0p47SeNriMgtxwR/8AqpnnpPFPJZ27R6ggD4PzYHcn1rG8N22o2E817LOyI27Mp/jPoQar3b6ka9NGJsk0m6S8uiXuQCIz0Bqtcz20k73TK6ySEAc5APXp0PPetXTpH1GS4fXgzQohZCANuR2FQXT2r3VvNplszxS/KkQcZzjv6UpwjGOjuVGTvqC3Fra2k/lySSSMpA2kcMe/0FZ/hjTJrTUba8eM/JlnlfhHB7mtcaNaSTE3aSKW+8sfTp0rM1dpLG8eNXMke1TEI8lWB6A+mKxcZQSkzRST91DNTlml1B97q32mU+UxOzy8DoPWn6rez6ZfxW1iRA54A2ZEjYySTVhSpKG7/f702qCuCDj1rVXSVZY4blYrdxjaN21ttNKUveEpKLSaKmqalqGk2Nje2GJ5LjG5t2UQjqPaul03xpNr2gSiCJba6VSu4ngn2zXBzTywagsDPm1WYxi1J4PPU+5qxrunJb6osUJMMM0mQIwRjj7p9K2hiakE0tjOVCDtzLUhGqarNby2btKrXDbQoPO0f41b8P209rcXS+bKbVQzyRSD+LHA56GtxI4dN1aKKJV89kGA6Z574qzNK1zqLu86RAKGweMHpjHfPqaUINPmlIbqJ+6kcRrN3qVhfCW2WKEXGIxt5xx1xWt4YvmhZoZ97mVtu9vl2dycHtSapHPfXqGGRBGDnITnA6ewq21zI8n2aa3R7pl2yShfuj8KUZuMroqSTjZkPia7ubu1ig0KTMQ4lSLhmIPTNUtQiGo21tb3NxJ9ujA80lQ4XPY57gd61U027sdKivbFXuJNxAWNfuj+8R1NZeu2DQ2unXfkTJd3DebNIBwGXoSOuac4z5eeWxMJQ+FHS/DyzSy+JmmRqf8AmC3wHsBPZ4GOwrf0qVl8XeOlBxnVYcE88/2faVy3wtuJLv4mWM86N5jaNfDzDn5wJ7P1rptNYf8ACYeOEOMnVYuf+3Czr2cI17CLX9anl4n+M7mxHZiaJPtC4dcglD1rDvrWzlviIMCVR8w7YrpLy5it02MQOOlYiW0UFwLhXLIx3AHpiurRIxi2ULe5851g2YCZXfnqPpS3bxoVVVVGB5Pcj+lOuJhIrSWq4HXaBg+5qvsF0qy703KMsDwKVrasuxbDGKAM0QYycKM5NVbZJUEgnjBXs6n+dWYIi0YBkC7TkFO351VczTOiAgICQyjOacXcNjE1e0eWOJrdysCyFpAOvtitVYo5SZN52P1V+PpmrbRCJhFGi8jKnqc+lUrfC2zs0W75slXGdpolKTdlsC2LVhcQ2yzISomxgYBwoo8pzI73BEmBjA9D3xUMUscgyJFXccAEcgUNBNLdtJHl4+gI4Jp8ltxXJY0WWR9mV4w3yn9DVfUbKJ7u3YFnXrj2471ZEpto8ugMmMFB0BqrJdG4iYbMMpOSAV4HrQ4uWq2GpHUSxI1qTGi529QOT+NY03zNuyDg87uhHpUGlvMnmbHdwBnBPA+hpgn+0BlYg5yQ2OQfes+WzHFF9IiJEd3G45G0dNp9/WrDr5NvIsgUBuEGRnJ71km5ihjhkldhhtoVCOe1W7ssAmQWQAMvqabVhdTn/D8N9cyyQavbMDAG2ydpBnitZUgWUFUVT0BBzWhY6vAlrL5q7wSeMiqdoILiaTapjeLkBsDH5USjfVopPoytPepA/EDLJjd8zdc9sVr2krRlEcgEjIVm55rJvEzdLE8uSAWO0c59RWfLps73okabbEpGXJ5UDnAp2iydzQv9eFvqxsZ8Qw4ADnJJz0qR7nnIZgRlQcZwPUVG8UFxMLkuAE+9uGTg+gqa0SC8kZisiY+QH7oI9amEGtWXJx6E+n3UTPIsjnft3Fccgf41KGV4pGCYlAOM9fpiobOyaCVmneNkU4Q92+tST4iuBhy2OTnpitGlczuSwK0yMJmUjIK+/FUZLP7NNlnjCDIGeMfSrNxI5mgjhIbJ3YA4NU7MG8uWSaR9yksFbnBHpQviuHQJocSrI7bkZ9wJ/hHtUkUbSOx81pcnIXsB60xCvyRRBgSSMtyeafYXkSX3lpG5T7itjAz9KHdgtiwbfcA6hjxz83H4VGUEUe1FzznJ5KirVxMSgT5cnrjtVSEtskGz58fKSc80gQ2S6RCUcg4O3AHGT60WzOjhJwvl85+b7vpTlsA8q3DMfvDcvYnFSkIzIBGWLHnPGaE76MdkLcFIyXVVbaMqO/4VFpjPJdCKXLg87jwR71Yt0SBX80bivPXG0VPbssd4j7AoY9RzxTu7CdjS+Eq7fBzr6arqg/8AJ+4op/wrIPhSYjp/a+q/+nC4opGRi/G0A23hPcm8f2w2Qen/AB43dcXbW0eqQENutzGShyv8Priu7+MBIPg8j/oMtkeo+w3ea4eO7nEjrahCsrY8s8MF+teTmFudJnpYO/I2u5He+J4dF097PSy0KQHZ5sn3mJ9B2GavQePLuTTIYbqNWuQ21nDbQR2P1rM1nSR9nW9lt42mR8Eg7sD3qnNfwzW6g2yt8wXcqA5B9vX3rilXqU3o7I6lSpyW1zq7e4TUMXmy2cEYKMg3EjqSa5C7eWHVI5UjcW0kwHlBckDPU/41pwT3C3lr5FvCiIdgVBncKGvLVLiZxbyLOu7G5+CR3xUTl7RK+44rkfkWI5bi3ujbh2MLjLl+WOT+WKqtCl9dzGBUcoASrcDg/wAPvVWJ572SB4CzsCfPLnCYNXtOs30q7ZoVYwEblJ53E9/6UNOT5R6JXGabfSWN5bIyCZDJgoxyRk449q6bXbt7GwuZImLXIQsiDrwOw71zVpLFP4ltXktQGzncvCqR3JrmtTudQm8SGSRzFOk+5Dk4Cj+mO1dVGu8PBu10Zzpe1kvI6SCxd47G/V9zzDzRlcBW/pUWr6bcancLJa2sT95FPBJ9Qa1df1E3KQ3mmIs0UiAKwICqR97I9M1m6kdUe4tLq0RirR/cQ8gj29KwqqKb+8um29S/ZTmKG2splZ5w3VWBIPYY9Kl1OyguXUSsVvAPkGMrux3Fc7ZW9/FcNLcRqWiw6OD824nkEfStaO/S6W4mWLddJh9oJBOTj9OaiE+b3WEoOOqZHfaPc3dkiiWWOWMHLrwc/wAqr6FEYzLp8EyLcztvkXONmO9XY9YlRjDcSuyA5VGGCCO+e9ULqCI5ukkS2uLs427vnVR1INKTimpQKjzNcszUlvFs0awmC3G79256OeeSPpSLPbaat7bWDOZpF2LKwxgkcY/E1m6rqtr5PkypGZUQASKf3gHrTLC1uXtpleGSNpDmIOMl165z6n0puo5S06B7NJalq3d9Ha3ur9n+T5pDyN56flVHVZnVpbhEkk8xxIFwM7Md6sLewGylj1NZgIGCxKwOXB/hI7itTSrXT7u1Z5ZXeOTHyrxs/wBmlGLqe4mDfL7zWhHodwWVZtPjJD4UyOwyc+/9Kj1HxDb30k9pdae3lk7S28A8fxY/pRfLb2uorY2rqqqyhYovvD0JrH1iKzXUp7lmkV4+TjnBPqaqpOUIcgRhGUrsv6fbQ6VJFNJM8ljOQVjIJLeoJPSrGt2VjHbxPYXIWSU7lLdR7AdqzNEmk1MXVrE8ptoYfMSVgCM+1aF7YLNZpKJEWSEDezjcCM88etStY6Ib0luGmtcyF4LwbkiXeS+efTGK5+6juJtUKRGUBm+UyHAPpyK6eO9mNlZ/vlubdN67sAvt64z3qGea1fYLSylRY9pbHzEN2+X0rSpySppJkx5oybHCCS2v1nIPmMB84I2LxisjXIdSv9QLQwS3g3jDR5GAPfpWv/Z88+kPLcLKr7xtEr7RIB1P4elaWh3xFjIjJ5S+o+UgHjp+tRyJ6PQHNpXWpz18kdsbVvI828hjDnA5Zs8cnuKn1IajfNBeqG3lF3cZC/n396vSItvdSXQuIkfAVQWyCPcdjVPUFupSoiG45GELcBSabp2g3cFJtrQuaZqC20drb3yTXDkhS5OWAJ4BI6CqurQXMesSKXLF1wA/AAz2pniO2j0i2tpUlCSufmZckCpraE6hDb6ldqVcNtjcthTxjODQ25e49wS+0tixFauLOS4jLx52qYzxu/2vpWZpq3Ud/eXUkUhCRtgR8bvQY71pqJlO20lWcbgu6P5s465PaqFzFP8A2kL15lccbXibPfge1DWq6BHqX7bXbqUzJKUhkWHhkJzHxnGar6fLqMlpLuc3CqrEtM2cg9MD1rWuLrT5LaaRIPLuTwcAdx1xXMauZ7a3hubcNc4b/VBscnjn8KqpKUd3cUFF9LG98MpriT4qWiXDMVTRb0KGzx+/s8/0rRmZz4z8bKjFf+JnEcjqP9AtOnvVP4ZzyyfEbTY5lKlNHvyufQz2XH6Vbl3x+MvHUyozBdShB9ObC1r2sGv3Mf66nmYj+M/66EsjgRxrM7k5BDMcsPc1ZlmD7I3UqhXClfWoEniZEdoZGcDbk9SO9OhhkMhkRgBxwBkrXRJmaWg7IWJo2l+ZkwOOCfeqkFrcpcMcqEI+XPRfb3qSZkSSSQqd33dy85+opbaVGLDMjL9zBHy/UVevLoBMkomcEz5YDadvOD6/SrBuCZYflTYzbWIHzdKqw20UDAQuSoB3ZPGKt5EKRuIwZOoPfFQ7W0A0IY4pZd6LkD1rM1aNYLaY+SuzOfQDPerE9zJEYliG0ffY57U3UjuSJNxdH+YgjPHWpV+YldjFtfs7W7idUgAOCdvX3qyfNEi+UpA/vA8AUt7bR7ykZQR7cEdh3zRFKVt47XaSwGQT/jWklfVFLQgaQI7G4O+I/wACjmoJbpYFDWkZUuPmZhndiqWoanDBdta+UZZE5bDABAf51p6bMZYbd7VP3TYbDqD0681kqsb8qepo6birsexmkMUihQgXIQDHPfioLycKr+dGvzkAFRggn1rWurUlhLGBubsfrUepwTPaTCODflcgkdDVRaZNzIklsgkSx5Y/dO4ZA981KIJJN7sVfJOBuJ6fyqHRgbm3mS5tynlHIZB1q5asJPMa3hIxkKM9T9aucdLIEIsEd3EkcoAAJOFXoff1qeKFFiOxXkb7r5A6dunNU7S4m88Z8sHdgoOOa0bwG3Rvs43M33hnnPHFLb3WJjra3ZTvnwM/wsOR7UXUqpM++JGQ/KxDYI9vemRF/JPmblIPGT0FWIbKPUsSox+TlgONxHSla2rAreShEkas2XH3yMEf/qqfTFjt1cM4kOzAHr781FK26V45SVYgq4PGPenx2zi3dxKvGFGDwo9cU9kS9SWVGuyN+MAHpxj3phjjCJl2wikHpk/4VCDNDbrudfLJJLEbeKmunSGNSShRl57hvak2wsQQuJJpJVJyGIHHHarEkhiYzsqKn3Q49aih2XEJ+z9T2Oecf0oKpMRbxuVVed46A+n0qXJXsyraFeZFUC6gbcwJOT/BUtrIrN5qw/N1DKOp9qht4pYJJMKmQAuGPH1xU8SH7Pt27QrFsKxAJPpWmr0EzqtNtokgVnQB2HzZ5rEvbfybpsDhjlSpxS2l/cR2ao/zHkgt2GelQT3CvLulX5AMeoFK0kyFoZt690LgGCJpJA2dwGB3/wAK0Z2L2g8lFSRhuOeCDTIb6Bm8qAmR/f8Az0qJdOY6mJ924KQxLHgVTfRlhayGOVortVDMM7c960IpxKsikKVxkEdc1S1W0WWcsxDjO7egw2Kn0y2aGJ5YCHJUBT2b3x7UN3Vxbmx8Iv8AkS26/wDIU1Tr/wBf9xRSfCEufBRMgw51TU9w9/t9xmipMjI+OHnfZfCX2bPmjWsj/wAArrP6VxenzTf2hLAIf9amd2OVOea9C+KsBubnwZCoyW1ph/5I3dPuNPtniSLKNcRLy+PmrixeF9raaep14bEKmnFo5TR9PcC6gmLeUVxhz97nPHpXJzaharqIs2RTbJIMADheeRmuxtFmn1eJVmDWqMQ6lssx7VheKIbX+1JfsVgBcuNoLNxx/s9q8+tdUmrdTupNc466spl1aR7e8iWCJSRGDjr/AFrLsJoLvX9+oJEVdiEVSQQD6+tNbbLcw+fcizZgCOM5P4d6pSxWT6tC1o1wZC/zttyQB7VyTkmk4o3im7pnTXWh3H26SIKY7XcuxgMKF+veqMWo31pryWeySVCwQBhuiI9AKsP4ku9TiW0KhEztjYjJ47tipW1IaNbs86jz3wqSMN7fUCtG4N3iyFzR0kiOHU5be6dtQiWNlG5vfBPGKTxDc2OpWouxcbLdYtu0Lhzn09axjetqX+kSJdSEtwzIF5759qiltLma0hurPM4LnMaqQR6cHkVDqz5XBaotU0p8z0ZpaRLZ6XFZfZnlMOTuSRcHfnJ4qlfR3VzqXnabK8u+XeHUH5V7g46Yrb8OeELu50+5e+cxvIMxFxht31rM0zT9U07UryDUCIsptUxHAHTOT9KqftJQi5KyFGUOZ8rLcltNFqIUs9wJArGYyfKnr+NSrZzLrnnombQgvvA4Zs4GKztUQWczRtdgbo8eSoLBB9fer8WoyaPoI8tDPbyjKOedrH09KlKLk0+gPmSui/4xihnsFEkOY/lT93wQ3cZFZBSzvIUiWQ20yrtYg5xk1Ri1GGSKSeRR5bthzIxAHoB781c0LSbUzvLDJJNcAEMjHlR2we9Jz5p3SGoKEbNi3Om6ZFYJOHuDcA+Wc4+fHO76Vo3d9FaWljc2ZNxOy4RpScRkd/rzS6pp0OoabMZLsWhhGd44UAjg/pVJbSxbSYSLxrqKB8O+7GM8flV2cG1Fbom6klzMqTw3XibUvLd4YZkUfvk4Vh0PFdZo+nQaJYizAN1IrEmVh1b0A9uKwrbTZIrxnsTH9kb70qZJX25709vEFwt5KsUkReIfKZFxuwOCSaVOSp+9PcJJz92GxXu5r2z1kmeN0Wf5lxHk4xzzTrhtMD+a7M8crhVtyMEvjlfpWve3lzq+kW97NF5Moby5SH+Veeo9qrakljfwRonmRzp8vmsmFJPf2puF721BT0Vyto17a2iypZWqRF32PuJOwegHrS+K0QWtslrG6o7MJX6ZPYGty308+HfDk0xg3zyNuZ3XcV9z/SsbR5Lu4zbzgSLcEhw5yD3DD0q5RlGKhLqTBpy5o9Cn4RMiX8liywlPKDN8xIRifyzV/wAVTWlk8cdq6R3EsqrJtO0ue3/6qq6TdXllf+RbQAhGy5fhT9c/zqK9t5Na8QyXYEL6eQF3D/lm9ZxklS5VvctrmnzPYsXt3cy6TJlzDKkgChfmwfan2l0Z4xDcRE3EChpdrYB/+v3pmuM+kW1oliqXD3THJZchQO5PY0miyw6okqrbPDeI2JBG3yyDHDc9AaaupJPcNHG/QfJDDdXghtyJHkcP1xk+h9RVB9RP20EbcwfK6AHHXse5qSx0GW31uB4UMMcZLyOWyDz29q2tXsoRKHRSjt91RgrnqCajlk48w+eKaiWJZrK+sQ8mZAWXKleRn+o71zYs7jUtQeHT3cxIvEe7IUZ7Ve0KQLrMiSxKkbqUIL53MRnOPSszw/eT6brpZwUjaQowQ/eGe47VbmpyjzdSFFxvy9DW063i0yCe0nkLrIx3yxnGw9AAO59TSWmmG01H/Sp4trcIVP3h/StHXWstQu7NbUKLssS8SvtwR/WsTWtXgjukjeIs0AEZ2dz6cdPrWk1CNr7IUXKWxNqLQ2mpzWAjh8hiEJYEyM3YqfWr+s2F1pZSQL9oS4wrM8YwPqOx96z/ABBMk8Nvfjy40YBEG396zeg+nrVS41Wa+ghtpHuWjVWDZOcN1A96cpU4J336AlN2t8zs/CKk/EvRpWXazaJfqflx0nsu341C1zLB4v8AHfljO7UoRzzj/QLXnFV/AD3TfE/Sxd540K82/Tz7OmXFwtv8RPGJkzs/tOHOB62NrXtYR81NNI8usrVWaen7rwbZdpIGVJGNppEVo2CR5kIOMg0MBHOJCx2A84H3s9KaZFjjZImcbjgk9c1t1uSSrNE0RBUMv8GOp/GprCSCdJAIpYBGMMjfdHvVMqqxBopAGUnnGQPrUk8LxRZjfc7cZX+I+49KbQmZ0eoBr4w26swjbKnGAT2zWn580ESvPGSf7p561LpNpZ2e2WQDzernHANO1W5E5HktiMdSe49c0pSu9ECLpeGXTmuJTgLwyjvWXLIsmwx5TZ/Ax4I9/UVHb3JmtzEyhYzyVB5PvS24gjy0jP8APlTuPSktFYEh8mxSiAhYgM9OQKpb7d7lFjAII+X5jkVPMQ93gKRGgI4Gc+1OgiilG5AOMgFRxVXSQzF1bw9Z6kzPLJJG7HEoiOBJjsfSt63ZrK2t0RMRp8qhewx0qE7hGiSMdpcgkDGfxptqpCyeav7vogB6H1rFUknzFubasy1CZbq8jA+XA3dTjBro44jHCzKx4znvxisLQ3SEOG29juZic+1ann+VvdcBT6/4VT3sQUJZi0iJ9mhMcjD5VGPxNVp3W0laG3iJAbLDOOtZzasbK5ZoLZnYvt5GOTU93IZ5txGyXAYMASPcGr5HcVhtkWuLiSVFjZVJwyEEgjrmrtsVmkbByue/euf0iOWDVCYYpNhJVm65zW6kcFsxLM3PXaDx9aKiV9BiuhuNx6FScdwVHapNJkmsJVZ0HlY+bHQCorRfLukd5FEb9Pf3FaepCKW1ljVQFZSN3v60tNmD3INRvLK8t3kSRf3bZOOprl/Ek0xsoo9NuJEkZ93mKMkDGQcVatNOV7aRIpUWRsfMAfxpbeIWl0VYq4AwWA9utKUVJWTKg+V3sRwG8vNPs5ZFLOq/vtw6se4Faot91qFkX5Cc/MO/emR3UDEqhIB6OBhTVe8WSWOOKHcSDg7jjGaadrIT1dwEs1qNiSlc5I3dT+NWQ0E0UTysUzztHIHvmomhYQ+XJiR8gqSM1NLbx3MSLKSkgHLJxgfShqLaYXIZZhHckM4wygHauR7VZmmgNsA3LL0XOOKS7SzXy4i7ptAG9R8oHvWfPBbi7DM7KmcDAG0nt+dN2uI0LcQzwpLyVzgcnoO1LPIMKUjAHU5PWnWcqyqsTJ8pz17H0q9PF5caZQLwct1I+lDdhNGO6YuUaFD5hOOmcZovzcebGI5W8ojHC/xVdW6VIHKxGJuhYjqKhgDXNtM9tJI/8KkcHNPn1sO11ca6MwSOQ/OMD5jgGrFrdxRFbaIMVBI3e/f8Kw7wXZhW1kmWObdn5xn8OOlbNhEsjSRquyQLt3njJxzitWk1uLY2/hGd3g1j66rqh/8AJ+4opPhCuzwWVPUapqY/8n7iisTIpfFu6eym8G3MRUSR60xXd0z9huxzXL3uvXTzRXEIWMOD5mORWz8d4zJYeFEBwTrXH1+x3VYGqyw7bSKdRvWMZ28Z9a8zGzkpcq2sn+Z6GEjFxu11/wAizo93CkkcrIfNYkBsYPX9ayJPElr/AGiVaw3IXKFurA57nt9K0JYbOSSM2MivtBb5m+76/wAqjvtL0smS6hgb7Vs37FOELnqwHrXHJzcbJq50xUE9UyrrGjQR3UV+W2QEsdpQs2T2GKjnjQ38bwxR2+wCRht5fA5H41Jp8M1wkk8kxaCE4BB5U+g9aydX1u5tY1OntFIrSbZGmTOysny25u5qnJ6dguUt7XUYGt453lkHmyAsAFHoPWtK+sb2K2+1xFpV+Vk3qMxr1JrBi363cm51KTakDALIgA3j+QrrfEl1dR2tiLLmy2bc54wB39TShFNSaHJtSijH0vVLqysbubyhcblwm6LbgehHepPD101806iNbZgud0ZwBz2HrVm2u7O60EvdvveLO0IuCMdc5rMvNPe4Szm0VUjiYeY3mOMZ96lKSSaDSV0z1ezVzaqLg5IHDMO3rXI+ObSCCeG6MixSYIO8ZDDHb0rovC8M9p4ft0u3juGUEqYzuBHXGe9VvEKQ3mk+feW7YiG4Ajp7V7VWHtMNc8unJwrNHn+sr5ssM9s8XmzRgbJDjaemSfStO0hWy0hNMu0juT9+RhwFLeh7gVn6nb2OoJFcR3TwZbY0LKTu9uPzrcmiittOshYQfa1YBW3nJc59PavGhFuTZ6k5aJMo2GjQX8SQMFjJk4BUEE/T8jUcVxZaR4iW3mZnGdgZFxz05rYv7WcGOS2aS3MYDGSJe/cVm6xpEFyPtayzpcsQXU4G7HQ49a0cVFc1tUQpc2je5seIbCOfQ9ShbbF5q5RhheRyMVw1lBPBAgcwvgAFC3ytzx06GrM8V3eWlzDJeSu5+aNTx/wH61W0KyjhjvYZzOqtFtUPzvOc859Kzr1fayTSsaUYcis2X7D7RZ3M0iKz7lMiLCd2wYqS3ZtQ1GKTUhBLETl1wcYHerug6beW8cssqSiFsBgxwSMdh6VemcQaQ4liMjSS7eEwwXI64p06TaSYpTSZZa90+4s44VVYbYZQpjJYdiBWDqcP2e/iEU7yQEDL7sK6noGHsTWlc6LNfZl0vCyxgpJF/eHTOe30rMHk2U0CNACY32KjA4Lf1q5tv4loRFWvyvU6i61ZdJs7aye6iZ/L+bfyRu+7nPYVztvHqsd8H8geQ3zRsM/M2eenFY/iTTLq81yW7ODE+CSH446Z/wAK6DTNfe0sTLKxeKL5G3rtII7jsKbqKc7TdkgVPkjeCu2WvFEd47wiOEhmUMVXoW9Ca57zLiW3lhiQx+YyoxjbaykHhsV2EHiBL/SzfWoDjIwqkNk1yMsNxqN5NNZLb2uoS8rl8gj6djSqwi5Xi9xUnJq0lY05bS2n0WSC5YgQ/vRKn3o2HGTWMgaHR5J9GkmkvJJNtxhQGOBwQo7VvSQy3kMNtdMJQU/fOgChSOprPsRZaVqEVxFJJc8MA7SAuvr8o7fWnWcJSTgrIdO6WupLoVnfnSnm1RnEjDITGNwHb2zXPat4j1ea9juLa2i8gMAIiclR0575NdvfXU0umkWSmaRBvUR8Ejtj3rF8OWlpcRG4vbDyrgsSzSNtVW7ZHrU1FqowegQlvKSMW8sdQ/tKCVbW73yEOrRr8rAnjnqK6Ql4tUEjRJE8W0S5QAe9SyXl5p4knilaUKmPLByEbpkH09q53Sp55b29hdvtCzREsxOVVj93J9qzXLTduppdzTZPFEs+t3d4AFtkzIgAzgd2zVq3vdHvYr648p47hB5i72GHwfvA96xrd3trZ5rzy1A3IQJQfNGOelO8Ppa3drHPJExtwfLWL69cn0pRv8NgklvdmpZQ/wDCQF9JkIidE86FgOO3Gf1qzY2cOk288cIaWdsxmTGAvtiun0LR9P0iB9Qi3pI64Ys2Tt9B7Vj7JbmSdrYbBuaREcfeNdEqXJFX+JmPtXOTtsM+GkryfFW2UwvHGmj3yqzMTv8A39nkj0qxcrC3jzxr5hZW/tKHBB6/6Ba0vw8aVviZpvmMGB0a/bgdCZ7PIpLra/jzxpDJECkmpwqHz0P2C14xXsYP+CjzsR/GZagt/wDSA8/+pU7eT/L1p1wm67YxoPLzx33e/wCFSSxiygCPwFOAM9Tnr7CrNrMIomLbVKndxz17CulsgiskiumWa3b9w+c8cZqBUMd0HdiG3k+mQa1kZnikC4DRkBo1Ayue7CsOC0nimmTeJQ7HGT1980ot6gXnC9VLNxtzngfUVEAIoRsxvYkMQP5D0NMVSGeH5vNjU5B6E9jQGmeWEYGf48YIFS463YD7Vg6GR0IiPf8AiFJDJDPdCGP90T03EHd/gacIZpiFKfKSQQp4NSDSXs0edBv8s5QEY59z3pq3UH5DInkaU+YQyDIwRgqKkjwqssSbCUyCOc8/zqjaakxmkNzbDepw2FwNp74PvVgXi8i3jPlK2MFew71TjZgQQQSK6qzOYWJJ3jIX2xUkoJnKlshACp6YHoamnnbzHZAxXI4PvVeQFN5kbCK2M9sGkkwEQqZ5ZYXzleBjjI70y1mnlkkkkkPy8HqAT6Y7GnWsWHZ1fzIkG4c7c+1IjXUjbGUFj8/I+7+FU3a4DLUJIdsu4OJMoHHPGc1ZlZbe1LxIX3Nzjt/+uqd1cSs5jCnCjaoxzycHmieC6ndPJdlKkho15z6U7WAu2Nw4tmUhg4G/PUgeme9HlG6jWYylEY4KHue2aWMSQ2hjuMBgpJ+XH4Z9aHhUuoTcGx0JzkdqV0ndAOlhBtwMtkLs3AYyfapEnJhMSMWYfIcjB3VHfJEUhUh3cckgnv3q5awxW9qsk2BgYEjcE/Wpb0TYCQWf2dAz5wcgkDApSg3kRquQOmOopzyzhtjMRG2Dgr1pLeJgzbzuHU+uKwm22Uin9nWOQtGgiJ/iPzUhieWESI4JYhufSrl6oa7A5BjXov8AhUEirltq7fx49xWiYrjrNX8mRmA2g8c9/WpFSRkJUKQ/TJxgVTT5o3T50LnqB0NLLc+UywOn3zwAOp9/SnGN3dCfYU2cl1IywyrsdcE46VrjTbbCqVDvGAM9fzpYoFjh2Kdu/kkHp9KoTpPbrK0O4ORgkc8f40+ZyeotibUHFtC8gwJCCFIXPJ6GptDjJtm+2s0hYfNvPJ+lZelGZw/2pl3gZz1x6CtPYWCyISYVA68YqpOyshWuT3sFskYVlyr8AEdayZLiO2hVYDh/4IwNuPfNLeanBeXiR2pZ5AuGDcCo7i2nS5iMX7xVxnuKiCTdytUZ2rSSQQJJ5StO+dzqMjPauq0Qi58OwSSgea64yRjGKwTJcy6iFUEAnGB0FaWkRXkUbxsxPzfIrfXmtW7RsiJa7ml8I1K+DGUnJGqaoCf+3+4op3wnOfCEhxj/AIm2qcen/EwuKKgg5/49u0em+FXQNuGtZG3r/wAed1XGX8V5ayre3cgj0zyjy65BJ7fnXf8AxmuFtIvCdw0YkWPV3YoT1/0C7rz7xRdah4r0J7W3tfLKosqeXwpHavNxdlU957q35npYO/Jp3/yMrQBNFK8qToYyCykt8x57Cuk0tpDbXrlTI0cZKPzjOOlcFptrd20ttb3IaN1PXBJIzx9K9IuvtjT28duIlcAeaxBwB7AdTXl0k7tPod1XyMDQ78pHMZg7QNkFEyM47n0OaSBorq0vG09BK27Lgjtnn8fetzX7S3hbZcusDT4UFfl/E/jVHSpLDRtSWCzlmnlkBUsVwnXnHrRKm42T2Eppq6G6PaXFwxknKqg+XIHy89dv862tRuksNM2DZJkAKJMFuO496wPE321r9/skoK5CRQKeAO7H3NVorqaWOWAo08Vuw5c/vEJ64NVzcl4oThz2kzZsbZbu1cXlspSIhgRhdwPY46mq2tXIhhdIoEATOE27duBUIv7i2uDYy288MDYc+YvXJ65659K1LzTIry1aBiogUFlZGyeeufrQvejyx3D4ZXlsaXgXxE0mlyG4VTHAu7PcH0z0pLvxh9q0y4MloFZSQiE/KwPrXKabEyTfYgnlwrLsf5uq+uKin1CzmMlkplMTSlFmwNu7oOPT3prFTVNRuR9Xg5uVi7ZR2etQsYJIrS4i5YHOGB4yKsWuu6foSW9hGHnBYgyg4K464/xrPESaLrcTyyeYw2q0USjAHvmui8Q6Datcx3Vu6oJE342gnkcgD3qYRnbmj8SLnKN+WexFealfveW89gGNi2Hd921VHbPqa3U01dcto57p1SYk/KBkEDoa4q71O6srk6XYM6WUKjYD9188nPrV0660ETywFSDEVDk8+4A7c1p7aKfvGcqUnblJJ5E0+GeKCLzJo22CZxyfp7U1rc3UMV1eZiRiNzHr+A7is6GeS2c3F55ew/MXC5O36d66a2kuNbtX+1JbtawgNDKFK+YMenbFRBqTZck4HO+JI7/+0ZGguG2fKY1ycEA9BV661O5sr+OC8BQEBTtGRz3z69qTxRcXMnhUeTjzg+N0Lckcc5rPWTUJ7Wzu2h8wQ/Ksjgkj/Z+vvRP3JWuOPvRvY7TTtUXT7poHOUYcbU9vXr9TXLXjz3eou3nKksikrtPJ7AA+lV9W1iHUI2jDLHd7tobGM8c8imaRYalFZtHFKxnVl8tyAXI9MHtTqVee0OiFTp8qcuo/TbNrEzJ4guEgt7gERhvvAHGDge+ear6lappFoot3jns2AJxuZnDHqc9vapb6G2ubpf7SuJ0uISUJ2gqCfYHtV3U9HSzS3hikLQbc+azZLZHcetZtc0XZbFqVmrswNEm2tJZxK8ayuFLp8qoPp6dquWNlDDeST+Zbpcx5RMuSz+2PSr3heGKPVcLpzySojAStk4GPyrM1SwiW+luEjMnz52g557EYpRjyqMpD5uaTSLOsavd6XGgjRgnlZfau7fmpIdLsZdGOoq8kHnJuuUB25x0I75q1BcpNaSNe2qzGP93FKqlQ49CM8Yp63enfZWs74PHGyhWiK5x9T2FVyq+rI2WhlXt7PAIriwVojIu1VDgcY7/3at6dpeq6kJVtHLl13FWHDHH6Guj0fw/p0qLdwOLi2ZABv6DHHQda6bRbKOzuLhbIkIMYjxgA/wB73rqw+AlV1m9DGtio0/hWpwyabeaT4fvodVESzXGUt42f7wHUnH1qhoEtlZ6WzXEf2SNQBuGCGJ6f5Nen67pzX8HlMuCBlWCjI9wTXFeLPDjRaDE8fljyCXmaTkuPUiniMLKj70NUiKGJjUXvbs5W+8OyajqEKWYJsm+bco+UD1/E1f0g6Zok32HVZN3mMPlUEoCPX0NTadrsdhoSR3Xml4mwEj6uD6e1c5ZaRqOu380NmvzEl2eY42DPXHQ/WsHUUpxcNzqUZWalsepXn9nvARPuXau4becDsQKwZpi1owtoWE4k8xckElR14HT6VF4hW6sbu38yYJEsYUlx8rkDg+1Y9tcy3siNY7pLmL5SiMA4B7j1p1azlLlaMoU1a8WdP4DnkuPiPpUkqkf8SfUACRjP7+ypY2VPiH4yd0LAanDj0B+wWtP8Hvcf8LV0uG5AUxaFejAwMHz7POR69KhlWQ+OPGxjG4tqcI25/wCnC15r28J/CR5tdfvWbs1ss7MTtMhBKj1/GoNLbfNHCUYAjHIAKn0xUbZe0mRHDMvPB7VT86WOJZULeb93eccj1OK2S0IszbsVuFm1BZ7CK3UzARyhhunGOp+lZptZIrkNuLMRxt6Y9aIrmVIFeUl2JwFP9f8ACqMdzdT6+T8y25j27c42kChXbdgSaNXUiEuIyi7pAAeTgN7ZqqsZYBkC7Sc8nr7VpM0iRKJo1OOTkZx7VS1CNYyyRSFd8Z8tTk7c9jSTuhljTbNnnkdJFIGAQeq461s7WkDBTlcdK5Tws32O8+zSOzKSckg9fQmugv5Vhtyu84kBAZGAIHtSnHsLcwtYjVBsJMcxOVUkfMKoRM7TKr/MFYLg8j/69Ryq114juHuQzQRRiOFgc7s+/rWzbiJYX2LufuDzj6VbdhkErt5jBCCzAlmZeMiklXzYkWRdobGD6n6VPFBi2dkXzMPhk7jNPFs8lmxuAyhc7c9cCo5kBXRPIVcu0hk/hJ7evpiobjzIryNo14j+XbH3J7mqWmX8eoX8toyywrncAxyTjua6cokYR9q7hzvxz+NJVVJ33KlFx0ZWmeFHXdD++ZeTnjP9KpwQyJKxwcducE8f1qzJNvuVkaLb1VsZHSqlwssk4ZFICtk+w7flVoQ+dnSJjnf0z6r61HAm5pcvvG75ST0HfFXMiSQEYZV4HfdT5ZlMBijT5zwAPlxSuIfJapOqXOSu0bSCeKimla5cQ7lBTgc9SaoK7PHFC5kAUEMT0H1qO92QSRyhhuJHzEdKVm9B8puRLOlpGjx5IHzFex9qZqiywwQXCqRnAIXrmstdSu49QRITvhQYZ26t9B6U/wDtWe4DIwBU92BAFLla1HYsxTFl+ZQG3Eknp9c1HI8TylXGUPU7uo9RUEUwePlcNgltw4weP8mrI2x+Uv7vaFyp25H0qiWOhuIWvOFCKV2qScbvSpYGhS4zMirKucc8t7VRVIvPViX+ZslCegB4was3CosjDILOQzewNEtdEPbczrGPUDe31zdzTLA4wqk/Kp7bR2x+tX7YzyAxySsSSfnPG7jvWjPBsi27gY8ZbntWXeQzACSIsysAoTGMnufypQvazBtMsidbO2VLk/unyC2OhqC41pITGLby3tznzCxxx0Ix61beyaazW3l2lwCfm5G3HHNQQabFaacThZNp3Z7Z/wDrVouTqIVbXT4JoZ1Mig/MqAcZPrT9QlnLeWj7RxuYDJ/KmRwG63B5AiRLu3gZyvpiq9tEsrvNA+UJwXzjB9DSUEtRJ9yW4lnhVHVlQbc59/cVBZavJd3bxxuFKcyHPP4VYsrO4lklMecbeFyCv1rPi0iK01NblnlBV8EL0A96as3Yeh13wi/5Es5P/MU1P/0vuKKX4SADwawQ5UarqmD7fb7iipMWRfEqKCfUPBkV5s+ztrEgfeeMf2feVxEzT6TfGK1iRLbzOF/hdO5B9q6D47l10/wqY1Zm/tk4CjJP+hXVcys8V7pUVutw5fYSJcHCevNebjaiclT67noYSD5XLoQXj2ceoMtjL5s07dCpOwe3rUFxqMzXiSqJoobZgrEHILfXuKWXSotSEDaVrEf2yEfOqDG5e9dDcLbXVkmn2u1WgUtuUg545/GvOUZTv0O1zUbdTE8Sw3U2pico90kmChBwgUD1FZEE9xHNEbWESLCTyRkfgT3rrFtmGnrbWztGN+WDnOR357Vz05jsZT9kwJCplIwCDg+lKvT2m36jpzuuXsWCl5bWLybyzZLNOUwQD0H1qnZW80dpeTsWDLGG3gY3tn9eK6eaeXUbe3mhQbnTDRFO/fismex1farNEJxsKMo5KHsdveiVJfEtQjUdrFCWS4v7acGNpWgwEZz82M8geuOtUtBaSC5dWScsu5pJXz8y+g+lbWhy3EUsSMIo1kO2XC87unAFSa5G1xLdoYnkdGBiZAVz6dKzULrmvqU3ryvYreFr+PULu7EULIucFnHLE+neqsvh7z9SeCO9itoN4aVAvzLznbx0zVqxVtPvMwKfNQhmaReSMdveraWSX9zcSRgRXO3zZHBLbwORgVSSnFXWtxOXLJtbDWe1m1xd6LNCHC7Wb5iR3I7dBWbrWoTy6uYSJknIyowQqKOOKtfZVjd77AF1JmSIouQWGOWq1FJftpF/LsZgqjy5t2WGTzj04os3eOwK10zI8T6rqK30MMEKLGhEZBAyePvHvVmLR7M2UdzLe4nuABtDbQTu5GaqeH3iluBHfjzYiNwdT8wI7ZrZltoLm4ge0VEtycNGx5THce9TH3nzMcny6LQoyT/Y7111C3ie3U7UUkAp6YroL/zbuC2ktJhDD5YO3kZ9KxteFjqN7xAHidQqMAfmYcAD8a19JDp9khS6AdW2tESMKc81pSdpOPQzqLRSKXiHUP7Me1sLdRIZhvkwob8qy7jWb2TWLCOINDbvtUKqkIWB4B7bfWty/wBAN9qErshlhtZC6SxttO3rsNcmjvfaydq3D5kCpbg4EZHfH9amtzwldl01CS0NS2tbG41W4jlnD7XLLGQMIeuAfwrSggsbmCe80uQOWPKxsSVI747CsPxAkEOurCts8bTLzjq7d8Yq61nJ4dVdSEiFjgrCOHwex9RVc3Lo47dRON+o7S9Bmv4pLy+LmSKQhJWHPPXjv9a3NI0jUb26kW6KvZhgFZxyAOoFZFp4n1DUbhraSJFiKOQbdeEIGfzqzZ+NLyxtYUulhm5CsYxhlz0zVwdBO7bM5xqtW6nf3EdvanyoUjD4wM4H6d6858U+HHsGj1O1dhCGJ/dcFD2+vNdTpeupqNjJc3Zijlt87iW+UKen41LFf6b4h0/yNNvIppLc/vlIwfyNehiI0a9Jcu/Q4qMqtGfv7HD6ZPLc26pdzIkqsH3A5A9R7HFRxQ2V2VS4mK28zbmd2zuOeOnrUusWVvapCXMhZ2KsQcBjnp9BWY+myy2kgkLC2GWKg7SuDxXk8sr8qV7bnppprmT3OittafS5zbWbO8Q+VUC/IoHQfj611F74pNvYo8NsDL8u5SMVxK6q11p6wWkHk3MboGO0cr6g/wA6urdyX9hab3BjYsMOmMsDjkmuqnXlCNkznnRjJ3aJdY8Q3uuuscb3Frbh9sgg+bIB+9n09q1/DN/DqtjeaXqUwlgcfIW449Oaq2F7FY2BF7p8Vs8ikSOrAEL269a5+HTpZ9WFxA3lwKAFkDkLs78etT7WcZcy96+4/ZxnFxtaxNdaJY6hfTWSXaK0Y+V4RknHQYPenWlrP4XtALJpLi4K4Mh6AZ4GO9UYLRrWSO6LywvuOcnduGcfnWxBd3hvJ7bfFhzui2n+HHXPeppyik2lZlyUrqN7okm1CUaM66pys6MT5i5CHtiuN0jwzfR3wu7a5URJIHV1fPPp64rorVpLm4eyuZ5DICyiPPBP49abot0yXM9rPayqBlAxGDwfX61Epc81IqC5Iux03hQu/wATdHllHzvouoAnGM4nsvxqlMSnjjxu4O3/AImMQDYz/wAuFpkVD8PLiab4qWaSidRHo18As3/Xezzj8hU8kTSeOfG3G9RqcICjrk2Frk/yr3sK7000eTWTjVaZY+zwxQNJPKxgcBeCc4/pUdovkxMJEVbTJ2vnnHoBVhIAySJICVjOQc5qWSFJLJUQBeMfN/EK3b1syEyo8Tq2+N1m5xk9AP8AGmaiqyXFrJGrRx9H46NUgMccLnrInQIcD8afaSNcAxxFFLqSN3PPqc07cvvIE7nQ2FqJrZPP+vPWqOu2UVur3TzGOMHHTP4VNoc0zERySM+EXdkd/rWjrluk+nSiV9qqN3tkVlF2dhNvmscgAX3hC+58cseSP8afmVbbbLNlAcbiv3aTThEZJMzGSXYdpxjZUkMEokWOfa0ZADE9SKq+rLIpJE+yRbtoLvkNjpip7JVijIWRp2ZcDIx70lzsfYsjBGUnI68e1JHeIIsligDYRjjnjvTabVkLQn24L4RgrYYg8HPvVi2nmaN1kVSQp2jOSfrSCFjHFIpYjd9zswPetKOFEsD5cYiLMAeKyU77oJaHKx2SrcTMpUO5yxx0rY02RTbyKJN57hu//wBarVzZxFCBgNIDnHBIxWNamCKCdFaRXKdXOVwD0q2t7KwJtjbS4eaYxueMjAxkDPt2p7K8EhBBYb8c8Hb6Z9KqWF7byQzNbXKNcMeQDyD3/CuissNbjz41aQ/LmlzXG1ZmVZqFuD5buwbkEnPP+f5VNLHG0rDzhvHIyucmotWiisIjHDKFcnI55HtWZdJNayu/mkGXGBu4A7072Vxpc2hYuJna4ZVGFU5KnnP0qSe0j87zZJ1Cn5trcke2KoJei3vVjdc3DkbAQTlSOtaC2a3KSMd26Qfe7KabezQysupW73ogtrlMRr82MFh7exqYNmUqoUoDkA9vauTm8K3f9sNLbFFti4kL78bW7/Ue1dnbRW6xSKJC7j73HJrKnOUpNSRdWMYpOLuOdo5owzsVIGBtHBHYU2VVeEIE3qOiHg49aYCFizJGeTxk4JHap4Fbc2xQcDAfGDjuDV8tnchHNvBcjXkudzCDcOc8bcdMV09skU8u8YIJyAfUetVY9NMhZjjbncAp61ajeOFlQBBk85zk/SnypbClLmGxxTSXDKrb05yd1XbaFw7PKUQ7ckZz0qkrrbXHl7huJyAKfE0l1LOSxVGBVs07vcSCJ5PtN1cfaWmhdQFyfu/QfSmuZwrOuHwvQDAalVNnmJv37RgkjAxT5IpwpMTYx0ZRnNDabEVbUvdNPAC6xMMAk4BI+laUENta2YgQruJBBHc+tZbvPbQuIlw0jEkAZKj1/GrKxzNYCaYENjBAHO3sa0k2/QVjd0xFVSSQWPGNuKh1VIo2PGx5OWOeKz7DUGtQVuCDCD+7cck/4055494klVpFbOBnqKzcWncLdjS+D4I8E4OAf7T1POP+v+4opfhFg+CyV6f2pqeMf9f9xRTMjN+MqeYnhJdzL/xOGJK9Rixuz/SuDGqNJLdWiWrwwxZU5GfMJ75r0H4ubS/g8SfcbWHU/jYXYrz2+sBBb3dwl9M5XaF+U7Rg8c15WPvzLl3PSwVuR37i6Tot1ba9ayTyrFBG+HG7lgR90im61pFxZa/L/Zm59/yxqOg781U0/Xrp0khuy0gDDEjKcoM4yavaRr72j3C3OwyglInY5bPb8K89ez5eTqdj51Lm3Luk3F5BdMl7DIgjGN85+Vsjg8e9VI47iW/UhYpk2nLHgA/3h6jNOlvL19Plj1hlaSZgIXU4PrmsdZLmzlWWPzMOjBgW3FOPvL6UTklaPRBGLWpfe71BNQ/c3nkQBQPJQ5DMOCB3rpLKdiFKyoLhU+YcDJFcdp6zw3NqIQssTuvmSOMDB7rXQQaXJFqPnzOEcFto/vk+1VRqS1sKpCOhHaN9ovpXk2BnP02uP6Gn3UslgGluJHwy4LAZDegWqtpPeXJlWaCGOdt6Bkj+8APXNU9KtLjVoJrco/kkbXzkbWHQgelTzdF1HZbyH6dLEYJ52ne5HOFk425659qWLUPskzR2A8psL86ksXHoCe3tWf4g0iXQnt7eTM32gHIQ9BVr+x5reyhdrZjuUlWGdy/5FZ8tSLtbUp8j1C/1GdrRPMQgxZZvLG0licdKq+JrzUrO9lgFzIlvGufKUZDAqPzOa6K10mQSWrToFyNxLsSRx8uR3NJeRFNRiMpjjZX+Vi+Qeep45/pVTpTUeaXUUKkXKyKiXls/h8GWG2jlYDdsXa3b5setUdPni1BJYkaSE53GVjtZz6D0/rTbiza11WG11CRpjK2Syn5SM5J/Kt7VtPhsY4ri2XOeEK88HnP196cYSnr/ACg3GOncr6jYf2VoM0knm7pEwsan5hnq3tmsTwzFJPdWcMPmxniR5GGcLn19a6PT1vNWieC5uEGFGWcgE/jU+vt9jt0h08AyQ8s/RSeOD7UuRStNbISm1eL3ZovrVvolxLZovnM5JkLknr2FQ3VzbQyLJYNGTMuYgBhj26muKNxDezNc26MJIgXcDu3GSM812Gluk/h15M+XNB8igLjdnkEZ5zXRCtKo2mtDKVNU9StrV1aWOmwXjj7RPG/yELkqcZOfasaef+3bqO4jhZCI8qjNwQec4pl1ctEkz3iOsGAI1QfMGzzx3/8Ar1b0hLlYJNRlnOLk+UiGPAQY/M1g5OrJI1SVON+pBYlnmX+zEhExJG4KRj2xXV2+mWZl82SzjLEBpBngn1FcxfCC10+WSzcz3EbEuA212HUY9B71p2euMlnBHcNGbuYDysnLc9A349+9b4eVOF1VV+xlWU52dPQju7a2u3udPsdsAeTdDK68ZHVWH9ayNFs9S0bU765iESmKNgAhBzn+I+vrWlZaoVvpv7agiieTKRPnJIxywFV/DllfXGrK0gxGPlBUnBB7n1rOXvTi43uaRuoNPYLWRtcuntpHlcwxmXcE5Rj0we4PpVJ5dTsb9bZIZWtcMp80ZMnHJYfoMV0o0zUdLvp8ebFGXzGQMhx6Gu4uI0uLJGkgTzDFljtyRx2rWnQnJPdNGNSuotWV0zyeynNjqEsdtbYTy8fZ5/TGeSfTFUtXubmSaRIz5a7AqBV3L0zx75rq7e4i1HSbkXMSi4j3RtcTrhmHYf0rH0IXEAvJZPKlEq7UJx8nOAwHoK5pU2mknudEZXTbWol5pu7w3p0es3Ktdqu9kfOCvbOPStWeSX+zIIrffIsZAHlLw4buP5e1cxcyzvNHkO7xIQZSOB9fc1oz6rqGnzWaWg3QKPnmJAznvjv+FUqq5m7aA4XS7mzeaVLILXfOsIUfMCQGYenPP41g3ur+XrtvDCQEiZYjIo5c7unPQewqxe3K38qyTTRpLIgBt3fkc+nbNdBb6BaT3lpc3dqnnx4LHdzkjjNaRg6sk4Ijm5F75zPiXSr/AE+/+3GaSQqxmjwOGJ6DNdr4OdtWtftmowI9yrAK+McY7j1rOeO9sLt4MSzhm/1MgDIwz2/CrOkarcQ6o1qlqyWxOVHZa6cHGMKrT27GGIlKdO0R+hecPjfEsqbY/wCxbwxnGMjz7SpLG5hh8ceNlZQZm1SLnHIX7BaVB4YvJrr4w2qzEbY9Gvgqjt+/s/8ACmRR7vH/AI03HEZ1OHOT1/0C0r0cNZ01bbX82cFX4/u/I0jJb3X7lY2iQtwwPUVSneVblokdQF+Ud8LTFhS3uzGZCVDZyO3NS3Zd5xGNg3n7xHOK6dFIXQFdY2xKNwUbEXGQB/WknjRY0YLIocE4B5Bz0FMZo2iBt2Z3ThmU8r+HpT2eVPIzHvjHHC55qet2NDY7ieyjRo2/eFsgMeFHp71cl1ee6jzPHiIgYXHB7VFBAHmRbrDHB3KVzxUflu9w5TbuOCoC9u+anRsBts8aGXjlBtyBwcVJ8zFXcqGK/dHIonZEQDaAOp5702yeBSEZDtb5hwSdtF7ajJoZURtrplV5diOlQ6jptksdxNEkpdhv2h+HIpZHh2qE5ilcDA65pbqKSaMrEyuwbnPAx9aafURd8LwTw2C3F67NLKPukfdXsB6VrOkkhxu2wFenqRWJbajDa2EisTI8fJX1+lLpGvpqE4jjSSEHuw4FS1J3kBqEpDt85zuycFuc+1c9qBUJctCQGkJRcfwZ7Gukb7MZ1HnxF887jx+FYttcNd+LzDDGo0+BDhio5PfmlumNOzuQ+GdBs7K1SRw+/eSWbj8/atyR4kGIXBwTj1NGrz7YDH5bP0IIHUVTmifyhIkTMygDHtWenQbcpaslu9KFzCbiTIYjcwxWTPHFKEJRivHysM5I9K2ReyvprRgjeOAuOSO9Yke0M2XKr22jJDfStY3EtxjzrFGj+U8gwUAPG3PvV3TplitDIkfOSoXOeKoaldSWu3LgBuhAyD74p9lcNNHFCkKoG+dmUcZzitJJctxFxlFyv7oKoOR7A1TWIRO0zyB36cfxe9NeeZLwomY1BK7MdvWnyhLQFlYNnnpnHtUJNfMBReTGCQiOMt1XcP6VPps0lzvCbRH0LbdvPpioknjhtSZQCzHAYDnFS2LzpKirghzgjb8pHr9aHGwC3nm21wIoQVjP3iOo/wDrVHJNuVXKAFRuJ71b1CSYblTLlT/ARnHfAqKyQC4leUlodo+VurN3OOw9qm47GSs0LX/nPMImH31bkY7Y9M1bk+0tdA27Dyv7qc5+tU7yNJbkFI/LBYEqo+8PQn2qDW7y5t0hOntLDGow5Red3vWtNN6MGdCSmF2pibaDubo2O2Klt7yGXC9z8w5qtbTLJZWs8gxK8e5lx1YU3dEjRybGw2Sq54Bo5UtBFJodTkvuWcJuwBnjFaczSeU/kuVKn72Acjvx2pxuyEEYVwz8cLVaSaO1mCyEkOvIHrT1fTYT8yQxPLkhQVC4Hoo7mklVJEjUbl2/x9Q2f17U6AnDYdpMpx2x7UyDJkCEsAw5J7ULUVuxtfB8Y8E4/wConqf/AKX3FFHwgx/whPHT+1NT/wDS+4oqTMxPjyZBpnhfyFDS/wBrttGcc/YruuV8KNHJbuurTbhGvmeXkneF/pXV/HZilj4TKhSTrW3DdObO6Fcnp2lJHciQqWhaMhFJ+YA/y+teTjb+3i10X+Z6WEt7Jp9ylfagmoawq2cjW6TZby1QMXI569hTPE8JurtGgnhjDxgOEHQjvV2S1tdOkFxbSl5GVkGcBQv09apJFLPFHPIyKAdjSg8ZHr+FcDT1Ut2d0ZLRo6OztbPVNDtPLmE91F907ecjtmhPCyauWnTfbzxEGRWzg8dgOv0qLTL7TNCntYpSzHjakC5Hrk11Gra7Y2IDXU7xLcJhEC/dB4BPpXqUfZTo8tZarqefN1IVPcZ514h2iW1tbF45JLZQu1jjGTy1aGlXUdyiwG6XeoKNvPQ/4+1Yw0O5fWp90i+U7iQTMwxt9q29CsLG61eO0czxwvL8shAALD9a8uCk6j5Tumo8t2U7zWJrTV3gtIEjjC48wpnecc/QmtS1mm09iFPzyhclgec9h9K2fGGjtY2KG1JYykryoOwdcZ681j6JaXUFq73kqsrkGMD5vLHfn39K2cJUqlpGSnGdO6LGp2bajL5pIWSL+MfeI7j6VhXd7f2N9hbwbYwoQFwCQfXtx6d6hTxXHceJRp8KBxvKHsW/2s+grel0iK+eY3Hl7Q/mKRxwOetTKTqfDuWk4aS2Fn1uSW/t4Io94lwXkPy9ewFUtYtWa/EWPLDEZkJ+7VnwRc2ja48V3F5Uu8mKNzkMPWuj8ajS5kWMlPtDnC7Tj86u0qtJuUtjNyVOpZI898SyxQa0JWaKRowAzSNgocDgVraprd1ZWNvbpbxfZTCpZ2XLNnsM9/pVTVdHsbmWF2u0jl8vaQwDHI/n9adq08EenfYb2FnRSIg7Lh/qMdq5m5Qctdze0Zct+hj2sM7MHWOfAYsxU8Kf7rf0qVtRukmWa9Kv5zKhUjB2joDnqfpWxcWNxH4aikgVkLN+/RVI+UDgCtHQ7B76xW4ks45jHjY8q/MvvmkqU7qKG6kEuYjih07ToPMtxFJcTrh1LZPX7v8AWudu7mazvUMUYdnLSAkkAY46fSrF74bvtMvLie4uCLeR9yheo9vrTIruG9gEV1b+XMCoXoNoJ7+5pznKOmwoxTV9yfUXsmsbK6inmDzqTs27mPrnPTmiGSe1awRHea2GSJMkZU8kEdOOmazb1o9U1AwR3otjbLsd0OQuO1aFvqudRTRrSRPskMZjZj1k/vZ/E1Kbb5irWVi3oNvaSas8iOVUHeS5+ZgO341navo1wutzXcMEk6NcKyuBwvv+HSppdOh043hS4NxevHvKKfmAPp9PSrvh6+vpftFrI7tZFAwO7LRkDqa0jraMiHdLmiUdU1WS61CWS6slQp8rMoOWXuQ1a3hnxFa2muxWtrErW0uFDu+WU+lZdqZby9MbTDeWzhhwRkYyPWsw2NvY6h+4uFeaOUtHvGASDgcjrj0qVOUZKa7jcYSTgz1O68Y2NxNf2lujSXFmrOc8AkdRXGaJ4r1O61SOW4u90MjbdnAVfQY744rm9JmuLPXLy8eN/tCbjIgG5DkYJJrodMMMsdzm0jjZ9zLOBkAdgB61tUrzqSV3YxVCFNNJCWUl9ceJGS9kkKFWaVWHykL1P0ORir9vBbxi5ZXSMeXtR2f5VXOMA9jUWkajJLfSGb/jyMJ88oDhCvQCq0cul3TXAUyJGiF/l6MBztxRBxUV5lTvrYzLC7h0a+ube7t5JoQ2x2djuYdQ2fSuguri2lu4lMKjIVok2fcWufj1PT57l5pbNVuFTavzbi4H95eh4rd0jVjcakY5hGrgYGQABxxj0FZU5q3I3oXOLvexy+q6NMfESWV7LFEJJ95kdxhh2IPY+1ek3mrQ2M0EIKBIlCFmAw5A5ArzXVdO1u4la2MCTTPJuW6WPc23PTPb610esT2q6c0kKlryMrmTOQD0OOwNa0akqKbSFWiqnKmN+IaNd6gLixkKTPbgkZ+43YYrO0YapBp8sqxTTwIygBmw27HOPXmq62+oags8xbzMHCyclgewxXZxreR+FlS4JN7Kgz7AdR7HHelCMpuVV38gk1TioaEPgJZm+KdjPcIA8ujX3zZBPE9nwcelWk2f8Jt428xwo/tSHr/14WlZPwxtZbX4p2qPEY4jo16Y8tngz2hI/CtJ3UeN/Gqtt/5CkJwe/wDoFpXs4TSir+f5nl4j+M/66E7+TLfK0hYYycY4IB71LqNyIYJJICpGf4v4QfX2pkhUu67hwNvyDOM04LHBEXcAnbtCgdvf3rqdiChY+XBbO+CszNtAz0H1q08rpb5RmJK4QHv9ar3kEUqw+XuhTGGGffjNW7iFooU2c5wMZyPwpvYBlpNPGjSM+JD8vJ6D+hqWQzSWsZIYBm5xwSPWoZ3hjgZZCSo+Zsdv8agtbi4jfzjmSNDz6Ef41kl2KepZuAIIRmJnZj8u7rjvVzzIgY4m2iRAACTg/SodFuv7RvWeRHQQjI3YPHoar3EqC6YuAYi+NwXoeoNCbnsJpR0I1v3NyymMgK20DaOg68+tWVma4DLbrnK8sTnP/wCqkgngmjdZITliBtxg/nUQt2a5Zrf5IwSVwc7fYVbkhFiO1EGbgbZEwMqO5pUQMzhUiiBwSU649KhhSeCVixbY3DB2+VfSnoXXzCfkjXrgdR6/WiTdtRpXC0gJaT7V8sAbK7TktV6xiSINLFhxvx8/GAfWqX2yWXfGyRgbdyFTz9DVjR7lZbeRS4fPJGOh/wAKmSdtRG1YNES5SRnCn7pHAPpU6MUWRiu0Z69axL1LwQD7JJtc/eDDBI9sVo28+IVSWRjJsClSOp9RUSVtUJXMC4jmjvpH80rgEZXpRFsklLSthlAAbtWhPCzjJUhMc471nTRx3ERVPkbOSrelUnoUTRCKZpFePzY+g7gH29KvPGiJGyIAwByM4JrM05BbfugOrH6flWpqR3GMQ4MjLnnj8ql3uGzMRrp5pD5UjB+QFUHgU1rlbaXDiPGOQx+8fSrNtL9ncrJARLzhx29iaZLbpM7vLbsO+0n5frW3PG9gasFw8c2MJgYBI9BVm0kbftQkALnBPQCq907iNW8oDp0H6U+CET+a7FokMe0sxx164qGtPIFYqxmaa7WRR8u4/vCcfrUUX2hL799Jty2Bu75q29iP3QtZWeJeoByQfep3sJ18vKCQHH3u3tWl1YL2KGqJ9lti1q5YhsMVPKqPrTND+1HT1nu03NIcqOje+4GrrxFJtq544ZCuVNW3QGTaEZUUc49MdqI3stAbTK7EoxdtoQ8FGOcewp8E4ZisiZj2kqu3G3HTmqaMk1wtuciMHjByGrSsi0jFJBtDjDMD0xQ0+pOxJBIkiZ2oojOCQc8e1NfTjfzb0YBS3finzR/ZZYkhP7mT7zHFT/aYLaNZUbCckrnoaL2E9dCpq8bQpEIlXG4ZZDg5HQ01ppleKNQAWUF3ODkkUs8kMiLLG5eRvug9s1NYRy4JkUMRxkryPpQpaDemhofCIEeCyGOT/amqZP8A2/3FFL8JP+ROfv8A8TXVP/S+4oqTIz/i+QH8G52/8hs/e6f8eV3WP9qsZZ3tZLhBM3AGcEfjWh8cEZ7XwmEGW/tkkcZ6WV2a81WyjWeS6uZJQ6DLqByG/GvJx83CaaR6WDgpQ1fU6Se50ma7+zXEiusZ+SSPpv8ATNZVzdR3EbWUHlxOoL7hyV92rBtbVJLUk3IUbhIIgMEc8Zrp7SeK9uVg+yR/aHQxPKq5O31JrgjUc3rodjioLTUh8OT2d7CG/dyXcIxHK/GRnABB9Kn8W6ReavFaXETBmUqsvO3AHt3rJ1TTv7MmaGKcTOnAHTHtUOsRXd1Y2zvLJHHESpXdwT2H1p+2dnTmg5LNSi9DUubSO2sYp7yaTzoGKKFPXPQEelVrHV5Lu93WUDC4iJdEVwcuo9O3FSXFxYnSreC8klkumHyknhT6VreG7PTdDu4rhVeeecbFYj7gI/nRSpyqyUYsmclCLcjJstdvvEkklrPcG5eNjsH3SrDqM1oz6feLZmO0cLvB3JG2SvHTIqtq0CWE97Jp6tE78+aw+VQTyMe/TNO0mS/lluXt544ZPJ65+QAe/rQ04z5JalLa8bJGr4Z8IWVlZT3tyCt3IuCW5KD0FZzalFY6g8TI7xvheASQD2qHwrNOmoztPcyTDBdFeQkup7Y9qh1Cze+1K5FvhItp+V2wT9PehztBcm5Kg+d87GmBhewlJYyU4LqpznOck9vSta+WK/v0SWQHd91wcbADz9azdNstsZhjnMbMyh3bkr7c9+1GoSQ2erpGZFeGH5XPQ8nnFZ3cY3ZbXNIs39nFHeCKyngleNgHT2Pb2NX9Xlmi0Xbawq1+rbdzLuIH+FZtzo15HcOLSOQpI24TjoVPOT7gVpaXdiKVTKFd2+6rvyR3NXF6u6Jk9FJamr4Xv7qbTpBqtvHFLEu5toyGPr+Nc9beOL1tRjRbPbZM5UEgANz1Ars7a7tZ7UywCEQ8iTHb2rnJdH0eK8nnM0qzbCyRFwQuemB+NdU+ZKLgzni4ttSR0C31hqcr2kiAtt3DcODWP4qsLS2SJ7a2RZCATngEVzmhKRrkZluirMhVMnBYe/pXS3PiKyN39gePzdgx5pIwrfT0qVWjVhapoP2Tpz929jlreS1W7EyweRJMMmNEB833J7CrS29xeXcFxZWgWByd7hANjDjn8a0rrT7bUrn7UVaKGGPLMnyn/wCvWtaQi9g2W+Y7XGwKoI59accHL7T0LlXW6WpwlvYNFfGe7lBaCTeWUk7yOwroxfx3sKG0jEMYIVoww4PqWFVEsdPk1GSye4kMw43IeCa1NG0tbOGeLycJu5kyBtz2xRg3KnUsrahX5Jxuzm9W1+X+1XjtV8ryUIBA5J7kn/JrOm05YLOGaU7VmPmD5iShPXjsO9a3jOW000QNFaI0yfPvILbsHsOhNJpEo162+0XDPHHGhOzG35fQgd65Z037RxkbxmuRSSNl5dOt7eJZpQC2BvUfK2fX/wCvXP6tazJfSMmBFK6iDdwAv94GtldP09JYeJRvdNi9V574PSl1a1skWK1nuXkMWfkUE7T16/WtKqc4620M4SSlp1HeGLu2he4hvsmJlyZGGQ/b8BV+102yZLiZIkKBCoY8cH0rB0tzeX32aHCxtj5hkFiByo9RWxDK6XDq6EW0QP8ACeo7mtaUlJK/QzqRabsY2n2Gk2GqzXDPLcSfdCsnAGP1wKWeGCa+dLazBkXAcg7X29sH1PpT9U8r7dai3WRXljAYqMEAnJAJq5fW11cxQtGWEYPLZwSBWVntFbGvNezbHWN3JBpi2Mcsj3CyH94TjfnqPYUg0uMW0lk7Bo9rTMoGcHr971qraOsVyuxWZkBYMcHJ9MUmnavdw3pOoWoFq2VLo+4uMdx60+dNWZPK4u8SvpFzJbN9hEDSRSlXCMSHAJxnPeu5gYsJLd3VgflXA4X8a46FNPnnkksXnhl5d/OOQvsv1FZthqOpz6jMlrHL5SNuLMOMDpzWuHxEqSTetiKtL2vqdt4Zkib4saekUm9k0a/DcY/5b2VV1RH8deNg5x/xMou3/Tha81Q+HWqDUvixbbo/Llj0e93rtwcmez/PpWtHCn/CWeO534xqcSk+32C0r16FR1oKfe/5nm1IclRxK62snnMwdWQ8kg9x6VYTYw+cEhz8wA5HPenWkOXJaQ7sZ3EYwvbjtUUcud7M6MrHaGGP0Pet5JiuSShjcMqtsjH8fai+uhtj2L5m0dAe3rilYxzp5UjcAZ255qEhQgeMCUr8vHr7VD2Gty1DZRSQ4wdwBOT0x3qm0ayqLeNNiE7gR/FWxa2r3WkyM0mJHBCjGOPf3rIt4GtZZRcsoK9FPT6UqbTVw5rEyzrbW8vAB7Fe/tWTdTXNxaNNbRFCGwxAySPatN3gt2kSaFhG/X1FPgEC24jhl2JJwuQeMds+9WkobIL9yHSA01gpuF2zhio7HbUdsZIrom4dYIVyqqDx9fetCZEjTcfnPpnGMdc1n3kZkdZF2KrbVBznn+tKKuwvcliSRbpmmUiM8seufekuoluraMI7xxkg/wC9U10yRQo2/Ea8D5cZ9eKybzUdrJDaD9yQQxwQc+3tSlHn0GnbU14okhEjhjLhdg7VoaRtaR8xopKZyfSqMSoluEYN5xXcRkYHpxWRpkskOrSSfvFtJN24twgHb8anlbuF0dhMqSjcjscL/DwQaACSgkkSTgM3HP51Riu4EY7237xtBQ9vU0uqzpZWCLbuql2AIJ5xUtdBCX8sh3KisYgCBjODWTHM73SrEkgCjmQ8DNSSJcT6fIsOSoOcOeop1rbFbaaJ2OWH3R2qrWVilaxShlvEu3bcrqHAUHoe3Wrhv/N8wRKoKYKnHfNVrW3HnTAGQsOcYyD7fWrNsojiKrw5PI+8V/CqdmOxElwrMZZXLb+fYEdaejP56yDccc+YTwV+lDQPIEEkZKpyrDr7ipDIQmEXbwSF7/8A16St0EyO9mBVUlZduQACOhpLdhdwuqLuMchwrnBYdjTrXTTdzRM+4RxfP83VjUOszSWd1EiDaW4JDZ7+lUr3tHcT1HwrcWsZEjt5jliMccdQM1dhln+zBWZtzDj5s81RF/JLfMoQFOAsYwepx09aju1lS9YkfPu+VFyBj2qrXXvaE7M1ZQWCM4yWzzng+xpGvxGoDqXbfgsewqrGjQtJNJJuUkBQxzuP9KYpklu45Z9qxOSGUnAxSh5jLMNqRdi8hROevv8AhWjduAkIj2qzAkxdCffFXYwDZqylIlUZ9sU6xltbgFpGRnU8Nj+VSnd3JkzH3vPA8SkGZW+Ue+OlYWvfbLSGKN4N7SAkgDjNbc8Ys9b+0KrKH6KP4j60txJ9rYrLIqKD34OPSnCTb1RVrFfRbK5FsHlyZBg7Qc4B7Veiaa3lZpA2MZxnHNPkuIrK0WOLaW27Vx1+pqvaJPcO743JtOCT0OPWmve1ewpO5qfB4s3ggNJ986nqZb6/b7jNFO+EKlPBZVvvDVNTB+v2+4opGRn/ABh4bwbhgn/E76kf9OV3WBrVpsgjmMqNGGLH5eo9K3PjM0Kr4QNywWL+2iCT/wBeV3j9cVyGt+KhZTtbpCqwZCgP1kHGSteZjZRUvefQ7sJGbXuov+HNIsblpp7mFIwCByfvDsPb6VheKpDBrkH2LfHDENrIvB9mJ71fuZJtTkD6fFI9sxBi2/Ko/wB73o1PTWkLtqLsrxoMsnAIxXLO06VoHZC8Z3kYOn6RNfMLhp1lYBpMEncTnofU1Zhg3I8eos/lDMi+aMbHHTjvWpot1pMdjcf2UZHvVTCxtk4HQkY6msua6nuYLi01OQAqTh8c56Yx1Fc3LCMU73ZqpSk3dEIWKC0W6mYzguzKxXCrj+HFWY/ENtYtBNcW0s83IdYPujuCM1aXSvN0a3WzBngjbLhmwQT356DFZtzY3MKbbWNPtBfJER3Aj3/+vVQnUpe9ATjTqaSLnifX7TxBpUUNpGUuIsyyxv12joeOv0rmtLvpY5PMt4/3a/Px33DBB/CvQtB8HG4iuftgWO3YYUscvnuM+lTaF4Ql0i5vLqZYSJv9XD94Aeuf6V0qjOrL209DH21OnH2cWYHh+1lmaKUh2ti+S78EEdvpVDxCk2mLLd215C75AQZBOM8nFdHf6m9xbTaeYVt7cgx+aBg5NcM+lz2V2kDWhaRWEYduQFz1FctblirQNqbcndk1vqFxEyo90TbzKzkhQxVh0JHvWxqFpaah4bg1DUH3mccxKvLkGoNLuoTqX2WOwhEBfyzIT8+ScZGeuKfcJOuqQ2Zia4gViCrDCDn72e1ZQ91O+ppPdW0NmS2mjELNM7QiABI92AP/AK/bNGvNbQ29vDZRQi6dcSMw5Ax8wBrG1+6ZZnktpRcWykRxxR8kEcEE1He3Ji+z/aIykUceS/JLE9senP41rKdrxMo03oy5pOqW2iAw3V0zS3KKTGnzbU6Asfzqtrkl/DdLcRSRxxSkJjb/AKxPXPrVHVfDrQ2xvWYRfaUVSM4Yr2A9KteZPZXMT+Y5tGVRtY7lH4GoSbXK9EaNK/Mi3YmNtQ82NmbnYHcglWxnkVBZy2C6iJZCFR5SzlDuRj2+ldPaJZXQjntfIDhlSUR47+tY2maOz+IJRc2aRW6sxG0/dGTj69q1lSlG1jOM4ttM3LS9hvWPkgC2QkHbzn2Naumvb36SRW7tGsJyVxjbx+tYdnara/aI0gEcEgKhi3J68isDw3rrR39xYXMoW1ZSHkbjYPXNa+2lSklMx9mqkbxJo7/Txqbi3ia3JdhG3DgtzjHpz61jWMt0utRiC72pwZ4Tndu6En1zT7i0hs7vdBcw3NsuWBXP5Ef1qzaX8ztsLJGjriRpQA3HTBx0xXFzNvVnZyWWiuV9T8SQ6jEtlqdixtTIPKZPvLzgc03VkvtD1J7XTZ1WNV3hCc5XHU+9bdtYaTG6lTF52eHB+QH1B6cUnk2clsp1wKrEfumjbazfX1FdFSlLS71MY1IrS1hkzyXK2kkhuAzxhnlWPO4A5wD25px0aae4eOCaJzIm5mMnzqe+RUtzqUtjBDZQRbLaSLKyO2QRnt6VnWshtruO9Y7RnlkHGcYAPrUScb2LV99h+lyn+2XeJTlMImMgbR1qzrtxe3d00W91h7xRn7/Hcj0qzHrscEbHUbRSqMP3iLgqx44x1ps9lbxXxjszIVfDqz9EJ9a0jCEoNcxm5S50+UrS3E+niFGIl2xpt3Rgljj1/wAKfqviOQQRGez2QGMo/bB9aj1i5t5/LtbCZnkgP3uoI77fpWjo2jR6qVmvnOYeQzHAkXHRh3FRGMptxg9Cm4xjzSRlaassLwTxNujC72DA7j6Zramuf7RAt5YSu5A3mqB8vrn0FTxzx3eoW0MLwSIrbRg5A9h2xWZqF5Jda4LOZZo0yUYou0SIPTFaOChG0XclS5pXaMWa8a1sTFu8p2LBZFXkp2x9a6nw80moeGUnkDl0JHAA3Y65x1rDudNsjcGHUGaMOdkci/8ALMDpk0tvPq1lqNtYaeWFmrnhUO1l7sx75qKTdKVpK9xzSmvd3N/wHbpD8UrBkSJS+jX2TGc5/fWXWtW2RJ/E/jmAvsZtXhPToPsFpWb4Lkjb4vWqQ7BGujX2ABg/6+z5P1xUsc5g8d+NWDED+04eM4B/0C0r3MPpSXKv6ueTW/iO5q3kGyN1ZlII25BGW4rIeGPYkcYYbWz0G1iK0xsklKrl92Tx61X4OEEeARxk9ea7FoQMZYEJnBLFcqcA9/6U23kWPbEqqpY/gT6VLFE6FiyoEHJGeoxxTYPJinja4jAReVKeue9Zt3Vh6HUpFFGkTbSGUAnHHWsjX7VLgJJG2xgegHWtrzo7iJTEcnoKyNXkCqYo2Q3BGQpNSnZ3iQtDJFqZ33RsGVhs57Y64qjaXqXupNp8cPlKgLbh39P5VfE06wfLuULjk9Se9SW8FrasLlF/0gjOcdfervb4v+GKRXlKyXIQZO7vnnPrSzCKNkQsfNDEEbsDB7VOpit5TJ1dyWAHJFRGBGdZlBcMc+WBzn/ClzW2GyK7WFo0tprjExJwQMA+1JFa/YUABjeQtuVj+mKlkiR5mkwgLNyT/D7Ux7h0ILBJEwcDHK/j6VOr06FryHwyrqN48cQ3NGvzkcA/T8ahvLBnQtbOSwbLIxxUXh+FjdTzRuoR+F2nGMnPIrSa0EL+aW2gc7Qfv0qd1uE0k9Cou2K2OVAct68c9qZLbNe75Z8Hyx8g9RUwKhSWjQ8ZK/wgmo5HNzFmNTFj5TtGDkVXUkksXmdgrn7w+UY4wO1PR3ALlfvNtJz0FIGZLcKoUSEAZ6ke5p9p+7jZmPmY5wF4JpNoZLBLGA80uUAbCsORmqjRSR3CMgXys53jHPvSCR7oGKMICjEjA6UkzmGJbYDcCMMozxVJO9xX0JdQnklRvJ25GRnJxz3+tKtq0tmkqtiThWb1HpVa5uVhQIu3zdoPzDGPapmnnjRDHwso3dOntS5XbQDdsQYLVVKgqwzgnnPYVzd7a3Et8I/KwrtuMgOQOn61vStJHbI8ijdtzxWXBNL5chyPMIJBXt/9elG62Etyooe1WaYW4CowG9RlgPX3qXT7iWWJ1kmLsR8hZcY/Gi2kliiaV1BBO3nkEn+dIZnuVVo8R/NjO3HP0rbl0Dd3LipsdV8zPy8jpmiawSSNUkOSmGIB4BpbcKEDSEAHjOOTjrVi7mVJN6JjIzuxnI+lQ9B3IormZT5cigxDIK98U2STdb7LSPZt6jGQaLo7pI2gAQuuTt4575pB567fLwc4yEPAPehLqK6KRhvZ0UKxDYGSw9+1XJQyRR7l+cA85wSPxqe8ilSVZWOF2446mmeTLLMskp3HIJJOQo9KfMFyXyYUtvPusF1GVVjnr2Iq9ayvPp25AqMVJVQMVhi3vLjVvMlbEROF46/WpdVmmFyY1LRqGULjp9auULqxJufCHI8FHdkH+1NTz/4H3FFL8I+fBjck/wDE11Tk/wDX/cUVkQWPiNZeFL7R7UeOLu2tLCK6EkEs+oNZATbHUYkV0OdrScZ5GeOK4K40r4MXJja48T6dKY/uF/F07bPpm44rd+OCJJa+E1lZkQ60clev/HldVxel2Gq6qmqTeH7HQ4rLSbjyZLzUdRkhk3CGOYtxC4CgSgZLdj0rOSV9rnRTguXmcrG3HYfB2NXWPxZZIrnLBfGE43H3/wBIqV4fhI6lX8ZWzLjGD4yuCP8A0prN0abxXrs0ttpGp+BtRWDBuIbHXpJHTJ/iK25K8j0q34d8Rtr+k6be3rhTqFqlxHCWyULKDsBwM4zjOBQox6xsCg5fDK/3jbfSvgxbMWt/E+nxMxySni6dSfyuKklsPg7KxaXxZZOx6lvGE5P/AKUVQuVv4rq6trGCDF064MxIKdj9aLLwxcLZXJmuEZYtzbS3zf8AfXes24p2UdToWHdruf8AX3l9LD4OxxtGniyyWNuSo8YTgH8PtFC2HwdViV8WWQJGCR4wn6en/HxWXbJqFvZRazxcRxJs2KNrxrnjb6jFV/E2mz2cVvrQhia4s3E6x7uXQnkE9zzQuVxu4h9WadlM6SMfCiOPZH42hVP7q+NLkD8vtNEv/CqJVCy+NoXA6BvGlycf+TNc7c3Nx4n1a1tLywmsoQv2iI+Z85Yfw+wq3YSz6HfXWm2xM8VxEbhmkbeYmzj8R7Vbklpb3er7EfVH1ev9dTQFl8HvN83/AIS2z8zpv/4TCfP5/aaR7H4OyOHk8WWTOOdzeMJyf/SiuaaDUdddzcpHCsakBgQV29yfX6dql0kGwintp0S4u4WXC7eWjxkHPSs+bVJw0fUv6rb7evb+mbo0z4NCUSjxTYCUHIf/AIS+fIP1+0VL9l+EGWP/AAl9pljkn/hMbjn/AMma5S3SfWElvLGyto7YSEFZRh8qeRx09q2nvNQi0xUlt40mVNzb13BRnp7k1KqK7XJYbwje07/16l0ab8GgpUeKbALnOB4vnxn1/wCPintZfB5wofxbZsF4UHxjOcfT/Sa4fVbi9tfE0F1FE1w8bASSM21kb+FQOgXnkDrXQ+J7640+zi1WVpLlhjcqrtj596zp4iM5crhYcsFKP2/6+815bL4PTNum8W2ch9W8Yzn/ANuaRrD4Osiq3iyyKr90HxhOQPp/pFeZya3Fr0NsYbadYGkPmzsMKBu67RyRXsDXEFr4TNtJOsls8OA5bPUfqK6Y8kr8qWhlPDyhypyepkjTfg0CxHiqwBY5JHi+fn/yYqfyfhHjH/CZW2P+xyuP/kms3TPCE1x4WhubuOGNlG9EEeTtH3Sfcisexs5S15BaRolxIVlikQgog6Mc9/p61nKo0l7u5UcKpOVp7eX/AATpza/CAjB8X2hHTnxjcf8AyTUD6T8F5Awk8Tac4Y5YN4unOT7/AOkVy/iLTXj1C1s767ldXj/dyb9nPGSAPyo02zs9R0eC7unN2yK2JMk4bkZyOhGOtT7R83LKnYtYP3eZT/r7zp00f4LJjZ4l01ceni2Yf+3FSzaf8G5/9f4rsZP9/wAYTn+dxXC2lhrFhJ/bEmoC5SNNypOOAo78fz61qa3qMHim80eCHzYrgSqVmwdiAjJIPQjj/GtUk1Zws30/Ul4aV0+fTv8A0zof7H+CvkrF/wAJLpvlKchP+Etm2g+uPtFLNpPwXnAE3ibTpAOAH8XTHH53FVNZg1ayvbFYtTguLeVtk6TRA4A5BOPYV0eqXUF3YRLpxhnEgJi2fdTHXJ+p6VlzxUnGUNhOhKylGd0+plTad8G5gom8VWMgUBRu8XznAHb/AI+OlPWy+DyoEXxbZhBwFHjCfH/pTXEjTbXQ7u8udRny8jkLt+6MjkKvr+tWvDFnDH4furbVbO5Mkm5VmmO4hCflOSeMZFOlUjNtONip4VxXMp3X9eZ1Ulh8HJP9Z4rsm53c+MJzz6/8fFDWHwcd9z+K7JmxjJ8YTk4/8CK4ua8lNtPpc2mTSX8UIiAAzFt6B93bPWp/D+jGQRW+u5We2jCpHng5HJB7irqTpxkoxVxRwk2rylY6uLS/gzFKskXijT0kX7rr4vnBH0P2ipja/CEnP/CX2mcEf8jjcd/+3muNn8MrqKAaaiD7NIWEm/KsRyev9KSLVraSKe11GxePU4JV8/yYiQG7FWArCNVttez/AK+4t4N2vz/1951sGmfBmDb5HijT49pyNni+cY/K4qZbb4RI25fGFqG9R4yuAf8A0prl/D1vFLFcMb27R3nYeUZMAD3HXJqla6nJp2jX0MqRTWDTyRRRiX5mHoT3FdjVOMeZ6aXMfqtRycYu9js5bL4PSnMvi2zc5z83jGc8+v8Ax8U6O2+EMefL8X2qZ5O3xjcD/wBua4vRvD01zoEd1HNtNqjSW7BsrbY/hx/PNW9FuLvVb21nsJoJ3t8STnJIAPG0eh96zhJOai47lSwtouSntuek+BLL4fr4ge58I6za6lqy2rxkJrsl+6Qs6FvkeV9oLLHkgDsM1U8V2Xw0HiPUJPEGv2mn6vOyPdwnxJLZsW8tFUtEsygEoqc45ABrG8Ea3HqfxihtfIkt7iy0a9WZHGOWns8Eeo+Wo/Et/No158R9Wtl3tZXv2gpv27wmm2rbc4OM464rZ+7scvs3z8rLSw/CNWDL4xtlIGAR4yuOP/JmkMHwjJBPjG2JHQ/8Jlcf/JNUfEM9zp15Bb+KW8DWt+FEipe+KXgdlJIB2tagkZBH4Gl1GPxPa3+kLr1todxo2r3P2aBbS/ecIfJklBw0CAqViIznuKhzktbDjThJ25vwL3k/CPn/AIrG254/5HK4/wDkmkMHwjIwfGNsR/2OVx/8k1R1DW7rTdZjsLGyhhsY2A8kjG6rNzosGpav9stLqJY1IZ4ieY/Xis3X6Jam31RrWTsiyg+FEYATxrCo9vGlyP8A25qJrf4RNIXbxhalyc7j4yuM/n9prH+IviSO3uYYrW3jeVRu84rzntg1h6k9xquiSai9rJc3FuFYE8rjoSR1NZVMZGEuVK5pDAOSUm7f16nbmP4Snr4zgP8A3Odx/wDJNI0Pwjb73jG2P18ZXH/yTXF/DrxJrQ1CVblmOnxgu6EfKBjgD8eK9B0K1t9Sl+23MQilVvMCjGB9aqnilUWiIq4N092URB8Ix08Y22f+xyuP/kml8j4R5z/wmNtn1/4TK4/+Sa6nWX0+/smikuQm1gxMZ5GKQxxT2IhLpJD0DFsDPWtvaa2SMFT2u7HLG3+ERznxha8nJ/4rK46/+BNI1v8ACJs58YWpz1z4yuP/AJJqjrR0uHxAbC7lW2ukQNFI/CtVrT9LjnEd80sLlG5ljYFHX0P61n9YvokbvCWXNf8AD/gkkdt8IYv9X4vtEzx8vjG4H/tzTjD8JCcnxlb/APhZ3H/yTWR4z1STTZPsumxJbxM3DRD5SPU07wbLPY6bPqmySdmYjYBkg464rJ4xKfLYr6k3Hm5t9jTNt8ISu0+MLUqecf8ACZXH/wAk05YfhGudvjK2GeuPGVwM/wDkzTPDOvT6ne+Y9ukT5O5QuO/vXaKLSzk82SNUmPAYCt4V1UV1sY1KDpuz3OO8n4R5/wCRytvT/kcrj/5Jo8n4R/8AQ5W3/hZXH/yTW5rDm9LSzxSERc7YyScfQdahstdeK6srVrKeOGU7QzH5h7mtJzjBLm6kRpSlsZSxfCRc7fGVuPp4zuP/AJJpDD8JCQT4ytiR3/4TO4/+Sa17u5sU1thFdRidsB4twIx71geJNOvLrXGeAM9rIAMAcKPasp13BXsaww3M7N2JpLb4QyHMni+1Yju3jK4P/tzTzH8JjwfGkH/hZ3H/AMk1l3dwfDqpaaQRJdlwzs33h7D2rQ1LWJhaJcXG9Sh+ZU4JJ7Co+tw6lrBPoyZh8KGGG8awkeh8aXP/AMk0wRfCRRhfGVuB6Dxncf8AyTWLoiaPqd5Nc29g1vOmZAsxB3euMVreH/FBt9UksLto2gUFt+NpB9MelVTxKkk2rXFPBuN7O9iQw/CMrtPjK2K+n/CZXGP/AEppPI+Ef/Q423/hZXH/AMk12txFDc2u/YpV1/MfhXkWoaFpcl9c/ZmIlEm0oGzznqKqpVlBpJX+ZFGgqt7ytby/4J1Jh+EhxnxlbnHTPjO44/8AJmlMXwlIAPjO3IHr4zuP/kmuRTUJnglUSb3tyQgAwOPeqGl6xdztcXN3L+4GC3GPwqPrcE0paJm31CVnZneeT8JP+hytv/CzuP8A5JpUi+EqD5fGduv08Z3A/wDbmuTOsR6xcCQ2alIeUJJH5VBP4K1e+1xLmJke3lcSiTIyAex9xUvGJytTV0L6jZXnKx2hT4TE5PjSAn/sc7j/AOSaTZ8JsYHjSDHX/kc7j/5Jq/a6VY2c9vcXCIdSiQI0oztIA4yO5FQatqVsqs8twsd1hhFGRgyEdxWzq2jzMwVC8rRZAE+Ew6eNIP8Aws7j/wCSaa0PwkYkt4ytyT1J8Z3HP/kzVLwbqd7fXM6zySFRuYM3DAgdMelZL6pZa7eiHV1InjY4miAzgdAal4iKt5mqwcm3rsezeCrfQ7Xw3ax+FbiG50ctK8U0V2bpXZpGaQ+aWYsS5fJJPORRWB8E3WT4ewOgIVtQ1EgE5wDfT0VundXONqzsUvjWENt4U8w7U/td8nr/AMuN3XCW+m6h4s+D/wATbDw7GRf3OpKIowcGTba2ZZfqwVh/wKvRPiwkbz+DBOEMf9tMSHAxxY3Z7/SuO021v7TxFqi6D4g1TT9PupPtVxHaQ2siCYRohwZIXI+WNeM9amT5feb0N4Jzp8i3vc77wNqlhqCadDB4f1Sxu7OwWFpb3TXtxbqNo8hZJFG/JGfk3L8uSRxnx3wLps+p6H4VTy57a2XSYMSAgHd5a/OPQGu1kutafTWlt/HGuC6UjMckFhgA+uLXiqljpEugaHpf2WdZk06KK3jlLA74goQZ6DoAc1lVtUjZam2GjKlLXroipY3F62vXNrfyW935GM7VKuT2z6Gotek1S1vYI1kSZbgGEBMqVU9SexPam+LdDu7O7OrpqG2eRCJ22gJgHIJHf6jmudF7rc82lzXVurSRKzKqqwMgwcH27HmsJSjTXLUb30PQhH2jU4Wt19TuLLzdYthpvkS2MduyhpNylj6KD3Brndc0vdrd3arfXU0FmIpkidsDOcke/Fbejrdtp8t2tzEz3K/MFXmNgMHB9aoz6I76Tquoi4Ks8Y3GQkHK/wCNdFTllFKKu+5hB8km29OxFrWo2+qa1pUNrqKWTgO0kqEBuB90k/UVSktorbxEktndPM7JtumZw7N/dOO30rRuotFttK0xHsIzLdSphyM/McZOKPHllp0Vnb3UMqWlykigNFnlCeQ3t79qKiqSXO7aIqm4xtFXs9CtDf3GjeIILPTxDdDUOsEjHCH+JgR29q2biG60ia4utbnhaC7KqZFGFj9FIP3QKyb7RPLtotU0tzHfx4xLu3q/qMeh9qh8T3usSaVEtzHBKL1dqrAhcqw5wVbtkdaI1FHWrot0gcJSkvZ210fyNCwhlj1e6vrMl9FZckhQPm/iIH9avyaXd6jeQtYzy3NqOXyNq7e3Pc+gx2rI07X0utGNhbxNll2XDudvP8Q9j+lbng7Wo/DXhMxXD/aL1ndysRLKuT8oJ7HHbvXNOarTSvpuE4ypxulqZOri6tmkN4iPf2zfLnGdpON5GevIPtVnX9QSHws0dxNF5TAKBgFT6cfWrCrputW93e69FGs0g2ZlblR26fyFYngS10nT4rn+1kka7SZvs8V4xwIweCmeOlddGm4vV3voRUknG7TvHUluNB0uymtbvQ/ILXrrFNDktGdw5IXPy49qn0jw7BcXDebMSlsxeK1C7k9cA1HbaJYan4nvbuzCJJaukSCJvlLnktgflUmoXWqaffvbWqFp4MMGVQV+bpuJPFc9SKptu1k9DVOU48qeu+p6VaXvnQYZdoK/cb0xXm/iGe3t5WHh1MCOQ+cEG9OvOB61ZmttQ1LRrm9ivJLe8MbRrDH8ylv/AK/rVLwfdyOLa0trRESKPbI8mUVX/iyOrNmp54zSja3Yzp0vZ3kncszXGjrbxXF44uZyu8kjdIf+Ajp6Y9q5u2s9OvNVliTSdQhtJWyVQNEJB34+uK1pY9O0+8aLc08MExIMCnEjtzgnqcH+ld34dv8A7dJIwt3MSJuVnjw3/wCvNOrOVWCTsn+I7+x96OqOb17RrnVdIgsoZIjCrK0mPvOo6Ajt9Kra5Hc3sEOi2tulnMsq7ZMDEa5xx6119xc7G+1XVqFiY7ZAhO5cd8DrXF69qiWWtLqttIbiBG8tk24U54AyejZ6Vd+SKc3uRScp35Vt+Y/+zr/R76NboLcoz7luIwQQ3RQc8VneIWvIbyyt7a4+xqN+4wLgbjzyaua1eXWrLbRTI1h5sgBR2zkA5BGP51yvjtZ9OhtLmKa5W6gm2uvUOp7kfrUVuWKbXT7zelGTkufqR/bIL7Uf7O8Q3YkUAGGdFwFb6kY3A1qX1/qFk0Glz3FtcW9xL5SzqfmK46EdvrUlrp9ndeHnujIsysjMxPzYxnjFYGjywnwYJHjddRhIeCXOSWB4wT19x1q6tLljZ7suMnOV+2h0Vzp97oV7Aumy/aXuXH+jznlD6g+nsat6gJdUvrXT9VjUSH5/OAwrHHA47ZqG7fUPs9nq+osD5CEtEvG7I5J+lMutft7+W3W33x/ZiJwW+8QTgD3z2pL2SjaTt5Evnck4/Nmvpt3baJazWkzGNIFJTPRFHr+NZPgzXIma+u4I223LlVaP51KjpkdQasDSTN4him1cLLG6FliZtu3POPcj0NRNYrd+L7iDT2+wWcMCC4aHjczchQOg9zW0cPUqKMl0MXOEeZPqZs8lrcwXYjkCz5BHO1wc5/LtVfUtShhnm87TXP2iPyIZI4TlHAxt/wDr1oWGl6LN4mltbXZdNarulySQxz37Zx2qa7hVru8ksNRhisreUOscvzGSUdVHp6ZrBwk3eWxspR+zchstNuln02K8MyQXBWGdFOFlAGQrfyzUt7rqaT4iV9LtbeJpm+xCNXwpPXJx1I6VX1nxBeatbpZ22mzJcW8ithmwQ4b7uRwfr71W8O6ZPJr0UWpKkU9pP5zeYgdGyOQJBxuHvWaxKptKGq6sHSc9Z79jqPhto8lh8ZhfXFy889/ot2z5GApWe14HoPmrnPi/Z380vxJntpJPssUz+aiHr/xLLXk+2K7TwhPPJ8aoI5LSeCCPQrvZJJjEpM9ruK+wwv51keLopNT1z4iaQjvHFcXiRzlPvFJNPtUOPfrXTUcXT00R58XKVZ33/wCAaHixZdM/aDGtX2i6vfaK3hdrNntNMmu0kkM7HyjsUjJX+9gcjJGawNM8O6zoPw48BadqsMtvdv4immhtN+9rWJ7a7ZYz24HOB0zXXaUviO6sWefx1rKTjnC29hjH/gN1p0Gi6tqd3pd7qHiXUtTSwnadLe4jtUQSGN4txMUKN92VsDOOa1T9pBtHPyOnL3uhZ1eHTYDBPqSkyAhGkU8Z7ZrGtNDFtqcs/wDaMIjm+6jNy34VN46itrS1jQrI5eQuWLdD71zNq51TUoDbsBIBnyd3OB0A9a4q/LCWq6Hp0IOUeZM39XjsNIRV1WyW5L/cVecCujhks4dJt5dNWOOOQYQAevauAjkuZvMnvkmmiUkABs7cGrbanbQ2SzWbFUY5w5+RMHt7ms4VIpuSRU6LlZNm9JfWMrtYQ2SRTyD5pEwAW/CuU0qXXobuW1S2lU7j8xyAy++a3vCs1pql+L+3kQxxn50H3gcc5/xrR8QQzrZXTaVdCZpAQBnlfpTlH2qUloKMlCfJb7zkNDtVh1G+k1LVElZUaQ28b5YYHT0qwPFUWseGr+1s0+zSgZgjzlyAeST6/wBKyvCPhe8ttTe7vQIkGfmc/eJ61V/4Re90l5L6JGVAcqykYYntiuRynHWx1WpzbuySaz/4Snw35N2XXVLRh5M2CS691Jq34W0vVtAik81G+yTA4iLZ/Sux8NwQ2+ltdaosVsAQV4wfp7mtm/tEvoIfsAVoyckg+vpW1Oi2lNvVHPPEcsuV7HI3d/Y2/h0S3NqLiSNueCNueg+maqya9d6j4bD6fEtpLZsC4i44PAOPrXTafpF5Z6xJFcxxvp7L8yBfl+v1rO1LRZnnJ0cFQ5w0QXHHuKpqafMtL+WolOk3yt/5HnfjHUdR1y70WW1UwzvH+8MY2hnB64HrXpjaxCtjDDqkrRXUKBWA5OcDIx61Z1CK10DSbUrZxSXcTAIWToe/0ridTKNqsWtXZH2NsuYej7um0jpj3ptOmnqVFqslZbHTt4hks7yKeyikeN/l2t8uPqe9TwXs+umWW1LJfKCEjboD61yl1eXeq6RImheZA8bZkIG75e23PSo/Dt3rml6ZeXShoZj9wygb29do70nXblaTuh+xSV46Mv8A/CJNaX8mo63cR2dvv3Fs/MW9B7967fRdbtNStZk01WIhQhWbv6Vykd63j7w+9jOBDfxMGLH7r+n0qvqun6v4c0iHT9OTfPKd8ssZzgA/d/GrjNQvKCuu5lKPtPcm/eOcXxDq1r45DXMEb5f5oSvb29MDmtHxpqQ1yd5dLuBNZxYR0QFWjceo7g9jXRaJBFe6eF1wRW97IdkTN/rCO4zjIq5qej2mhac0VnGhkuMK4Zckr7VhKlV5dNjf2sFNJrU4nwNHdSeJFEKMlr5LAmQYw3XFb+t6Dp7akbq3vBBI3LoRnJ71ZsbSOwspbtyUghQnaBzgVh6dPF4ivJ5LC4PmquVicZJ/Gqp2UOWS16A7ym5J2XU6LT/EtxZ+daRW+6KHJ8wHG0Y964AeJETULj7MIlWafMkoGWH49q7/AEU6cZwuo2+Lgr5blmwjfh3qlq/w205pHuoZpYY1y/lqo5z1571pNVnFSTM4zpQlZq1ynpYhnggnOzknKk8EVz2qWGyVjAd9rGcxoq/KxPetfT7vR7a6/s63iuZooWCAygjcTwcflXU2N/Jc2mo2kyQRARNsTbjHHH5VnNKa0eqLc5QfNYyvCd7FBpVw8lsssasCDs71c1WbUYRaT2CyGDgYQHG7vn0rj/h5qsmmX18lyS8Kqzne37v9a6LwX48OuX8ulzQKkc4bBXjA6ce9awkqiXK7NkVabjJyS0R0lvqOka22xLn/AEwfLJsONxHXnvWf4p8MWs9ukwYiVHBiV2AyewGf6Vzt1pcPhvxQj26/uiB5alsk+vFUvizY6i2tWWrXF6EtNqmFCSoUDk+wNE5R5OdomFJ+0SjLQ1ba61Gw1S3F6NkoYbwfTvXT/wBi6CmoGfMX2qZC/lb8ZHsOtZfgZofE+mfb7hl3RvsbPXH1rjPivFfWviJL62kD2PyoskR/1OOxxVOSjFc6vf8AIOVzm4p2f3HsvwXUL4BiVRhRqOpADGMf6dPRUPwJma4+GllM2d0l7qDnIxyb2c0V6EdkeRP4mL8V2t1n8Gm82eQNZbdv+7/x43eM/jirHh1rKRmfTpInt2JYmIDaT3wfWqPxkcInhJmXcv8AbDAjHX/QbuucijvbK1tYbSHZM7E28asVwO5IHbmsarleyVzqoU1KDu7HZa/pUGo27wvEA8nSQcEntnHUV5vfTyQafLYraSx+VKkZG7hAD1x1Oa7lfEculfY7bXMO0x2C6iAChj2I/rVnxHpum38DS3KEEDIliOGzjg+9Ek2rRVmXRm6TSnqr6Hn+sy3F3FGb2ZVd12LGq4wDjsepwKu+D4prWY2V3FJciQmSGYDI2HsfSubuJLrT9Yd9VdZILeM/ZpPLyFbPVs8ZrW0rW7+2spBbXhd5hujCRjaD2XJ9c1jUlTg1PdrQ7XCbhyLY6PxTbWFjYme+uJLJGAj8u3BJJPfaM5+oqhavb6rEF0/UI5rFVEUIRfQc789TTLtJtfvVh1Dy/Mih8yORAQwH8Q4I7/nWXeaONMgWy0mYW88vzqVQJgE/MSc8ml7XmfNGOnUzjTt7spe8XZdMSOWHzJlJViCtyu5QB2XHQ+hFWIWtLbTLhdLRr2UZV0dPmy2OpPUD0qnDYJol1HfT3M93bTrsJnO4xH1A7A1Z0PU7M3t9FM2xmdnUEgbQAORn6CiP7qoul+/Yc/3kb727aFfUI5NB8NSXKzwvbhuIGJAiLHG1R161zMF1e3elm6fAuLJwsluM7liP8S+vFV7rxK9x4lSG4US6Za3G8LjPmMemAOuOtdRaWkWq3sk0jTW9sE2gONjTE9ffAH51ovZ1ZOSfl6+hbUqUeWS8zHubWwn1CE6FMolkhZ7hs7kYHGCQe+adJ/aBFpoqeVIJWUPPIv5sT+VUtTtf+EY1oDQUhS12b7mGcttJ7EN9KWxvtf8AEuqPqWmRQ25tot5twCQwznBPc8VM40rtfaXRdi17S1/s23Zv3Gitouo28N/cSXkV4xXzGxuBxkKD6Gr1voGnf2tJbtAHmjtQ0STSGRFDHkDPYYxXG6jr114iexCxSWMMUm3yw4JRj94s3TOM4HvXVeKvD+nros2oxTyRatbJvM6zkFlGMqe34VrQ9lKbdPVRMKvtFGKm7N9iHw7oGkprV8kKbAGyhhmZcN3wPSrU9zp/hSe8juJZbg3hMiGXLuSBgqT1IHAz9KpWDQ6nqEFxpoexkgUEyEhjIcfdKnoP15ptne2KJqv9uETXrMYHdlwqA9FT09TUSqKcUrW1ZSpvnd7tWRox6frWkaEt4ZkuC/76SEDaUHXIPTpWVLBfWNldyvdFZrwm4hgC/Ko/3x0we9LY67r2oacunWwgkMMJdppHyWQEgfKvfjoa1tOhgSwXV7a6WJDFtIufmQYHKtnoeorOpSbtyaJDjNxup79v8zm9Bvr2VG0iPTXWW2jEjskiMN7HOSfT2rf0a7axvv7Re+83fGV2Dpu/uj1wRWHZ67GxuIzYvaXOpy+a9yEwhA6bTT302KxmjaWYRGMklncrlj1XHTHOaxqq8VNO9jbdtNHX6LfSapp8VxqFwysc7okYBSxPSki8O6TqEd1p0eohY96yiBW3Mhzn64ri9SsleXTrWG5lzeT5j8p8FMdW4/L8auadPeeF/Et1aSQNqc9zGJPMjAUoBwAxropyVaKvH5nPOk4t8ktd7Ca3FLb+I7LQr65lFjOfMimB+Yhe3tXKa7FNDrdzJYtLqKxRkv5b42EZ6gnuO9N8UT3nizUJrh4Z3NuSixxkq8R9QT0rQ0O503T9MuLK3gnnu1UeeEjZncnruNKU1WjyyWqN4QdKz/A5i00TUJ9FiuYNRKRzuXNuHIVSee3XitO0mtdMisGtJLi6khG5oiOBng47e9aj21tB4WIMwZjk7AdruufuAd+uMVJ4ds7O/sLWztYJUuyxcMwKqPUDPXHpXDVfvcqZvH4W7G/qGm31popupXSWyZQJUHWPPoO4rOinewi0q9udNdzb5SWYD93sP3SfXHH0r0BdHnl0hrUSZd0MT5A4Hqff2rD8UWmr6LpsOm2ElvOpTYWeItsXoNxrvxNJQjz36I4KNfmlyW6nP+Ibu6v4raWwS5eSGUSwS7flTnBJY9RWhZwzwxoJbxIri4j82ZsbWZs/07Vt2OqaXY6Fa2OqTvBcKFVC68MccAY7Vj3GpWus3bqsMkvytHAoTrjqQe4rllUqNr3tTeHWKjojg7pZbO+H2K7dN9xsacJ8xbPRgMfnWrZ+HJIddjmnuXdLZ/tElunMe7POT6nIOeau6rb6kUXRRpCrcyL56SNINp2nlvXNVLB9dmvp5pNPWTyFzKgbqq85X24rN0HCNle5rzp66HoXgcW9j4fvX1a0SzKzu6pLkjYT8hx3JwR+tU/F+p6hLbQeTp6jTJ5P9QvDzcdO2B3xXOy39/p6WOq37O1uzbjAU3MiHoW9SO4HSr03iSPxDdmSwkc2dpyshXYGbuea65R5qCWzONQ5ajmtUa3w71O8u/irZWV/bmKSz0S92ncDlWns8DjgEbf1rnfH99cab4x8YzRLiOTVIFMg5Py2NqSMfjWx8Lp7y4+K0U13biKJ9KvmibdkuPOs8kjt0FZ3jTVIrXxr4xtbyyS5tW1KKTJHIb7BajHt0rSsuWjZsxpL/anZE2laza3Xh57mSX7LEzbQ7ITlj2xXU+E47v7MJ7O5jltW+87Z4+lc1J4WTxTo1lNozGxtEBUwNkAN6g9/rVvR9Pg0nTk0BL6QXvm+ZJIoyrE9gaxp1Jq19jaqouLUXqanji1RtNaW5tpLqGQgOqtgAeork9E8GpFHLqWjX0lw2cJFnBiz1zXp7W8iwC2LecNuHzzmse6C6HeQmOOOC2ZCXcAAD2Na16Uar5mjKjVlCHs46s4yx07UNNt7h7tWSGF95fqGBPOal8Sw6VqcNvEYPL84ZMkJwAemSOldL4psptbWKIPL9hcA+bA4x9SO4rl77w3qNlcxbi9xbLwpjUgsPfFYThyKyjdHRTqKWrdmbmi+GrLw/pUy28kkslyAWYnG1R9KyotRntj+9hCxq2PMH3uvBo1fVYrC4tN1zHBcJHsaKRuDz0PpWBd6rdWer/aJkbyJx8oAyrAfpU+2hCFl0KhTlJ3lrc6bV/ECLpl0boq8QXAkHB9hR8PJftNtdXFzJ5kAG8RHoG7fpWXp4sfEMckUdo6yEbym/wCRiO/t/Kp73VIPBlpALuzZp5QSE3ja/PUkelTKpzSUvsj5FyuEVqPutfudZ1w6fNbpLakhVjYY/EV6T4Z0yWwVo3/1Sn5BnP5Vyvgm+0zU1/tBLSOBv77t8y+uK7ywu4rgFoZUdD2B6V0YdbtyuceKm17sI2RSDPJqLRz79zsQiY+6nvWksQjYHgpgZbGD+dQvd2aTsklxEjL1XcAabNPBcWTRxuGVvlyjZxXY5KWhwqMlr0MvUm03UrGef7SjxW5IZgcbWArzf/hJFTR72VdNE1mi42yJkBu1elpoVjDpL2kzh4n+8T3+tUJNNsbDQLjTrO3jkEiMQp6Px3rlrwcndPQ7KFSEVZpvU4fwv4n0668NCCG0+xXckvRB6c7s/wBKz/Gek6xD4ghuLBpZ45AHUjJYZ7inW6abpWmr59rIpMnLKMAnuAO1dhceI2bw9BdaFG10oOx+MMgrnUXOHvu1jtb5JXgtH3OAutav7TWYLKy/dybkEuz5cv3zWrrp1rUL64UElThYHUHBPbBrV1O507S1g1W9tJTfOhcjaAePX3rR0PxpY6pbN9mtykijcY2IyR7Vn7NO8ZSHKpK3Monnut+Qt5aR3Gtxx6oGBlR2IVSPccZr1LULT7faWl750Z8mLDSRnORjqK8p8YeCp9c1V7zR2Rre4be4dtpjb0969J8C6Fqul6FFp926mMR8srZzz29q2w9PRxaIxMkoxlezJbfULKXSry2v/mgMRLhh1Xp+BrA8FaNpFob3UNDv5LmSFG2QScFD2/Cukv7PSY1uLGZ5Ua7TYZDxg/Ws7QvB83hz7fqEMhnmKYiCDr9ferjdSu+hnzR5W07NnPWN/qN9OXu0DzeZsOQBknsKx21XxLpfjmaOVpXWRtixsMjbjjHt05rpdHj1XWnulukW1jhPmeY/HPcGurFzFbWjTyOlwyKoRwoYjjtWPK3s7Grq8rta/kefjWdd/wCEvltPsZw0irsWAENxgnOOK9DHh5YpJLp3LssZ3buc+1TWl22rWTm0kWO7XgnAz+NbGmxSfZhHMW3AbTkda2p0FyvW7OWrXasloeRWmhS67Y3VjYSrYrHcF5GxzKM/dPoKn1nRx4Y0h5bO0gic8faIwRnPqf8ACvQ1t7XQJpppiStzIMkAbY6g1e2g1aB7a6Q3FpKRjyznB9RUOg1C0fiNFiW5X+yeSR6jfal4fkOnpPPdrKF3hd3lrjjBPODXbW+nPqvgNtP1+X9+4zEzcNux0Gav3XgmOwQRaK0sELfPIwb5mI6AmuX+KD3UUWm2waU3UKgs4/iPpWbXsotS66GvOq0oxgZOg2M9nA2ix+fAS+cnIDH1J9KntZP7A8QMNYKTJINjwj5gwxwT2613NxfQwaHYyalbN9qeJQzADceKr6lpGm+ItPS7swVmAAbA+bjtVOg07p3sJV76yWm1zqPgpKs/w+glTAWTUNRYADHBvpzRR8EoDa/D2C3IwYtQ1GM/hfTiivUjsjxpfE7FT4yo8o8HpGWVzrfBU4P/AB5XXeuGR9T+33CXuoG3voR8kkLgr5RPTB75HNdp8bp5rW38Iz2yh5Y9a3BT3H2K6yPyzWYfB6X8sGo3l5JHcSJlljXqp6A+lYVINzunqd+FqRhD3tr/AORwj6kt5Pd/21cm7uoDst1Y+WNnZyo4zXWf2m8ljbpFdSPJA6hgeVbtgVVm07SLOe4shdNdBd0jh0G7I4wT3x7Uyz0q7t2txfsGsSQ0LhcPj0b3ArK1SLcpa3O1ypzt0sXL3UbS2eKAmNp7l87WPDL3zUfiJLeKDT7XTlUOk4PcbVByfwqr4ssku2i+wQj7apHlmJ/mT0JPbNS6I/8AYVpJFrFszzNkm5LZVh7Ht9KcrxladvXzISXKpU9+xX8Si7toIbrTHkWdWDCdDuDZ/hrTXT7y2s0vrZzNqCp8/wBqOE55K57H8Kfb39w8MqaZaxx2bAEC44JbrgDsp9a5ybxA2syS2GrSPa2bEqQp+WQr/t+n0pe5F8816BapL3Yu3fuWJ9WGuC30/wCbzTMiz+Xzt55+boBWjqHg4anqCtp8Nvby2yMsqmMkSZ6Y/Ic960/C15b6hpTw6ZabLOE+S48vH/12rr9OnMk8VvJG6ymLdvYcAZxilJQqSaqO+hlOs6WkFax5jNBaaRoVraNs3rMrlnXnGcE49a1bS0j13UbhTIfKsF8sLEAN7Nzz7AVZ+IFraWsysmnJdXjggZB2KO5J9fT3rO0KGWwRZNLRbaO4QCSC4O1xIQQGyOOfXtWlTFU6dVQS0sVGLlS576mFb6ba2niu9TUDJNaRKrxbssrHvx7eldJo2mrqd9JewGS3tUHloMbRLz0b+la2l6L5OoCK9YieYb5VjfP7wjjr0GMjIqe5t9WsY1tLeK2ZEJFvJK/JHXkDjNLCpO8eXQmvW25Je8cX4g0O1j1TUEkwqyRiZti4IA4/rVK70a3n0i1jbUZZrZPnlj83MbDsc9T+NWdavb621q4TUoGf7RGImeD5lQdefQGoNT0HTbWxsLy38/7HHKpmRZW2qn09ATWfsrylyqx1KTjGPOxms2tvY6b52nfaLO6YKTLCMoRnqc98VcubaxfTYBaXb+fclUV8Bgp/idR61oajq1jZWAEBW7eX92tuozliOAc1xUkd5c32nWN9FcafKGaWKJlwiY5BQjqT3BrPErlcb+9cdFOcddDrX0CXw75+p+Hb1WYp+/guSCkuB1B6qazbbw/C2mNJqq75LstJM2T5QLdgoPT3xmrmq2muS6NcT+ctxsjLSxKuC/HYjvisvTLu/wBd0VY4FllsUJjFyP3QJB4wO5Het6sqcYqlKLRFJTa5lJb6sLnQL9dFimtZ97Qxfu4ZFGxgOB7+lbng28L/AG6513T57nYREZhHvWMAZPy9ceprG1y8vbOG0sriWRrWHY8p8sB+OxYHkH070eFvGZtLa7tbGwur+5d3ltQBhXjJ6s56EH1rGhKlKrZaLt5lVFUlTdlf9DV1O90ttXVrSGTZsC+fBCSEHvioNN1S1j1u6nklyrBI/OfIBK9ce3PSlstSh0zQZFdhDOVYyKhzsZuSB9Ca3dCsba88NsGgjnR4zltoOcjqP8e1bU/bOdotWM5ckIe+jmZnGj6rf6lHat9nu9pAC5zgckDrWZ8O9XtpNf1a5v3aGZ33BTGdmMY69ic1qaHbXV9BFaX4by4ZHRWZjh0U4Xn8wa05iugatF9hs1vDeI6iFABtI/iHYDHFEHOUk+iKbgouNtznfCJtdQ1l4X8vypJ5JSoO549rEDgjgHrxXX+IjYrq+jW0ksUAiSSUbDsK9v1zXGeGZDJrOrvqUcNnqsk+x4wMLHH/AAkeufyqbU/Cc0+ktfSSyztDJ5rljjzIye34Y4qKc3CKhy3d9xzjFyTcraG1aePLXR9cls3d7uxbbslRDhST0z3rpLzxFpy6g12blZopIxueLJMRweCo5rz3UbTTb46XbiRA8rh9kT7WCDqR/Lium1rT9NisluLOExSWpEgCPgygf3vXvW3LUqe8mrRMpQpK3uu7LGrXVo7WOpzW8jWCHcJSBx6AZ6g9q5+51OGDxKt1aTRxPKMxw52kcZA5457kVLqnibT/ABLbadY2pdLeadWd2B8sbedp+ta2qeF4b+0Fk1tHdM+BD820FsdM9hj+VYzpy5uam9ioyUEo1NL/AJHO22p+JL6/l1l4LQiWHy4Yd5DKueT3GTin+Hda1PU9DvfsHk2moCdkmnV1ebZ/dA9MVP4y07UtF0ezRrpLON3WGRlAfYvQ7cdeBUcHh7QrXw693aE2szKzpPDL87k8Z9+fWumN50m29SG4ppJadDnbPVpL6dLTVrl7eG0fa8hHDr2+tTefa3Os6hLb3ElpayRiOJipSOUL/EM1LP4Sufsdjci6eR4yszJMv+sI65Nbc2rWeo3Gn2lysSQyOD8w/dMRztOf0rCnecf3jtLb/I3k1ze6rosfBS+vLv4kW0V5eLdJBpN8ImEe07TNZ8n1/wDrVNqdxND8XfFcP2RbiC4voUw65Xd9htuv6V03hhLdfizpphEfmf2HfBtn90T2ePw64/GsO6XUJfih41SzVniW8gZkA6n7Dbd/Xiqq6UlfXU4ISU8Q5Wsa2h3WqtNHazW4jg3FNqoFCiq+nabcW/iSU3dwkaKfk3n7+elGnaxH4fikvtfeWCGY7I0wSSR3Aq3q15ouu6VDqFpeK0c33HXrkeoqHD3bX21sa8z5nZWT0Maz0fxRB4teeOaRLHeZXZjuDL1wK0nkbxTbXelag6omC6y91I9fatG7v9R0/Qrc6VAdRJwCVbt64o0WSCbTp5bm2+wyzhlztzyevFNNc1m9yXKTXNbVbGJ4Is7nTzLYz6naTovCoXznnjjtVW813ULfWtlxHNtjcx/KCB9ayG8GXlhqQnadZLcS5WWJw3IOefSug8UWt7fyebHL5EzxgjLdCO9c3vKDjFWszqSg5XvdP8zP8bfDr+3LmTVLTUFikmUNslHGevWpb61s7rwzHpVxNH9qt0UBxzk98H+ldRokd3d+GxFqvlPc4Kgoc4HY1z7aFNY6BcPJiRWcsSPmOB0puHVLcmnUezezNDwBo0Nlo8sqs0dy6sm+QDB54p2peG7DULVm8QSxNaI2QVfbsPsaw9Ie41qwuNMsHEEsZEsbuT83qDWzpnhy4j8P3Vlr08f7xgwIkzg54PNKKtFRUf8AIid4ycnLX8bEd/badL4RuU8P4T7OPux8sMd/xqv8OEvRFLJcu62ygMRJ/D61D4NjsfD+pX/laiLmR1KRxjocc4+taPhzU7nxHYahY3MDwPIjKHwBk+nFFNptS2fZDmmotbruxmvvpfiO5AsLlEukO1vRxUeo3E/hLRVFo6zzyt80h5WL8KzdL8F30F1C7RiOCNiXz/SqNlDNDqQt55Q1q8paYsf4fXn1/Skqsviasy/Zw0UXdIvprF1r1i8Wq3y2qxEOs+cA+3HrV7Sbm80uaFLthdwHmOZDuz9DTPGnh+LVNCjGhNCArh3JcfdHTNafw/0+bTdBeB5xcSbt4AxhOORiripuVp6+YpVI+zcor5HO+O9euNPkihtbGHyHO8o0WQzV0enQi/8ADFtdabEtoXHm+XEMAsOua1/7Kh1WzZL+3Rufl3ckCtDTNKh023dLXc3lKQiOflHtxW0Kbcm5bHPOvFRUYrVHJ+JYbZ9Ehn1GNI52jwWbk7vQVh+BNP0bUrDUECSQ3O3a0me3qtWvEeu6ReXcdhrdtcRdt8bZArR0Ow0/RfOi0yG4umvCiCTHCow+916DvWbgnNs2c5QpcrvdnFeE9WsX8VLF9tWO3jYxod2d4B9DXumQAvkAcDKgd68Bsfhlq0Pi43kgtDYLIZDJC+cDPp2NejeGviLpeq602kWUcjNGSiyHo23qfp71eFfL7rM8bTVS0qettzodSgR4ZpLpVZogX2svKntXMWfj6ynM9vYxvLcRJ8qf89MDnFbviS4trOG91CMs0wTa67uMH2riPh7HoV94hl1GKB7S4gBcqTlPcitaralyw6mVGClScpq9hul+KtQ8RPd6dBamOSYYDAHCjuM+pqfwf4ebStXkW+vw3m5xACW2c9zWhoeq38+u3vlxA2zEmPy0wPY4FdBpWlyxzSXF+xMhYv8AL0H1rnowb1budFatyJqOiJVnsNLkmS1RhMWwVHJJ9qfpPiKKfUZrCU4mTsT1qvPDBNeJPIZ0kDhj5Z4cdADXMHwnqKeKf7VMikNLubDdErVupCSstDmjGnOLUnrYg+IfjsWWuDSlgjlgVQZ9wyefT8Oa2vBswhiLtfC58wbliRfuqegNUfFHg6y8QXQvHla2Vf8AWOBksBVzQdMtLLUIUtLr5FjVNrDBJ/8Ar1EI1I1LyN3Kk6XLA7O5uIorU3DMygDcSoycfSsPW7uxuLJrz7P57xcq23r7VNr73SxxrakoQQWIXt61zfiXxJNpt6NPFj51qijzHYHLZGSRiuqpKPK09zjo0m5XiRpqdnrLGz1GVbdyP3W4AEdsV1Gh6L/ZVuwQtOHIJ3cYFeXf8IosusQ6ncO1vpzkSh5JccHkY9D7V7BYXkF9Yj7EyywxgKGByG4qMO3JOTWpti0oWUXoxPhZj/hFZ9vT+19Vxj/sIXFFJ8KBjwjKOn/E21Tj/uIXFFdJ55S+Kyq1x4NEkQlX+2W+Q9CfsF3isPU9e1GyQRQLarISAACSR/jV345XSWVp4TnlNwFXWsZt2w+TZXQGD9SPwrzW2uJbPVHmIFw8gw1tuZiPRtx5J9a569aNNeZ6GDo88W3sjUfV7U6nb7opr3Uo5TJPasiblyeSpHA+hrqJtTg8V2729v5kUETDezjbIGH8IHb61z2j6np1nYTzzFTdSOWMMaZLH0x1P0rPsb/ULu4vmsrd9OwRuilX5846ge/rWdOtyNSbumdVSkqmys11Zo2i2uheJrmG1uJo9Plj3OjuHCMO+Tz+FT393bapIuk6fMLnccuQfuL1yP1rAksorC2udTOmtdIQD5k8wOWPXcO/J6VP4Fs9Ktru8u9ShWyluQpX96QyN3UkcfSs/az/AISXLGTKdKP8Ru7St3NvU7GbRNFjtY7/AP0eRggaRf3gDHsfasDWRoOm6bDYANMNyqVJ+6CeST0Gc1P4mn0+a5jS2v7i7CgH7JKwZcZ7e/arDaBf32jyWAWC0tsF9i4JIxnaxPP60V5e0k6cNbFU1yJSm9zrnSCDRIv7JMEEcOJY5NvC4HO7HUVNf/2qNHtr211KJ22BpNhCg57/AE9jXn/gy002ONrXWprq2lLkJBJMwjIHdM9RWrrmtadpev2tquox/YLhts0ZA/dso+Ug9MGkqdoqcdF2MXT99wWttdiPWdTt7mzvFs78jUMofJSQ5l2+np7+tZ1jdaibmOSWe3Wex+RLY7nkucj5hgdQPUdBU3je90aazL6YkJ1JAfKlgUM/qeRXL6d4o8RjU0sLeeKSYwYeV4g3lA8qy9x6VhVw0oVN09Dppvmp6K3qeleFNcluNWn8+WY+W5WVnXKRnGQgPUrWxqN6dVtjPBI8UcDcFOTkdfwxzXk/hi+v7a71Ox1C6eS/uT51vNE+AX7hh6VraZrmo6VbS22pKZZxgwlCF35PEbA9frVYWv7JONQzrYbmlzR3NHWNTEFihAEurO4wzHIlDHjj6flWNLbXtlamC9u3exkfdLbqvUHqOOcZI4qY2AeX7Rdskd3buJo48cDbztDHqOavaxqMWsCzGjTYuAwmeQghRj+E59TVRt70qj97oaJctlBadSjaw3Ntqf8AaTaTPLpUI2GbG2RcdHAP86XUde0291mCOW8RVjXekuCyofQN6kYrdvNdmvvCs7tKqysfKcxnGzJxkiuFv7LSn1WxguZ0MbEL5G9ShxjDH/a9jWk2owShbUmmnKTlNbbeZo6142T7VBpenzrKJP8AWOHICj3YV2PhzV9CstGWw863UJydzjcW69O+aw/EXh9n01YdD05WZGDM8IUBQff19q57w/pF3Y308OoW8SyQIszNKRnbnJPHPpxRWrzpVHLe6JVKnWhbY66106+ubK4uw8csdy26SJ1IdFzwM9+1VNFhOn3lzaeWbmQn7sK7iBjue1Tyaz9tiVfO+yaPLuhknRScEjlge3PSs2007StK8R2LaZNM29W3L55YyEDqTnvVU1Jy9pT/ABHLVOEzY0htPuvEepRlYJb2CJImhddufUYPU+/NZ19bTWPiJdL0PUJLOwlj86aADdsGcFEPUZqLxhd2lnpNxcmBI3V8QMG2suegB7VxXh2+1jS/EDIGiv5riHzQ8jfOR6bqurVVOSpvfd2FSpucXPoel2818moQ6TpEZkt0QyCKQ5CMOvPcEnBHrVGEa42tXlzNJbh0cWkURjICqeSVP+elM8J382q3V3qt5GtnIoNv5UROVHHzN7/pV3Tbu/l1m90iSe3nTyRK00rndGCcAHb3IrOnGy5pXtcJ8ybSSvYwfEnhOJLp9UvppJb8bdjKcDqcggV1fhjXYr6y8jU4GhvF48lhu3jpkdjXBz+MbganNperWg8qB8GaPJUop+Vsnt71ND41NxfbXSGOwQlQ7x7vNPIAz/AN2KdWtCMZSp9egexnNKM+h1CeCrK3s5tYubhbGbzHb7wVlRgQFHpn0rl9SsoT4PllF5dRXUg8vyD/AKyX2A9OufrWqniV9Ykis9Wisbu22rLMkcu9ZGDABWzyoU1dtXuNF13UtV1DSAdPvMMJocyeSuMAew+lY4WfxOK06lTUoW9o9ehx5tNNvobWysEjtXEQLb1ZGQ9M4zyTXoXgC8u4r9I7+6a5EMZihXHQjuT3OK4u6l07xBfeZbXbRfZ2KxL5WWKn0B7Va8D6hd6X4iubG6WO0tgFYC5U79p6spHA9SKblyPmezKlHmi4s7BdZ0fVtSuRdzQmexkKeXKeeo5A9K4vxRK8+q21xpdkkWnwTgyh2KeaxPYegrT1mWG61q7Hg9YPtm4NNKqjavoSxH6DrT0ivvEbXUGqypa3FiwTED8E4zu6Z5rSMp1aaXLovxMYwjSfMt30ItVi1S/F5FBcQWkRO1SoLeZkdPY1m6XpZXXU03xJLGyrGPsi54Ze7Y9c8Umn6/b2d8BetJM9iHMkjfcc9MjsW6YAqo80OseJBPqCTxSsgFskuVOD6egxUucXP2m/Q0UJpOK0Oz+GFpHZ/Gho42B3aLdP94nA8+1xjPbitDWBdp4o8ay2YJxq0QIXIOfsFpWL8H7a1tvi/Itq7uTpN5vyxYAia06H0pPFfi260Px/4vs7VEw+pQSszLuyDY2ox/47+tbucY0eaWhw8jlinGOv/DHQeJfC0virw7bfa5Tb3MIyC/IA96Z4Y8Nadp+jNpVtefaZlYyEkYUEjoPauxg26rokcisY/NjDDI4ANZOiaCNH8+VZVaVl2pzknvyaSgpcstxxrPlcXKzT2Of1O6m0OwmtbFlLgZYq2CtWvBmoNrejzw6uzGWBsK+eqntWNqv2ifVH+0WrmV2+cgjG3vkVfjFtpGlC6iLOgJfbjDHB6GsVGSnpsuhu0nC3Vmd4p0957Rl0qK4lkVvl2nj6VzniHxVfaXfW9i7i6MKKkwkGCGxzWlPLr11qNjqFhJNDp7PltpBRO5yau+LPC1vqesSarbWrXMbJvYxyZWQge1Y1U5XlA3jaNozO68GTQ3egwXUSLG02dwHYg81xvi7WNU0/VZ7WO2Y2rNj5ORirmk+JE8P6TZpqyNHJcMVWONNojFaFtrFnBHM+pMkgnbdDgZLe4rRz56ap81mc0IShUc+W6exY8LGwtdGe5aNbSSRf3sjnGB0ryl9M8QTeKHBmmnsLhyY7mNy8QHbJ7fSvXb7SbPXNAkENy0EMinDjnafcdKxvBVgNL0ue3tbxLqQyFtqk49OM0pU5NKL2Kp1VHmn1MrQPD1jpGu27XdyGupW3IgyQTXUanrUUDNFpKBX8zbIyjHfnNc34hS48OaBdahIXlu5XEUL4/wBUp61i6Hc6jqfhjV7AOLm5FsZ4X2fOQDyDjrx0qNKXuQW5o4e19+TPWLy/jtdPWe+njhjCZLseM+1eW3VkbQXerzRi9jlcmMxvhcfh0H1rkPD/AIgl1GyPhq/uHT7Sd0UsgJML59PQ/pXZabYy+C/D93p+qkX/ANrbcUVsqg9c+tOpP2q97RIKVJ0Pher/ACNDwd9m1O6MokMEBj2shb5ST2zUvhTSdSsfGbQ7pEslyWG7IYGuZkFrrGhvBoUDJc2zZkiTJLL/AHx9O9ekeB57mDQbVNXdftuNpGQXC9g2KmiuZq70XXuGIbgm47voXtHjvLPVLlplLW2SVYt1HtTIvEUjXFyJVGxSGjZRwRnvTYbm6l1OQl1EAO1U6kiub8e65BZ2yQ6VJGbxphwvOPXPtXS6nIk7nLCl7SfK+pJ4h0fQtSuZdUa42zxDOI+jjPSjVrye98GzDS3a2uCBHGFIDDHXDfSsfUddJ0/TkGmRvDcKruYxt5zjOR/KtXxLo1xqGjWMelxyQoq4Ow4YA1i3z83Iuh0JcvKpvqcx8L4tR+23Ntcyyukg8uSPcSDnIJPtWj4Q8G3HhyPVr20lgl1AFkgwPmRM85PrisLTdYvPBupXFm3+kzthZS/3q2tKXxHb6ompQbriwumJYHkBT2I/rWVKatZXua1Yyu3okSanq91LBbW5ji+1XOY5ptuSV9Np705NLS106a204KnmriWfdgjnoB0o1HSLjTtZfUYs3DyEYGchB3z9KreOru7ju7eDT4RFZykSmQDO8+nHerbtrJ3CK1UYE8zah4Q0pYWndlmI2OjdB7mur8J6s82gvfanOSseC2OevTNUZ4bHxF4f063vHayu1X5A3P5juPStWysdP0nS/wCy9SuI83A2s4O057EVvFTjK6enQ5asozj7y96+pasNZ0+/Fw9rcqoiOXzxtBrSsZo2hcJNHIjP8hXqK4y+8MWVrp1xbaXeqt1KwYAkHIHStPwhpd7ZDyb+MbXzJuPY1tGbl7rMJ06fxRf3lzTbW/KXUGqSwNbkkIEbk88Gs3V9BuVeGSzdmYSbwM1xd/bXkusXxsribfFKf3chwev612ug6pHdhEubyN76NeYUOMEdRWcKiqaWs0bTpyguaL09C3Prs43W2zY4wORnJ7/hXN+LNQ1aK6t7m2s99ts2FlXIJ9/atHVdZt/NHmwRltx2OpyVb3rK1XxkYo/sq2yeSEyzsd3H0qajsruQ6VNppwjucp4nvTrMccmrObOYAJFtOY2Hpjt+Fek+GLU+FvBkl2rNcsyhwAvAGPSvOdP/ALM13XYklaTzeXRsAIpA79q6K1nvDrJSC5VrZTtMfm/KRjnjvWFCq1zPdvY2xEFNKC0S1PQ/g3cfa/AqXJGPO1LU5Memb+c/1opfg2iReBVji/1a6lqar9Bf3GKK9Zao8SSs2jnP2i4mm0LwzHGSHOtDaQSOfslzjkc1xHgC4j0EXNve2V6t053PdTD5cezHoPavSPjV5xi8IfZ7b7VL/bfEOcbh9ius8/TNcNfapHa6zHBf6dcRoFOIyN2PoO9c1ZPn5k7WPTwbvScGv60G3niS1j1aS6ubCa5DNlpbYK4VB08zHQ1oxaXDripexzGFCSSI2w5U9VPPFclLpS2Oh6pq8lpusbg5j8g7ZoVHBGzo2fSsHQvEt5FYrprRvFDeOwjlZSjRgcjPUc/jWFV1IQ556p+VjsUVJ2ho/wBDas5r3+3/ACY3lvLOB2h8llzGkg6EkdePwrV1XxDBpeqW1rqkdu4lQSfuz5gi+uB1qrpepXuk3sdrbvJb2ckpKW+3LOmPmZscEH8K6fwfLpn2XUX1V4t/nMSZtqts7DB6D0Ga5sJOdSfLeyLrWir8t7dupxXiG4LanFq1g8cMdrhkjB2M4IwwUD29a3rXxlaXGy3toLzzHI3yyIdsR/2v8Kr3GkW+q3st5Z35NikgMKS7Ssh6cHrgGs7RrS/uZ5SBLDYOSZCw3B3B6DHQVf7yFV8vXQJRhOC51sdVJfw6hvg16zEsOd1myRAEAdD+NYmtf8IzLqEra/pVzZWKQ4jLR7hKc85C88UltqN7qF3ZWmnzQFoJHMuUyq9RtJPU8Zqlrtvqmh6na3uoyRX9srMAgI3Zb0Hc1rG6hdK9mZqK5uVuzaLWnJo1lqUy6Jo72ttJHucM33j2AzypI5qlo9xHYa7qq6pbx6eLoKYSH35Udt3amWd3qVzqsq6vCmmW8hMqSsBl1AwEPPGBVe+gt/EfiOIW1qtysCkQbpCIXcdz/e+nWt4TlFqUVqHImmpbW3NDRbGbUdX1DVLSOOWxih8qNg/LtnJ2+h961Y7e0vtH87UpzFqELbhcOwLxkcqTz+GOlW9KstUsruCxnjsLQXYYf6OCcED7uO3HSrmu+H9Pa0thBaRERXCiR1GPM9c+o+tZPDVal6k0J1oKSgnucXL4h1+5uV0i3gstRv4FMonhcYdSOhHritp9QNlDDBf6dJZMxAPGVb8q176x0rw9qtrd20YQTK0ZjhG4467sDoB3+tY3iLX4tW00WmjFri5l5RVAO5B3yeh/wqadKKg5Sn7yL5+aaUY+6Q+IdEgsrCa4sDJFM374+S3OD/P2rNhh0rSrBIYpYJJZBu27Nzsx5+cHoc1p6Bb3dzq8P9uSuF27VjfAzj0xxV3xCLaKRra1WFLwyg4kUF/97HGRjtUwpzmnONl6jc1BqD3IdBvNc0Pw6gktY1tGkKpPktsDtx8vWpy32q71VvMj+0svzMwxkAdvbFaPi9Z9O8LwXN3qHmR28qymBogiS+ue/AINc1pGpWd/4i08RyW7rdBhGGcgo3cEHjaR0qasZxqKM3uKm06bmlqNt75U8NXGlaascolt+EWQEoxHOQa52eyt5LXToHguTcJ80kkGfMx/ntXfeJtDt7PWrJdLWFdSkkEjNsB8tRnJGOvoKg1Gyi0PVI9VE1xcO+Ekidtx3HglfSn9Xk3770RSrQtZbsxfCWh6RqN3dfarp7uKAhxHeMTsJHQg9xVLXU0zQfF9jLYLGyThkMaHIUZzkgdK6XT9Pu9U1HVbmwiiNrPgbn+RkkAwTz2IAzVG80F9btbXTYraOG7sm/eLkDII6qepUkUVJprkj06hFrm5pPpsZf2m9GpedYE2kd1OsJk3AAjryp9frV/VfCk3hyHUNbku7idJ0Cybny24ngnHbtjoKra9p88mlJBZyMDE25Y0YMYjGSSdoznNbFzeaj4g8MQeRcxweasaQb42QPIMko5PALYwAawhUXLJSfvLYqTakmtupy2kSWK+FzNq6ieZw5DE7yWzwvstRaLbR6XbXVxqenrHcXXywFwCq56cngHHNdDf6O15olpdTxKBOsaxW0aYIcHJDHsO5q+kDabfQv4t+z3NrIu23WGM7FbvkH+dawptyV9hOpHvqN8Q6Np8GhI9lbJ9skx5Yi4bfxycdf5Vaj1nXW0IadcWMCXAXYJDKeFA+8RjkgdulZFjb6paXEuswRpeacgIitVkIkQZ42g9u9WNR1K7fS57ieJrVGAEh8wM3J9Pp6VrOtpKysjJQ2u7mF4a1/R9AupxLBLMJnLpIse9iQepI9/TgVvE3Ws3t/JFcPbM8aNuEfzBevX0xmua8YXFv5EMPh23aW4gTLmOM7Y068/XuKtQpqGmaTpzrfpEblQku45Gw8hV9Bk96hSnZQmrxRrKC1mtGzSnsl0mxa60S83y8OAZM7W9GPp/KkudF0tPDs2pT6i7arcKXnlil2nPpjoMfrVS9S30BILa3ijkmnJfdJJhWAGTkHr7Y602K3ia5+zNan7dcqzymVcbEPQp257elEJOCkort8v66inBy3f/AARFksbwWC3EcIityGRVfO4n+I47966jXDaXXhpnhg3XDRlIZEXLTH0XuPrTdI0uKx06NJbVJEiTLHcNwHUkiqOiS2UE95epNixn/wBThiRjH3R+NdUYuEbStqYSactnodD8K7iG48f6R5CLDt0S+VoMYaM+dZferJ8WWenv8RfFl1qNtJMqalCuVOAB9htT/WrHwpmS5+MpnSMRFtFukMfcYnteSPU5zXZaVDbT+NfHEd55RjbVIdqt1z9gtM/0rSbjXp36M4b+xxDdr/8ADCWGpsvg2S5t/MZIztUY6DsK4yDXLi+u2EcjrKGxg8YNekXjrp1ncJIkS22NqR8KG9q5KaeCwR3htYo7x/ukDIx1yKxnQlJLldkjWhUjZ+7ucH4ut9Uh8QJ5l4kUkoQxDcSTnqD/APXr0i6nttM8MxSBI7iZgEO9SVz3yO3NY629vr81tqVzDvvYHCeYhwCo6ZHetp9PMymC6YPHknceFwe2KVOk+ZuDvc2q1FLl5tLHCa0134phXTLeSO2ntQsvlj5I2U/TvW74MXUvDumTyXU9oIXcKkTSBlHPzNxVbxTaxaXfSS2ceQqBZdqkCQVhaPHdyW4SBJdrT/KH54xnA965ai5JK+rN1apTstEen+INI07X5UVpUZxGdhjOSmR1FcJbR2X2oaWdQX7RD8kby/IC3oKp3GmeIoPEAuis0SSyL5ZjPRQRkfU+/atvxR4asNZ1M6tb3q25t1DXIUbuR1+hq5v2iulYzhH2b5XK6/Ij0G48V22prZ3Fq0un79rK4CqB3P0p1t4n8I6Z4kuUt52E0JJkZRuQn/ZI4/Cul03W7bWIJ9OBZZJISkbZ+8uOp9K8ktvg/rb3qrI9tBbM53M0mTt9qcW1G8NQfLJv2umm3c90TU7DUo441MMvm4dUkUE+30pPsEcFrfz2kEUF15RCvGoUg1izWq6ZYQW8EaFoiqCUDawUdD710kV4d8asAyuMMMe3St01L4kcNSKh8Ox4tZ3cVp4xtzq2lJdyuwKy7cMCe4I4P410epwW2j6jdTa3dxpYTYAjkf5znuBWxLqujw6zFDHpiPOH2iQcbPp9K5Tx1pGn+O9R+12eqR2z2ceyZJlP3Afvrjr9K53T5YtRdzvU+aSclZWNPTtHi07RtV1HRpXmujAzxFB7cY/CuJ+Ex1d/FizyLMtsM+e8gIXHvnvXdfDfUdH0qzOnWF5NdBW3CWRNuT6AdcV0+oz2eq2c9rDOgcHcwQbSccmqilZNPVClOcW4NaPqbEeJrgNHFF5TD746EdxXnXjrSYPD8V3qE0KXryNttEJOUJ/vY6iux8IT2wsZhbyuUU4zJwcetXNTawuow15HG6qNpLDd+QrWUIzgmzjhJ0p7XSOO8HXF/LpFzea/p8AjhQNB5UYQ7foKuaR42F7qiW4iRIs4OR0AGc+1Gq+KYLS/j0qOzMlu48uRjxwf681lSXHh/TdXn0X5knu4zHu67Aw65PSs72S5HY6eVTblOO5PqGoeDPEWtbYr6E368GRVxvx2yetPTWDaXMiSBltYVwo6ce9ecL8OItN137PqHiDT4drbkHm4YrnuOxrs/F/iVNClh0k6dFeW5gU+Yx+Zl9QaUnZ8236mipx0jG7L7SWbvHdhmMaH7qHcefaqXjN9Uk1O1OivAbTYB5DOAVJ55B/pUOqappuheH7C706yaRLv96Umk5U/3c1V0e903XpnvXuGtJl+ZoANxOOgHrUylF+43qVCLj+8toh+sG9lv7JS62+3C7gMdexp2sW1zf6xBbsz+bGojjY8j6571T1XWI9W1cW4gZE+VFaQbWyO5Fbn9uJosbw2/wBnudQjAI3LnH4+tZKStZvS5dpJe7uSP4TlguLWW+1ARXCOHDk5AA7fX2rvrXVYZCEMmCwHlhxgdccn0JxXlVhrj+I77br++0K5wYkOCB6+npXpejJY3NoqDlFAwzcHGc/zFdmGnBt2Whw4uEuX33qM1mC2ju1nu7dDKg2l0HzDPGa47whY6fpus3t7ctLIxDMJJl27VGTkivRtTuLQW5afayjnOeTXP6xDpeoWFxA91HChj+cg42+2aJRUZcyM6NRuPKyvbXXh+6ikkhuFCbs4ZcEfSubvdMs/EVzOI5zFJHG21wMs4HbFZlj4em3O2ngXduMr5kZ2kE+orptOt4PDenCS6hY3k52MfRSetSnzQamrI6HCMHeEtTj/AAnptnJHPaKXjvArJC8ny73xjn0rT8PeE9YtbmOe+a1t40fDGcjJ+grF17UW03Xs2cyPk5jVF+7n+tWPF2t61NYW4a3kDTMNir1IrkpOEVzJXa0Omopye+jPZfhGAPBjBSCv9qapgjuPt9xRVP4ECUfDOyFyCJxe6h5gPUN9tnz+tFe0tjwJaSZH8YpJ4v8AhEJLQxiZdZYgyHC4+w3eefpmvPJPFks2qw3p06SN0iaKMS9JiDlipHfjiu7+OCTSWnhRbc4k/tgn7u7gWV2Tx9M1yug6hb65JDZyQsI4wkqyLEMAj0/rUVZyUeWGjZ24SEXBykrmR/a/2+8Fh5sttFODcukgwUXuoJ469DUuqadbaheR26umxCGULxnHJB/+tXTytA+uzxapbRhpo8RPsyCPQ/4iuB1TRppNU1C40+V5FSXyY03kBBj/ADzWS56kXdpvax2wcU/dVrGtaWkX9oNbLH/ow/fLIGDOh6EDvj1zT7XSNL1HXrq4mVZxBEqruXk+vHc1yunjUbbXoLRrpQJISTuHKqDyMjrWjs1+XUDPZeQY4kZNhbHmDucetci0lZQubSV18VtDWu4tPfU/sdhILf5NjRJ1b0OPWtLRXvNNtV0+AGSfpG0mNir3J9fpXHR6PNrGrPcWN49gEbbMyHc0jgcnB/L6UiQXOjeLLW6vNTmlgeMiMykDLA/dGOgNaxVv33LZXJmov925XdjW1rRrvRo4bs3jTWqyeZcx7RESCcnlew7Club/AMPPq8EtpMAiRFyHJOG4x+NWPFesReRaC+u4GgaVGmiU/Myfh2qfxLb+H9U0uGOKK1Ns5X94iD6gAj1FFSMZ3lGXKkKMpQ5VNXv/AFqUtbuLbxTo4SNR5Mj/ALgBcb3HVj3A/nVuazkbQYNONi1tGcI0qsG2c9sHjp1HSrWnW13Le3Gn2gS3DRq/zRg+WAOBH2I9TU9xe6haW76fdWha8eNniaMZR/fk8GroTlP36rtdWInaNoU9dbmZrax6fcadqNu92wjJQ9ZAFIwTgng8da19L1FPEbm1tWZLGFQ0ro2Hmz0UHt71LpNrYSWgKl5ZVi/ebz3x3Bri7X7VaWNmukvLbSmYxC4WMeXt3Hk+v1rbnlRs5O6fQz5Y1U0tGup0Gp6VY6drVvb2txdSfaAWRCxkMYAyRzWW08mj+L7OR7CSSCdGVI4Y8Mh68+3NbDaZd6Ff/wBrW9yNQuZl2SJckdM5yp7Vymu+LrmTxPsns5raaOI7Y4WB2Enq5I4HH61jVUYyvaxrTTkrR95WL/ji7QXFvd3tpe2UKgtBIyYSSbsDg8cfnWKwh1dZWs5fPmJRzLOx8wsvTGOVHJFd7aPDrFvAdSlgmYkYjb7oPqR3rH1bw7/ZSS6voiwT3MYZrkuNquvdQB6etTWwspSdRvR/gVSrqK9nazRmaDdQRi6XXQ4MDDdHcS+aqIewB7GtbRdHtdMu724l02MaNeMPI3DMkGeMY7AnpjmqcOn6Nq+mtfXd00l9JFuMzoUWE9QAvpn1qVNb1DxNp62/2ZbGG3KmR1b5rkKcExD8M/ypOjFWlJ3Y3O9+Xbr/AMAs65YJpE0N1pc0NpJuCNI2XDL3QjOevPHSpdKmt7/Xw17fLPNagGKOJCqnI4c55Pf2rK8QaTPfR2U0d7cWzxkExsitkEDJZeucVLf2zPILe3hWbVGwYrhhs8lO3TsTniilKomm1ddu4SiuW19e/Y0fF11HoUllqMDtEzPsmttpIlGD2HQnHWuag12R/FFrrsc8FrI6m2aJmEn7ojOCc8HIHNQXkGtW2n3On6ope+Ki5W5Vv9YoblOegHStXSrq1/s2C9j0dHdnMlzGYVy3pjPYHHTmufFKpUk7e6uxdOKhDX3vM6DwhZ22ra40kEV1pYgLrhcEykkFgHyTjnlT61z/AMVLKy0a5+zW2pX0b3EwmitFwYE5G4ZPKnpj2yBT/CunJ4p8RXOpXLXFlHGw2Qoxj+YdS2OvFXr3QLY+N7lTG17bJAJFSZvMCsQd3J55xxWkcPP2UU1uZOpFVnaWyKsOm6xp1vAbO4FzMH8yEyMfKCnquOpHv1ql4nk1hdVtf7Tiia22HaIFZjGSPvc+vTmrsUv9l+ILNVS4n0+bcotySfKx6GrNneSJrEscygtIpeDMgAUDkg5/nVN+xvSkWm5WmjIk1iTT9PtoLOd76SNwIoZhywPVSOowKfqM1zby2UuqCGOwfBj8xiQZCeAWHQD1p0uh22qw3niGWV4LxW/dmJ+AqZB59Tzk0vhjxBZa54fshrqBXiu9sURHLJ2OO496y5KkpJN2THzRjHmSv3NK1kW68Lz2sFt52pS7pCkbAlR7ngfjVa10tLvTzdXik/Yx81rI2NrAc5+orbbWLHR/EkiRKPs10FkBWMkrt6qccjPaudvZYvE3iDULmynubS0YKPKP7vzio5f69sGvQr0rWcmc1Od27Ky3J9LtUk1eK+vrNUswM2qPy6kjknNblxBb69exXWnswjtSwM8XysT6c9R61hQazYnTZdO1JzNcQoWUYOTg8Mf/AK1a3gjwr4ku7M3jaxDbWd0u6MIm50Hb5ccGsIXk/ZJab3KqpQ/eTdjnNb1SQXGrWFsXvNSRxEqADcq456cD0rU8KeE9XtLWG5kjlilclxHI/wAkOT2WvSfDnhbSvC8DPDHvupf9bcyjMkp9ai8Ra0i5hUo0XAl77RjuKUqcaK592Y/WHVfJDY5H4a2Fvp3xlMMc73F02j3j3Erj7zGe04/Dmq2q2WqXHxZ8Ty2CFoU1KDnsrfYbXJ/LFTfCyB7b4spHIzODpV86MzZIQz2eB7Y54960dQ1aXSPFXjm4WHeq6pBtJ6Z+wWuf0xVq0qKuzKTksS0lr/wCLxjHf67KLc7ohChwGOOe59KytL065jitzcTRzSRnawVsgdhj1rYj8b6fPp0N1fRMC7tGVjOARjPP4VLYnSL/AFBbqzaQInJj6ACuZKM5p3uzqvKCs42Rr+GNDGnwTvcqzO4+VM8YzmrtzeQ2WmyNJEHODtXqKt6TfW135v2e4DuOzcY/Cs7xRmZDbW8beYOWRRjcPau5cqT5VqcPvTqWmczeak+r2lwLKPDoMuuOcfjWz4f0mNdJJjysrrkfxbT3I9KxdNsHtNLvrOOXbqMrbyFOSi+ldHpIn0XSUEzFpJCRkjGK44K8veR1VnZWizNjsb2xs74tITH5ZYK5zzz0rjPhZqa3mv3MN5FJLM4KjH3SvcMDW94sutUnuo1RiIHIIVTlm+ldF4ZjtbJi8mlx21ycK0ypgv703FSmkug5S5aUrq7Zkf2joXhbXJ1jikkm+6STkRD/ACa8/wDiDrOuy+M4xayzKo2m3KHAKt0OB1r1zW/Dun3vn3EzrED8zv2wO5rnta1fTbfRFGgz29xc22IxPt3NGPYnvUODV43siqNSLfNFNu1tTnPEWqalbeONKht3l+1R28XnBQWV3Yc8Usmqalca5k70eOXgAELkdjVTVdb1OOxsb5JFluJN6SXkUY3A9AC3auy8MxjUNItLrWcm75zJjaXA6E1EfelZM3qSVOOqMSXxFoWn+ITBMlx5kx2ySHG2NiOSB14Jrd8N+Df7OvHluniuLZomClV4kU+tc14u8Kwa94khuNJ1a1RiRvhb7wPqPWpdZvNcTXU021edI7RVEYwdrYAznHrVXUG3NXIcVNWhK3c1LnTNB8N6y7RxSmWRGYDPyqPYVgXlhKNL1C90S6JklJCIQQy5PIz9Ku+JPEOmXesw20scn2wIEdgML781keLL7UNLNvDp6bLOQCQTKOGJ6YP+NROUbt208jSnGVkpb+ZsfCe21i2knj1K1kXTpY9rtKfukdDzXaW1pb/ZJI4rxLkBztIIyD6VzvhiTUNS8KPBq14be4nb92JDsZ1HfFanhLSbqzuHeZVSJT8jdz710U4rlSOWtfmlLZnOePZ7nQrH7XaWdvLeBx+8kXLKOxA71y2lXem6raDxHrEjQ6gspzCoGJWHpnpnvXqXixrWW3vLQQLcztGTCJEyN3pmvB7SDUtX1aLTLsLbRISUUJtWD1B9qwrJwfunTh3z09dCHxRoeo6rrcmp6Fay3lrNJu+Ry7RNnlW9K9PvLnTbTwhZ20sNtLe20Y5mXzCvfGeuM9qlksrnwv4b/wCJHKtzOy5lkUb9g78DtXH6lqKS6JPOsKEqwjyI+AW74rOc5Qja2vU0jH2kl2R1NpDH4o8Oi4eKIuf3bRoABGV6YHYVpeBtI0zSrK4vraH7TeqCHyuCB7e1eSaLrN1pV/m1upRsBDjrGQexUcY9+tdBfeJbnQdMtZbO7eOW4HmBkXK49Of5UoVEpXsKdGT91PQ7RZ7W71KS68Q27LFGcDEW3GOecdfpVU+HdP1SV9Ts9UXzUk+YKONp6ZHao7XxJFr/AIMtrvW7iO1l80xgBRmYin6FZw2VrPd2L3Fwbl9iQupBHufatuVaJq6MlzW5r2exd128sdDEItrIXEsyAyztkqQP7i9hVfxVeaiNDsrvRVlSErvkCHGD6fSrMr217qVlY6pCHlLYGx8Fc+1T6hqEuma5HHaxobSFvLaNuSR34NNRunbRMnZpbtdyr4Y0/VL7SANXuRD5rrJHG5+YDvjNQeJJ9N03Ujp0+pxpLI4wGXIzjjNS+LdG1K51ZZoBLsLbgQcKBjjP0HaqHiHw3Za9qOntBex/alRVmkkzhsD+H0IqnKVlFq1hxtzczl8kat1HcaL4ZUWdxsneTfIyjPAHbHrVvTr59R8NPPqFm080D8B2xn8ax01azg1qKwSZ5ZLQCJpDjE3qCKXxVqF8b46bZ27w2R/hgTPPYkinOqvXoSoX0e+5inR08R6lILOeOC4QljExw2O5Brv7+0mXwg+n2c4k1SK3YRygAkH2Pb0rDm8OW+l6aHhaRb+9UB5QOIcnp7VQ8N+H9bsfEEckVxI+JAJXJO1k9s1EYqCdO2+7HJ89pJ7dD0X4CLOnwv09bwsbpby/EpY5O/7bPnP45oq98IGZ/BO50CO2qamSo6Kft9xxRXqR2R4kndtmT8blvWtfCi6WEN42sMsYk+7zY3ec/hmuQlsNUhWxYOluNwh82JM7VOP613vxTtmvLrwZBGwVm1l8E9OLC7P9Kqnwtc3QVdQu5pUX5lEeEAPr74qKkOdWudeHqxpxdzKt9Ftn1DfcyXN4Yh5ZnnfOeOduOlVZPDNrdTS3mnTNaM/GVO4Mw6nHrXY3unWtjYIZ7zyIEwMucA4/ma5vTY55bmRNKux9hcmVZnAYnJ5AX0GO9TGEE1KS1ZoqspJuMtDzubS2Et//AGmLm71WKRljuIwBtQ9AR6etV01o6Lp8dlc287XTusYlJwSjdwepxXU+MrO4PmQwajIb1gHY8RsRnAXA6HPfvWbrnhvUJtPtrvW7uS7ltBv2pGEVR06jr71nOE+eXItTvhUi4x53uZ76tpuntGmgTQyXW5jJAxwJD65/hP8AOuj0ywgewNzqOnSz3V1kt+6L7B6A4rldGtdKggaK2tIjd3kgjCOCQCe5Ndl4ftG8F2dy1zqF9tk+5GZC+GxwApqYe0pytJq3awqiurx0f6epgnwj5Gt/2tBavFpUUW2UTLjB9Ap+vPpXS3mjaZY6FNfRrApVBIrJjanTGBUtz4q1DUbBovsMsVzbMBM7KMBCMbtp/wDr1z994PW4MEtne+db53Ph8Mue+BwcduKmNrOVOPN+BPNJuPtJcvpr950EkksyWM2kTxidMAMzj5geq1V1+31Y3i39upngEWGiQbWXHJIz3qCTw0mj6SqWF44U8id8OGJ7nuBWZb/8JMukNNaapatHC+ZofLJdlBxuXPT8ac6j5VGorX6Jkwgr80Hs+pYn8Oz6jaTajc3s6i4jzst5QMjHf3qleaxZ3vhy00qytJY5X2weaIziLHAJNNuvtMWnpLY3X2clsZY5ZVY9M9/rW/Iuk2GhmSW8UrHHnBbOf/r1lGbk/ZxdvU2acUnLXUwbfUb6y1tArXGpWaKkcM7QbUaXoNx9B6iuh0KyhuLrVv7Wt7aS9llzI0bblVSvAGawrOC+1rRHkvtSFnbujKkMS5ZR/CWz6f1rl9ItrrUrdbKwvJk1eJ3jlKSYTYP4iacJzw8lPdMJ0o1otXtYteJHTStTE3hyznkt7YFp3jbKx5I3Yz1BGfpXQv8AEHTZ7RLOxtSJiMeZNhEX1Jyefwrm/Ccccmu3WjXl8sK4BlwQRJgfyPvWleaNax6rcy6YLWRoHVDAxBXeQeB6cEUfWKjTlH5lOnDSMunUTxXq2mTm10uya2nvZlHmTgkIw67Sw4z7VaPjCK0lh+x2Lb3iKqg4WPb6n19KwZ9LvbOY200dqtq0xkkaKNg3rlfx4zXdPeW2tWaaXpMsVvcRoP3hXeqEdQfX/wCvRCvOor3t2FOEYWja66nIw+Kk1LVSXdrOWQAui8Fs9QWPp7VqxXiaFrUtxaia6WVU+0Q8yOM9Nvrk9qLjw/BarqD30AkukXcsoTBK9h3xUWkeEjprHWjeTT3yDeI2Y4Q9sc88evSppUq1+cJzpONuhrX1ybvWFu9RsJ7W18gpEkgBabJ+bAHQj0pND1SxGnala3atCIThYpk2kj+EjPXtyKrR+Im/4SCJ9UkWWGMFfljJQEjIcN6Y4Ppio/EWu6Tda1ZXMafaIbaJxLOqZjjJ6Dd9K7KVb2kXVvqYSpWag46MU2+paYLJtNuU+1Xg2srZZWXuxx0xVG1sfEdne6jIdTLTCIStOgAAGcABe4HpUulXtteyTavp98BPAMRpOp2svdR9ah8OjV9YYlpLeG41B3jillBAhQDJ4zn6VnOpTqtJrX1NVGVO+unmi7Z2OuXkVtqst1DHcRDcqJH+7cd9w9T69s1b0d9N8UahLfan9mjuIFCeVE+PLyOT+lb8Xg2Wz0U2S65dPAsJx50Q3BwCc/T61xulWlrploZJbZwgRd7IG3Sc9SOvNVVTU03G663Mqc4zjK0vS2hzXjS2vba1urXR76YWs9wFit4eEcE8nI7etY13pGqW7PaW0WyfyFcKTlW2nkIex6cV1WiXBsGFytu4hEzrHbuhJhJPy8HqtdHc2M2v3traEeRApM7SRPj5ehCnsOxFcUKaqNcz17HS5+z9DP8Ah3Jq11psl9faYu+ZcxzIeTjjJPapm07UdTtp5rNEgjZiqzb8ZHqB2OfWuhhuV8PXlpouliSaykChcEsYMnABI6811ulaBIlg9rfbBCrt846sue/vk12ygm3B7I45VuRc9lqcp4Y0mSaxitrOGFb5SBdyty6H+8T7+1enQpBpliBKypDEvJOAB71Vgns9Ng8qKNYYlX7/AEzjpzXnfivW7rWNQhtGuUt9GMgSWNf9bIT0z6KcdKtyUOWl3OXlliJOS2Rf8V+NNOtrmN5VkaJuIZcny29enWuctdOHiK2nnubkrDNkxLG+FC44ziovFWqW9vfrClurYg4hGMqo9F6A1hxzGz0q4uYrsws4Gy1Y7ic9hj+I1zSqRdRwlr5HfSpOFO8NH951vwhj8vx3piuVedNK1FHl5y+Liyxmt2TTRq/iXx5bSZ8ldVgZxnGQbC0HB/CsP4UXeozfEbTYb/TBYQxaLemD5stJmez3Fvf5R+dbj3N3D4n8cJYxF3fVot2PT+z7T/69dTdo+8rHnz1rvlfzOVvraKzlbS7aEHTg+7dIOVIHUd85pbfV7PRoJYbO1TzW+dn35z+fStrxXIttotvcCCG5vs5cEkrH9QOtY2iW8evNLFc2NtBaFfmnUldrY4OM15k4NTXLuepCSlDmnsZevhtkM9hLJCbkb8K/Ct6V1/hbxAYIYotVR5LvaAJOpAPQE1j+IZxoOnWttFZ290Aw2ztyKz9f8W2Nhp9nPLp6y3UpJbDGNTjvWkp8krOWtvkZ+z9rFaHcX72UJN60LefnAOeT9fWr+h6yNQuPs13EhB5GR930yKyNA8R6f4g8PLd29uheMbZIs7in1NNSWezhuZ7SENcqNybBnOe5rpjFyjzrY5pRv7jWp0fiGO4htXl0uBPtIwscuOn1rkdXutf/AOEX1GW5L+ehUrJsw2M84Ap/h7x9eyXot9VtCsLHaJQMFT34qx4111xCsGnAs8nJmxlEH9ahyjNOdyqcKlNqEo3fc47QdXuhp+pRaxO4tbmMwgyZwGPQ5/Ctb4eeEh9mujeXUNxaSgJsiOdw7N7GmSaS3ifRPKjZXaJ8gH5SW6fj7VY8K6dqHhvS70CQpdvGRFHN3PbiuOmnzRctUjpqNOLUXZnaLbafouktHCI4oI8kbgCM+tctZ3R1LURLZ3KywswRlIwqr3Fch4d8Y3mp6lcWGvt52n7G3SFfmj2jk/0xUHhvxjpVtq62dpZyxRTt5Qld8su7ocVrOsp2sTTw8oRd9WdrrPw9N1rMVxpl28EaHcY+6n0B9Kj1nWNT0HWPsbyRzQrCCCy8t7+9WfELappmmva2V2huJSuyPzsOy55I79K503Ilso38ZA20okzA235tuefwrSb93TQinGT+PX8yW78JQ6g8Op20xilnHzgjlW/oK0rlUS4treTMot1ChSRhiO5qp4nu7qxSzh0tJJrIqJEl67j6Zp8Xi60t7iMXGnL9udAskgHfHUVk3CGsjW85q+43VNKudV1qEyXdsrk/JG7/ADjHbAqVdS1KKe7htyYFiT5d3cDv9TXA6rZ6tp/iNWtluH86QSxS8ndnkYrsdW8T6bcXkdpfSPDcsoikmRMgnvn0GalVbXt1LdLZbo2NA1O1vL4/b2KuWADc/OccH69queOfC2oaruOlSQQxOPnTAVmP1qPT/C1pp9xHqUspliji/vcA+v0q1oPjIatrZ08wgJjCup7iujRx5J7nLKTUvaUuhgeH/tHhzT7+a7i8wxoVTDF9xHUVj6LfDxJcnS9S0qLYd26SAbdvHXj0616/9nhNwYRbxtGVxjGc+tZ0uj21hDJHo8CQM/LlPlIP19Kr6tLS7IWLg7u2rPHLr4d6jHO9rp+p25glB/ezrsdY+59+Kktb/wAOme18P6vbC6RW8uGaL+90xn3PftWvr2neIG11LiVDLEpwyqcKy9CM9qjHgfStKkgv9JjlaV/vNO2/ySey1y+ykm+VHd7TRc8vuK1xY6drWntHeWf2Kz00kRLD1UE8g+p966vR7aLUvDcaaXciIwth5JWwxHYfSsNrix8I6bM2tbp5L35hbhscDq341ppYW17oNtNoFwognbcULY3DHK8+lXBtJ3MqruvIuX+m2FpIurwOLy/T5JHVsKrY+99Ko213Pql1LcpCsl0qlklZPukDpTNJt7rQ72OfWZY0gf8AdiIENnPY+1VD8RTD4hGnx2UEFuZtjHb1HTdmqbi1a9hcs72iubz8hfh94kuIm1WTxHcSpYMcq03GGzggA1ek0C2li/tLS9QUWKtvBIIZvb61gX1tquq6pcWmryyx2gdmSYrhU9COPSuu8K2MFjo8lsbtLiPdgvn5Vogo1Xyz6BUXs05w3fTocxong+e/ub65eVFgzvjcn5uvQ/41Zm8V6fpcdzowvJIrhvlW4VQVBPqev41ryXbaXc3NtErfeOeMqykdsfWuQi+HV9d6kxIxFkuXxyc9KU6fI+WitOpSqKetV+hr+HLjU7ZrmO8ikMLRsxdssr8dRWheXmpppa3NzCQNuxFRsDA6ZrpLqEWPh62tLgkKoAkUYJZQOma4bxppOparLptxpQd7YL5TKjE7fQ4qq8ZJWhqZwmqjvLRf1+Z6d8DZGm+HFrLIQXe+1FmI7k305oo+B1u1p8ObW2cYeG/1GMj3F9OKK9CKskmePP4nYt/EAgax4ILEKBrMmSTjH/EvvKzdc8Y29peQWtmHmklJVXVCVLegJ61X+OaXElp4RWzCmc62NoY4Df6HdZH4jIri/GcuqXq20ElmNPFoplaRZVJCgcCM/XtQ5RinJ9EdGGoqo1cTxH4p1KHXJor6Hzwo/cwkAY9WIrG03X9bvoZ5NPWDTRG5bzpB9/PPygdqrWN3rtsJrqeztry+vSIBJNOC4GOv0+lRz6dq+i28UV3NHe+YSFtol2lSwzwe4rmnUhXjza27Hqxg6b5Uldmlpt+8uny3eo2s9/fudylF3ZbPD5rft9U1bULZ5bq5tLW2tl3sQnzuB2YHpXKaFqYsdJgguoJ49QjYhIQSHf5s4A71qXdyD4hsbjVbaSGBEIO85UsegYDt9c1UElFczem//BJnBtvT0/4BJd6tb3XlxmzguImYM7QNiWT0IxyMe1LYX1oviUw3cF5bQwoGCXTlgrf3snjPsaoaxPcazfwXGgPbWUlmC7XQIHGCO3WqCeLrbTPD7C8s7m6uJMiUOmVmb+/u7U61e7snp0FCgrXtqadrrV9rHinUJNIeFbZAIPOnOAB3PqT7Guu8Ma7p95dx2t3Ywq7Zh80KPLLKcde+a8TXxJHDE1pame15JKoNzzEjuex963NUlvYfCun3VtMkJhdMeQQfLJ4+Yn3rnoPmcppa9TWrRTSi9DvfF7Qy+I47eydVtFjIcKcKGz0GeOOtYWoXjaDexQWh84Oy7UzksD1JPWufuo9aaD/ifXl2dPYCQzWyqTH/ALQI5xW1psL2ul+bDbT6pMmXjuw+GI7A55xSbk946v8AAIxUUk5XsT3F7Zf8JNH/AGhbJFGYgyuX4PJzwewqhq4W8uLd7OzP2I3C7bgrjZzyQD1H1pbyC11Dw+dS1u4tJbiWJmAY4aEjlVH48mtKwv59W8KxLDps0pnhCZJ2rnGMj275pwoprkm9/vHKXL70VsTXXgqx/eALcSTSD95N5zZY965HS9SPgzxfqFtp0CXVnKiRCN5CVU9WLEcg9a23v9bXT40uboPaQjZI8akEjpn8P1qCHw7Z+LHuLXRpZLWBQouLsgjziOVAB6kH1NViJJpQhDlaJpXSk6srpmVrkc2v3Woz6JFBa2qlHl2482Lj5iD398e2a39Ig07w4tl9h8y9jdd+ceY5b1OOgNY/gvTdS8O+N0s2aN4py0crOMqyBSckY4613uiQadpM121kLdIS5ywPGT/KscLF3d5F152WiurDdC8QQa66SxQuqwyMnmyLgqQPug+vc1h3lxPp/ihrrTbWL5SPMcPsRMjoR/ePrW94YvrGZdSitIxPNHM+I4hkuSe1YOtafrdpE8k8AsRcMN0cgyxUn5iWHHtitqsYqCcXdp9DKDtNxemnUxNR8Wy6tq97bLJcoVjEQVVz5sgbOM10t3e38K2kdzDHbQXYKyz90OPunn9ahure3uNW0q3iEaSRuJiYgOFA5Jrp9W0a+1SO2kEEM1pbsW8gcMx6ZPr61kp8jfLLVlylDRctrHIa3qFpp1tDaW0VsUdNjOOFVe4/Gtq58SaTb+FRaWVo5xGYIoynJY4+TB5IOc5rl9QcSeL3tEtGihgjAihdRhz3Yf8A16z4tT0S91C7TXJTDbI2UZXO8MOCuf6VnCrUg3ZrUqVKMopu+mp1bS6Qnh6O2sBE2rBCoiAw0JHU/h6021tbTTtCfUnWM3Cgs7ucbT/s9gM44rKg/soTpf6bKPs1uqoHfO6Uk8ccE/WtPWdGv10qaO6mtleQNIIY/uIPXHU4/U1pSau5yV2hTWlk7X7k2t6prupeFYGtdVsliuR+/fy9rICOR16CuT0q61u7Nqlrf297PppDRQyPsaXtkHvx2NY72mrxW66ZJjfOytJs+6Qxwv0GK6/XPCI0PT4NT0klZ7ba06Hq2T0zXTKnOt70PdXUlOnS919djojZa1rzRrdNDoKBlZZlbzWZuu3b3B71p6b4HSzkmu5fEJYyNhjAm1cZ5ABPGfQVWv8AxRbHQUumcJKVAUE9D9B6VQ0fxB/asE9rF5stuy7VkwQiPjk+prLFTjCa+0+5jTjVlH+VHfaeND0i4kMRSORR81xKchvU5PX8KmvvEdk9rvtJUnJk8uMBshj6/T3rkNLaz/sxRevBvTMakNw/55yfpXC2f+la3qCXLywWg3izkQYWTBwfwp1asla0k7/gZww0ZSfNfQ7iXxKz6s1hqkapJGDtUcKxHvXM313Y6i+r3pkWRIIRGoUgb2XOSMc9+tc/rmnx2lkJCrSGEF2dJCCwHqScntS6Jptu6WVys2HflgFxnP8AsjqBWUakkuSeq7nUqUF70Hub3gvw0Ln+zTfJsjnhM/yuckA8bs8k81ueLvD+naZdWF2pjSC2cB8sBwf58iszw9rDLp7QrOq6hpG5SGPEkeeh/D+VOubifUb+1mvrGQwOzKkJGd/H389NuOgrr5qdNRUN9zG1WVS7eh1fgrVbPUvihpa2M8cyxaLfFih6Fp7P/CjU1uTqfxENiW+0HVIMAHsLC1zWX8MrWGD4s28sFo9v5mi3gLFcB8T2n8s1Y1K/msvGHjySAOWj1GBsDpzY2o5/KqqybjeZwxilXtE4+DVJdFikvbqMyNKx2oxwBjrkU6TxW3iXS59N0+0hhlQbtsII8zjnb71tq1v4sjltJIY4WRN7yL3H9Kz00W20S5jOgIDOQcGP5mGeCCT0ry4wkleEvdPW5ot+8veM0atN4b8LkahZxXZuph5CODlMDlie3pXR6Jp+g/ETw+lzd28loLZzBlGADHGeKu6/Z295o+n2viG1El2Pm25xgDpkjv7VleJIbu30+1GiWrW1jw6RxJkZ6HPqfetoRUJWT2WxnJucbr3Xfc6fSPDWjeELGWG2aaRrk/dkYEtj6dq0zal9InSGbCkbwM9vSsLUZ7UaPpw1hXjvjEMnP8PvXQaFa2baVuWUPA6nccnAXvXTCXvKJyTVkpSbOV07TYb6cRi4jZUO47Sf0o1Pw7JtMNgzuzZLsW5A7YFH9o6BoUF++mSzNcqCU3ZOeewrD0vxpc6hJcrLCzOkJMbIMEEeprGU6S92Wp0wVST5onW+CbCPRLK7lMyzyud7EngEf1qLXddjXSdRv4ZBPcW6EqMbtv8A9auRs/EH/CQK+msk8Zc43wjIZu2fatHSNFaxlmstcYIlwpTAIwVNZKt9mmvdB0lGTlUepi/DLxZYavqdxpepabaxz3qMDcxptZ85yD9eea7Cy8B6DbapDfEzYjw2x3G0sO5P0rjpvDek+Btdjv0uZbt48mKMAAKCOCT3ru/D11JrOh+bFEssM+QuTnB961pqDbjLVomtf4oPRnJfE7QtQvvFSXtiGlik2iNkOQvsMdBTtU0mw1IWVtqOrJb6hbQgSROxYDBzmtPw3PqkWuS6faTeX5Zy6uuQBnpjtV+9+HKS682p/acR7t7oQST6ipUfa3mlbuX7RU0qbltsQWmvvCslrZRw3dvbQhYgy8sfX8e1cXZ6v/aPiaOLVrYI0z4d422457Ve8N6xaWHja5sktJEt5ZDGinqOe1afiO9sLG6vbiHTwmoRuFEm3gEfxY6Vz3k43m9mbW5Xypbmd4t8e6ro+vrZ2UUaQWpEaQtHkkfWp7zwPa3uoRXz6isCyj7TJBsO7k5IH41f8E6jaeKhJda3YQ3NzZlZBcFAGzn5Qcda6XWrmzeKS8hBWaFSSBxW0bSXM2ZSnKnLlgrNHEaF8QpNU1+XRL6xMdjK3kqg4ZFHA/Gux0uTRtM1MjSoBLdbim5h0PeuT07W0toH1i90+NnhHDCMb2z0waXwdq8GvS3l9FbiyntzvVQ2Vbnr9KcZtuyHUprVpWX6nqMupquoiBQCrfe5+YH29RVwNDLcGNSglfkqW5P4VyWmfYdZ1WcQPIlztDqp/iHfFOn1ezsdceCW2l+0j5I5APvj2rpjWsuZs8+VBX5Y7nTeIdVsNIsFa5wFb5QcZx65rlILmWO2nure2FzEWzHzhcev0qr8RdNurtVjtxOTIo3xA8Z9QOlZng26l0WC407VopTAwJAb0IwSK5qlSXtGnsdFKjFUuZO77Fbxd4VXxkh1Q39rbSWa+XP82Y9o5zx0+lc3qUVlf6fZ2Wgzvdf2bHtchSrE93A7rRcfEPSBFe6Ja6Y1tplyTA0wf51OcbsdwKZ4a8Ly6Prcdxc6jbpEpziJ8mTPT8D6VjUbmuVfM7KcWleXyKw07UbPS/7QviZE3bYo5WJAPXcfStLRdTstRvvtepaZbSSFVRZY24cj1HrXVST2tldtbPGl3bTAb4SeBjua57VZ9IF+n2K2MEKNlIV4U+9TyqnJTT0KT9ouVok8dDxBqev2ptYJ1sUVRGiD5ce9X9NhuIp7iylRNjFGjTdhiwyCMe1bum+KQLq0geBDFJhQ+cEA8Zx7etcpdXyXnjpha7zAr7RExwCc8kV0RaTtDqYWbXK1axo/FDVrrTjpkdo5QKgEoTG4njBPesHxVrWtf8I/pyW80scU7Eu65XJ969G1/wAK2GsXgvbtJULIAxRuCB2HvXO2d299eNpEMVs1lGCv7wjEePfuelTVptN677BSqRcVZXtuZPgzxFDLHFpOrXbLcyjbGw5G73rV8IX99beK5bDY7QRSEcA8n1NczpfhG7tNam1G8uLRUiLGKMNk57H6U7xT4i1fS7q1uLa8TY+XLJjJ56EiiFVU+Vy3LnBVOZQ2Z7p8K2DeFJmBBB1fVSCO/wDxMLiis/4FXJvfhrZ3RGDPe6hL/wB9Xs5/rRXrI+fkrNop/G+ea3t/CEtsIzMuuDAkztP+h3Wc49s15frmta5e30tnPpSbpGIikjO4Fe5Fep/GuD7RD4RjEjRn+2iwZRkgiyuiOPwrz832qTTpqrwRG2s3aNIcANM2MFuegrCtRlUTavY9LATjFa7m3o/hCyvrKIyzPDqEQBLQgq8bY96q+IrS406+tJNVjmW2Rz5d2wDKxA5LkfdGP51seHdeur3EsmnTW8yOA25gd3Y4PpWn4m1NxbiO98t7e4HklIuhBHXJ7iuaMqSjZX/U0vVjUtJHna+IEuRHc6fbyXNzbuApZQigY5y54xjvTNX8WQ6jp07Npc2GGzccFQfbnn2qTR7W5bVbu2S3i+xABwZu27tt7kjnJqe9T7LCLKLRUEsedksTKSR/uk044mvZyntsdDpUk0ktVqjP8QTaVY+CY7jQ5ILYPCI2O0ly+OQR/DzXnJ1jUdWtrazSEsEGzylXG73969d8LfDD+2s3+vIy+bIH2ew4GR0Jx3r1Gy8K6FYpGlvptqDHjDlMt+daRpKcU5aGU8bGg3Fas+SrWyudG1NXv9PkETHaTtPyn61v3Ws6THJNaXljcSK8R+YpkFuxyPSvpDxF4b07VrB4rqCNmCkI2Ohr5+03RpMT7JBOYpzHtOBtAPBBNbfVuaypOy6jo4qM4uU1qibwnYarrWl3aaVfIbNGKJJOpYxccqB6Y9aji8SX2m2Rs5PMjubUmNwsJ8mXb3DD+VdMlrP4Ou3ntIY75bqLznitzjBA5YdvSn2F9bLa/aZomEl43nbJ0wST2HrWEXGmvPua8zlra8Sl4T0/SryIatfxQyXU4DqhA+Tr/DnqauTQuuv2tno169tbXamOdSQRGfVM9DRb+HNEu4bq6lTybg5YlJdpXHpXOLpsk8U0yNNLawyA+YZSXVF5JX0rLESqU6a5WioKM5Npmrr8k+hyTaTaoxXb5Mcko3iduq5H580vh69n0rR5Jdkl1dXssbuqMuFb2HXaBznmtLwbpNpr2p291quo3MU12SyWxYjzo0b5d7f0FaHxXaw0G8t7mCxSP7KFdp4mCSYdsBE7HufpXLBVqqdVPYU6kIz9i1qye2k060ut9xKk97Lzu3Akkjt6jtXM2nhwarYXt2zzxSNJI8KRFQEIJGCO/wCNarWenvaLfRJGiyA4CYI+YZHPY9+K5y0tfEHh/e9tqKXEMzO7RTp9wn+IH6V1tcrUqkbryFB7+zlZ+Z3vgK1s9NWC5tydsgzIuQfm75PY57Vt/FHUI49KgVovNExwkRA7dTWL8NNDb7PLNJKP3mCdpwHbklsdql1+0udN1hDfwfbNPZQU2D5lYfjWspNUU7WORKMsT8V7Hnos49H1Oz1BbwQoziR1C/NKAOmPSluNYWOb7ZH/AGgsBcgedN278LwB3qy12r+IJ7jxFbmOIt5dv5allij7A+h965PxLMuo6zJLo9jLJbRrjCAoJif48VxVKNOVLmg9ex6UHNytJaG3bR6jeh7lYZWtZAwUCRQyOTyytg7hj14pnhOS0XxFPJfwWhRotsS7cbDnBHPckZ5rW8O3WpJaTaleaY6WTIEhXcFYY6nHQfSub8TSv9pW9iRnhiG54ETld2TubHfp9KlUfY8so7i53NtPY7hNLtNStLy9ktgHhYLCoXlcckgds1T8Qz3rQWk1qirJcfu1Vh/D1IJ7dOtYnhC81q58y8+1MLe4BCQY+VRjkjP9au+HLOXUk+2XerTeZp9wyW0ZYbuuDuHTGO1be0lNcsVYzlHlblJ3sXVurLVtTt0gcxTSRrG+SCY5Rz+XFaPi2/1Z9Ok0+5smgnYK7TkAhlB5IIqjplvp2mDVRcCG7lidi0w65POMjoRV2+0+8fw9baxeak8wtF+0CIACIx91z3OOnrXTT9py2UvUyqez5k2vQzoJtBe7t52jnRd4Em/hS3cjseewre1ErNf2dpbSNbmVjtcAAbfTArnr7Uzq89u1jo072UJEtwzKMICMgcd+9U/ERnOqaVeaW81pZtIAsrkjPHYGs3ZTTaumVyuS7G/4j0FLLW7TT7WePZeoUbf8zYHJI9DWd4z8NiC+0Ox0yNoU+YEoxxxgkEHqT1qhqUN3ceKrS4nurlbYgBDCRkEDk89qlu7mS71B1klnvXtMmCSJSJAp746D/wCtWc5R5bcmrZcFOMk+bS2pJ4h0aDTbe3Se9Z2mlCujnJlB6r7AYqXToYrnX5pLG6e3ntEV1tSFKFyCNw78D04qK20rTb+B3a8nlvA23zZmz5Z7jB6VRnhj0lbiNp0N0cvHIXxIT0xn09K1lKabvsRFJpLqdDqkVhFo1jLthM4nXz2TGXLN8w47+1O1fxKtv4mtUSKQ20QOyJgUaUEfw5/zxVbwVBs1/TvtrSSsQZAk6gDzccYPtXa+NmsjDay3UKNMpyuwAOOuQP8ADrWsveoxnJ2Oe6hV5LXuJ4QuzdfFDSiLJ7aIaLflS7ZL5nssn9K47xVrtxYfFDxfYCLdaTX0DOQmSSbK2GM/h0rtPC2D8U9KkRSkbaHfbVYYP+vsucfiKrXWj6beeLvGl7qsoijg1aHnOM4sLQj9TSrXrUrpnNTlGnXehdsrHSrOzNrGVt3uEG5jwxrjLbQZ7LxE/kXA2Bx8+cVreNpT9vtRa2yyqAHWUsela8DxXcEslrBILuMA/P3OOcetYSSmvZP7zqTlFc19zA8UeJbKx1mC01GN5fKI82VDjbgc/WsLxF4tuDeR2+j+bFaW6q8UiHO8N3xXQa34dXxbH5nlPa3q5TLj5X/wNS6boZ8PQWFjc20V1Ki8zld2Dnpn0FYuFTVxdl+JtCVJJJK7XQg1u9stYi02DWJDHqDoGkx0BHr70i6pd2WsxaRpv7yzOEA6hsjkk1S1W30+71OSeKRX1CRTJmP50VRxkY7+1b9tIljFYaoqp5jYRV2ck/3iO1UpOTavsDtCNl9xHZ+DntL7zb8K0YfAC87gfWjxZfaP4EsBc2mmJ9puQQq44/Gu9+127LGWZVLgFSeOfSsLxg2kTwRRa9BCdOfgSynBBPQLjmuxU4KLscUa85zXMmzyfwT4xiudVvbuPREEsMJfdAx2/iDwPrXYaJLp/jCa4vLomCaFQZY9+Vx6+1dF4ah8LwwXEHh+K38oAmZUAYsAO/rWTo6eH7fVrqGxtJY/tSNG7k/IAfbtWEaairxd0zd1eZtqNmcv4rk8P6hrLRnUmhWNAnmRjcAPQj+VXvCviVbHX4tKtsx6fEuyMf3/APaNcZeaBolpqkzafcX11aJJhyQApweVyeo7V0GoONVu7SXRbbyoV2o+0fMh9zXHzv2jfU65RThaWqt1J/iB421PSPFklvpAiRFC73EYLOTzya0NY8T+ILqG1ltN9rHJCrAKo+93zntVjxcNI0sRXFzai5uFRd0g6Ej1NY118QxfaJcSWdgsd1booQEBggyBkVpfkk7v5GcYpqLjHY37mLT9F0621v7CJtSl5LnkbvXFX9J1HTde0K6n1GCJMITcHHTA7elcb4F8Vz+KNal0XXEMsEoLRkDHlsB7dq6g6fBpqPaACOyn3RHvuznNbRbkudbdjOcLe5Lfucf4Z8W6NBfXWm6ZZtBDdOCsjnLOR0zjitjRdYh/tZlaGSeJyQWYYAOelc7oHgD+z9Ye+uLxZtOgfepRvmcdh7V0Whx2FzqNzeR3BigibcyOAMDPrWDVS+5u/Za2V9C74Y8QpN4lOmzWEC2TB94aPofqetY1nq2haJ42vPD9vpU4ivJPLaUS7tm7so7CvQrXSNFnvE1VVUvg5ZTndjvXnNidGvPiF/aKx3DHzNyE42ZHQ4rVv2aV3e5hBqfM4p6I0rDWdK8N69cRWk819djdGoC/6vB5GetdmLm31GK3vJYl+1J82BztJ5xmuAtNOtLrWLwyTBXjlcxsMjLHkKT3qDSY9WTXI7GyiuFV597uxz8vTmop1J35XsXUpxl719Tvde8ZRaVDAHg82SYbjGeuM84rzvxHqd/rupRXOmNN9mD4kUoD5RPqOpruPFc2lmER30IZoMkEDDfgaw7vxBZadYNHY2JEtwwZvMYbgKqvNP45aE4aKik4R1OL1/wFp2j3UeoXd3JKkzeYbZVC89zntXRWV7YvYxyW8Akk3E7ZOdo4wK37nWND1zw5MdUhZnhH7xFxnPsa5fw3rul3AubXTLB7Z0TP79t7Nz0NRNwT0ZpBzlG0lsV7+0SS5N5HFcq833vLXft9ia0JdHQ6VJf38MhViqxgL+8LDqSB0qbTWuUnuJbBJhMYmdl2kBT0yBVbwta69cSzTlJzHGr8N3ODjjvSULq1rlOVtmJp7w2V5HLE8cs1spPklsmtfwnoVtfy3GroXVkJbn7ue5rjfA+iapaXV/qVzbN5sJIEbLneSeflrqb/AMexLbTaSLNmaSPa/wBnYKVyOfxrWHuS97cVW70hqW1+I2nTXsuitFLhj5STRLn5jxVHTvAcllrE2o3l4skMP77ajfNKevNczrPh1raKy/s1bmztZIhJ52P3jMeoPsPSuy0phZeGl1PU7x08tcM0h/1mP9n1NXSlzN8+jRnNezinS2ZWmuNP1hZoQxt7nBEa/wB6uIOm6rbXZtbuwNxZuSF3nkE/Sq+ueLLC91uOS2sniQN96N8Fj64rtbGVNR1KzezuG3gDdEPmIJ9R61mqXtbNLQ0UvZrU9P8AgOnl/DKxQxeTtvNQHl/3P9Nn4/Cir3wkQx+DnQ8ldV1Qc/8AX/cUV6iPn5O8mzH+NyGS28JIvnbjrRx5Iy//AB5XXT+vtmuEvri8gxbRW2xzzsuY9pA9a9D+L10lm/g64kEhRNabPlrubmxuxwPxrk9ctrvWb5ZrHajxxASPPGScE5G0A8e9ZVYOS0bPQwUmo6rQg8PrFcRyyXkqi5BO6JWIKegHr9akv9QjmsYmbzGa1kJDspOf9nA6H3NZP2LULfWxNqP2HzI4tpZshCM8A+hrXstSivyrX0T2tmCQ0nlkRtjooI6g/Sudcy9y1n952SST5zno/EEk2uLNo6BdQmPlGKUbkI9SfYc/pXRCAxTk6pOjTSgENEMDI5xj3q9r8Gn/AOjtC8UfloZEa3IB4Hak0tLITxXF/JJe3UqjZ5hBEQ7ADgZohGV3CU7/AJEzqqymo2/P7z0DQ703unRSNCYnK4KH09quyAKMnp71Dp8YSEHHQ4qeUKUY9cCumKaVm7njTS5tEZWrapb2VtJJKxwqnOxcn8q8j0mS1aSeUWU16Xmd4kRcFwT/ACHetzxXf6jql5PYaBA7hHCyTbfk3dxu9vSszR9M1Dw7q9z5PlTTzxhlG4gp2wM9BnrWVac0+SN7Pc9TD0Y06blL4vUp293cRTKLu2EUpX57ZACB1wOv6VpXttL4gvxZXG+wtbIRyYMY8xnPQD+7WNrmh31xdR37TLPc3I8sRE4RV9BjnPvVqw8P3kscs9rPdfanQI7XE28Agev3hURp1qT9ly3i/Q3lKnJKomk/mS22hSaot0jzDfayZjl8vG7B6E9SK4q+1WC/1P8As2F5LK3lYx3Zxny/YY4x6V3mn2OoQ+HbnTWvIlLSFNxch8Hk5Pf8O1Q6Rp3h/TNNEUupW7Wfm5eRjuZ2/iAPUgHnNcc50pPlvY1jNpXlr2sSWPhm0htrKaxvXM1vgRu7btuOlQXTeHdW164tvFLnMMamNrlyAT3CD0/rW7c+HdPtbaNNPNxtlJl81piuB/ex3rkvEfgZL22iMt9K2ob8xyN29v61oqVRJTgtDNVIydnLX8Tm7pH/AOEluD4bluYrRZVWC2dSYnjx8zLnjORV7X7w3NtIIdUSCVUO1SpznHQj68U6z0y/tb63trqb7ZbRSmOQxNsl3EcAdsZwa0vDvgK1u/FM1zI8klvGgfy2yS759/SpoxnVdr27m9SpCn70tbHffDG/XUfCdi0ckYkxhgp6YNdHLZvfyjzztbkqV521iaXpttaXrLZItvbqP9WnG5/92t+41iztJRE88KTbR95woLHov1Nd0qt1ab0PHmvf5qfUx/E3h9BZtDaRpFFMCZWxy/Hr2ry+w1B7F7uwsbLdLCrKhPA+me5zXpGv67eCeO0ihJSSNmkyykkjqAPYdq4zVLZreBHtsi1MokyFwVJPp1Jz79K5HGLlzUzuw7ko2qdThdai16a1tdMnS6mupZGcJCdsbDr/APW/CrF80mhWqWEFk01/ck7Is8t279QOntXQf2nJZ+Lba/azYaXHG8ayejn+Nh6elY2sa/BD4rimupIgkACp5Y3M249Bn361alThdyd5G/vtpWsjf8PWt8umwi/SIXEB8uS0ZdvlknpkHnjnNUNU0iz0vULg3E1wJ7jtbycEnjJGK24LmxubG61PVkKmTHlhXIIwPlOB36VBHqkcNjZS6hZ3v2lHDzNNB/D2/SunlXIjHnkpP8ir4JsYNLe/GoWiQyEeZEbl+ZscZH+1WBYMt411p3iG6u7GxEmYbVjtDcnGG9B71v8AizxJHPr1iNMngaOzAlkjZCWk7Yz2q9qdtJ4wSOaO2NulsCS1xGDhuvA71z+67qk726GylJe9UVr+ew/wz5Gl6TcwWEzhgxLrKd/mjHH6d6o+F7qaeW5XxGYZGiB+yWiruIQclh+dY/hW2gh1a40yaRjqaIzySsSFwemCevHaobzU7fSPEEELhriYptUxHJ5PH0zW6qPlSlbXSxlKmuaVn5kl9Je3ujRTzWbeT5jHzAxVgucA4xxW94B1Ox07z7W9lEd2zeYC4z5nuParWrQ6zb+F5LkaOsMZbfjzMgR5yc561jxeGZNdtZtb1+7NnGISsMcOGbYf8jgVnFShUbpduonKE6TU3p5Gdf8AieSfxNeRaJZwXaSksV4wGHBJPpVHUZrKy1PStU1V/tF7NMFuIFwUiUDgBunFOufDC6U10bS1uAm1SXMm0yIevTp9BXYtpmnw6HFpUkFttnXfvaPoeuB6HvWDhVcue+q1N3KmkkiDV/EFrMYIdKtZ/tBlDRsq598nvjFc9Yajq58Rz3GoTSW1pcOEXf8AOUmx8p2nkDr6CuwsIB4Tu59U1aaS4huFCmQJny+4UY7emParFjHHf2L3kcEZkupGZYnHA64B7jIrp+re296UryW6Of26p25Vp3Op8N25tviD4dR5lnkOiaizSIcqxM9jyPauV8b6Ve6lqfjY6ezvLHq8ZEQzhj/Z9njjvW14ImSb4jaKY5HCjQ7/ABAU2iL9/ZdD3BIP5UXGsHSfFXjZ8ZB1aLIx1/0C0rSpKHs9tDgpqca+mrOT8Ma7d6XoT/29aSSNG4jjWVMEE9VHqK2tOvptTvpZ7WBkcAZxkbBXUasdLv8Aw495ex7rXaZOODux6etcT4a8Z6bNbmDSoWWfJLrLjKqDjHHWuLkdNRtL3Wdyn7ROSjqavjC91YaTHHpiurhv3hiXLFcdayrtdc1DwM9vLN9nugxKFnwzpj0PNO+JHiDWNIms5bU/Z4ZFDbIx1Hcmua8Rw6r4n1DTtQtxKsF1EOp6EcHrRVq8smknexdKm3FN27ieCtFvrHzBqDSKoG9XU4JFdlN4nt44IolglKIDl2XIJ706ztLd9GjtoLwSTWyFnkDA59selLoS2FxAlzf3KyxbxsjKbRn1+lTTiuVNaNjnJSfNLodRbQtfQQXcZ2RSKu5Gxx759a5j4xWdpd6HbQSX0Vtdhy0O9iB6H8ak8Va8lzplxp0SNb87RImVAGeorE0fQ7jWto1+czQwqEjfOS4/xrSpV/5d01dswpQcf3s3ZI5rwpfS+BNSaXWmWTKbfIicFnVhw30rtbC4smsn8Q6NZyzJyAjHkE9eO9UvGfw80vUL2GUauLNmUJ5cpB4HFU/FAufCfh6z0bQrppIpAZHm7yHP3R6CsuV0YvXQ3coVWnHdnI+J4XWcPBDPNC7Fh5anA7kHHcV1fw0F5BYTraq0nnspG5OVPfmuW8atewaBpk6rPHFcKTI6ty7E4GfTiuu8J3OuaX4P0qS03FZpHZnI3HbkcVjTpvnUu5vVfucqNI6jomras2lSWrzwK5jkleTA3D0HtTIP7K0TW5rTS7GOR5PkaJjlnUnmsXWtc8OaL4ka4ezn+0TbWuQpAVWx1FaNlYSaZqDeIJpI3hmBe3AO5tp6Z9q0cpXdjJQsrbf5nVjQbFZb2XSYFtr+eHy96rjZ9PSsWx8OamY7m3uHkVUO9Hds7z7elJoHiGS2kub/AFW7EOnn7zE8E9gPU1jeJNQ1PV9Vhm0S9kurbzFlQIcBRnuK3dSD23MoxqKTV9O5o6ZcadZpc6Rq15FBPIRtJOWz3Bq2dA07TzJYS3JeS7QbGCfKg68+tef6/wCFdVHxBed7C4mtZSrkr0YkdAfWu8vNT0XUdX0+CC88m9jQLsIyFwMFc1CelpGjVtYN26mRqd9LY3kGnaVLLMiH5mx97PUCur0fwlY2Oy/CTNG6hjEw+YMf6UmhaXo8uto0NyWuFJYRlcZPrXoE06xOsZj3AnA4yK0oUU43lqc2IxDXuRPKvGXhq4S//tG0CR2pTcys2Cpx/hWBB8Q57txpwCIzp5KXAXD7ugJ9RXqnjHSf7T0h2t2Ixn5ScdeK8hn+H8+n6hb3zXccFuJN53HkkHOAO9ZVKUoy9zRG2HqwnD390WNIhv7hLoasr+VCAGkkOAm3rz6VTvjp2pwubu4EMURx50TZZgewU9q6C7vWOpXYE7zWM/yzB/4R7ViwaTZXkrabp90DdzOH8xlyiqO31rnnT6HVCWuoX0+jeHvDFpPFBNdtK5iCk7QcDkk1U8GxaZfa6lyZv7OBI2xSN8sn0q7fahpV7Bb+GpbZpI4X2tcqQG3+qjpin6v8PTY3VqY7pRbR/MrN2HXB9KpX5+dbIlNKLjJ2udFZXusyeN5bVSFs8gbdgUFc/wCea6HWLPUReB4pxDaqDhg4UDPrV/Tr6w1LTimnXkJuliCuyY3DAx19K4XxrfXcejW1tauyrM7BiOTj1rrlG0bbnEm6k9rW7m3bm4u/EMdqziaYrmV4+QF+vrV1fBGlaMJtRigNzd4LgOc5PUfjVn4dWpsdBjkvl/0lsKJMZJXtXTjaxcKwY54zXXCmrK6OeriJRnaOljx2LwJ4r8Q62mr6vq/2aNGEkMCMcR/7AXp9TWnqHgDWdYvJTeXg+y9PJAOPrn1r1C2uFRzFIMEdDjirnmxqpJZQF6nPSipSj1RKxdSPwnkumfBbT7C/ju5LhrpEIfyyMZx613umaNYxak1xHCscyj+FQARW800YgMpdfLA3E56CsSyv7e5vmltpPk2knPHFaRqJLkMZSqVLyZP8Lf8AkVrjH/QY1X/04XFFN+FMgl8JSyKcq+raqw+h1C4oqjAzfi/5m7wd5Mfmyf202E45/wBBu/WuO1GXWdMv18hoY5rhQqW+ch/cewrt/imkkl34MWGQRv8A20xDFd2MWF2elctqVtIviaGfyxNcxREtM3ReeAB64qZWSu1c7cLqmtPmVL7RtRuE+1a3dI1qZFMka8Lj0p/ijUI4rEQ6fNFJ57rEChB8sDqcVQk1UT6xcHWIx9jTCjaTtGOpde9WtP0vRru3ub+cxqrnMRTIwo6Y+tU+SGsNGdC5tOfp22MOfRrdJorqJjlSGndM4KZ+bj/Cu8tHg0/V2t7COOSJI1Jdz+7jB+7n1Jri9N05VSRrjULlI/LYGNZflwc44q1aSXMlnDboESCdyZbjeMsAMce3FcvLCL5kjWac1a+x3kHieNbxLZmaYPuHmKPljPp7jtRqWsXtyzQWrW6x4O+RnxtH0rmbnQZ59LZrI4uoyjKoOWVc8kAHrWdpSutzP5Ie8uF4dpFEYz6//WpQrOMraNGP1anJc0S5out2mi2U9ndmV3W4YgKh43Hjp1yPSqyTXmuG81SNpEkhcwRxou0KgHIfPXNVLaWSK+uTqRjnecnaIiRgAZIx3xUdjr89jb3djbaaZXjYuZQdqsCc5PvUe3k9JaJdjodFJuUFq/MxP+E4Np4hm+3RILrZ5dtDG3y9eTnsfrS+FZtf1W3u7zSbiNfOkYfvSSgPTCkdau6dpNjq6yajd29rK8vBymCmTgjPfHSpPD2qWumy3ui2KNEpmbY6Rny1U4yA3rWibaU6sropqMbqnHX+tjL8NaLqmq64TNcH7RZSbZp25TeQcCP6j2rornQ0vtYh0K8MP2WKP7Qs0K4cEnoPXn1q/pdgnhq8W1XNw1+5kRzxtcj+WKh8W2C6Mj6hZXbvqUhWMK/Kcnpj0680lgaUoOSjqRLETdTlvZNaHL+JbrXtK1F57UXF3NbxCJrj78ZQn5QV/hx7VI0l86xX+utJM8Kl1eAlVBI6D1rQayvGmhs2uQ0l4wE7HA4AJ+X3wD1zUXjCwlsdOtbWO+nvLSVtpSUhSCpyST/SodJQg5dOprz3mo9TP07Ttehs4J7e0QbphO7u5Zmz/GfTiursNYuLrV1g02zaG9jhxPcOv7k57g9zUFn4ktJNNX+yTJczbSgCqSDxjb6Z9ai0HVbzQrWJNct0geY4RUl85gDyQ3pWfIqcUqT917ilKU78y1Wx2OjK1hHONUuRLNuJjmcgbt3WuK8ZxrrCRNa2WHMhEm9sFmXpjnBq/qN5NqLy3SW5WxX5XUg7m4657ZHtWD4nsW8R2VjaaKTG5IdvmI2gevqamUJySjFXXQmlFRlzt2b/AAIby3tTYSXUErPdlN7zFiADjkAdh7Vk3HjW4nNk8a27xRrulQgnHY49/atG48My2xj0t4pJ5pVzGyEhcjqWHpWDrmjp4YmmHiCLcbj/AI95rdNoAxwuOxz61LjWgrpWsdCdOXW5f1zUX8YWyWlgJreGAiR4V6v0K89hxWBOP7Sv7aCC13su/m4U4LgYIJHoa3rfTdUjthfWkrrLNF80KAISADjB7EdTVK80oabNplzo961zfuQVUsGDlu2O1RJVJzvMuLhFWjoXPA1hqb+K/Jl+zzT2sW9X2kRgnvt7kV13inVNR0SVG1Zo7sSo3lhE4LDnkVQ0rTtTufEqPHLBp8oXzMgbjKe6+mKtazcahLrtrb6iI4hGr5uoeUII7A8hvauqfuUFzR0uc3/L610cXYW83my3V1bravftteW4Hy2393HtXS6V4r0vRNHnsL+4nla3cp56xE/aQOQynpg1n3Or219on2S1hW4lw0Z2jOcHv78cVPLqmnRGDT59Nntm8jcI2jznjnFVCcYR5oOysOpTdT3ZL8UZd8yTQJrMkrWl5NOZNxHSI9B+VW/A0MUvitL+3+zR3FsS/lXKly4PRlJqHQ7+bULFoY9Kfy4SVjM5wJM8A88YHcitbw9ciw1CDTr/AE1HuUjKfKwkEmDkAHrgZqFD3lO9+xbleLidd4y8Tvd6xa6fMqpapEZS6EPmTsCP7vtXGX9y0Wtwi2aOON4yWVjsTcOcY6AE81b1MQ6ZeWVxLY3EaSS7HTG/PGRyOa0byeDUr6EPpLZ2nDSx5jJ/zk1L5rNt6mUIKPKorRnJz+Lr2+spoLcW5uGDpPJs3ovsPr1qp4RsrrVNP2QXbxyR5YQbuAQepJ9e4rbms7SJpxZ26rG5bcsabVVgMDd/n6Vm2tpdaNaqulyBvOIZ5FTJRu4/+vXNNONRauR0Ra5Hyqxf8T+MDZ2C6fdWTx3qFfMAJ28H7waq9lrLarEbXRlkm2MH3znIUsME4/Oty18MBbC+1fXn+2zyIeHxhVx6/wBKz9M0uWxt9PfSRGt4V3F5FO11PY47DiuutTqUp++733sY06lOcGo9DsPh5Ymx+Keno9zJcynQ7zc79f8AX2n4dz0qe+axbxT47iu2/eDUopFQEbmAsLTgflWT8KTdn4todRYNdf2Pe7yv3R+/tMBfaqvim1sx8Q/GF9dX4tpI9QhCpj74Fjanr+NbS92j7iPPUebEtSf9WMeLx9Nfan/Y1xbhtLlIiCqPnjycbs1or8PF8PT3WqTXsccSA4VmxgHvn+lYmuPofha5s9TtrIXl9O3mJ5j/ACKM9cDqfrXa+KooPE/hi1eymYzXOJBEG49wa5INaqT9D0JtxklDRMlCW+q6C0mrRi+tbcZjw3U/Ws7S7p9fMthHCLWCOIiOJFOUA9T2BqHwZ9i8L6TPbaxLJOJn2LEB8oPcitzXtLNrC+o6bdvbpIyyS+uMcAY6inrPVPVfkZ3jGTh+JSXRLHQWD6jcGOWdSpSPn8fYe1YOo3mneGdXMF3dm5PlgqsC52g+vYGtW+0P+3Lm2vJ9USG0OFQMSCAO3v8AX3rO+IfhzStOu1vppZ2hmCjESBuRxnOaJJ8r5Ei4NOSjJlqTWxql1ELURXFtIBh9mCvsff8A/XW7od01/aahpunlhKgJWQDBz6Cqfgiw0vRrF7zQxLcrcYV2mX7uOwFdPrOpWeix28xiWOWQF22L2/ClSg4vmlLUyqTu+SKOGuNEe+Ek+oXDW723zneCxI6fzqzYWFvrtki2M8txND/DMNj8ensa2IYhqF/5qSM9rcoVYAjgZ/nWj4S8GW2j6096k0jnGFB6c9frThS5pXtoFSuoR1dmjU0/QrS/0eO11W1VlVQNprQ1T7PpOk5iVEijGxQBkAVbu3ZbeVo8b1UlR7/SuN1vxTaaXp0cOuESPcHy9gHJz1/Ku2S5Kbdzz4c9Wa33PNda0vQdc1d7qQ3Imd8uiHgmu4ubzRLW3ttP3+Q8MKokbrnaQOATXMeHfEGhQeLkEGmSEEiJJi2cZOM7aveK/C02oeISthPDKN/7yNXXeB+fQV58eZx5otO560+WU1GeiWpj6r5WpabNZ6teLZwq26JVi+Xf2IA68V1/w306007RY3t9RtrpHfGRxz6HPOawfFHhx7mxtlsopHaJBG4H86par4Zm8NeFLVrWKeW4mud8yjJ2ZHGAP50o0p0nzWvYJShUgoqW4291DX7X4jSxt9qFvJL5fRim0+n+NY9t4Uni8UTb7hB5L+ZIFcMdv+Ndrp8+r2dtp8ty8p8uMk7jzkngH14rl7vwjfQ+ITP9sX7HcuZmbfhlz/DSqRfKmlr5mkJrWN0dR4OvtEbxFLc/b90p+XbtwrH616w8YlAaNwoOCa+abbQ7m71mO2s0mtdjbvm6Sc/pXrHiyLURpFm9vceRAgBlbB3eg4/Ct8PUmqeqOPFUYzqK0ldmz421eXSraEW5+RzghR/OsPSNVtvFkH2HUIfJvYlYxyJyMenPrUS6z58cVneIJX45fGcf571V8e6xL4X0+zj0PT1S4uQTJMVyUXvS9o7ubfyFGiklTt7z6lbSr6z0rW5dM8nd5r4beoyy1qw+FrTStRlujMsdrIS5J42r35ridG1y4MMl5dab5l1Dj96ynIB60alrkviPRdQ01ZDI0kZaPJ24YHkH2rL20be8tTplSne6dibxJa+G9Kv3vtJu/Nn2BhCp3An1BrrNKlGueFpbrVZCBGD930x2Fcd8LfDulQOYtXeGe93FkRZNwiXHOcdzXoWpWQt9MS30ODKxuWx2GfbuK3p0WouemqMq01Fqn1Mr4U6dZRXd3JaJM8brteWTgH6D3r05dOtdgDW0RA6ZUHFfPtr4z1fSLmNJ90QDEiJVCqoz6V7n4O1h9c0KG8mj2O/X3PqKvDVVNWXQ5sdSnB+06MuXtpG0GFUKB2HAqjLLDbxiQv8AuicFumK0nnieYxBwT3Ga82+LENxPBb2WmvPFcSnafLzjb3P1rpdRxWhyUaftJcsjb1rxDaWMRmLDy+gbPU+grPutSgnijP2iOEXK4EDHAfjtXlxtNQmdLa7ikFlp8e5g+RuI9RXQpNB4ttYLdmW1NscI4GAuBXP9ac1Zbs9L6pGD0OUuZ/EWieI3je4uHsg+fJ83cjJnn8MV6BqfiEvpu7T4ZFMUYb04Hv6VUtdHs0hAnuDdyREeT5TZ3L3zV7VZZr+yksUhSG3ddglGBtHvUQco03G5rPkclodr8CpmuPhrZzOMNJe6g5+pvZzRS/AuD7L8NrO33K/lX2oR7lOQ2L2cZFFd62PDn8Tsddrei6Vr1qtrrmmWOpWyOJFivLdJkVwCAwDAjOCRn3NYv/CuPA//AEJvhv8A8FcH/wATRRTJD/hXHgf/AKE3w3/4K4P/AImj/hXHgf8A6E3w3/4K4P8A4miigA/4Vx4H/wChN8N/+CuD/wCJo/4Vx4H/AOhN8N/+CuD/AOJoooAP+FceB/8AoTfDf/grg/8AiaP+FceB/wDoTfDf/grg/wDiaKKAD/hXHgf/AKE3w3/4K4P/AImj/hXHgf8A6E3w3/4K4P8A4miigA/4Vx4H/wChN8N/+CuD/wCJo/4Vx4H/AOhN8N/+CuD/AOJoooAP+FceB/8AoTfDf/grg/8AiaP+FceB/wDoTfDf/grg/wDiaKKAD/hXHgf/AKE3w3/4K4P/AImj/hXHgf8A6E3w3/4K4P8A4miigA/4Vx4H/wChN8N/+CuD/wCJo/4Vx4H/AOhN8N/+CuD/AOJoooAP+FceB/8AoTfDf/grg/8AiaP+FceB/wDoTfDf/grg/wDiaKKAD/hXHgf/AKE3w3/4K4P/AImj/hXHgf8A6E3w3/4K4P8A4miigA/4Vx4H/wChN8N/+CuD/wCJo/4Vx4H/AOhN8N/+CuD/AOJoooAP+FceB/8AoTfDf/grg/8AiaP+FceB/wDoTfDf/grg/wDiaKKAD/hXHgf/AKE3w3/4K4P/AImj/hXHgf8A6E3w3/4K4P8A4miigA/4Vx4H/wChN8N/+CuD/wCJo/4Vx4H/AOhN8N/+CuD/AOJoooAP+FceB/8AoTfDf/grg/8AiaP+FceB/wDoTfDf/grg/wDiaKKAD/hXHgf/AKE3w3/4K4P/AImj/hXHgf8A6E3w3/4K4P8A4miigA/4Vx4H/wChN8N/+CuD/wCJo/4Vx4H/AOhN8N/+CuD/AOJoooA0NE8J+HNBu3utD0DSNNuXQxtLZ2UcLshIJUlVBxkA49hUOqeCvCur38t9qvhrRL69lx5lxc2EUsj4AAyzKScAAfQCiigCr/wrjwP/ANCb4b/8FcH/AMTR/wAK48D/APQm+G//AAVwf/E0UUAH/CuPA/8A0Jvhv/wVwf8AxNH/AArjwP8A9Cb4b/8ABXB/8TRRQAf8K48D/wDQm+G//BXB/wDE0f8ACuPA/wD0Jvhv/wAFcH/xNFFAB/wrjwP/ANCb4b/8FcH/AMTR/wAK48D/APQm+G//AAVwf/E0UUAH/CuPA/8A0Jvhv/wVwf8AxNH/AArjwP8A9Cb4b/8ABXB/8TRRQAf8K48D/wDQm+G//BXB/wDE0f8ACuPA/wD0Jvhv/wAFcH/xNFFAB/wrjwP/ANCb4b/8FcH/AMTR/wAK48D/APQm+G//AAVwf/E0UUAH/CuPA/8A0Jvhv/wVwf8AxNH/AArjwP8A9Cb4b/8ABXB/8TRRQAf8K48D/wDQm+G//BXB/wDE0f8ACuPA/wD0Jvhv/wAFcH/xNFFAB/wrjwP/ANCb4b/8FcH/AMTR/wAK48D/APQm+G//AAVwf/E0UUAH/CuPA/8A0Jvhv/wVwf8AxNH/AArjwP8A9Cb4b/8ABXB/8TRRQAf8K48D/wDQm+G//BXB/wDE0f8ACuPA/wD0Jvhv/wAFcH/xNFFAB/wrjwP/ANCb4b/8FcH/AMTR/wAK48D/APQm+G//AAVwf/E0UUAH/CuPA/8A0Jvhv/wVwf8AxNH/AArjwP8A9Cb4b/8ABXB/8TRRQAf8K48D/wDQm+G//BXB/wDE0f8ACuPA/wD0Jvhv/wAFcH/xNFFAB/wrjwP/ANCb4b/8FcH/AMTR/wAK48D/APQm+G//AAVwf/E0UUAH/CuPA/8A0Jvhv/wVwf8AxNH/AArjwP8A9Cb4b/8ABXB/8TRRQB0Gl6bY6RYRWOlWVtY2UWfLt7aJYo0ySThVAAyST9SaKKKAP//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Immunostains of MIB-1 (A), Bcl-2 (B), CD10 (C), and Bcl-6 (D) in a case of classic Burkitt lymphoma. Note that all cells are proliferating as defined by positive MIB-1 staining, except the phagocytic histiocytes in the section. CD10 is strongly expressed by the malignant cells, and Bcl-2 is negative. Note several small, reactive lymphocytes in the section staining positively for Bcl-2 that serve as an internal control. Bcl-6 staining (D) shows strong nuclear expression.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Non-Hodgkin Lymphomas, 2nd ed, Armitage JO, Mauch PM, Harris NL, et al. (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2010. Copyright &copy; 2010 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_0_37897=[""].join("\n");
var outline_f37_0_37897=null;
var title_f37_0_37898="Atypical pneumothorax CT";
var content_f37_0_37898=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F59597%7EPULM%2F71341%7EPULM%2F58631%7EPULM%2F70959&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F59597%7EPULM%2F71341%7EPULM%2F58631%7EPULM%2F70959&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 541px\">",
"   <div class=\"ttl\">",
"    Atypical pneumothorax",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 521px; height: 267px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chronic atypical pneumothorax in patient with known rheumatoid arthritis, bibasilar pulmonary fibrosis, and left pleural effusion. Chest radiograph (left panel) shows right infero-lateral collection of intrapleural gas with an atypical concave pleural edge toward the chest wall and the costophrenic sulcus. CT scan (right panel) shows right basilar hydropneumothorax and the collapsed right lower lung with a thickened visceral pleura.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1088px;\">",
"  <div class=\"figure\" style=\"width: 518px\">",
"   <div class=\"ttl\">",
"    Chest radiograph of an atypical pneumothorax",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 498px; height: 264px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left inferolateral atypical pneumothorax in patient with emphysema and pleural adhesions. Left panel: Chest radiograph shows left basilar collection of pleural gas with concave visceral pleural edge toward the chest wall. At first glance, this resembles a bulla. Right panel: After drainage of the pneumothorax, no evidence of a bulla is seen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    CT scan of a loculated pneumothorax in a patient with AIDS",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan shows multiple pockets of loculated gas in the right hemithorax due to multiple adhesions from previous recurring bouts of pneumothorax. A small loculated effusion is seen in the right major fissure and simulates a solitary pulmonary nodule.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    CT scan of a trapped lung hematoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 326px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chronic left pneumothorax in patient post CABG due to trapped lung. CT scan shows left pneumothorax with chest tube in place, filiform posterior adhesions, and a thick visceral pleura encasing the collapsed left lung.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_0_37898=[""].join("\n");
var outline_f37_0_37898=null;
var title_f37_0_37899="Noninfectious causes of arthritis in children";
var content_f37_0_37899=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F57993&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F57993&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Noninfectious causes of arthritis/arthralgia in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Noninfectious arthritis",
"       </td>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemarthrosis",
"       </td>",
"       <td>",
"        May be the first presentation of bleeding disorder",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inflammatory bowel disease",
"       </td>",
"       <td>",
"        Extra-articular manifestations include abdominal pain, diarrhea, growth failure, weight loss, rectal bleeding, perianal skin tags, and dermatologic findings (eg, erythema nodosum, pyoderma gangrenosum)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Juvenile idiopathic arthritis",
"       </td>",
"       <td>",
"        Joints are warm and markedly swollen, but not especially painful (patient remains ambulatory); the hip is rarely the initial joint; gradual onset of symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Psoriatic arthritis",
"       </td>",
"       <td>",
"        Positive family history, nail pitting, psoriatic rash; painful tendon or ligament insertions (enthesitis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kawasaki disease",
"       </td>",
"       <td>",
"        Fever; conjunctivitis; erythema of the lips and oral mucosa; rash; extremity changes; lymphadenopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Serum sickness",
"       </td>",
"       <td>",
"        Rash (usually urticarial); fever; lymphadenopathy; polyarthralgia or polyarthritis, beginning one to two weeks after exposure to the inciting agent; usually involves the metacarpophalangeal joints, knees, wrists, ankles, and shoulders; swelling and erythema are uncommon",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Henoch-Sch&ouml;nlein purpura",
"       </td>",
"       <td>",
"        Palpable purpura; arthritis/arthralgia; abdominal pain; renal disease",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_0_37899=[""].join("\n");
var outline_f37_0_37899=null;
var title_f37_0_37900="Methacholine preparation";
var content_f37_0_37900=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F51312&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F51312&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Methacholine challenge dilution schedule",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td colspan=\"4\">",
"        Schedule for making dilutions from a 100 mg vial of methacholine chloride for the 2-minute tidal breathing protocol.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Take",
"       </td>",
"       <td class=\"subtitle1\">",
"        Volume NaCl to add (0.9 percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Obtain dilution",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dilution, number",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        100 mg in vial",
"       </td>",
"       <td>",
"        6.25 mL",
"       </td>",
"       <td>",
"        16 mg/mL",
"       </td>",
"       <td>",
"        10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3 mL of dilution 10",
"       </td>",
"       <td>",
"        3 mL",
"       </td>",
"       <td>",
"        8 mg/mL",
"       </td>",
"       <td>",
"        9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3 mL of dilution 9",
"       </td>",
"       <td>",
"        3 mL",
"       </td>",
"       <td>",
"        4 mg/mL",
"       </td>",
"       <td>",
"        8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3 mL of dilution 8",
"       </td>",
"       <td>",
"        3 mL",
"       </td>",
"       <td>",
"        2 mg/mL",
"       </td>",
"       <td>",
"        7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3 mL of dilution 7",
"       </td>",
"       <td>",
"        3 mL",
"       </td>",
"       <td>",
"        1 mg/mL",
"       </td>",
"       <td>",
"        6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3 mL of dilution 6",
"       </td>",
"       <td>",
"        3 mL",
"       </td>",
"       <td>",
"        0.5 mg/mL",
"       </td>",
"       <td>",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3 mL of dilution 5",
"       </td>",
"       <td>",
"        3 mL",
"       </td>",
"       <td>",
"        0.25 mg/mL",
"       </td>",
"       <td>",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3 mL of dilution 4",
"       </td>",
"       <td>",
"        3 mL",
"       </td>",
"       <td>",
"        0.12 5 mg/mL",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3 mL of dilution 3",
"       </td>",
"       <td>",
"        3 mL",
"       </td>",
"       <td>",
"        0.0625 mg/mL",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3 mL of dilution 2",
"       </td>",
"       <td>",
"        3 mL",
"       </td>",
"       <td>",
"        0.031 mg/mL",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        Start with the most dilute solution (#1) and administer progressively more concentrated dilutions via nebulizer in 2 minute increments; each dose is followed by reassessment of spirometry. Progress to the next more concentrated dose only when there is no significant decrease in forced expiratory volume in 1 second (FEV1) and the patient is asymptomatic.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        Actual starting dose may vary depending on patient conditions. Some laboratories may choose to skip some doses to shorten total duration of testing. This is only done when the patient is not showing any symptoms or decrement in lung function.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Crapo, RO, Casaburi, R, Coates, AL, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000; 161:309.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_0_37900=[""].join("\n");
var outline_f37_0_37900=null;
var title_f37_0_37901="Gated PET perfusion protocol";
var content_f37_0_37901=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F80718&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F80718&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 474px\">",
"   <div class=\"ttl\">",
"    Rest and stress positron emission tomography (PET) perfusion protocol (&lt;30 minutes)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 454px; height: 201px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The stress agent is dipyridamole and the perfusion tracer is Rubidium-82 (Rb-82). A non-contrast computed tomography (CT) transmission scan of the chest is used for attenuation correction. The first 70-120 seconds of the acquisition are rejected to allow for clearance of the tracer from the blood pool.",
"    <div class=\"footnotes\">",
"     CT: Computed tomography.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Athanasios Kapetanopoulos, MD and Gary V. Heller, MD, PhD, FACC.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_0_37901=[""].join("\n");
var outline_f37_0_37901=null;
var title_f37_0_37902="Contents: Esophageal surgery";
var content_f37_0_37902=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?5/48/5902\">",
"       General Surgery",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Esophageal surgery",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Esophageal surgery",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Achalasia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/26/14759\">",
"           Clinical manifestations and diagnosis of achalasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/35/19001\">",
"           Operative management of achalasia: Laparoscopic and open Heller myotomy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/39/18039\">",
"           Overview of the treatment of achalasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/7/43124\">",
"           Pathophysiology and etiology of achalasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/32/12810\">",
"           Pneumatic dilation and botulinum toxin injection for achalasia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Dysphagia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/38/17000\">",
"           Diagnosis and treatment of oropharyngeal dysphagia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/17/12569\">",
"           Evaluation of dysphagia in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Esophageal cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/10/44202\">",
"           Chemotherapy for locally advanced unresectable and metastatic esophageal and gastric cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/45/7898\">",
"           Diagnosis and staging of esophageal cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/36/27208\">",
"           Endoscopic ultrasound in esophageal carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/31/32250\">",
"           Epidemiology, pathobiology, and clinical manifestations of esophageal cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/25/30106\">",
"           Management of locally advanced unresectable esophageal cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/60/20426\">",
"           Management of superficial esophageal cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/51/39738\">",
"           Multimodality approaches to potentially resectable esophagogastric junction and gastric cardia adenocarcinomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/31/39418\">",
"           Radiation therapy, chemoradiotherapy, neoadjuvant approaches, and postoperative adjuvant therapy for localized cancers of the esophagus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/30/34282\">",
"           Surgical oncologic principles for management of resectable esophageal cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Esophageal perforation",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/58/29606\">",
"           Boerhaave's syndrome: Effort rupture of the esophagus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/29/43481\">",
"           Esophagectomy: Complications and management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/39/34426\">",
"           Initial evaluation and management of blunt thoracic trauma in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/48/32518\">",
"           Management of non-iatrogenic traumatic esophageal perforations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/20/329\">",
"           Surgical management of esophageal perforation",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Esophageal stricture",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/57/10137\">",
"           Complications of endoscopic esophageal stricture dilation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/24/39305\">",
"           Management of benign esophageal strictures",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastric cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/38/11882\">",
"           Adjuvant and neoadjuvant treatment of gastric cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/10/44202\">",
"           Chemotherapy for locally advanced unresectable and metastatic esophageal and gastric cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/36/11850\">",
"           Clinical features, diagnosis, and staging of gastric cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/35/4661\">",
"           Epidemiology of gastric cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/15/33018\">",
"           Invasive gastric cancer: Surgery and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/51/39738\">",
"           Multimodality approaches to potentially resectable esophagogastric junction and gastric cardia adenocarcinomas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/38/618\">",
"           Risk factors for gastric cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hernia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/22/7527\">",
"           Hiatus hernia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/43/19128\">",
"           Paraesophageal hernia: Clinical features and surgical repair",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Obstruction",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/41/6809\">",
"           Expandable stents in the treatment of esophageal obstruction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/22/1386\">",
"           Foreign bodies of the esophagus and gastrointestinal tract in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/47/44793\">",
"           Gastric outlet obstruction in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/54/21353\">",
"           Ingested foreign bodies and food impactions in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Reflux",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/56/15240\">",
"           Chest pain of esophageal origin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?21/41/22168\">",
"           Clinical manifestations and diagnosis of gastroesophageal reflux in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/51/19253\">",
"           Complications of gastroesophageal reflux in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/5/25688\">",
"           Endoscopic therapy for gastroesophageal reflux disease: Sewing and full-thickness plication techniques",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/8/1161\">",
"           Epidemiology, clinical manifestations, and diagnosis of Barrett's esophagus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/56/39816\">",
"           Gastroesophageal reflux and asthma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/10/33960\">",
"           Laryngopharyngeal reflux",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/61/35802\">",
"           Management of Barrett's esophagus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/53/42840\">",
"           Medical management of gastroesophageal reflux disease in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/12/8391\">",
"           Pathogenesis of Barrett's esophagus and its malignant transformation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/38/13928\">",
"           Pathophysiology of reflux esophagitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/57/42905\">",
"           Surgical management of gastroesophageal reflux in adults",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-53E3620B53-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f37_0_37902=[""].join("\n");
var outline_f37_0_37902=null;
var title_f37_0_37903="Algorithm for vascular testing in asymptomatic PAD";
var content_f37_0_37903=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F85752%7ESURG%2F50445&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F85752%7ESURG%2F50445&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Algorithm for vascular testing in asymptomatic PAD",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 307px; height: 251px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Patients with diabetes or end-stage renal disease may have falsely elevated ABIs as a result of arterial calcification. The toe-brachial index may be more accurate.",
"    <div class=\"footnotes\">",
"     ABI: ankle brachial index; PAD: peripheral artery disease.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 574px\">",
"   <div class=\"ttl\">",
"    Algorithm for vascular testing in symptomatic PAD",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 554px; height: 348px; background-image: url(data:image/gif;base64,R0lGODlhKgJcAcQAAP///wAAAIiIiERERLu7uyIiIt3d3ZmZmTMzM2ZmZhEREczMzO7u7lVVVXd3d6qqqu/v75+fnx8fHz8/P8/Pzw8PD19fX39/f9/f37+/v4+Pj09PT29vbwAAAAAAAAAAACH5BAAAAAAALAAAAAAqAlwBAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJikwBjY6PkJGSk5SVlYuYmZpXAV+dm6ChokafXaWjqKmqNKdbrauwsbIir1m1s7i5mrecur6/mLxWwsDFxnmtDAONCgI3AQQ7xMfU1W+tDggiBwPP0TrT1uLjZdgIBiMG0AAEAQwBBY0JjdrtCPAL840GAvQLAPDk0QOw4F6ABiXCkVvI0FUJBgkUBEBwAECCBBYxBnCWoIABdQTa/WuAcN2CAP8S/3TbaNEjSAHaTihsSLNmFF4H3BFQoA7dOgHdAIb8JKCAUAAHjLIz+jMoNAMNJlYkMdOm1atHWjVwhlQBAwADECA8CpTWUBEIND4giBJAg5XRyh4VUTQh1rt4m7Qq2qjAtwfryDodSg+dPn7+BJvt12jqiKp5I0tm1UKuinZCIE/ezFnFNAMK1q7AHERz59OoTTNCzbo1C9VLYLuebVV2Etu0cy/EnVW379SefgvfzJvU8ON5LSlfzrw58ufQ7UafTl1a9evYZxTPzt339u7gXX8PT77z+PLoI59Pz/7q+vbwG76PT99E8/v48+vfz7+///8ABuhcfYLMR+APBh4YnP+CpjD4R4IO5gBhhLZQqMWEFg6TIRYYbjhFhx6+AGKIS2BAAS0iUIABiUyYiCIAKrLYBgQBTBBBABFMEAAEMipBo4046shjj2tYAIkFRCph5CNIJqkGBZCc6OQRUD4i5ZRo6NjIBFgioWWNXaZxYyMRhGnEmDiaiUYFAVSgphFsuvmmGRcEcMGcRNR5J55kYBDAinwG4SeggYqRQaFCHIrooowWKOCjkEa6Xy6SVmrppY+0NiIfm87RKTKaUvNpHKPeUaoop9qRahurehrqMa2uESuprxozaxq3XlNrEKQ99s0KA3A1Q7BS5HpGrL2ahYaxiSQTVSMOlEDsOsmiUC3/NNWaQKxMv6KwrQzfSkgpDIBhxI5C2ZpwbbdHWIYDs4i0ggACXxEQk33sXtZKYMAKC66/TsBLRlUDDODVuTysu4S7z+x60ldUJaWSAPoEkBMABhjUgDr0MLAuZnxNZNBaYcmTEAEFNYIQYyiVHABGGZsc8ryNkOxMPPicm+9r47qgzgIFVIRzASqJMIADRUlEL2YxH8TxRB7vG82z9LrliL8HSLRR0WAhjTPNAZBsUAJPk21QtDOPDIADjvzz2K4EKEXVWNNGg9lbJqjzwMedFPURS0UPgNBJbi9270m/FnwuVDArsIDf6nDUTbgFRNvOzisIPEYrT6NDAkwAlEVa/089FcUAAwUIcHdQJOi9LkxfISCAADyB5e/R6QTwNz8uAT754CjJRRJBChAAue8AiSYdcCOc5LmvRjtDbSdBN79MY3yHPpj2ttPimFBQSZUUCcT2hHNjcjVlO0SOmEsZLjOdr3uvwTqAkVwDJIBZ9SIscL3F66rYyy4SPRLYKwAD+Ef97re9smzLYnLh3wAOkL64dIMvCYDYi5g3gnmhw15zmdZaVjeCBGjjHQfIXgW5RyzAPG8uoSsA4kZQPt01wH3cU0ywchI7jFxOBpoTA7rcYTQHtANicXMc90CTwk7gTQQmBAAKX1c1uhTgdKk7wQ2XosQVOtAZLgSdW4BnvP8Gsg4ACvheEAnBuespIFqBIZY+Lta0BuwkIE08GcjMCJarnYxlFWGZ/5xBOoPozouTE0DTiKYzIPaMBQkYS1cYcA+lICAoLEMI0zR2x3jkkSpTc8QBKNmX2/XFbZekCx//54wFSMRs0MphUxigtSpu8DRrXNYjb0DLbzDsB6j7ngl6yYJw9SCXBRLVLm2QjRH8kgeOOOMJmllMgEFzV8BAphe0OTBs/oKbXACnEL3pC3FeCFbk1IU5K1QDflVGmnVY5x7kuaBZzIQBzwoAHDGHgi9Ws4DdZA09t7lMFcyrXtpwJwue6S1rbi6dBV2FQh52sqfR62IZCV00uyfIih3/ICeNIRZjEPCPiTSGnRzMnB9HoxmG6hJ+JeicAeUGPRHoDaMXmeEXZ1iCKG4rWISzyEqcURcOQTQhFQGMBq010GvCtAXOO5n/RInTBIyPhQK4Kl20ZpSfZlUpcTuKVjUkUBdYLHQKwNjYutKIkNHUZRgB6ctYuFZcRRQFHmRHQgkQxSnqLmMJCCregBoYva2tq9GynWDhghSaVqGppmqdI14IEHpMrXH+SyzCpAW8wvHQgd1oB2UDas8XGMCN++zkWZehgLRYhB6J1GgjpgoPo4CUG0RNzDrG+tijRsyVa5FfCu+RwGw98KOG5Edse2LXpxYDsqoya1Idt0UT3PCI/9ICo+4qB4AwLld3zS2trXz7mKn4LbnXkyEp3+pHxsRDud1j7kvF+1zy7sCYkXVuNu2rA/xGV7/f5K9E7wpgzkD3nAVWp4BVceCbYOrBEAbQgkvDz/Cyp8F4CYf8NqJQG3SYDRhGFaJmki4JVXi+Fx7xC3oFjZQdRBnMAEAWC2kyUPYRgQxwcQNgHIC0hiHEoQCyeyS7D3WVAhpiPJcGZ2xDzILSdJSc3b2w+1D4CLk2Kz4yAcJHkbX1+GaE3O4j1MhXc1GMyxVhWzPGaWUVu4DFvyoqW057vyajAMlXRJ2w5BxVMFx5F25uAZwB2Q6TFfoeH0muja83AAYQun1sbv/Pn2sy6Zukx0UASRGh1FRpKHTaED+6UY52hKdPB4w9S3JEk+Zkar2wp0qOuNKbWr0a9nyJS3zCkH9T4NIY9LoItCYEmsqUa7O2BaMw2HU/Y2uDX69ALs6WCXziVCiF1BYpmlH2CaL9zmbDMwbBJoSeqm1W2mW1E01DWwHiYUuj1ZVqDJArA7tn0rM2zZ1Mhm/c2to0BvZD3mUTnUTSCJa6Lu/SfyJ37oocsX70Y4zEM55HaPnRvoAltIesmuxG8NnYsqQuDYgJvsMM3zWLYIugeZxfSNBxVaLRGVlTBsZHG25CKCpQ1h4lzmQ8lQlGUJg1NIAArZpcf+7WKPwbOcb/DjkA+cp4zHI5QNEx2XTwAuS0JLdPoyQtXWw7kYw/z+7S+WFL7nqX3tEY3/B4arQ6l1xY1XW5jKMVxpiUZc20U0bWD7518uRcBPFQayzDTr6s55OCfWE62htLkHjEo1uHVvwdN3Jv+Mr2va58mcB7XJGgaz0QEQ696EcvKXSaoc8ofRB6at6bMRSaJQ4B/epNP17Zl4f1xqG96m+v+/3a3u+9D/Dvw4N7YLuAfSorXCaKf8stuEvbOQTiiQEqoumX4AEylMFOaB58b50DYw0Q5iKYn+nPnVWj4mfC8x36uW+3wJ3PDNevP6yCAiiPbeZ1xMonG/231X4FqGdTjrA0/ybVRRsVLAPgEWtVFOz2FfB2LMlkfjHhSVKwfs/mfq9hfdCHLzAgdSNAS4oTQ0YzFoHxDpRFfplBZFa3DZ9wPY7hOuuQPyexFg70fSjnOH5DcbADABtnBuS3F+tGAA+wDBUBbxaVYxoDEoyHgApYYyMwNCVlEIHUDUlBACJ1SiWQNFBzORYDhbKFEvU2ha91UvI3OWt1b6EENbTzEQRXQpqVNcxVVD3ILz3of/XFAqgXNLQFQJ9wEVflT08nSj83dBA4fDFEMeEHQRonLHqTZEo4PmGBDjeofE8IR0RlFEAhdegAVErkABszWVCWOu0AMJXDdh+HiWfkU/4CWovzRP9ItohrMy8AM0E0FC1XWErKAkUAg4Kl4QLz4jZp1Fd8CEWB1RaDxRVxl0NBs4MW5gdAqA5pZTFDt4cHgGaP2FVcIVwfWDEakXaYKBGisUOP4Fj4oz+fgHwvM1ZHxz20Y3FlGF/bNRXQQIgydi80NBVPAw8iyBZrwS8JsIvddwLo2AALoFqfRED6UADMVnlhd3iFCAhA6BbSQ0G2JIyOURerhY0nh0McR0SutY4wkRPRwImU6EzdwESkwUM8WIy/ApJVtxYOoJEmCY9QAXbt5gAJCDAJkFhiREsPUFQzRIcA+X9CkIx68INZSFNndXgGCUiyhQAyWXnpYBCM5JLYhlv/X8iRmbRZi1Rns2WV6SWTLhd0QGNSaQhBV3QS3+OBMiYskcQyLMF/Jsh35SQE1/N9fYCUnWF/NPBLvAgEfwmYEcgZ2FeSLLB9n3eHROmMs7eYwgeRjamYksmYvOeYdWmI3RGYPkB6nNmZkTCYxOcgmrlNnlmapnmajSCafedUqxl7rfkur+masdlOs5l6telIt0lWuYmbu/khvcmbv+lpwQkDo0keFCABGkAjEKABEiBrwyltz8kEOhInYIJLqHmd2Hma7YEmZJJS9FGcdiABjiABZXUg4FkHddIIe4JLCnKedEAjjTAk7Gme8WEkqzafBOKedJABAXBz+Fkf+kkH//f5n98ZncvXngYaDAi6G9nZoKN5nMm5I8zpnOEBoco5oeJQnMU5nW1SnbbWoWyCa9agoYnAnWmynZBAbCPaLIogno1AnvHhogEAoxnKoomQnnZCHzi6nisaL4oAn6QWH0Aqnz16COdpnwSCpOSQSwYQD+yHIIvAn/4JH1K6GyYgV1nUPT1AGiUmAjj5AluJFlZXMQiwM+45oPXJEK/whyb3A11aAlsBpkbRpM6wEz1IQK9VkgGaoKBSAloFOsTihSxjhiaTbgShMUOzSSrTkfvAaFHTDhepFFsUSVeFp26hWXbIp/l5pXKDGZTjADPIQjO3dsWTZFzqRN8mUnkmO/+jmJTEM0qhQUyW6pdU4KC2milGeqv6YQhrKjeAKgDoaFVK4U/m03PVGBUUcao8dwJyZGbmaAIsE1ePgBGW2gCY2nxPsKejCVmB2atb1Xnn1kOLRZNrxy9FgV0kpC2XiEWq8wpy1jUicER4Og/c55uAZqRq0K1Xqn89p0hUSa198V2JNniitF6KehCFZzSN0GjZImc/84QUM4CGOSva6qPNiJk0YJQoJpz3yqv56rE2cJej9ZCW1rGFwK0gi6/2mgVZVSwWu7EYC5ocSwLvIDePoEkWt1AdA6cL+xVNk1RiYUIjWxkoABr54kbssq3DpI+04Ag4y7TOtLMk8CyNZlP/xVO0VystzJC0Kdu1M+tMCJC1ZyUSmyWQEcEW/4AAmGo68Do8SrV0ssE218oY/ERNmcpG0Bq23zC2bVEtQaW2n3NF8Eq329YIdWuP5Ye3L1uyJJA6eHpW2FcvtQAT3BU6dndGMfkVoBMaZvEAYhGJNJtea3EPUaE8IsA+GWRjKGCUSlsCjmsukCu41SJG7pK5lltT3JICrOu1iuuyBqQTB3Oz/5AtFDiT+2hTBtFac3F+LcuzD4A6XmFIptu4p/BhOeERdCmzR7QTXyG8ZSt379o0ypuLOOMY1gsPJ8iruoqatdpTYwYQUxFy3wu2lUu77jc8nAtDJyARsRM292CY/6i7VPR3vNgqswJUEecnv7N7uasrSQM8wO+auJJBoh+Yv6CTwBiXAhCRVn8bLcimUVODEG+ru2EDvaRUknKbu9imVujgAD52t4NwCj5JFwkVvxlMAh0sVObXkvwUGHT0fS6cvXdBwdvwwj/zCCRVaI61YXSxsxjlePgohSvAYwgwum2RhYVrMheDT33BtSpbxLlzEhKrxFm4s1wDxU3shFGrxZ3AxfDgxZNBxAr6xSSrHjZ6oHTsgwZ2x3PMu6Q1wXw8fourx8QRyIrQujCbYYa8yDEbaXdhoRLanCe7CYhcx1jBoSHqx4Mcwx8bGSaqojG8vg4aL6J8H5MhozRqHv8Lyh47Wp6b2h5D6soAWp8BgKaFTJ9U2p8Tlh17Kge2fMuvrKl5HB+9HJzFTAfHfEylLHqLAMnLKcnp4cwYuqScvAiY7KHpcc0iOg4o6J6fDB/fbKUyiwioTB/lrKbVvAitHB/rLM6NTAixLKSOQKTcnM6LoKT0gc/ubJcIRAMbKC6ZUKX1IdDobAOvt3Im8AAH48/+8qa0qQm/jGqUdgOiFYvbhoEtEC4O/T7CHCG2UdHD029Pg3g504UTk4AepaWA1xeG2jAd7dEUHU2SiFll4Ur/4IkAQTd4CUXaoNGfQKrW5xlKsMxEbcpyUNSPMs4xIFpwGIjoQ4XjGEJc0Y7/+ujTgGesLo0EyexhroIHelkDFZ0N+IRDNa1ENVVDMCmWSgZxbMfRrVekcNBqX00DFX1xDIlJkBZHXBGWKi1FldTSXH0b9XzUfQqZSj0EW/3QtOLVhz1PQz3Yi51fhv3Ogql+GG2XT4rYXS3Zu0fZUOoCLpalybaKlx0EdXMCymodhM3Ynl0D/0xhxPnYLQAaZiZJNcBtPnDaRlbZkc2CkObamZ2Fpb1ZuA3DnGLawd1fDoUtr5Atm6IQSUZDPWsPPbYAPJZWt9jP+7ZaQEFTgnRHBAdXh6oyVWU7FXOEiYpuZ3Mu92DW77fZ2+BYRhBtGy3Urc3QAYM5zi3bjEqO/1q5qu06kuaoQYRlQWg0XQX3Qmy3ZjGnOKKVZOWt2wK4N59wN4NTPD+UPyIC34w3Au0wuhgBb1xI0i0DrG50eYVTNv3GVhsxNDVYY/k0lJNtEXTjAPLG4s7wLDyxjoGKhSbdPBoDEFK83RWx3UBxMz5+FlnTVkNDFfz9bI6FpxRDGgSkZs6wQ8NadY+AdX4qN/KlO0GHZhEuPdFAjcoqQQfJkfbd215nMgqNNzvIqizBdsFCZTa9NrYtPJiFO/FKFJMzc2vY1xJMmX1uAKjHQ3weQ55zjX3NXQj7Ofb4cWlFcAr9cjTkL45+Fom+34I92wowFgKwFXkmin3oPs5DWP8j0Q1tSH39wy945xWeZ0WiBVj0thYWia5fxxZnkVFmxeG89VpfMXQp+VbOYOVyBbXKOGYHVFx+TpN4akxzbTv2gxTJtez54D6MHizBqr/gJxVHIVqQ4HTazo1CgRnWzulavWIGsXGOSuXmaDJyBFtL4Y7W9N0DB65j55Ss5VrxbjES4UkGq96x5O4bvtoc51jYpzjMuFl0LiyE496QvpFaNOBYle+jLuOdXcRXa3YreEN+U15ggY0q+ZGYg5HREJMHTgJtKo49VO6ncF1E5OSdDte6wnLTKhKoE+Ki1CuCVOeQFq04/EqVl17WXUnEqjukBA8YT+hPiNcBcVpYeOL/I4WNXcntTql/dtPkk3fkVc/cN6ZelSTz6V6jBu8GwSTER8kJQc2ab10NfxZiG4X2hV2ra6/aY0/zbiDXjZ32M+/2HI7Mez/3ubcDxd1Odb+lqvH2gp+X9jz4rLDrhf/4wJYvewStGKj4rD3jGe/4YN3sRDDARNClLoX5nM30m298LYDTYCsULr5uUNO4zuCTKc02s1VHZ4zAWzaAj3p+OE7d2edeIxFjT6H7lU/7YKjGxg1iSB0gjrL8l/LkKlDpRROnXq/oFBe4BBxFYTMCT6TDy8ovMDiLmkW2JHHnnvjxubh0FM492y930KlgL83bUxw2R5M1JQX5QcE/p1s8/10GAoISBAUgFEHCFAfwJsPbAgGxDGRwEMH7AwiIwGDRe6EOulIiAbThdDyfQIZSMarArW/r/YLD4jG5bD6ja+k1u+1+w+PyOb2O7pYbisNCoXjZ9DCcyADQACUUKDAYBDwAOJj87DUUnpgQ7NUQJCAAMOwcgTUkiCIk9C38oBj82HR+hlJZAuwJeILh2e3y9rr6AgcLDxMXA+uOiQyeAhIwDBVoGboANQq85JQUMIwEIDAOBTQYpCBoBo6kTHllFxjpILQK6Dhl/6GXyBJyk3z3qXxBZmwgQYEEDyJMqHBhGYMMgYlC6PAhRTcTK2LMqHEjmYsc4UQ86PEjSUAlT/+iTClRJUsxI1tWfAlzJs2av2zClIlT5M6ePmfq/LkwqFBhRIsiTRrsqNJiTJvWeQp1KtU0UqvyuopxCdeuXr+CDSt2LNmyY7Gi/ag17Zy1FN1Shct2rhy5uQjQDWNX4V6lffMCPiOzhw5aAfFuWmOjzIBrABqj/MszsBnJlC8HNNOjVUPEi60iHgOZpeWBpX+exqx6cADOAGLMmEJYR6NwLgik2PG4iqTXtOeVWMDAnhISBxr3GKJAFW4dD1MTg75TuurAyIr3fjH7VaEWPRx/DnANRS0XD/4MiMcFbypIDQT9GI188QAnChwEoe7Sp/6a/avPxZprsE0TUXh4HVD/QCNLGDDaEwguYYIDAShwjXwCiNJEI62ElNB/vXyYE4Aj2iHgKpjsYeAjiSVYHhAOuvJIe1ss0NoA+O2WoX3jhcgFfyRmBqSQb5j4AjnepIhHAiQ0giAmuZkAIwxMAqfCbE4UdxyGXTQBAHY9PmETBhGYBEAEGIw4ZplnDtmmYFiRxxCYcUBQQQUXBHCBnRCMWOedee7ppqBjzCkMcAqExhdOHHDFAZCMLuHooJMGSWkchcKBAVdokqjpEpxaGiqmaY36xgY6bDDkqSSkGqqrpWIFaxsZ6JDBkLSSYKurotIhJRzSaCerF5/p1ZMEAUjg5rHJ7sprGR2ycw2xeiX6/wWw+RGkha/DVjtsTxoEoIGb4IrbrKVybXtXMrRAW0y6DxLaEwQS8NnmvPWaOylrl5QzSAM6SIvXvxQaQoI7S1JpsCpVsutNcATe+GJuA6SgQCtQLlzYY+E4UUVxO0QDwIYGhLPYwN/42JOubq6c76D7ssLNAazstgnNWxSA32LtOdBAjXhd24MqDYzT2oYvyqAEXiH/kHONj2grw2baOhbyhpU0c8syjt3kstdfZwRzdwd0WfMrTrzAAMIALfZxCS0SAoQo5DXmANrxXSNKY2rTAzfVIrf2tyHXbHjIK0vcXSaRZjHeuOOPm6UX5JNTXnlZYJMkdmwoMMBCwDcrsf+ME44AMGPpAQzd8AvM4LbcFpDpLUDoAJxSY+o1b6gtjvWd0BrRpxOgdS6XVjeRsB5irpZms8T2DIUh00eCxeEU4ATCBlRpfT8N98MZAobVHDvJBmtfggyQ5Z60cYQNYcAC5ZgsRcpEFl/saslzdPwZ3HTLBinDrEV/k6nUZQSIOQOSwQG4cEM21GMU4t1veBHEX9goGC84INAYxqufBbfSQfvRzw7t2sW72LDBlFxrFxn02gqFEkA5PAAg2BJGCRUDwjn0YBuvAZ8bUliiD8akhyRwVgjhMIABLGKGwaihVW4ohxxaj4dt8GFUgPiWNoCif3XR4nQg+IZGvO82DnP/Rw1sE4QRaKIxFLuCN8LxiLW5AHbTasMJ6dADpcEmExRyQRXmoYSKDQw/H+tYIcSjQis+pw018sUcUePFHnpCC0IDwO8MSZ4KeWkR6ZGHgqyxQ0R4Qo5cfJME7Wij6skAkwdYBArw0oOlqQ8IoZOGIX+IyKGcIRsDYAEJ7raAcDRglYO4RQ1ygzBPJOdhtNHlIPKhgn6UDpiZe2QbcsOkuZmgbQpqDSAa5BhaAs0K3YgS1+rixDhspkZEOFoNsFeI2GHrACVz5zFuicsycO4ZW9oCMZvmAhoYMhEGaNIkKwm0beizBtcQaJP6WZIXvgE+j3GAKUbnpFqMR5PfLGQ4/xvxiEiEr5E2LCUOubmkVGY0C+/sghwNgZ8Y0lOhh7Qn8spQNgGUAhkG+BcC+DiAB0hiMeDEZmJuatG4bWKn3qBG/qi5hgQ04AernI16tHnGPdYMqUI9n8HImZ9RVuacIOFmI6SGRp8GCxt5o4LBAlfIcraFpjUlQz6jMULycAMB4AlnMypaA6ghFHp8TQwSsqMRiGKmjgWU60rMwMwOVYkaDkhiYoYKj1Zcj5mV5Whkp4lBDhKQMi3MV2mYOMKkIHaxJBUtYwe4ixgOYgynRUpqWbta67S2IIytLW5vC5jRmgu4PeHtb8WaF+HuCrk4IS4aqEgHkYqhfdi4bA2YNP8/b73BuW0Bqxek+xjq0ua6uQWgSLjrF6emQbsHyYReseEEbuwVu6Fdg3oJwl7H8A6+zZDveMnrhgWRAEedQQMTxTBbDTrVYbrRoyZWSYLs8VNhIhioJk6m0nkolWBQkCZwyIiIYEqCdwZwHWHDdFsF3+asmXwwPSIcnAmP2AUW7qPvpLeJX5Igqh1WxYfhJmISN1K5RGTD0YQQ1QHThbeW/IMqNSlgaeSGD67rGSQQ0F7h6bWVl3CNDRzKsyOnTQEP4N93+0GNIJ9zyRjN5HCe3B3jfLnKV0ZZlgtwUC4Hb4Fx/gE3xoyoMi91v+Ltbz3/y83TqW1sySRj/LyRBYv/xfhFWwJkgL3U4vGRgABHQEG/ekcCKdqyiK5wZWsO3RohEGEBPnSbJAqAi7WpQBpla4ZSe8pqWSLuMWibRzO7pdj9bsbUBkB1EVYdoRm8GnGyTpwNan2AW0s117zrXa/5S+hCkwE71Tj0JgjkHdRRMqpdpvM1FNheSb/SELGMNgMagItAUEFBMnsaUpeSYLyAFJPK+AEpHPoD00FijSdAGRIKcbMSowDg8cGRIKa9bzSfGN8m0DdlKZkAf78A4A4QuPAKXlg8n0jh2GB4AIaz6yRC/Nr2NjRnapTo2BD1cC02xALxBs8jyJM2htM086bhN1BXMQwQAFWaDeZKFbdj/wH/SJynY72NGslYCsCyh83kB2EjgXsGVdABQK1r4vly/ehYTfrSXex0BkCdklK3BNW7bPWZA47Hg8vG26rLbcWpnJFf5KYQOoaiddDOoh1/wcaZZnOWrtWlAIDp73626bHZjpJAfy4YKGCBAFCgI9xKcprNS9u8r7wNAK7lkcwxhe4lZmA74FzaD69WbHW4Ne/LB8+RSgOEFWDycd1CBCZAggk0ZPMB6jznQa/3YBzYFzVyjRj+98AXYEBPSyCT5ido7d4aPyvCSL4IASYa1D8fV5AD7fWLm33tyxUP0a/A9INv/UGb//yhtqdAev9799NX97yAUX1JOV9TMpLn+f+f/FFe+lXe5WXeBeXfQfCf/uFf+ZVUAM4fAZqTAQod0fkWPjmgHTTg7v1fBIKIAIYVBRagG+BYCVSJDjhDCbyfCaWXxjSHblQJDvAGpmFJizmYIVmY2j0YEKDACHwDxAjYA8IfGCgBDNQDx4gMMCWT62BMGRnHEqqgDUphpsmNitEY8+0HCXogkSnArh0ZsNzCn6mWqJHBz8SNJpwHGmKDevzPiMld6EQMEpAbzfBfYAnAyNxd9X3gFxzha9SD1PiOJaTbtM2AzoyHCbhbM7zhcmBNia2ZMGnZAHKhGaZXza2CJUTDrGGfRaDBz40eyEjaDCzBs80TsS0ArDUB2nT/oK7tht00UQb6IZfUA+G0xiHMUBPwTS+xiAnsnDWBzJmFBju5VSxW4meVgbatAtN5XH4wQCbEVifSERpEHtZoQsYRy2g43yEuHrf1G8FdQucYXtxEWuvI3Qj2oRdsBsnUIuDsFCHS4uwwg1U1ng1sY7gBDxBQnEoZ4zF6Yg8ZVjPCGlPF3z+ewTFJDZQ0HQ0ayTzFXoMoDA/ugPMowDhWCZh9z0ilIztQCDOgj9EwIS1iWvX0YumkQAoQAKbJHvwkCoOh1R34IzKKngKEYRjKQJ/RYRka5E+QWT8W4UIsn2nEpCWmAap5w0Zl0g+AkW0RJU4okAvK4np5n1AO5TRa/2BTFt9GkkpVWiVNMVdWQiBYciUlItJXDl9UsoWQnctuoVdPDIAW8mFYotAGKuBYkqUVmaUZTEhwTJcMDcNo9AwCPOVd4t0bFNgu9B862qVi3lJebkEMECQlDY2ObcOIrQgNcY0S0KUaoOVJJCYRLmZdrkEPoA1pAhqYxRAzpmVbhsEB6MEKbAGVNcDulFN68CIVZuHA/MGOQeEOfMwBBCYsECZnxgFkoFgQ5IYA5GY/MAI8oB2HRSTDdGFoimZRksAgLEk9OIFlYgMSRaNYQqVi6IZ2WExWGeJjRJXtNKKq2dmWZdyUiVsiZhU2wGV1do0RSYt8YlJhAQ25KaUjeP8ZfKLhZ8YldW5hG/TA3iiARzpB5IERLoKnRpqBa35hNCYIj83m6+ENICRIKS5btHFdSR6mcREnfvYiOyGVKkaBcTgbq/3cdBpoZ76AMgZLguAU79jDN0XSZhaFYyLCAERmekQj53DnhjJe4kjDzQCcVc3hTv5kGhjnRe0nUg0eLIACUyUciZ3O7VRgjB4oG2xGCuCAdj4DjgBjfcYKa34BrO1AKLZCNjAd3RGOQ7KdjUGYVWWJk36diVqVHokHsKgeD6TD6r0dLyIkjHrpk5LB1JyPdopMksRWk54lVu4fXHmQjKZpopLos3AbjpZmCYDZKhVkV/6lpQYRplaFWlL/iqoChZquJqrGhaZuqgX5aKZqJVqw6suwpUzqpKJupazeavLUaqrO6q8Cq6/iz7DGKqxORa4KirMS6D1R6qsGhOVY67Va67HKpV6OJ2OYanbxaGMtDraSa7lGjra+ChxwwxEpRLQqCrrCa2TAwSodDac5WtOdj4V82jBpjBpVj/zYJkDYaxAWgqTKSbwirGdlm8G8Dn5ARszsAb1RTT7plcSejwPBQCilJ+pA7AHoIZqKa8KK7KmK3rFB2bNJAtUY1YuOhggw7Gis3ti8omq+68ja7MFCUpg9wMlWY77WlQD0LO6QDkhBBkydLHJq6RXd7NLOFRsYHlQdLe7la5ntipJvmI95dhWgjYfM0k64hh7Tgq1TFMM9hgHZRssY9OSlhu3aPh8wNBDIlhnGgkENDWYFse3dHp9X4u3ezpTe8u3fdin9Ae7gTisFOSvhqtzhqoTiIm5/mevjQm7kkkXjUm7lWu7lYm7mau7mcm7neu7ngm7oiu7okm7pmu7pom7qqu7qsm7rAkMIAAA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Patients with diabetes or end-stage renal disesae may have falsely elevated ABIs as a result of arterial calcification. The toe-brachial index may be more accurate.",
"    <div class=\"footnotes\">",
"     ABI: ankle brachial index; PAD: peripheral artery disease; MRA: magnetic resonance angiography; CTA: computed tomographic angiography.",
"     <br/>",
"     * Diagnostic for PAD.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_0_37903=[""].join("\n");
var outline_f37_0_37903=null;
